CA2722619A1 - Pluripotent cells - Google Patents

Pluripotent cells Download PDF

Info

Publication number
CA2722619A1
CA2722619A1 CA2722619A CA2722619A CA2722619A1 CA 2722619 A1 CA2722619 A1 CA 2722619A1 CA 2722619 A CA2722619 A CA 2722619A CA 2722619 A CA2722619 A CA 2722619A CA 2722619 A1 CA2722619 A1 CA 2722619A1
Authority
CA
Canada
Prior art keywords
cells
protein
mrna
homo sapiens
hypoxic conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2722619A
Other languages
French (fr)
Other versions
CA2722619C (en
Inventor
Alireza Rezania
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Priority to CA2948488A priority Critical patent/CA2948488A1/en
Publication of CA2722619A1 publication Critical patent/CA2722619A1/en
Application granted granted Critical
Publication of CA2722619C publication Critical patent/CA2722619C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Abstract

The present invention is directed to pluripotent cells that can be readily expanded in culture on tissue culture substrate that is not pre-treated with protein or an extracellular matrix, and do not require a feeder cell line. The present invention also provides methods to derive the pluripotent cell line from human embryonic stem cells.

Description

PLURIPOTENT CELLS

FIELD OF THE INVENTION

[0001] The present invention is directed to pluripotent stem cells that can be readily expanded in culture on tissue culture polystyrene and do not require a feeder cell line. The present invention also provides methods to derive the pluripotent stem cell line from human embryonic stem cells.

BACKGROUND
[0002] Advances in cell-replacement therapy for Type I diabetes mellitus and a shortage of transplantable islets of Langerhans have focused interest on developing sources of insulin-producing cells, or R cells, appropriate for engraftment. One approach is the generation of functional R cells from pluripotent stem cells, such as, for example, embryonic stem cells.
[0003] In vertebrate embryonic development, a pluripotent cell gives rise to a group of cells comprising three germ layers (ectoderm, mesoderm, and endoderm) in a process known as gastrulation. Tissues such as, for example, thyroid, thymus, pancreas, gut, and liver, will develop from the endoderm, via an intermediate stage. The intermediate stage in this process is the formation of definitive endoderm. Definitive endoderm cells express a number of markers, such as, HNF-3 beta, GATA-4, Mixll, CXCR4 and SOX-17.
[0004] Formation of the pancreas arises from the differentiation of definitive endoderm into pancreatic endoderm. Cells of the pancreatic endoderm express the pancreatic-duodenal homeobox gene, PDX-1. In the absence of PDX-1, the pancreas fails to develop beyond the formation of ventral and dorsal buds. Thus, PDX-1 expression marks a critical step in pancreatic organogenesis. The mature pancreas contains, among other cell types, exocrine tissue and endocrine tissue. Exocrine and endocrine tissues arise from the differentiation of pancreatic endoderm.
[0005] Cells bearing the features of islet cells have reportedly been derived from embryonic cells of the mouse. For example, Lumelsky et al. (Science 292:1389, 2001) report differentiation of mouse embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Soria et al. (Diabetes 49:157, 2000) report that insulin-secreting cells derived from mouse embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.
[0006] In one example, Hori et al. (PNAS 99: 16105, 2002) disclose that treatment of mouse embryonic stem cells with inhibitors of phosphoinositide 3-kinase (LY294002) produced cells that resembled R cells.
[0007] In another example, Blyszczuk et al. (PNAS 100:998, 2003) reports the generation of insulin-producing cells from mouse embryonic stem cells constitutively expressing Pax4.
[0008] Micallef et al. reports that retinoic acid can regulate the commitment of embryonic stem cells to form PDX-1 positive pancreatic endoderm. Retinoic acid is most effective at inducing PDX-1 expression when added to cultures at day 4 of embryonic stem cell differentiation during a period corresponding to the end of gastrulation in the embryo (Diabetes 54:301, 2005).
[0009] Miyazaki et al. reports a mouse embryonic stem cell line over-expressing PDX-1.
Their results show that exogenous PDX-1 expression clearly enhanced the expression of insulin, somatostatin, glucokinase, neurogenin3, P48, Pax6, and HNF6 genes in the resulting differentiated cells (Diabetes 53: 1030, 2004).
[0010] Skoudy et al. reports that activin-A (a member of the TGF(3 superfamily) upregulates the expression of exocrine pancreatic genes (p48 and amylase) and endocrine genes (PDX-1, insulin, and glucagon) in mouse embryonic stem cells. The maximal effect was observed using 1nM activin-A. They also observed that the expression level of insulin and PDX-1 mRNA was not affected by retinoic acid; however, 3nM FGF-7 treatment resulted in an increased level of the transcript for PDX-1 (Biochem.
J. 379:
749, 2004).
[0011] Shiraki et al. studied the effects of growth factors that specifically enhance differentiation of embryonic stem cells into PDX-1 positive cells. They observed that TGF32 reproducibly yielded a higher proportion of PDX-1 positive cells (Genes Cells.
2005 Jun; 10(6): 503-16.).
[0012] Gordon et al. demonstrated the induction of brachyury+/HNF-3 beta+
endoderm cells from mouse embryonic stem cells in the absence of serum and in the presence of activin along with an inhibitor of Wnt signaling (US2006/0003446A1).
[0013] Gordon et al. (PNAS, Vol 103, page 16806, 2006) states "Wnt and TGF-beta/nodal/
activin signaling simultaneously were required for the generation of theanterior primitive streak".
[0014] However, the mouse model of embryonic stem cell development may not exactly mimic the developmental program in higher mammals, such as, for example, humans.
[0015] Thomson et al. isolated embryonic stem cells from human blastocysts (Science 282:114, 1998). Concurrently, Gearhart and coworkers derived human embryonic germ (hEG) cell lines from fetal gonadal tissue (Shamblott et al., Proc. Natl.
Acad. Sci.
USA 95:13726, 1998). Unlike mouse embryonic stem cells, which can be prevented from differentiating simply by culturing with Leukemia Inhibitory Factor (LIF), human embryonic stem cells must be maintained under very special conditions (U.S.
Pat. No.
6,200,806; WO 99/20741; WO 01/51616).
[0016] D'Amour et al. describes the production of enriched cultures of human embryonic stem cell-derived definitive endoderm in the presence of a high concentration of activin and low serum (D'Amour KA et al. 2005). Transplanting these cells under the kidney capsule of mice resulted in differentiation into more mature cells with characteristics of some endodermal organs. Human embryonic stem cell-derived definitive endoderm cells can be further differentiated into PDX-1 positive cells after addition of FGF-10 (US 2005/0266554A1).
[0017] D'Amour et al. (Nature Biotechnology - 24, 1392 - 1401 (2006)) states "We have developed a differentiation process that converts human embryonic stem (hES) cells to endocrine cells capable of synthesizing the pancreatic hormones insulin, glucagon, somatostatin, pancreatic polypeptide and ghrelin. This process mimics in vivo pancreatic organogenesis by directing cells through stages resembling definitive endoderm, gut-tube endoderm, pancreatic endoderm and endocrine precursor en route to cells that express endocrine hormones".
[0018] In another example, Fisk et al. reports a system for producing pancreatic islet cells from human embryonic stem cells (US2006/0040387A1). In this case, the differentiation pathway was divided into three stages. Human embryonic stem cells were first differentiated to endoderm using a combination of n-butyrate and activin-A.
The cells were then cultured with TGFB antagonists such as Noggin in combination with EGF or betacellulin to generate PDX-1 positive cells. The terminal differentiation was induced by nicotinamide.
[0019] In one example, Benvenistry et al. states: "We conclude that over-expression of PDX-1 enhanced expression of pancreatic enriched genes, induction of insulin expression may require additional signals that are only present in vivo" (Benvenistry et al, Stem Cells 2006; 24:1923-1930).
[0020] Current methods to culture human embryonic stem cells requires the use of either extracellular matrix proteins or a fibroblast feeder layer, or the addition of exogenous growth factors, such as, for example, bFGF.
[0021] In one example, Cheon et al (BioReprod DOI: 10. 1095/biolreprod.
105.046870, October 19, 2005) disclose a feeder-free, serum-free culture system in which embryonic stem cells are maintained in unconditioned serum replacement (SR) medium supplemented with different growth factors capable of triggering embryonic stem cell self-renewal.
[0022] In another example, Levenstein et al (Stem Cells 24: 568-574, 2006) disclose methods for the long-term culture of human embryonic stem cells in the absence of fibroblasts or conditioned medium, using media supplemented with bFGF.
[0023] In another example, US20050148070 discloses a method of culturing human embryonic stem cells in defined media without serum and without fibroblast feeder cells, the method comprising: culturing the stem cells in a culture medium containing albumin, amino acids, vitamins, minerals, at least one transferrin or transferrin substitute, at least one insulin or insulin substitute, the culture medium essentially free of mammalian fetal serum and containing at least about 100 ng/ml of a fibroblast growth factor capable of activating a fibroblast growth factor signaling receptor, wherein the growth factor is supplied from a source other than just a fibroblast feeder layer, the medium supported the proliferation of stem cells in an undifferentiated state without feeder cells or conditioned medium.
[0024] In another example, US20050233446 discloses a defined media useful in culturing stem cells, including undifferentiated primate primordial stem cells. In solution, the media is substantially isotonic as compared to the stem cells being cultured.
In a given culture, the particular medium comprises a base medium and an amount of each of bFGF, insulin, and ascorbic acid necessary to support substantially undifferentiated growth of the primordial stem cells.
[0025] In another example, US6800480 states "In one embodiment, a cell culture medium for growing primate-derived primordial stem cells in a substantially undifferentiated state is provided which includes a low osmotic pressure, low endotoxin basic medium that is effective to support the growth of primate-derived primordial stem cells. The basic medium is combined with a nutrient serum effective to support the growth of primate-derived primordial stem cells and a substrate selected from the group consisting of feeder cells and an extracellular matrix component derived from feeder cells.
The medium further includes nonessential amino acids, an anti-oxidant, and a first growth factor selected from the group consisting of nucleosides and a pyruvate salt."
[0026] In another example, US20050244962 states: "In one aspect the invention provides a method of culturing primate embryonic stem cells. One cultures the stem cells in a culture essentially free of mammalian fetal serum (preferably also essentially free of any animal serum) and in the presence of fibroblast growth factor that is supplied from a source other than just a fibroblast feeder layer. In a preferred form, the fibroblast feeder layer, previously required to sustain a stem cell culture, is rendered unnecessary by the addition of sufficient fibroblast growth factor."
[0027] In a further example, W02005065354 discloses a defined, isotonic culture medium that is essentially feeder-free and serum-free, comprising: a. a basal medium; b.
an amount of bFGF sufficient to support growth of substantially undifferentiated mammalian stem cells; c. an amount of insulin sufficient to support growth of substantially undifferentiated mammalian stem cells; and d. an amount of ascorbic acid sufficient to support growth of substantially undifferentiated mammalian stem cells.
[0028] In another example, W02005086845 discloses a method for maintenance of an undifferentiated stem cell, said method comprising exposing a stem cell to a member of the transforming growth factor-beta (TGF(3) family of proteins, a member of the fibroblast growth factor (FGF) family of proteins, or nicotinamide (NIC) in an amount sufficient to maintain the cell in an undifferentiated state for a sufficient amount of time to achieve a desired result.
[0029] Additionally, formation of pancreatic endocrine cells, pancreatic hormone expressing cells, or pancreatic hormone secreting cells from human embryonic cells may require genetic manipulation of the human embryonic stem cells. Transfection of human embryonic stem cells using traditional techniques, such as, for example, lipofectamine or electroporation is inefficient.
[0030] W02007027157 discloses a method comprising: (a) providing an embryonic stem (ES) cell; and (b) establishing a progenitor cell line from the embryonic stem cell; in which the progenitor cell line is selected based on its ability to self-renew.
Preferably, the method selects against somatic cells based on their inability to self renew.
Preferably, the progenitor cell line is derived or established in the absence of co-culture, preferably in the absence of feeder cells, which preferably selects against embryonic stem cells.
Optionally, the method comprises (d) deriving a differentiated cell from the progenitor cell line.
[0031] Therefore, there still remains a significant need to develop conditions for establishing pluripotent stem cell lines that can be expanded to address the current clinical needs, while retaining the potential to differentiate into pancreatic endocrine cells, pancreatic hormone expressing cells, or pancreatic hormone secreting cells.

SUMMARY
[0032] The present invention provides a cell population with characteristics of human embryonic stem cells, that can be readily expanded in culture, in low serum, that requires no feeder cell line or a coating of complex matrix proteins, can be passaged in single cell suspension, can be transfected with a very high efficiency, and cultured under hypoxic conditions. This combination of unique attributes separates the cells described in the present invention from the prior art.
[0033] In one embodiment, the present invention provides a method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Obtaining cells, and b. Culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
[0034] The cells may be human embryonic stem cells, or they may be cells expressing markers characteristic of the definitive endoderm lineage. The human embryonic stem cells may be cultured in normoxic conditions prior to culturing the cells on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
Alternatively, the human embryonic stem cells may be cultured in hypoxic conditions.
[0035] The human embryonic stem cells may be cultured in normoxic conditions prior to culturing the cells on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, and treated with a Rho kinase inhibitor.
Alternatively, the human embryonic stem cells may be cultured in hypoxic conditions, and treated with a Rho kinase inhibitor.
[0036] The cells expressing markers characteristic of the definitive endoderm lineage may be cultured in normoxic conditions prior to culturing the cells on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
Alternatively, the cells expressing markers characteristic of the definitive endoderm lineage may be cultured in hypoxic conditions.
[0037] In one embodiment, the present invention provides a method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Culturing human embryonic stem cells, b. Differentiating the human embryonic stem cells into cells expressing markers characteristic of definitive endoderm cells, and c. Removing the cells, and subsequently culturing them under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
[0038] The cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum, activin-A, and a Wnt ligand. Alternatively, the cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pretreated with a protein or an extracellular matrix, in medium containing serum, activin-A, a Wnt ligand, and IGF- 1.
[0039] The cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum, a Rho kinase inhibitor, activin-A, and a Wnt ligand. Alternatively, the cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pretreated with a protein or an extracellular matrix, in medium containing serum, a Rho kinase inhibitor, activin-A, a Wnt ligand, and IGF- 1.
[0040] In one embodiment, the present invention provides a method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Culturing human embryonic stem cells, and b. Removing the cells, and subsequently culturing them under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
[0041] The cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum, activin-A, and a Wnt ligand. Alternatively, the cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pretreated with a protein or an extracellular matrix, in medium containing serum, activin-A, a Wnt ligand, and IGF- 1.
[0042] The cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum, a Rho kinase inhibitor, activin-A, and a Wnt ligand. Alternatively, the cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pretreated with a protein or an extracellular matrix, in medium containing serum, a Rho kinase inhibitor, activin-A, a Wnt ligand, and IGF- 1.
[0043] The cells expressing pluripotency markers derived by the methods of the present invention are capable of expansion in culture under hypoxic conditions, on tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
[0044] In one embodiment, the present invention provides a method to expand cells expressing markers characteristic of the definitive endoderm lineage, comprising the steps of culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix. In one embodiment, the cells expressing markers characteristic of the definitive endoderm lineage are derived from pluripotent cells formed by the methods of the present invention.
[0045] The cells may be cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum, activin-A, a Wnt ligand, and a GSK-3B inhibitor.

BRIEF DESCRIPTION OF THE FIGURES
[0046] Figure 1 shows the expression of CXCR4 (CD 184, Y-axis) and CD9 (X-axis) in cells from the human embryonic stem cell line H9 at passage 54 that have been differentiated into definitive endoderm following treatment with low serum +Activin-A + WNT-for 4 days.
[0047] Figure 2 shows the real-time PCR analysis of cells from the human embryonic stem cell line H9 at passage 54 at day 4 and 6 of the definitive endoderm differentiation protocol outlined in Example 5. Panel a) depicts expression of AFP, Bry, CXCR4, GSC, and SOX-7. Panel b) depicts the expression of SOX-17, GATA-4, and HNF-3 beta.
[0048] Figure 3 shows the isolation protocol used to derive EXPRES cells from embryonic stem cells according to the methods of the present invention.
[0049] Figure 4 shows the morphology of expanded EXPRES cells at P0, at day 11, that were cultured in 2% FBS + DMEM-F12 + 100 ng/ml of Activin-A (Panel a) or 2% FBS +
DMEM-F 12 + 100 ng/ml of Activin-A + 20 ng/ml of WNT-3A (Panel b). Panel c shows the morphology of the EXPRES cells at passage 3.
[0050] Figure 5 shows the real-time PCR analysis of expanded EXPRES cells cultured in 2-5% FBS + DMEM-F 12 + 100 ng/ml of Activin-A + 20 ng/ml of WNT-3A for three passages. Panel a) depicts expression of AFP, Bry, CXCR4, GSC, and SOX-7.
Panel b) depicts the expression of SOX-17, GATA-4, and HNF-3 beta.
[0051] Figure 6 shows the effect of the addition of Wnt-3A on gene expression in EXPRES
cells. Panel a) depicts real-time PCR expression of SOX- 17, GATA-4, and HNF-3 beta. Panel b) depicts real-time PCR expression of AFP, Bry, CXCR4, GSC, and SOX-7.
[0052] Figure 7 shows the effect of IGF-1, Wnt-3A and activin-A on gene expression in EXPRES cells. Panel a) depicts real-time PCR expression of SOX-17, GATA-4, HNF-3 beta, Bry, CXCR4, and GSC. Panel b) depicts real-time PCR expression of and SOX-7 and AFP. Panel c) depicts real-time PCR expression of OCT-4.
[0053] Figure 8 shows the morphology of expanded EXPRES cells derived from the human embryonic stem cell line H9 at passage 54, cultured in a) 2% FBS +DMEM-F 12 +

ng/ml of AA + 20 ng/ml of WNT-3A, b) 2% FBS + DMEMF12 + 100 ng/ml of AA, c) 2% FBS + DMEM-F 12 + 50 ng/ml of IGF-I.
[0054] Figure 9 shows the expansion potential of EXPRES 01 and 02 cells cultured on tissue culture polystyrene under hypoxic conditions. EXPRES 01 was cultured in 2% FBS
+
DM-1712 + 100 ng/ml of AA + 20 ng/ml of WNT-3A + 50 ng/ml of IGF-I and EXPRES
02 cells were cultured in 2% FBS + DM-F12 + 100 ng/ml of AA + 20 ng/ml of WNT-3A.
[0055] Figure 10 shows the morphology of EXPRES cells derived from single cell suspension of undifferentiated ES cells on TCPS (tissue culture polystyrene) in DM-F12 +
2% FBS
+ 100 ng/ml AA + 20 ng/ml WNT3A + 50 ng/ml of IGF-I.
[0056] Figure 11 shows the protein expression as determined by FACS in EXPRES
01 cells at passage 24 cells. Panel a) shows the expression levels of E-cadherin, panel b) shows the expression levels of CXCR4, panel c) shows the expression levels of CD9, panel d) shows the expression levels of CD 117, panel e) shows the expression levels of CD30, panel f) shows the expression levels of LIF receptor, panel g) shows the expression levels of TRA 1-60, panel h) shows the expression levels of TRA 1-81, panel i) shows the expression levels of SSEA- 1, panel j) shows the expression levels of SSEA-3, panel k) shows the expression levels of SSEA-4, and Panel 1) shows the expression levels of CD56.
[0057] Figure 12 shows the protein expression as determined by FACS in EXPRES
02 at passage 21 cells. Panel a) shows the expression levels of E-cadherin, panel b) shows the expression levels of CXCR4, panel c) shows the expression levels of CD9, panel d) shows the expression levels of CD 117, panel e) shows the expression levels of CD30, panel f) shows the expression levels of LIF receptor, panel g) shows the expression levels of TRA 1-60, panel h) shows the expression levels of TRA 1-81, panel i) shows the expression levels of SSEA- 1, panel j) shows the expression levels of SSEA-3, panel k) shows the expression levels of SSEA-4, and panel 1) shows the expression levels of CD56.
[0058] Figure 13 shows immuno fluorescent images of EXPRES 01 at passage 10 cultured in 2% FBS + DMEM-F 12 + 100 ng/ml of AA + 20 ng/ml of VVNT-3A + 50 ng/ml of IGF-I. Panel a) DAPI image for panel b, panel b) Nanog, panel c) DAPI (blue) and Oct-4 (green) co-staining, panel d) DAPI image for panel e, panel e) SOX-2, and panel f) DAPI (blue) and HNF-3 beta (green) co-staining.
[0059] Figure 14 shows immuno fluorescent images of EXPRES 02 at passage 9 cultured in 2% FBS + DMEM-F 12 + 100 ng/ml of AA + 20 ng/ml of WNT-3A. Panel a) DAPI
image for panel b, panel b) HNf3B, panel c) DAPI image for panel d, panel d) OCT-4, panel e) DAPI image for panel f, panel f) SOX-2, panel g) DAPI image for panel h, panel h) NANOG.
[0060] Figure 15 shows gene expression as determined by real-time PCR for cells, EXPRES 02 cells, EB derived from H9 cells, SA002 cultured on MATRIGEL
in MEF-CM, and undifferentiated H9 cells cultured on MATRIGEL in MEFCM. All the expression levels are normalized to undifferentiated H9 cells. Panel a) shows expression, panel b) shows FOXD3, MYOD1, POU5F1, and ZFP42 expression, panel c) shows ABCG2, Connexin 43, Connexin 45, and cytokeratin 15 expression, panel d) shows nestin, SOX-2, UTF1, and vimentin, panel e) shows GATA-2, Brachyury, TERT, and tubulin-beta III expression, panel f) shows CFC1, and GATA-4 expression, Panel g) shows AFP and FOXA2 expression, and Panel h) shows IPF1A and MSX1 expression.
[0061] Figure 16 shows the expression, as determined by FACS of CXCR4 (Y-axis) and CD9 (x-axis) in a) EXPRES 01 cells passage 5 cells cultured on tissue culture polystyrene in growth media and then switched to DMEM-F12 + 0.5% FBS + 100 ng/ml of activin-A
and 20 ng/ml of WNT3A for 2 days followed by additional 2 days in DMEM-F12 +
2%
FBS + 100 ng/ml of activin-A, b) EXPRES 02 cells passage 4 cells cultured on tissue culture polystyrene in growth media and then switched to DMEM-F 12 + 0.5% FBS
+
100 ng/ml of activin-A and 20 ng/ml of WNT3A for 2 days followed by additional days in DMEM-F12 + 2% FBS + 100 ng/ml of activin-A.
[0062] Figure 17 shows gene expression as determined by real-time PCR in a) cells and b) EXPRES 02 cells treated with low serum plus AA + WNT3 a.
[0063] Figure 18 shows immuno fluorescent images of EXPRES 01 cells at passage 5 cultured in 2% FBS + DMEM-F 12 + 100 ng/ml of AA + 20 ng/ml of WNT-3A + 50 ng/ml of IGF-I and then switched to DMEM-F12 + 0.5% FBS + 100 ng/ml of activin-A and 20 ng/ml of WNT3A for 2 days, followed by additional 2 days in DMEM-F12 + 2% FBS
+ 100 ng/ml of activin-A. Panel a) DAPI image for panel b, panel b) GATA-4, panel c) DAPI image for panel d, panel d) SOX-17, panel e) DAPI image for panel f, panel f) HNF-3 beta, panel g) DAPI image for panel h, and panel h) OCT-4.
[0064] Figure 19 shows immuno fluorescent images of EXPRES 02 cells at passage 4 cultured in 2% FBS + DMEM-F 12 + 100 ng/ml of AA + 20 ng/ml of WNT-3A and then switched to DMEM-F12 + 0.5% FBS + 100 ng/ml of activin-A and 20 ng/ml of WNT3A for 2 days followed by additional 2 days in DMEM-F 12 + 2% FBS + 100 ng/ml of activin-A. Panel a) DAPI image for panel b, panel b) GATA-4, panel c) DAPI
image for panel d, panel d) SOX-17, panel e) DAPI image for panel f, panel f) beta, panel g) DAPI image for panel h, and panel h) OCT-4.
[0065] Figure 20 shows protein expression as determined by FACS of CXCR4 (Y-axis) and CD9 (x-axis) for a) EXPRES 01 cells at passage 19 cells and b) EXPRES 02 cells at passage 14 cells cultured on tissue culture polystyrene in growth media and then switched to DMEM-F12 + 0.5% FBS + 100 ng/ml of activin-A + 100 nM GSK-3B
inhibitor IX, and 20 ng/ml of WNT3A for 4days.
[0066] Figure 21 shows immuno fluorescent images of EXPRES 01 cells at passage cultured in 2% FBS + DMEM-F 12 + 100 ng/ml of AA + 20 ng/ml of WNT-3A + 50 ng/ml of IGF-I and EXPRES 02 cells at passage 14 cultured in 2% FBS + DMEM-F12 + 100 ng/ml of AA + 20 ng/ml of WNT-3A and then switched to DMEM-F12 + 0.5%
FBS + 100 ng/ml of activin-A + 100 nM GSK-3B inhibitor IX, and 20 ng/ml of WNT3A for 5days. Panel a) DAPI image for panel b, panel b) HNF-3 beta, panel c) DAPI image for panel d, panel d) GATA-4, panel e) DAPI image for panel f, panel f) SOX-17, panel g)DAPI image for panel h, panel h) HNF-3 beta, Panel i) DAPI
image for panel j, panel j) GATA-4, panel k)DAPI image for panel 1, panel 1) SOX-17.
[0067] Figure 22 shows gene expression as determined by real-time PCR data for a) EXPRES
01 and EXPRES 02 cells treated with low serum plus AA + WNT3a + GSK-3B IX
inhibitor for 5 days. Panel a depicts expression of AFP, Brachyury, CDX2, MoxI, OCT3/4, SOX-7, and ZIC1 and panel b shows expression levels of CXCR4, GATA-4, Goosecoid, HNf3B, and SOX-17.
[0068] Figure 23 shows gene expression as determined by real-time PCR for cells seeded at 5000-40000 cells/cm2 on tissue culture polystyrene in growth media and then switched to DMEM-F 12 + 0.5% FBS + 100 ng/ml AA + 20 ng/ml WNT3A + 100 nM GSK-3B inhibitor IX for four days under hypoxic conditions. Panel a depicts expression levels of AFP, Brachyury, SOX-7, and OTX2. Panel b depicts expression levels of CXCR4, HNF-3 beta, GATA-4, SOX-17, Cerb, and GSC.
[0069] Figure 24 shows the results of a telomere length assay in low telomere control cells (lane 1), EXPRES 01 cells at passage 24 (lane 2), EXPRES 02 cells at passage 17 (lane 3), undifferentiated cells from the human embryonic stem cell line H1 at passage 40 (lane 4), and high telomere length control cells (lane 5).
[0070] Figure 25 shows gene expression as determined by real-time PCR data for cells at passage 21 that have been differentiated to foregut endoderm cells (S3), pancreatic endoderm cells (S4), and pancreatic endocrine cells (S5).
[0071] Figure 26 shows immuno fluorescent images of EXPRES 01 at passage 35 cultured according to Example 18. Panel a) DAPI image for panel b, panel b) Anti-1 trypsin, panel c) HNF-3 beta in green Albumin in Red, panel d) Albumin in red and DAPI
(blue), panel e) DAPI image for panel f, panel f) PDX-1, panel g) DAPI image for panel h, panel h) SOX-17, panel i) DAPI image for panel j, panel j) CDX-2.
[0072] Figure 27 shows scatter plots of microarray data comparing, panel a) EXPRES 01 cells (y-axis) to undifferentiated cells from the human embryonic stem cell line H9 (x-axis), panel b) EXPRES 02 cells (y-axis) to undifferentiated cells from the human embryonic stem cell line H9 (x-axis), panel c) EXPRES 01 cells (y-axis) to EXPRES 02 cells (x-axis), panel d) EXPRES 01 cells (y-axis) to cells from the human embryonic stem cell line H9 that have been differentiated into definitive endoderm (x-axis), panel e) EXPRES 02 cells (y-axis) to cells from the human embryonic stem cell line H9 that have been differentiated into definitive endoderm (x-axis), panel f) undifferentiated cells from the human embryonic stem cell line H9 (y-axis) to cells from the human embryonic stem cell line H9 that have been differentiated into definitive endoderm (x-axis).
[0073] Figure 28 shows the morphology of EB bodies formed by EXPRES 01 cells.
[0074] Figure 29 shows gene expression as determined by real-time PCR for cells of the EXPRES 01 cell line, cells of the EXPRES 02 cell line, and cells from the human embryonic stem cell line H9 at passage 43, following five weeks of transplantation beneath the kidney capsule of NOD-SCID mice. Panels a-e, show mesoderm markers.
Panels f & g show ectoderm markers. Panels h & i show endoderm markers. Panel j shows extra embryonic endoderm markers. Panels k-m show pluripotency markers.
[0075] Figure 30 shows the proliferation and cell cycle status of EXPRES 03 cells, as determined by BRDU incorporation. EXPRES 03 cells were cultured in 2%

FBS/DMEM/F12, supplemented with, panel a) activin-A (100 ng/ml) and wnt3 a (20ng/ml), panel b) Activin-A (100 ng/ml) and wnt3a (20ng/ml) and IGF
(50nh/ml).
Other cells shown include, panel c) hES cells (H9p43), panel d) Amniotic Fluid Cells (AFDX002) and panel e) mitomycin treated MEF cells. Panel f) shows the frequency of cells in S-phase, G1 and G2/M-phases of cell cycle for different cell populations studied.
[0076] Figure 31 shows the transfection efficiency and expression of EGFP in cells and human embryonic stem cells plated either as single cell dispersions or cell clusters. Cells were analyzed 24 hrs later by fluorescence microscopy and flow cytometry. Panel A) shows data obtained from EXPRES 01 cells. Panel B) shows data obtained from single cell dispersions of human embryonic stem cells and Panel C) shows data obtained from cell clusters of human embryonic stem cells.
[0077] Figure 32 shows average OD readings representing dehydrogenase enzyme activity versus cell number as measured by MTS assay for a) EXPRES 01 cells cultured in atmospheric oxygen (approximately 21%), b) EXPRES 01 cells cultured in 3% 02, c) EXPRES 02 cells cultured in atmospheric oxygen (approximately 21%), d) EXPRES
02 cells cultured in 3% 02 conditions.
[0078] Figure 33 shows gene expression as determined by real-time PCR for cells seeded at 10000 cells/cm2 on tissue culture polystyrene in DMEMF12 +
0.5%
FBS + 100 ng/ml AA + 20 ng/ml WNT3A + 100 nM GSK-3B inhibitor IX.. Panel a depicts expression levels of AFP, Brachyury, SOX-7, and OTX2. Panel b depicts expression levels of CXCR4, HNF-3 beta, GATA-4, SOX-17, Cerl, and GSC.
[0079] Figure 34 shows protein expression of CXCR4 (Y-axis) and CD9 (x-axis), as determined by FACS for EXPRES 01 P27 cells cultured on tissue culture polystyrene in DMEM-F12 + 0.5% FBS + 100 ng/ml AA + 20 ng/ml WNT3A + 100 nM GSK-3B
inhibitor IX for three passages.
[0080] Figure 35 shows the effects of siRNA transfection on the expression of GSK-3B and beta-catenin. EXPRES cells were analyzed by fluorescence microscopy and quantitative RT-PCR methods. A) Fluorescence microscopy of cells transfected with i) CY3 labeled siRNA and ii) Fluorescein labeled siRNA. B) Target gene knockdown expressed as % remaining activity in cells transfected with i) GSK3b and ii) Beta-catenin siRNA oligo sequences.
[0081] Figure 36 shows the karyotype of two cell lines derived by methods of the present invention. Panel a: EXPRES 01 cell line. Panel b: EXPRES 02 cell line.
[0082] Figure 37 shows the morphology of EXPRES 15 cells at passage 0 after 24h culture in a) 2% FBS + DM-1712 + 100 ng/ml of activin-A+ 20 ng/ml of WNT-3A + 50 ng/ml IGF orb) 2% FBS + DM-F 12 + 100 ng/ml of Activin-A+ 20 ng/ml of WNT-3A + 50 ng/ml IGF + 10 pM of the Rho kinase inhibitor Y-27632.
[0083] Figure 38 shows the karyotype of EXPRES 15 cells cultured in 2% FBS +
DM-F12 +
100 ng/ml of Activin-A+ 20 ng/ml of WNT-3A + 50 ng/ml IGF + 10 pM of the Rho kinase inhibitor Y-27632 for 12 passages.
[0084] Figure 39 shows the proliferation as determined by A490 of EXPRES 11 cells cultured in basal media supplemented with IGF, activin-A, Wnt3A, and GSK inhibitor IX
at the concentrations indicated at 24 h (panel a), 48 h (panel b), and 96 h (panel c).

DETAILED DESCRIPTION
[0085] For clarity of disclosure, and not by way of limitation, the detailed description of the invention is divided into the following subsections that describe or illustrate certain features, embodiments, or applications of the present invention.

Definitions
[0086] Stem cells are undifferentiated cells defined by their ability at the single cell level to both self-renew and differentiate to produce progeny cells, including self renewing progenitors, non-renewing progenitors, and terminally differentiated cells.
Stem cells are also characterized by their ability to differentiate in vitro into functional cells of various cell lineages from multiple germ layers (endoderm, mesoderm and ectoderm), as well as to give rise to tissues of multiple germ layers following transplantation and to contribute substantially to most, if not all, tissues following injection into blastocysts.
[0087] Stem cells are classified by their developmental potential as: (1) totipotent, meaning able to give rise to all embryonic and extraembryonic cell types; (2) pluripotent, meaning able to give rise to all embryonic cell types; (3) multipotent, meaning able to give rise to a subset of cell lineages, but all within a particular tissue, organ, or physiological system (for example, hematopoietic stem cells (HSC) can produce progeny that include HSC (self- renewal), blood cell restricted oligopotent progenitors and all cell types and elements (e.g., platelets) that are normal components of the blood); (4) oligopotent, meaning able to give rise to a more restricted subset of cell lineages than multipotent stem cells; and (5) unipotent, meaning able to give rise to a single cell lineage (e.g. , spermatogenic stem cells).
[0088] Differentiation is the process by which an unspecialized ("uncommitted") or less specialized cell acquires the features of a specialized cell such as, for example, a nerve cell or a muscle cell. A differentiated or differentiation-induced cell is one that has taken on a more specialized ("committed") position within the lineage of a cell. The term "committed", when applied to the process of differentiation, refers to a cell that has proceeded in the differentiation pathway to a point where, under normal circumstances, it will continue to differentiate into a specific cell type or subset of cell types, and cannot, under normal circumstances, differentiate into a different cell type or revert to a less differentiated cell type. De-differentiation refers to the process by which a cell reverts to a less specialized (or committed) position within the lineage of a cell. As used herein, the lineage of a cell defines the heredity of the cell, i.e., which cells it came from and what cells it can give rise to. The lineage of a cell places the cell within a hereditary scheme of development and differentiation. A lineage-specific marker refers to a characteristic specifically associated with the phenotype of cells of a lineage of interest and can be used to assess the differentiation of an uncommitted cell to the lineage of interest.
[0089] "AFP" or "alpha-fetoprotein protein" as used herein, refers to an antigen produced at the onset of liver development. AFP may also be expressed in extraembryonic cells.
[0090] "Albumin" is a soluble monomeric protein that makes up about half of all serum proteins in adults.
[0091] "(3-cell lineage" refer to cells with positive gene expression for the transcription factor PDX-1 and at least one of the following transcription factors: NGN-3, Nkx2.2, Nkx6.1, NeuroD, Isl-1, HNF-3 beta, MAFA, Pax4, and Pax6. Cells expressing markers characteristic of the R cell lineage include R cells.
[0092] "Brachyury", as used herein, is a T-box gene family member. It is the marker for primitive streak and mesoderm cells.
[0093] "Cells expressing markers characteristic of the definitive endoderm lineage" as used herein refer to cells expressing at least one of the following markers: SOX-17, GATA-4, HNF-3 beta, GSC, Cerl, Nodal, FGF8, Brachyury, Mix-like homeobox protein, FGF4 CD48, eomesodermin (EOMES), DKK4, FGF17, GATA-6, CXCR4, C-Kit, CD99, or OTX2. Cells expressing markers characteristic of the definitive endoderm lineage include primitive streak precursor cells, primitive streak cells, mesendoderm cells and definitive endoderm cells.
[0094] "c-Kit" and "CD 117" both refer to a cell surface receptor tyrosine kinase having a sequence disclosed in Genbank Accession No. X06182, or a naturally occurring variant sequence thereof (e.g., allelic variant).
[0095] "CD99" as used herein refers to the protein encoded by the gene wit the accession number NM_002414.
[0096] "Cells expressing markers characteristic of the pancreatic endoderm lineage" as used herein refer to cells expressing at least one of the following markers: PDX-1, HNF-lbeta, PTF-1 alpha, HNF-6, or HB9. Cells expressing markers characteristic of the pancreatic endoderm lineage include pancreatic endoderm cells.
[0097] "Cells expressing markers characteristic of the pancreatic endocrine lineage" as used herein refer to cells expressing at least one of the following markers: NGN-3, NeuroD, Islet-1, PDX- 1, NKX6. 1, Pax-4, Ngn-3, or PTF-1 alpha. Cells expressing markers characteristic of the pancreatic endocrine lineage include pancreatic endocrine cells, pancreatic hormone expressing cells, and pancreatic hormone secreting cells, and cells of the (3-cell lineage.
[0098] "Cerl" or "Cerebrus" as used herein is a member of the cysteine knot superfamily of proteins.
[0099] "CXCR4" as used herein refers to the stromal cell-derived factor 1 (SDF-1) receptor, also known as "LESTR" or "fusin". In the gastrulating mouse embryo, CXCR4 is expressed in the definitive endoderm and mesoderm but not in extraembryonic endoderm.
[0100] "Definitive endoderm" as used herein refers to cells which bear the characteristics of cells arising from the epiblast during gastrulation and which form the gastrointestinal tract and its derivatives. Definitive endoderm cells express the following markers:
HNF-3 beta, GATA-4, SOX-17, Cerberus, OTX2, goosecoid, C-Kit, CD99, and Mixll.
[0101] "Extraembryonic endoderm" as used herein refers to a population of cells expressing at least one of the following markers: SOX-7, AFP, and SPARC.
[0102] "FGF-2", "FGF-4" "FGF-8" "FGF-10", and "FGF-17" as used herein, are members of the fibroblast growth factor family.
[0103] "GATA-4" and "GATA-6" are members of the GATA transcription factor family. This family of transcription factors is induced by TGF-(3 signaling, and contribute to the maintenance of early endoderm markers.
[0104] "GLUT-2", as used herein, refers to the glucose transporter molecule that is expressed in numerous fetal and adult tissues, including pancreas, liver, intestine, brain, and kidney.
[0105] "Goosecoid" or "GSC" as used herein, refers to a homeodomain transcription factor expressed in the dorsal lip of the blastopore.
[0106] "HB9" as used herein, refers to the homeobox gene 9.
[0107] "HNF-1 alpha", "HNF-1 beta", "HNF-3 beta", and "HNF-6" belong to the hepatic nuclear factor family of transcription factors, which is characterized by a highly conserved DNA binding domain and two short carboxy-terminal domains.
[0108] "Islet-1" or "Isl-1" as used herein is a member of the LIM/homeodomain family of transcription factors, and is expressed in the developing pancreas.
[0109] "MafA" as used herein is a transcription factor expressed in the pancreas, and controls the expression of genes involved in insulin biosynthesis and secretion.
[0110] "Markers" as used herein, are nucleic acid or polypeptide molecules that are differentially expressed in a cell of interest. In this context, differential expression means an increased level for a positive marker and a decreased level for a negative marker. The detectable level of the marker nucleic acid or polypeptide is sufficiently higher or lower in the cells of interest compared to other cells, such that the cell of interest can be identified and distinguished from other cells using any of a variety of methods known in the art.
[0111] "Mesendoderm cell" as used herein refers to a cell expressing at least one of the following markers: CD48, eomesodermin (EOMES), SOX-17, DKK4, HNF-3 beta, GSC, FGF17, GATA-6.
[0112] "Mixll" as used herein refers to a homeobox gene, which is marker for the cells in the primitive streak, mesoderm, and endoderm.
[0113] "NeuroD" as used herein is basic helix-loop-helix (bHLH) transcription factor implicated in neurogenesis.
[0114] "NGN-3" as used herein, is a member of the neurogenin family of basic loophelix-loop transcription factors.
[0115] "Nkx-2.2" and "Nkx-6.1" as used herein are members of the Nkx transcription factor family.
[0116] "Nodal" as used herein, is a member of the TGF beta superfamily of proteins.
[0117] "Oct-4" is a member of the POU-domain transcription factor and is widely regarded as a hallmark of pluripotent stem cells. The relationship of Oct-4 to pluripotent stem cells is indicated by its tightly restricted expression to undifferentiated pluripotent stem cells.
Upon differentiation to somatic lineages, the expression of Oct-4 disappears rapidly.
[0118] "Pancreatic endocrine cell", or "pancreatic hormone expressing cell" as used herein refers to a cell capable of expressing at least one of the following hormones:
insulin, glucagon, somatostatin, and pancreatic polypeptide.
[0119] "Pancreatic hormone secreting cell" as used herein refers to a cell capable of secreting at least one of the following hormones: insulin, glucagon, somatostatin, and pancreatic polypeptide.
[0120] "Pax-4" and "Pax-6" as used herein are pancreatic R cell specific transcription factors that are implicated in islet development.
[0121] "PDX-1" as used herein refers to a homeodomain transcription factor implicated in pancreas development.
[0122] "Pre-primitive streak cell" as used herein refers to a cell expressing at least one of the following markers: Nodal, or FGF8
[0123] "Primitive streak cell" as used herein refers to a cell expressing at least one of the following markers: Brachyury, Mix-like homeobox protein, or FGF4.
[0124] "PTF-1 alpha" as used herein refers to a basic helix-loop-helix protein of 48 kD that is a sequence-specific DNA-binding subunit of the trimeric pancreas transcription factor-1 (PTF1).
[0125] "SOX-1", "SOX-2", "SOX-7", and "SOX-17"as used herein, are a members of the SOX transcription factor family, and are implicated in embryogenesis.
[0126] "SPARC" as used herein is also known as "secreted protein acidic and rich in cysteine".
[0127] "SSEA-1" (Stage Specific Embryonic Antigen-1) is a glycolipid surface antigen present on the surface of marine teratocarcinoma stem cells (EC), marine and human embryonic germ cells (EG), and murine embryonic stem cells (ES).
[0128] "SSEA-3" (Stage Specific Embryonic Antigen-3) is a glycolipid surface antigen present on the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG), and human embryonic stem cells (ES).
[0129] "SSEA-4" (Stage Specific Embryonic Antigen-4) is a glycolipid surface antigen present on the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG), and human embryonic stem cells (ES).
[0130] "TRA1-60" is a keratin sulfate related antigen that is expressed on the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG), and human embryonic stem cells (ES).
[0131] "TRA1-81" is a keratin sulfate related antigen that is expressed on the surface of human teratocarcinoma stem cells (EC), human embryonic germ cells (EG), and human embryonic stem cells (ES).
[0132] "TRA2-49" is an alkaline phosphatase isozyme expressed on the surface of human teratocarcinoma stem cells (EC) and human embryonic stem cells (ES).
[0133] "UTF-1" as used herein, refers a transcriptional co-activator expressed in pluripotent embryonic stem cells and extra-embryonic cells.
[0134] "Zicl" as used herein is a member of the Zic transcription factor family. Zicl regulates the expression of neural and neural crest-specific genes and is expressed in the cells of the dorsal neural tube and the premigratory neural crest.

Method to derive cells expressing pluripotency markers
[0135] The present invention provides a cell population with characteristics of human embryonic stem cells, that can be readily expanded in culture, in low serum, that requires no feeder cell line or a coating of complex matrix proteins, can be passaged in single cell suspension, can be transfected with a very high efficiency, and cultured under hypoxic conditions. This combination of unique attributes separates the cells described in the present invention from the prior art.
[0136] In one embodiment, the present invention provides a method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Obtaining cells, and b. Culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
[0137] The cells may be human embryonic stem cells, or they may be cells expressing markers characteristic of the definitive endoderm lineage. The human embryonic stem cells may be cultured in normoxic conditions prior to culturing the cells on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
Alternatively, the human embryonic stem cells may be cultured in hypoxic conditions.
[0138] The cells expressing markers characteristic of the definitive endoderm lineage may be cultured in normoxic conditions prior to culturing the cells on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
Alternatively, the cells expressing markers characteristic of the definitive endoderm lineage may be cultured in hypoxic conditions.
[0139] In one embodiment, the present invention provides a method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Culturing human embryonic stem cells, b. Differentiating the human embryonic stem cells into cells expressing markers characteristic of definitive endoderm cells, and c. Removing the cells, and subsequently culturing them under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
[0140] In one embodiment, the present invention provides a method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Culturing human embryonic stem cells, and b. Removing the cells, and subsequently culturing them under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.

Cell culture under hypoxic conditions on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix
[0141] In one embodiment, the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not coated with an extracellular matrix for about 1 to about 20 days. In an alternate embodiment, the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not coated with an extracellular matrix for about 5 to about 20 days. In an alternate embodiment, the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not coated with an extracellular matrix for about 15 days.
[0142] In one embodiment, the hypoxic condition is about 1% 02 to about 20%
02. In an alternate embodiment, the hypoxic condition is about 2% 02 to about 10% 02. In an alternate embodiment, the hypoxic condition is about 3% 02-
[0143] The cells may be cultured, under hypoxic conditions on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum, activin-A, and a Wnt ligand. Alternatively, the medium may also contain IGF-1.
[0144] The culture medium may have a serum concentration in the range of about 2% to about 5%. In an alternate embodiment, the serum concentration may be about 2%.
[0145] Activin-A may be used at a concentration from about lpg/ml to about 100 g/ml. In an alternate embodiment, the concentration may be about lpg/ml to about 1 g/ml.
In another alternate embodiment, the concentration may be about lpg/ml to about IOOng/ml. In another alternate embodiment, the concentration may be about 50ng/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about 100ng/ml.
[0146] The Wnt ligand may be selected from the group consisting of Wnt-1, Wnt-3a, Wnt-5a and Wnt-7a. In one embodiment, the Wnt ligand is Wnt-1. In an alternate embodiment, the Wnt ligand is Wnt-3a.
[0147] The Wnt ligand may be used at a concentration of about ing/ml to about 1000ng/ml. In an alternate embodiment, the Wnt ligand may be used at a concentration of about I Ong/ml to about l OOng/ml. In one embodiment, the concentration of the Wnt ligand is about 20ng/ml.
[0148] IGF-1 may be used at a concentration of about ing/ml to about IOOng/ml.
In an alternate embodiment, the IGF-lmay be used at a concentration of about lOng/ml to about lOOng/ml. In one embodiment, the concentration of IGF-1 is about 50ng/ml.
[0149] The cells expressing pluripotency markers derived by the methods of the present invention are capable of expansion in culture under hypoxic conditions, on tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
[0150] The cells expressing pluripotency markers derived by the methods of the present invention express at least one of the following pluripotency markers selected from the group consisting of. ABCG2, cripto, FoxD3, Connexin43, Connexin45, Oct4, SOX-2, Nanog, hTERT, UTF-1, ZFP42, SSEA-3, SSEA-4, Tral-60, and Tral-81.
[0151] In one embodiment, the cells expressing pluripotency markers derived by the methods of the present invention are capable of expressing markers characteristic of pre-primitive streak cells.
[0152] In one embodiment, the cells expressing pluripotency markers derived by the methods of the present invention are capable of expressing markers characteristic of primitive streak cells.
[0153] In one embodiment, the cells expressing pluripotency markers derived by the methods of the present invention are capable of expressing markers characteristic of mesendoderm cells.
[0154] In one embodiment, the cells expressing pluripotency markers derived by the methods of the present invention are capable of expressing markers characteristic of definitive endoderm cells.

Further differentiation of cells expressing pluripotency markers derived by the methods of the present invention
[0155] Cells expressing pluripotency markers derived by the methods of the present invention may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage by any method in the art.
[0156] For example, cells expressing pluripotency markers derived by the methods of the present invention may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in D'Amour et al, Nature Biotechnology 23, 1534 - 1541 (2005).
[0157] For example, cells expressing pluripotency markers derived by the methods of the present invention may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in Shinozaki et al, Development 131, 1651 - 1662 (2004).
[0158] For example, cells expressing pluripotency markers derived by the methods of the present invention may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in McLean et al, Stem Cells 25, 29 - 38 (2007).
[0159] For example, cells expressing pluripotency markers derived by the methods of the present invention may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in D'Amour et al, Nature Biotechnology 24, 1392 - 1401 (2006).
[0160] For example, cells expressing pluripotency markers derived by the methods of the present invention may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage by culturing the pluripotent stem cells in medium containing activin-A in the absence of serum, then culturing the cells with activin-A
and serum, and then culturing the cells with activin-A and serum of a different concentration. An example of this method is disclosed in D'Amour et al, Nature Biotechnology, 23, 1534-1541, 2005.

Further differentiation of cells expressing markers characteristic of the definitive endoderm lineage
[0161] Cells expressing markers characteristic of the definitive endoderm lineage may be differentiated into cells expressing markers characteristic of the pancreatic endoderm lineage by any method in the art.
[0162] For example, cells expressing markers characteristic of the definitive endoderm lineage may be differentiated into cells expressing markers characteristic of the pancreatic endoderm lineage according to the methods disclosed in D'Amour et al, Nature Biotechnology 24, 1392 - 1401 (2006).
[0163] For example, cells expressing markers characteristic of the definitive endoderm lineage are further differentiated into cells expressing markers characteristic of the pancreatic endoderm lineage, by treating the cells expressing markers characteristic of the definitive endoderm lineage with a fibroblast growth factor and KAAD-cyclopamine, then removing the medium containing the fibroblast growth factor and KAAD-cyclopamine and subsequently culturing the cells in medium containing retinoic acid, a fibroblast growth factor and KAAD-cyclopamine. An example of this method is disclosed in D' Amour et al, Nature Biotechnology, 24: 1392-1401, (2006).

Further differentiation of cells expressing markers characteristic of the pancreatic endoderm lineage
[0164] Cells expressing markers characteristic of the pancreatic endoderm lineage may be differentiated into cells expressing markers characteristic of the pancreatic endocrine lineage by any method in the art.
[0165] For example, cells expressing markers characteristic of the pancreatic endoderm lineage may be differentiated into cells expressing markers characteristic of the pancreatic endocrine lineage according to the methods disclosed in D'Amour et al, Nature Biotechnology 24, 1392 - 1401 (2006).
[0166] Without being subject to limitation, the following sections contain examples of methods to obtain cells that are suitable starting materials for forming cells expressing pluripotency markers and markers characteristic of the definitive endoderm lineage according to the methods of the present invention.

Isolation, expansion and culture of human embryonic stem cells
[0167] Characterization of human embryonic stem cells: Human embryonic stem cells may express one or more of the stage-specific embryonic antigens (SSEA) 3 and 4, and markers detectable using antibodies designated Tra-1-60 and Tra-1-81 (Thomson et al., Science 282:1145, 1998). Differentiation of human embryonic stem cells in vitro results in the loss of SSEA-4, Tra- 1-60, and Tra-1-81 expression (if present) and increased expression of SSEA-1. Undifferentiated human embryonic stem cells typically have alkaline phosphatase activity, which can be detected by fixing the cells with 4% paraformaldehyde, and then developing with Vector Red as a substrate, as described by the manufacturer (Vector Laboratories, Burlingame Calif.).
Undifferentiated pluripotent stem cells also typically express Oct-4 and TERT, as detected by RT-PCR.
[0168] Another desirable phenotype of propagated human embryonic stem cells is a potential to differentiate into cells of all three germinal layers: endoderm, mesoderm, and ectoderm tissues. Pluripotency of human embryonic stem cells can be confirmed, for example, by injecting cells into SCID mice, fixing the teratomas that form using 4%
paraformaldehyde, and then examining them histologically for evidence of cell types from the three germ layers. Alternatively, pluripotency may be determined by the creation of embryoid bodies and assessing the embryoid bodies for the presence of markers associated with the three germinal layers.
[0169] Propagated human embryonic stem cell lines may be karyotyped using a standard G-banding technique and compared to published karyotypes of the corresponding primate species. It is desirable to obtain cells that have a "normal karyotype", which means that the cells are euploid, wherein all human chromosomes are present and not noticeably altered.
[0170] Sources of human embryonic stem cells: Types of human embryonic stem cells that may be used include established lines of human embryonic cells derived from tissue formed after gestation, including pre-embryonic tissue (such as, for example, a blastocyst), embryonic tissue, or fetal tissue taken any time during gestation, typically but not necessarily before approximately 10-12 weeks gestation. Non-limiting examples are established lines of human embryonic stem cells or human embryonic germ cells, such as, for example the human embryonic stem cell lines HI, H7, and H9 (WiCell). Also contemplated is use of the compositions of this disclosure during the initial establishment or stabilization of such cells, in which case the source cells would be primary pluripotent cells taken directly from the source tissues. Also suitable are cells taken from a pluripotent stem cell population already cultured in the absence of feeder cells. Also suitable are mutant human embryonic stem cell lines, such as, for example, BG01v (BresaGen, Athens, GA).
[0171] In one embodiment, Human embryonic stem cells are prepared as described by Thomson et al. (U.S. Pat. No. 5,843,780; Science 282:1145, 1998; Curr. Top.
Dev.
Biol. 38:133 ff., 1998; Proc. Natl. Acad. Sci. U.S.A. 92:7844, 1995).
[0172] Culture of human embryonic stem cells: In one embodiment, human embryonic stem cells are cultured in a culture system that is essentially free of feeder cells, but nonetheless supports proliferation of human embryonic stem cells without undergoing substantial differentiation. The growth of human embryonic stem cells in feeder-free culture without differentiation is supported using a medium conditioned by culturing previously with another cell type. Alternatively, the growth of human embryonic stem cells in feeder-free culture without differentiation is supported using a chemically defined medium.
[0173] In an alternate embodiment, human embryonic stem cells are initially cultured layer of feeder cells that support the human embryonic stem cells in various ways. The human embryonic are then transferred to a culture system that is essentially free of feeder cells, but nonetheless supports proliferation of human embryonic stem cells without undergoing substantial differentiation.
[0174] Examples of conditioned media suitable for use in the present invention are disclosed in US20020072117, US6642048, W02005014799, and Xu et al (Stem Cells 22: 972-980, 2004).
[0175] An example of a chemically defined medium suitable for use in the present invention may be found in US20070010011.
[0176] Suitable culture media may be made from the following components, such as, for example, Dulbecco's modified Eagle's medium (DMEM), Gibco # 11965-092;
Knockout Dulbecco's modified Eagle's medium (KO DMEM), Gibco # 10829-018;
Ham's F12/50% DMEM basal medium; 200 mM L-glutamine, Gibco #15039-027; non-essential amino acid solution, Gibco 11140-050; (3- mercaptoethanol, Sigma #
M7522;
human recombinant basic fibroblast growth factor (bFGF), Gibco # 13256-029.
[0177] In one embodiment, the human embryonic stem cells are plated onto a suitable culture substrate that is treated prior to treatment according to the methods of the present invention. In one embodiment, the treatment is an extracellular matrix component, such as, for example, those derived from basement membrane or that may form part of adhesion molecule receptor-ligand couplings. In one embodiment, the suitable culture substrate is MATRIGEL (Becton Dickenson). MATRIGEL is a soluble preparation from Engelbreth-Holm-Swarm tumor cells that gels at room temperature to form a reconstituted basement membrane.
[0178] Other extracellular matrix components and component mixtures are suitable as an alternative. This may include laminin, fibronectin, proteoglycan, entactin, heparan sulfate, and the like, alone or in various combinations.
[0179] The human embryonic stem cells are plated onto the substrate in a suitable distribution and in the presence of a medium that promotes cell survival, propagation, and retention of the desirable characteristics. All these characteristics benefit from careful attention to the seeding distribution and can readily be determined by one of skill in the art.
[0180] The human embryonic stem cells are then removed from the treated tissue culture substrate and plated onto a non-treated tissue culture substrate, prior to treatment according to the methods of the present invention to form cells expressing pluripotency markers and markers characteristic of the definitive endoderm lineage.

Differentiation of human embryonic stem cells into cells expressing markers characteristic of the definitive endoderm lineage
[0181] Human embryonic stem cells may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage by any method in the art.
The cells expressing markers characteristic of the definitive endoderm lineage are suitable for treating according to the methods of the present invention.
[0182] For example, human embryonic stem cells may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in D'Amour et al, Nature Biotechnology 23, 1534 - 1541 (2005).
[0183] For example, human embryonic stem cells may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in Shinozaki et al, Development 131, 1651 - 1662 (2004).
[0184] For example, human embryonic stem cells may be differentiated into cells expressing markers characteristic of the definitive endoderm lineage according to the methods disclosed in McLean et al, Stem Cells 25, 29 - 38 (2007).

Differentiation of human embryonic stem cells cultured on an extracellular matrix into cells expressing markers characteristic of the definitive endoderm lineage
[0185] In one embodiment, the present invention provides a method for differentiating human embryonic stem cells expressing markers characteristic of the definitive endoderm lineage, comprising the steps of:

a. Plating the human embryonic stem cells on a tissue culture substrate coated with an extracellular matrix, and b. Culturing the human embryonic stem cells with activin-A and a Wnt ligand.
[0186] The cells expressing markers characteristic of the definitive endoderm lineage are then subsequently treated by the methods of the present invention to form cells expressing pluripotency markers and markers characteristic of the definitive endoderm lineage.
[0187] Culturing the human embryonic stem cells with activin-A and a Wnt ligand may be performed in a single culture medium. Alternatively, culturing the human embryonic stem cells with activin-A and a Wnt ligand may be performed in more than one culture media. In one embodiment, culturing the human embryonic stem cells with activin-A
and a Wnt ligand is performed in two culture media.
[0188] Extracellular Matrix: In one aspect of the present invention, the human embryonic stem cells are cultured and differentiated on a tissue culture substrate coated with an extracellular matrix. The extracellular matrix may be a solubilized basement membrane preparation extracted from mouse sarcoma cells (which is sold by BD
Biosciences under the trade name MATRIGEL). Alternatively, the extracellular matrix may be growth factor-reduced MATRIGEL. Alternatively, the extracellular matrix may fibronectin. In an alternate embodiment, the human embryonic stem cells are cultured and differentiated on tissue culture substrate coated with human serum.
[0189] The extracellular matrix may be diluted prior to coating the tissue culture substrate.
Examples of suitable methods for diluting the extracellular matrix and for coating the tissue culture substrate may be found in Kleinman, H.K., et al., Biochemistry 25:312 (1986), and Hadley, M.A., et al., J.Cell.Biol. 101:1511 (1985).
[0190] In one embodiment, the extracellular matrix is MATRIGEL. In one embodiment, the tissue culture substrate is coated with MATRIGEL at a 1:10 dilution. In an alternate embodiment, the tissue culture substrate is coated with MATRIGEL at a 1:15 dilution.
In an alternate embodiment, the tissue culture substrate is coated with MATRIGEL at a 1:30 dilution. In an alternate embodiment, the tissue culture substrate is coated with MATRIGEL at a 1:60 dilution.
[0191] In one embodiment, the extracellular matrix is growth factor-reduced MATRIGEL. In one embodiment, the tissue culture substrate is coated with growth factor-reduced MATRIGEL at a 1:10 dilution. In an alternate embodiment, the tissue culture substrate is coated with growth factor-reduced MATRIGEL at a 1:15 dilution. In an alternate embodiment, the tissue culture substrate is coated with growth factor-reduced MATRIGEL at a 1:30 dilution. In an alternate embodiment, the tissue culture substrate is coated with growth factor reduced MATRIGEL at a 1:60 dilution.
[0192] Differentiation of human embryonic stem cells into cells expressing markers characteristic of the definitive endoderm lineage on an extracellular matrix, using a single culture medium: In one embodiment, the present invention provides a method for differentiating human embryonic stem cells expressing markers characteristic of the definitive endoderm lineage, comprising the steps of:

a. Plating the human embryonic stem cells on a tissue culture substrate coated with an extracellular matrix, and b. Culturing the human embryonic stem cells with activin-A and a Wnt ligand.
[0193] The culture medium should contain sufficiently low concentrations of certain factors to allow the differentiation of human embryonic stem cells to definitive endoderm, such as, for example insulin and IGF (as disclosed in W02006020919). This may be achieved by lowing the serum concentration, or alternatively, by using chemically defined media that lacks insulin and IGF. Examples of chemically defined media are disclosed in Wiles et al (Exp Cell Res. 1999 Feb 25; 247(1): 241-8.).
[0194] The culture medium may have a serum concentration in the range of about 0% to about 10%. In an alternate embodiment, the concentration may be in the range of about 0%
to about 5%. In an alternate embodiment, the concentration may be in the range of about 0% to about 2%. In an alternate embodiment, the concentration may be about 2%.
[0195] The time of culturing with activin-A and a Writ ligand may range from about 1 day to about 7 days. In an alternate embodiment, the time of culturing may range from about 1 day to about 3 days. In an alternate embodiment, the time of culturing may be about 3 days.
[0196] Activin-A may be used at any concentration suitable to cause differentiation of the human embryonic stem cells. The concentration maybe from about lpg/ml to about 100 g/ml. In an alternate embodiment, the concentration may be about lpg/ml to about 1 g/ml. In another alternate embodiment, the concentration may be about lpg/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about 50ng/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about lOOng/ml.
[0197] The choice of the Writ ligand may be optimized to improve the efficiency of the differentiation process. The Writ ligand may be selected from the group consisting of Wnt-1, Wnt-3a, Wnt-5a and Wnt-7a. In one embodiment, the Writ ligand is Wnt-1.
In an alternate embodiment, the Writ ligand is Wnt-3a.
[0198] The Writ ligand may be at a concentration of about ing/ml to about 1000ng/ml. In an alternate embodiment, the concentration may be about lOng/ml to about lOOng/ml.
[0199] The single culture medium may also contain a GSK-3B inhibitor. The GSK-inhibitor may be selected from the group consisting of GSK-3B inhibitor IX and GSK-3B inhibitor XI. In one embodiment, the GSK-3B inhibitor is GSK-3B inhibitor IX.
[0200] When culturing human embryonic stem cells with a GSK-3B inhibitor, the concentration of the GSK-3B inhibitor may be from about 1nM to about 1000nM.
In an alternate embodiment, the human embryonic stem cells are cultured with the GSK-3B inhibitor at a concentration of about lOnM to about lOOnM.
[0201] The single culture medium may also contain at least one other additional factor that may enhance the formation of cells expressing markers characteristic of the definitive endoderm lineage from human embryonic stem cells. Alternatively, the at least one other additional factor may enhance the proliferation of the ells expressing markers characteristic of the definitive endoderm lineage formed by the methods of the present invention. Further, the at least one other additional factor may enhance the ability of the cells expressing markers characteristic of the definitive endoderm lineage formed by the methods of the present invention to form other cell types, or improve the efficiency of any other additional differentiation steps.
[0202] The at least one additional factor may be, for example, nicotinamide, members of TGF-(3 family, including TGF-(31, 2, and 3, serum albumin, members of the fibroblast growth factor family, platelet-derived growth factor-AA, and -BB, platelet rich plasma, insulin growth factor (IGF-I, II), growth differentiation factor (GDF-5, -6, -8, -10, 11), glucagon like peptide-I and II (GLP-I and II), GLP-1 and GLP-2 mimetobody, Exendin-4, retinoic acid, parathyroid hormone, insulin, progesterone, aprotinin, hydrocortisone, ethanolamine, beta mercaptoethanol, epidermal growth factor (EGF), gastrin I and II, copper chelators such as, for example, triethylene pentamine, forskolin, Na-Butyrate, activin, betacellulin, ITS, noggin, neurite growth factor, nodal, valporic acid, trichostatin A, sodium butyrate, hepatocyte growth factor (HGF), sphingosine 1, VEGF, MG 132 (EMD, CA), N2 and B27 supplements (Gibco, CA), steroid alkaloid such as, for example, cyclopamine (EMD, CA), keratinocyte growth factor (KGF), Dickkopf protein family, bovine pituitary extract, islet neogenesis-associated protein (INGAP), Indian hedgehog, sonic hedgehog, proteasome inhibitors, notch pathway inhibitors, sonic hedgehog inhibitors, or combinations thereof.
[0203] The at least one other additional factor may be supplied by conditioned media obtained from pancreatic cells lines such as, for example, PANC-1 (ATCC No: CRL-1469), CAPAN-1 (ATCC No: HTB-79), BxPC-3 (ATCC No: CRL-1687), HPAF-II (ATCC

No: CRL-1997), hepatic cell lines such as, for example, HepG2 (ATCC No: HTB-8065), and intestinal cell lines such as, for example, FHs 74 (ATCC No: CCL-241).
[0204] Differentiation of human embryonic stem cells into cells expressing markers characteristic of the definitive endoderm lineage on an extracellular matrix, using two culture media: Differentiation of human embryonic stem cells into cells of a definitive endoderm lineage may be accomplished by culturing the human embryonic stem cells with activin-A and a Writ ligand using two culture media. Thus, the differentiation of the human embryonic stem cells may be accomplished as follows:

a. Plating the human embryonic stem cells on a tissue culture substrate coated with an extracellular matrix, b. Culturing the human embryonic stem cells with activin-A and a Writ ligand in a first culture medium, and c. Culturing the human embryonic stem cells with activin-A in a second culture medium.
[0205] The first culture medium may contain serum at a low concentration, and the second culture medium may contain serum at a higher concentration than the first culture medium.
[0206] The second culture medium may contain a Writ ligand.
[0207] First Culture Medium: The first culture medium should contain sufficiently low concentrations of certain factors to allow the differentiation of human embryonic stem cells into cells expressing markers characteristic of the definitive endoderm lineage, such as, for example insulin and IGF (as disclosed in W02006020919). This may be achieved by lowing the serum concentration, or alternatively, by using chemically defined media that lacks insulin and IGF. Examples of chemically defined media are disclosed in Wiles et al (Exp Cell Res. 1999 Feb 25; 247(1):241-8.).
[0208] In the first culture medium there may be a lower concentration of serum, relative to the second culture medium. Increasing the serum concentration in the second culture medium increases the survival of the cells, or, alternatively, may enhance the proliferation of the cells. The serum concentration of the first medium may be in the range of about 0% to about 10%. Alternatively, the serum concentration of the first medium may be in the range of about 0% to about 2%. Alternatively, the serum concentration of the first medium may be in the range of about 0% to about 1%.
Alternatively, the serum concentration of the first medium may be about 0.5%.
[0209] When culturing the human embryonic stem cells with activin-A and a Writ ligand using at least two culture media, the time of culturing in the first culture medium may range from about 1 day to about 3 days.
[0210] Activin-A may be used at any concentration suitable to cause differentiation of the human embryonic stem cells. The concentration maybe from about lpg/ml to about 100 g/ml. In an alternate embodiment, the concentration may be about lpg/ml to about 1 g/ml. In another alternate embodiment, the concentration may be about lpg/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about 50ng/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about lOOng/ml.
[0211] The choice of the Writ ligand may be optimized to improve the efficiency of the differentiation process. The Writ ligand may be selected from the group consisting of Wnt-1, Wnt-3a, Wnt-5a and Wnt-7a. In one embodiment, the Writ ligand is Wnt-1.
In an alternate embodiment, the Writ ligand is Wnt-3a.
[0212] The Writ ligand may be at a concentration of about ing/ml to about 1000ng/ml. In an alternate embodiment, the concentration may be about lOng/ml to about lOOng/ml.
[0213] The first culture medium may also contain a GSK-3B inhibitor. The GSK-3B inhibitor may be added to the first culture medium, to the second culture medium, or to both the first and second culture media.
[0214] The GSK-3B inhibitor may be selected from the group consisting of GSK-3B inhibitor IX and GSK-3B inhibitor XI. In one embodiment, the GSK-3B inhibitor is GSK-3B
inhibitor IX.
[0215] When culturing human embryonic stem cells with a GSK-3B inhibitor, the concentration of the GSK-3B inhibitor may be from about 1nM to about 1000nM.
In an alternate embodiment, the human embryonic stem cells are cultured with the GSK-3B inhibitor at a concentration of about lOnM to about lOOnM.
[0216] The first culture medium may also contain at least one other additional factor that may enhance the formation of cells expressing markers characteristic of the definitive endoderm lineage from human embryonic stem cells. Alternatively, the at least one other additional factor may enhance the proliferation of the cells expressing markers characteristic of the definitive endoderm lineage formed by the methods of the present invention. Further, the at least one other additional factor may enhance the ability of the cells expressing markers characteristic of the definitive endoderm lineage formed by the methods of the present invention to form other cell types, or improve the efficiency of any other additional differentiation steps.
[0217] The at least one additional factor may be, for example, nicotinamide, members of the TGF-(3 family, including TGF-31, 2, and 3, serum albumin, members of the fibroblast growth factor family, platelet-derived growth factor-AA, and -BB, platelet rich plasma, insulin growth factor (IGF-I, II), growth differentiation factor (GDF-5, -6, -8, -10, 11), glucagon like peptide-I and II (GLP-I and II), GLP-1 and GLP-2 mimetobody, Exendin-4, retinoic acid, parathyroid hormone, insulin, progesterone, aprotinin, hydrocortisone, ethanolamine, beta mercaptoethanol, epidermal growth factor (EGF), gastrin I and II, copper chelators such as, for example, triethylene pentamine, forskolin, Na-Butyrate, activin, betacellulin, ITS, noggin, neurite growth factor, nodal, valporic acid, trichostatin A, sodium butyrate, hepatocyte growth factor (HGF), sphingosine-1, VEGF, MG 132 (EMD, CA), N2 and B27 supplements (Gibco, CA), steroid alkaloid such as, for example, cyclopamine (EMD, CA), keratinocyte growth factor (KGF), Dickkopf protein family, bovine pituitary extract, islet neogenesis-associated protein (INGAP), Indian hedgehog, sonic hedgehog, proteasome inhibitors, notch pathway inhibitors, sonic hedgehog inhibitors, or combinations thereof.
[0218] The at least one other additional factor may be supplied by conditioned media obtained from pancreatic cells lines such as, for example, PANC-1 (ATCC No: CRL-1469), CAPAN-1 (ATCC No: HTB-79), BxPC-3 (ATCC No: CRL-1687), HPAF-II (ATCC
No: CRL-1997), hepatic cell lines such as, for example, HepG2 (ATCC No: HTB-8065), and intestinal cell lines such as, for example, FHs 74 (ATCC No: CCL-241).
[0219] Second Culture Medium: The second culture medium should contain certain factors, such as, for example, insulin and IGF (as disclosed in W02006020919), at a sufficient concentration to promote the survival of the cultured cells. This may be achieved by increasing the serum concentration, or, alternatively, by using chemically defined media where the concentrations of insulin and IGF are increased relative to the first culture medium. Examples of chemically defined media are disclosed in Wiles et al (Exp Cell Res. 1999 Feb 25; 247(1): 241-8.).
[0220] In a second culture medium having higher concentrations of serum, the serum concentration of the second culture medium may be in the range about 0.5% to about 10%. Alternatively, the serum concentration of the second culture medium may be in the range of about 0.5% to about 5%. Alternatively, the serum concentration of the second culture medium may be in the range of about 0.5% to about 2%.
Alternatively, the serum concentration of the second culture medium may be about 2%. When culturing human embryonic stem cells with the second culture medium, the time of culturing may range from about 1 day to about 4 days.
[0221] Similar to the first culture medium, Activin-A may be used at any concentration suitable to cause differentiation of the human embryonic stem cells. The concentration maybe from about lpg/ml to about 100 g/ml. In an alternate embodiment, the concentration may be about lpg/ml to about 1 g/ml. In another alternate embodiment, the concentration may be about lpg/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about 50ng/ml to about lOOng/ml. In another alternate embodiment, the concentration may be about IOOng/ml.
[0222] The Wnt ligand may be at a concentration of about ing/ml to about 1000ng/ml. In an alternate embodiment, the concentration may be about lOng/ml to about lOOng/ml.
[0223] The Wnt ligand may be selected from the group consisting of Wnt-1, Wnt-3a, Wnt-5a and Wnt-7a. In one embodiment, the Wnt ligand is Wnt-1. In an alternate embodiment, the Wnt ligand is Wnt-3a.
[0224] The second culture medium may also contain a GSK-3B inhibitor. The GSK-inhibitor may be added to the first culture medium, to the second culture medium, or to both the first and second culture media.
[0225] The GSK-3B inhibitor may be selected from the group consisting of GSK-3B inhibitor IX and GSK-3B inhibitor XI. In one embodiment, the GSK-3B inhibitor is GSK-3B
inhibitor IX.
[0226] When culturing human embryonic stem cells with a GSK-3B inhibitor, the concentration of the GSK-3B inhibitor may be from about 1nM to about 1000nM.
In an alternate embodiment, the human embryonic stem cells are cultured with the GSK-3B inhibitor at a concentration of about lOnM to about lOOnM.
[0227] Similar to the first culture medium, the second culture medium may also contain at least one other additional factor that may enhance the formation of cells expressing markers characteristic of the definitive endoderm lineage from human embryonic stem cells. Alternatively, the at least one other additional factor may enhance the proliferation of the cells expressing markers characteristic of the definitive endoderm lineage formed by the methods of the present invention. Further, the at least one other additional factor may enhance the ability of the cells expressing markers characteristic of the definitive endoderm lineage formed by the methods of the present invention to form other cell types, or improve the efficiency of any other additional differentiation steps.
[0228] The at least one additional factor may be, for example, nicotinamide, members of the TGF-(3 family, including TGF-31, 2, and 3, serum albumin, members of the fibroblast growth factor family, platelet-derived growth factor-AA, and -BB, platelet rich plasma, insulin growth factor (IGF-I, II), growth differentiation factor (GDF-5, -6, -8, -10, 11), glucagon like peptide-I and II (GLP-I and II), GLP-1 and GLP-2 mimetobody, Exendin-4, retinoic acid, parathyroid hormone, insulin, progesterone, aprotinin, hydrocortisone, ethanolamine, beta mercaptoethanol, epidermal growth factor (EGF), gastrin I and II, copper chelators such as, for example, triethylene pentamine, forskolin, Na-Butyrate, activin, betacellulin, ITS, noggin, neurite growth factor, nodal, valporic acid, trichostatin A, sodium butyrate, hepatocyte growth factor (HGF), sphingosine- 1, VEGF, MG 132 (EMD, CA), N2 and B27 supplements (Gibco, CA), steroid alkaloid such as, for example, cyclopamine (EMD, CA), keratinocyte growth factor (KGF), Dickkopf protein family, bovine pituitary extract, islet neogenesis-associated protein (INGAP), Indian hedgehog, sonic hedgehog, proteasome inhibitors, notch pathway inhibitors, sonic hedgehog inhibitors, or combinations thereof.
[0229] The at least one other additional factor may be supplied by conditioned media obtained from pancreatic cells lines such as, for example, PANC-1 (ATCC No: CRL-1469), CAPAN-1 (ATCC No: HTB-79), BxPC-3 (ATCC No: CRL-1687), HPAF-II (ATCC
No: CRL-1997), hepatic cell lines such as, for example, HepG2 (ATCC No: HTB-8065), and intestinal cell lines such as, for example, FHs 74 (ATCC No: CCL-241).
[0230] The present invention is further illustrated, but not limited by, the following examples.
Example 1 Human Embryonic Stem Cell Culture
[0231] Stem cells are undifferentiated cells defined by their ability at the single cell level to both self-renew and differentiate to produce progeny cells, including self renewing progenitors, non-renewing progenitors, and terminally differentiated cells.
Stem cells are also characterized by their ability to differentiate in vitro into functional cells of various cell lineages from multiple germ layers (endoderm, mesoderm and ectoderm), as well as to give rise to tissues of multiple germ layers following transplantation and to contribute substantially to most, if not all, tissues following injection into blastocysts.
[0232] The human embryonic stem cell lines H1, H7 and H9 were obtained from WiCell Research Institute, Inc., (Madison, WI) and cultured according to instructions provided by the source institute. Briefly, cells were cultured on mouse embryonic fibroblast (MEF) feeder cells in ES cell medium consisting of DMEM/F 12 (Invitrogen/GIBCO) supplemented with 20% knockout serum replacement, 100 nM MEM nonessential amino acids, 0.5 mM beta-mercaptoethanol, 2mM L-glutamine with 4ng/ml human basic fibroblast growth factor (bFGF) (all from Invitrogen/GIBCO). MEF cells, derived from E13 to 13.5 mouse embryos, were purchased from Charles River. MEF
cells were expanded in DMEM medium supplemented with 10% FBS (Hyclone), 2mM
glutamine, and 100 mM MEM nonessential amino acids. Sub-confluent MEF cell cultures were treated with 10 g/ml mitomycin C (Sigma, St. Louis, MO) for 3h to arrest cell division, then trypsinized and plated at 2x104/cm2 on 0.1% bovine gelatin-coated dishes. MEF cells from passage two through four were used as feeder layers.

Human embryonic stem cells plated on MEF cell feeder layers were cultured at 37 C in an atmosphere of 5% CO2 within a humidified tissue culture incubator. When confluent (approximately 5-7 days after plating), human embryonic stem cells were treated with lmg/ml collagenase type IV (Invitrogen/GIBCO) for 5-10 min and then gently scraped off the surface using a 5-ml pipette. Cells were centrifuged at 900 rpm for 5 min, and the pellet was resuspended and re-plated at a 1:3 to 1:4 ratio of cells in fresh culture medium.
[0233] In parallel, H1, H7, and H9 human embryonic stem cells were also seeded on plates coated with a 1:30 dilution of growth factor reduced MATRIGEL (BD Biosciences) and cultured in MEF-conditioned media supplemented with 8 ng/ml bFGF. The cells cultured on MATRIGEL were routinely passaged with collagenase IV
(Invitrogen/GIBCO), Dispase (BD Biosciences) or LIBERASE enzyme. Some of the human embryonic stem cell cultures were incubated under hypoxic conditions (approximately 3% 02).

Example 2 Fluorescence-Activated Cell Sorting (FACS) Analysis
[0234] Adhered human embryonic stem cells were removed from culture plates by a five-minute incubation with TrypLETM Express solution (Invitrogen, CA). Released cells were resuspended in human embryonic stem cell culture medium and recovered by centrifugation, followed by washing and resuspending the cells in a staining buffer consisting of 2% BSA, 0.05% sodium azide in PBS (Sigma, MO). As appropriate, the cells were Fc-receptor blocked for 15 minutes using a 0.1% y-globulin (Sigma) solution. Aliquots (approximately 1x105 cells) were incubated with either phycoerythirin (PE) or allophycocyanin (APC) conjugated monoclonal antibodies (5 l antibody per 1x106 cells), as indicated in Table IA, or with an unconjugated primary antibody. Controls included appropriate isotype matched antibodies, unstained cells, and cells stained only with secondary conjugated antibody. All incubations with antibodies were performed for 30 mins at 4 C, after which the cells were washed with the staining buffer. Samples that were stained with unconjugated primary antibodies were incubated for an additional 30 mins at 4 C with secondary conjugated PE
or -APC labeled antibodies. See Table IB for a list of secondary antibodies used.
Washed cells were pelleted and resuspended in the staining buffer, and the cell surface molecules were identified using a FACS Array (BD Biosciences) instrument, collecting at least 10,000 events.

Example 3 Immunocytochemistry
[0235] Adhered cells were fixed with 4% paraformaldheyde for 20 min at room temperature.
Fixed cells were blocked for 1 h at room temperature with PBS/0.1%BSA/10%
normal chick serum /0.5% Triton X-100 and then incubated overnight with primary antibodies in PBS/0.1%BSA/10% normal chick serum at 4 C. The list of primary antibodies and their working dilutions are shown in Table IA. After three washes in PBS/0.1%
BSA, fluorescent secondary antibodies (Table IB) at a 1:100 dilution in PBS were incubated with cells for 1 h at room temperature to allow binding. Control samples included reactions where the primary antibody was omitted or where the primary antibody was replaced with corresponding matched negative control immunoglobulins at the same concentration as the primary antibodies. Stained samples were rinsed; a drop of PROLONG (Invitrogen, CA) containing diamidino-2-phenylindole, dihydrochloride (DAPI) was added to each sample to counter-stain the nucleus and to function as an anti-fade reagent. Images were acquired using a Nikon Confocal Eclipse C-1 inverted microscope (Nikon, Japan) and a 10-60X objective.

Example 4 PCR Analysis of ES Derived-Cells
[0236] RNA extraction, purification, and cDNA synthesis: RNA samples were purified by binding to a silica-gel membrane (Rneasy Mini Kit, Qiagen, CA) in the presence of an ethanol-containing, high-salt buffer followed by washing to remove contaminants. The RNA was further purified using a TURBO DNA-free kit (Ambion, INC), and high-quality RNA was then eluted in water. Yield and purity were assessed by A260 and A280 readings on a spectrophotometer. CDNA copies were made from purified RNA
using an ABI (ABI, CA) high capacity cDNA archive kit.
[0237] Real-time PCR amplification and quantitative analysis: Unless otherwise stated, all reagents were purchased from Applied Biosystems. Real-time PCR reactions were performed using the ABI PRISM 7900 Sequence Detection System. TAQMAN
UNIVERSAL PCR MASTER MIX (ABI, CA) was used with 20 ng of reverse transcribed RNA in a total reaction volume of 20 l. Each cDNA sample was run in duplicate to correct for pipetting errors. Primers and FAM-labeled TAQMAN
probes were used at concentrations of 200 nM. The level of expression for each target gene was normalized using a human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) endogenous control previously developed by Applied Biosystems. Primer and probe sets are listed in Table II. SOX-17 primers were designed using the PRIMERS
program (ABI, CA) and were the following sequences: SOX-17:
TGGCGCAGCAGATACCA, AGCGCCTTCCACGACTTG, and CCAGCATCTTGCTCAACTCGGCG. After an initial incubation at 50 C for 2 min followed by 95 C for 10 min, samples were cycled 40 times in two stages - a denaturation step at 95 C for 15 sec followed by an annealing/extension step at 60 C
for 1 min. Data analysis was carried out using GENEAMP 7000 Sequence Detection System software. For each primer/probe set, a Ct value was determined as the cycle number at which the fluorescence intensity reached a specific value in the middle of the exponential region of amplification. Relative gene expression levels were calculated using the comparative Ct method. Briefly, for each cDNA sample, the endogenous control Ct value was subtracted from the gene of interest Ct to give the delta Ct value (ACt). The normalized amount of target was calculated as 2-ACt, assuming amplification to be 100% efficiency. Final data were expressed relative to a calibrator sample.

Example 5 Differentiation of Human Embryonic Stem Cells Cultured on Tissue Culture Substrate Coated with MATRIGEL to Definitive Endoderm (DE)
[0238] Cells from the human embryonic stem cell line H9 at passage 54 were cultured under hypoxic conditions (approximately 3% 02) and plated on MATRIGEL (1:30 dilution) coated dishes were exposed to DMEM/F 12 medium supplemented with 0.5% FBS, 20 ng/ml WNT-3a (Catalog# 1324-WN-002, R&D Systems, MN), and 100 ng/ml Activin-A (R&D Systems, MN) for two days followed by treatment with DMEM/F 12 media supplemented with 2% FBS and 100 ng/ml Activin-A (AA) for an additional 3-4 days.
Figure 1 depicts the expression of CXCR4 by FACS at day 4. Figure 2 displays the real-time PCR data for cultures of cells from the human embryonic stem cell line H9 treated with low serum + AA + WNT3A at days 4 and 6. This protocol resulted in significant upregulation of definitive endoderm markers. This procedure will be further referred to as the DE (Definite Endoderm) protocol.

Example 6 Isolation and Expansion of Human Embryonic Stem Cell Derived Cells Differentiated to the Definitive Endoderm Stage
[0239] Cells from the human embryonic stem cell lines H1 and H9 various passages (Passage 30-54) were cultured under hypoxic conditions (approximately 3% 02) for at least three passages. The cells were cultured in MEF-CM supplemented with 8 ng/ml of bFGF
and plated on MATRIGEL coated plates according to Example 1. The cells were exposed to the DE protocol outlined in Example 5. At days 3-6, the cultures were exposed to TrypLETM Express solution (Invitrogen, CA) for 5 mins. Released cells were resuspended in DMEM-F12 + 2% FBS medium, recovered by centrifugation, and counted using a hemocytometer. The released cells were seeded at 1000-10,000 cells/cm2 on tissue culture polystyrene (TCPS) treated flasks and cultured in DMEM-F12 + 2% FBS + 100 ng/ml activin-A + 20 ng/ml WNT-3A under hypoxic conditions (approximately 3% 02) at 37 C in standard tissue culture incubator. The TCPS
flaks were not coated with MATRIGEL or other extracellular matrix proteins. The media was changed daily. In some cultures, the media was further supplemented with ng/ml of IGF-I (insulin growth factor-I from R&D Systems, MN) or 1X ITS
(Insulin, transferrin, and selenium from Invitrogen, Ca). In some of the culture conditions the basal media (DM-F12 + 2% FBS) was further supplemented with 0.1 mM
mercaptoethanol (Invitrogen, CA) and non-essential amino acids (1X, NEAA from Invitrogen, CA). The first passage cells are referred to as P1. In parallel, similar cultures were established under normoxic conditions (approximately 21% 02).
The outline of this isolation procedure is depicted in Figure 3.
[0240] Following 5-15 days of culturing, distinct cell colonies appeared surrounded by a large number of enlarged cells that appear to be in senescence (Figure 4a-b). At approximately 50-60% confluency, the cultures were passaged by exposure to TrypLETM Express solution for 5 mins at room temperature. The released cells were resuspended in DMEM-F 12 + 2% FBS medium, recovered by centrifugation, and seeded at 10,000 cells/cm2 on tissue culture polystyrene (TCPS) treated flasks in DMEM-F 12 + 2%FBS + 100 ng/ml activin-A + 20 ng/ml VV-NT-3A +/- 50 ng/ml of IGF-I. This media will be further referred to as the "growth media". Figure 4 c depicts the morphology of cells at passage 3 seeded at 10,000 cells/cm2. At passage 3 (panel c) following the initial isolation, the cells appeared to have a uniform epithelial-like morphology with a large nucleus to cytoplasm ratio.
[0241] In some cultures the growth media was further supplemented with 1X NEAA
plus 0.1 mM mercaptoethanol. Following three to four passages, the attached cells appeared to have a uniform morphology with a large nucleus to cytoplasm ratio. Parallel cultures established under normoxic conditions failed to show robust colony formation by attached cells. Following 2-3 passages, the cultures established under normoxic conditions were abandoned due to poor growth rate.

Example 7 Role of activin-A, WNT3A, and IGF-I in Expansion and Maintenance of DE
Markers Following Multiple Passages
[0242] Cultures derived from the parental human embryonic stem cell line H9 according to the methods described in Example 6 were passaged every 4-7 days. Figure 5 depicts real-time PCR results for the expanded cells cultured in 2% FBS + DMEM-F 12 + 100 ng/ml of activin-A + 20 of WNT3A for three passages. This data is for a line isolated at day6 of the DE protocol outlined in Example 5. There is a clear decrease in DE
markers, such as SOX- 17 and HNF-3 beta following each passage. As shown in Figure 6, addition of WNT3A to the growth media containing activin-A led to a significant boost in the expression of DE markers. However, addition of 50 ng/ml of IGF-I and withdrawal of Activin-A and VVNT-3A (Figure 7 a-c) led to a precipitous drop in the expression of DE markers along with OCT-4 and an increase in expression of visceral endoderm markers, such as SOX-7 and AFP. Figure 8 a-c depicts the morphology of expanded cells derived from H9p54 at passage 5 cultured in a) 2% FBS + DMF 12 +
100 ng/ml of activin-A + 20 ng/ml of WNT-3A, b) 2% FBS + DM-F12 + 100 ng/ml of activin-A, c) 2% FBS + DM-F12 + 50 ng/ml of IGF-I. Morphology of cells cultured in the presence of activin-A or activin-A + WNT3A were very similar and distinct from morphology of cells cultured in 2% FBS + IGF-I.

Example 8 Expansion Potential of Human Embryonic Stem Cell Derived Cells Differentiated to the Definitive Endoderm stage
[0243] Cultures established from the parental human embryonic stem cell line H9 according to the methods described in Example 6 were passaged every 4-5 days when the growth media contained 50 ng/ml of IGF-I or ITS. However, cultures fed with growth media lacking the IGF or ITS supplements showed slower growth rate and were passaged every 5-7 days. The population doubling time of cells fed with growth media +

ng/ml of IGF-I was approximately 55 hrs where as the population doubling time of cultures fed only with the growth media was approximately 75 hrs. The cell population expanded according to Example 6 will be referred to as EXPRES cells (EXpandable PRE-primitive Streak cells). Table III lists various EXPRES cells established according to methods outlined in Example 6. The expansion potential of two cell lines (EXPRES 01 and 02) is depicted in Figure 9.

Example 9 Derivation of EXPRES Cells from Suspensions of Single Human Embryonic Stem Cells
[0244] Cells from the human embryonic stem cell lines H1 P33 and H9 P45 were cultured under hypoxic conditions (approximately 3% 02) for at least three passages.
The cells were cultured in MEF-CM supplemented with 8 ng/ml of bFGF and plated on MATRIGEL coated plates according to Example 1. At approximately 60%
confluency, the cultures were exposed to TrypLETM Express solution (Invitrogen, CA) for 5 mins. Released cells were resuspended in DMEM-F 12 + 2% FBS medium, recovered by centrifugation, and counted using a hemocytometer. The released cells were seeded at 1000 to 10,000 cells/cm2 on tissue culture polystyrene (TCPS) treated flasks and cultured in DM-F 12 + 2% FBS + 100 ng/ml activin-A + 20 ng/ml WNT-+ 50 ng/ml of IGF-I + 0.1 mM mercaptoethanol (Invitrogen, CA) and non-essential amino acids (1X, NEAA from Invitrogen, CA) under hypoxic conditions (approximately 3% 02) at 37 C in a standard tissue culture incubator. The TCPS
flasks were not coated with MATRIGEL or other extarcellular matrix proteins.
The media was changed daily. The first passage cells are referred to as P 1. In parallel, similar cultures were established under normoxic conditions (approximately 21%
02).
Cultures established under atmospheric conditions did not result in colony formation and there was poor cell proliferation. However, cultures established under hypoxic conditions resulted in formation of many colonies (Figure 10) resembling embryonic stem cell colonies cultured on MATRIGEL or on MEF feeders. These cultures closely resemble the properties of EXPRES cells isolated during ES to DE
differentiation.

Example 10 Expression of Cell Surface Proteins by EXPRES Cells
[0245] The cell lines EXPRES 01 and EXPRES 02 were evaluated for expression of various cell-surface markers including markers associated with pluripotency. Cells from EXPRES 01 were evaluated at passages 9 to 24. Cells from EXPRES 02 were evaluated at passages 7 to 20. Both lines exhibited strong expression of pluripotency markers typically assigned to undifferentiated human embryonic stem cells.
However, the EXPRES 02 line showed a higher percentage of expression of differentiation markers, such as CXCR4, LIF receptor, and NCAM as compared to the EXPRES 01 line. Representative FACS plots are depicted in Figure 11 for EXPRES 01 P24 and in Figure 12 for EXPRES 02 P21 line. Table IV lists the mean expression levels along with the ranges (in brackets) of the evaluated cell surface markers from three different experiments.

Example 11 Expression of Pluripotency Associated Markers by EXPRES Cells- Immuno fluorescent (IF) Staining
[0246] EXPRES 01 and 02 cells maintained in their respective growth media were stained for pluripotency-associated markers using methods outlined in Example 3. Figure 13 depicts IF images for OCT-4, Nanog, SOX-2, and HNF-3 beta for EXPRES 01 P10 cells cultured in 2% FBS + DM-F 12 + 100 ng/ml activin-A + 20 ng/ml WNT3A + 50 ng/ml IGF-I. Figure 14 depicts IF images for OCT-4, Nanog, SOX-2, and HNF-3 beta for EXPRES 02 passage 9 cells cultured in 2% FBS + DM-F12 + 100 ng/ml activin-A
+ 20 ng/ml WNT3A. EXPRES 01 cells strongly stain positive for OCT-4, Nanog, and SOX-2 and weakly for HNF-3 beta. However, EXPRES 02 cells show stronger expression for HNF-3 beta and weaker expression of OCT-4, NANOG, and SOX-2.

Example 12 Expression of Definitive Endoderm and Undifferentiated Embryonic Stem Cell Markers by Real Time PCR
[0247] Real-time PCR analysis of embryonic markers (POU5F1, SOX-2, UTF1, ZFP42, Connexin43, Connexin45, FOXD3), extraembryonic markers (AFP, KRT15), ectoderm markers (SOX-1, TUBB3, NESTIN), endoderm markers (FOXA2, IPF1, KRT15, GATA-4), and mesoderm markers (GATA-4, GATA-2, MYOD, MSX1, CFC1, ABCG2) expressed by EXPRES 01 passage 11 and EXPRES 02passage 7 lines cultured in their respective growth media is depicted in Figure 15 a-h. All of the data is normalized to fold change with respect to undifferentiated cells from the human embryonic stem cell line H9, cultured in MEF-CM on MATRIGEL coated plates. As a control, EB bodies were formed from H9 cells using standard methods of collagenase digestion and seeding on non-treated surfaces in DMEM-F12 + 20 % FBS for approximately 10 days. Gene expression of various germ layers was upregulated by EB bodies as compared to undifferentiated ES cells. Another reference RNA was collected from undifferentiated SA002 line (Cellartis, Sweden) cultured on MATRIGEL in MEF-CM. As expected gene expression of various germ layers was strongly upregulated by EB bodies as compared to EXPRES 01, EXPRES 02, SA002, and H9 lines. Both EXPRES 01 and 02 lines showed expression of FOXA2 as compared to undifferentiated SA002 and H9 lines. Neither of the EXPRES lines exhibited strong expression of extra embryonic, mesoderm or ectoderm markers.
Furthermore, expression of embryonic markers by EXPRES cells was similar to the SA002 and H9 reference cell lines.

Example 13 Various Growth Media Useful for Expansion of EXPRES Cells
[0248] EXPRES cells have been successfully cultured in the following media compositions for at least 2-30 passages:

1. DM-F12 + 2%FBS + 100 ng/ml AA + 20 ng/ml WNT-3A

2. DM-F12 + 2% FBS + 100 ng/ml AA + 20 ng/ml WNT-3A + 50 ng/ml IGF-I
3. DM-F 12 + 2% FBS + 100 ng/ml AA + 20 ng/ml WNT-3A + 10 ng/ml IGF-I
4. DM-F 12 + 2% FBS + 50 ng/ml AA + 20 ng/ml WNT-3A + 50 ng/ml IGF-I
5. DM-F 12 + 2% FBS + 50 ng/ml AA + 10 ng/ml WNT-3A + 50 ng/ml IGF-I
6. DM-F 12 + 2% FBS + 50 ng/ml AA + 20 ng/ml WNT-3A + 10 ng/ml IGF-I
7. DM-F 12 + 2% FBS + 100 ng/ml AA + 10 ng/ml WNT-3A + 10 ng/ml IGF-I
8. HEScGRO defined media (Chemicon, CA) The basal component of the above listed media may be replaced with similar media such as, RPMI, DMEM, CRML, Knockout TMDMEM, and F 12.

Example 14 Differentiation of EXPRES Cells Cultured on Tissue Culture Substrate to Definitive Endoderm (DE) cells
[0249] EXPRES 01 cells at passage 5 and EXPRES 02 cells at passage 4, cultured on TCPS in their respective media were exposed to DMEM/F12 medium supplemented with 0.5%
FBS, 20 ng/ml WNT-3a, and 100 ng/ml activin-A (R&D Systems, MN) for two days followed by treatment with DMEM/F 12 media supplemented with 2% 1713 S and 100 ng/ml activin-A (AA) for an additional 3-5 days. Figure 16 depicts the expression of CXCR4 by FACS at days 4 for EXPRES 01 cells (Figure 16 a, approximately 17%
CXCR4 positive) and EXPRES 02 cells (Figure 16b, approximately 40% CXCR4 positive). Figure 17 displays the real-time PCR data for EXPRES 01 cell (Figure 17a) and EXPRES 02 cell (Figure 17b) cultures treated with low serum + AA + WNT3A
at days 2-5. Figures 18 and 19 depict immunofluoresence images of EXPRES 01 and cells, respectively, treated with the same treatment mentioned above for 4 days.
Overall EXPRES 02 cells appear to show a stronger expression of DE markers as compared to EXPRES 01 cells. As evident by FACS, immuno staining, and PCR
data, lowering of serum concentration and removal of IGF did enhance the expression of DE
markers. However, the overall expression level of DE markers such as CXCR4 and HNF-3 beta was lower than what we have routinely observed in undifferentiated human ES cultures differentiated to the DE stage.
[0250] In order to enhance expression of DE markers, the DE differentiation protocol was changed to the following: EXPRES 01 cells at passage 19 and EXPRES 02 cells at passage 14 cultured on TCPS in their respective media were exposed to DMEM/F12 medium supplemented with 0.5% FBS, 20 ng/ml WNT-3a, 100 ng/ml activin-A, and 100 nM GSK-3B inhibitor IX (Catalog# 361550, Calbiochem, CA) for 4 to 5 days.
Figure 20 depicts the expression of CXCR4 by FACS at days 4 for EXPRES 01 (Figure 20 a, approximately 57% CXCR4 positive) and EXPRES 02 (Figure 20b, approximately 86% CXCR4 positive). Figure 21 depicts the corresponding immuno fluorescent images at day 5 for EXPRES 01 cells (panels a-f) and EXPRES 02 cells (panels g-1) cells differentiated to the DE stage. Figure 22 displays the real-time PCR
data for EXPRES 01 (Figure 22a) and EXPRES 02 (Figure 22b).

Example 15 Effect of Seeding Density on the Differentiation of EXPRES 01 Cells to DE
[0251] EXPRES 01 P31 cells were seeded at 5000, 10000, 20000, or 40000 cells/cm2 on TCPS
plates in DM-F12 + 2% FBS + 0.1 mM mercaptoethanol + 1X, NEAA + 100 ng/ml activin-A + 20 ng/ml WNT3A under hypoxic conditions (approximately 3% 02) at C in standard tissue culture incubator. Following two days post seeding, the media was switched to DMEM-F12 + 0.5% FBS + 100 ng/ml activin-A + 20 ng/ml WNT3A +
100 nM GSK-3B inhibitor IX for four days under hypoxic conditions (approximately 3% 02) at 37 C in standard tissue culture incubator. Figure 23 depicts the real-time PCR analysis of definitive endoderm markers at day 4 of differentiation. It appears that a seeding density of at least 10000-20000 cells/cm2 is required for the robust formation of definitive endoderm.

Example 16 Telomere Length of EXPRES Cells
[0252] The telomere length of two EXPRES lines isolated according to Example 5 along with undifferentiated cells from the human embryonic stem cell line H1 was analyzed by using the Telo TAGGG Telomere Length Assay (Roche, IN) and following the manufacturer's instruction. Figure 24 depicts the telomere length for EXPRES
01 cells at P24, EXPRES 02 cells at P17, H1 cells at P40, high and low telomere controls provided by the kit, along with the scale marker. Both lines appear to have shorter telomere length than undifferentiated ES cells.

Example 17 Further Differentiation of EXPRES Cells Cultured on Tissue Culture Substrate to Pancreatic Endoderm
[0253] EXPRES 01 cells at passage 21 underwent a 5 day differentiation by treatment with 100ng/ml activin-A, 10ng/ml of Wnt3a, and 100 nM GSK3beta inhibitor IX in 0.5%
FBS, DMEM:F12 media. Cells were analyzed by FACS and showed 80% of the cells were positive for CXCR4. The cells were then treated for 3 days in each of the following steps: 2%FBS DMEM:F12 containing 50ng/ml FGF-10, and 0.25 M
KAAD-Cyclopamine (Calbiochem, CA); followed by, 1%B27 DMEM, low glucose containing 50 ng/ml FGF-10, 0.25 M KAAD-Cyclopamine and 1 M Retinoic Acid (Sigma, MO); followed by, 1%B27 DMEM, low glucose containing 1 M DAPT
(Calbiochem, CA) plus 50 ng/ml Exendin4 (Sigma, MO); and lastly followed by, 1%
B27 DMEM CMRL containing 50ng/ml each of IGF, HGF and Exendin4. Samples were taken at the end of each step, and RNA was extracted for the cells. Q-RT
PCR
was conducted for the markers shown. As depicted in Figure 25, Insulin levels were increased 100 fold over untreated cells and PDX-1 levels were also increased over 1000 fold.

Example 18 Further Differentiation of EXPRES Cells Cultured on Tissue Culture Substrate to Foregut Endoderm
[0254] EXPRES01 cells at passage 35 underwent a 5 day differentiation by treatment with 100ng/ml activin-A, 20ng/ml of Wnt3a, and 100 nM GSK3beta inhibitor IX in 0.5%
FBS, DMEM:F12 media. Cells were analyzed by FACS and showed approximately 70% of the cells were positive for CXCR4. The cells were then treated for in each of the following steps: 2%FBS DMEM:F12 containing 50ng/ml FGF-10, and 0.25 M
KAAD-Cyclopamine (Calbiochem, CA) for 3 days; Step3, 1%B27 DMEM, low glucose containing 50 ng/ml FGF-10, 0.25 M KAAD-Cyclopamine and 1 M Retinoic Acid (Sigma, MO) for 4 days; and Step 4, 1%B27 DMEM, low glucose containing 1 pM DAPT (Calbiochem, CA) plus 50 ng/ml Exendin4 (Sigma, MO) for 4 days..
This protocol is based on a prior publication by D'Amour et al (Nature Biotech, 24, 1392, 2006). Cells were fixed at end of stage 4 and stained for PDX-1, HNF-3 beta, SOX-17, Albumin, anti-trypsin, and CDX-2. As depicted in Figure 26, EXPRES cells can be readily differentiated to foregut endoderm as measured by expression of PDX-1 (approximately 20% of culture stained positive), HNF-3 beta (approximately 90%
positive), albumin (approximately 5% positive), anti-l- Trypsin (approximately 70%
positive), SOX-17 (approximately 70%), and CDX-2 (approximately 5% positive).

Example 19 Microarray Analysis of EXPRES Cells Versus Undifferentiated Human Embryonic Stem Cells
[0255] Total RNA was isolated from cultures of the human embryonic stem cell line H9,at passage 44, EXPRES 01 P 11 and EXPRES 02 P7 using an RNeasy mini kit (Qiagen):
All groups contained three biological replicates and each biological replicate was repeated on two separate gene chips. Sample preparation, hybridization, and image analysis were performed according to the Affymetrix Human Genome U133 Plus 2.0 Array. Following normalization and a log transformation, data analysis was performed using OmniViz software (MA) and GENESIFTER (VizXLabs, WA). Significant differences in gene expression between the samples were evaluated using analysis of variance and an F-test with adjusted P-value (Benjamini and Hochberg correction) of less than or equal to 0.05. Only genes with a present call in at least one group were included in the analysis. Table V lists the mean normalized log-transformed signal intensity of genes showing at least 5-fold difference between groups (undifferentiated ES, EXPRES 01 and EXPRES 02 cells) along with the adjusted P-value for each gene.
Genes representing primitive streak or definite endoderm are highlighted in bold. Only the top 200 genes that are upregulated or down regulated are shown in Table V.

Example 20 Microarray Analysis of EXPRES Cells Differentiated to the DE Stage Versus Human Embryonic Stem Cells Differentiated to the DE Stage
[0256] Total RNA was isolated from the following cultures using an RNeasy mini kit (Qiagen): A) H9P33 cells cultured on MATRIGEL-coated plates (1:30 dilution) and exposed to DMEM/F12 medium supplemented with 0.5% FBS and 100 ng/ml Activin-A and 20 ng/ml of wnt3A for two days followed by treatment with DMEM/F 12 medium supplemented with 2% FBS and 100 ng/ml Activin-A (AA) for an additional three days; B) EXPRES 01 P24 cells cultured on TCPS and exposed to DMEM/F12 medium supplemented with 0.5% FBS, 100 ng/ml Activin-A, 20 ng/ml of WNT3A, and 100 nm GSK-3B IX inhibitor (Catalog# 361550, Calbiochem, CA) for five days C) EXPRES02 P 17 cells cultured on TCPS and exposed to DMEM/F 12 medium supplemented with 0.5% FBS, 100 ng/ml Activin-A, 20 ng/ml of WNT3A, and 100 nm GSK-3B IX inhibitor (Catalog# 361550, Calbiochem, CA) for five days, D) H9P39 cells cultured on MATRIGEL-coated plates (1:30 dilution) and exposed to DMEM/F

medium supplemented with 0.5% FBS and 100 ng/ml Activin-A and 20 ng/ml of wnt3A for two days followed by treatment with DMEM/F 12 medium supplemented with 2% FBS and 100 ng/ml Activin-A (AA) for an additional two days RNA
samples were collected from group D at 2hrs, 6hrs, 24 hrs, 30 hrs, 48 hrs, 72 hrs, and 96 hrs.
EXPRES 01 and 02 cultured in their respective growth media were also included as controls. All groups contained three biological replicates and each biological replicate was repeated on two separate gene chips.
[0257] Sample preparation, hybridization, and image analysis were performed according to the Affymetrix Human Genome U133 Plus 2.0 Array. Following normalization and a log transformation, data analysis was performed using OmniViz software (MA) and GENESIFTER (VizXLabs, WA). Significant differences in gene expression between the samples were evaluated using analysis of variance and an F-test with adjusted P-value (Benjamini and Hochberg correction) of less than or equal to 0.05. Only genes with a present call in at least one group were included in the analysis. Table VI lists the mean normalized log-transformed signal intensity of genes showing at least 5-fold between group A, group B, group C, and group D at various time points along with the adjusted P-value for each gene. Only the top 200 genes that are upregulated or down regulated are shown in Table VI. Genes representing primitive streak or definite endoderm are highlighted in bold. Table VII lists the correlation coefficient for each comparison group. Scatter plots corresponding to the correlation coefficients are depicted in Figure 27. The global expression profile of EXPRES 01 cells appear to resemble the expression profile of samples at 30 hrs or less of the DE stage, whereas the EXPRES 02 cells appear to resemble the expression profile of samples at greater than 48 hrs of the DE stage.

Example 21 Formation of Embryoid Bodies and Differentiation to Various Lineages
[0258] EXPRES 01 passage 27 cultures were removed as single cells using TrypLETM Express solution, spun at 200g for 4 mins, and resuspended in DMEM-F12 + 20% FBS. The cell suspension was seeded on low adhesion Petri dishes. 3-4 days post seeding, embryoid body (EB) like structures were formed (Figure 28). Treatment of the cultures with DMEM-F 12 + 2% FBS + 1 micro molar retinoic acid induced expression of ectoderm markers, such as NeuroD.

Example 22 Formation of Teratomas in the Kidney Capsules of NOD-SCID Mice
[0259] Undifferentiated cells from the human embryonic stem cell line H9 at passage 42, EXSPRES 01 Passage 30, and EXPRES 02 P22 cells were released from cultures using TRYPLE, washed in basal media, and then suspended in DMEM-F 12 basal media.
Approximately lx106 undifferentiated H9 P42, 1.5 million EXPRES 01 and 02 cells were injected into the kidney capsule of six week old NOD-SCID mice. Five weeks following transplantation, the animals were sacrificed; kidneys were excised and fixed in formalin or placed in lysis buffer to collect RNA for subsequent PCR
analysis.
Figure 29 depicts expression of markers characteristic of mesoderm, ectoderm, endoderm, extraembryonic visceral endoderm, and pluripotency markers for collected samples. Similar to H9 line, both EXPRES lines show strong expression of all germ layers along with extra embryonic endoderm.

Example 23 Proliferation And Cell Cycle Analysis of EXPRES 03 cells
[0260] Human embryonic stem cells have a unique cell cycle status that is distinguishable from other somatic cells, characterized by high proportion of cells in S-Phase, and shortened or truncated Gap phases (G1 and G2). The cell cycle control mechanisms in hES cells may be functionally linked to their self-renewal and pluripotency capacity of these cells, and may be different from control mechanism in their differentiated/committed counterparts. These experiments were designed to determine the cells cycle nature of EXPRES cells that have been shown to express many of the markers of pluripotency hES cells.
[0261] Methods: Cells were seeded at 5,000-10,000 cells /cm2 in Cell Bind tissue culture flasks (Corning) and cultured for 2-4 days. EXPRES 03 cells were cultured either in growth medium containing 2% FBS inDMEM/F12 and Activin-A (100 ng/ml), wnt3a (10-20 ng/ml) and IGF (50 ng/ml). For comparative proliferation analysis, IGF
was sometimes omitted from the growth factor cocktail. Cell proliferation was analyzed using the APC BRDU Flow kit according to the Manufacturer's recommendations (BD
Biosciences, San Diego, CA). Briefly, cells were pulsed with BRDU for 1-2 hrs at the end of culture period, released using Tryple E Express and counted. Cells were fixed in BD Cytofix/Cytosperm Buffer, incubated for 30 min, followed by incubation with BD
Cytoperm buffer for 10 minutes on ice. Cells were then treated with DNAse for 1 hr at 37 C to expose incorporated BRDU, followed by staining with APC conjugated anti-BRDU antibody. For cell cycle analysis, cells were stained with 7AAD, and analyzed on FACS Array.
[0262] Results: Similar to the highly hES cells, EXPRES 03 cells retained a highly proliferation rate, as shown by the high percentage of cells that in S-phase determined by their capacity to incorporate BRDU in culture. The frequency of cells in S-Phase was typically greater than 45% (range 40-60%), similar to hES cells (Figure 30 a-c).
Although the number of EXPRES 03 cells grown in the presence of IGF were 2-3 times the number of cells grown in absence of IGF after 3-4 days, there was only marginal differences in frequency of cells in S-phase when cell were exposed to BRDU
for 1 hour or more (Figure 30 f). This high frequency of cell in S-phase and cell cycle structure is unlike that observed in somatic cells, as shown here for human amniotic fluid cells (AFDX002) (Figure 30 d). Furthermore, mitomycin treated cells Mouse Embryo Fibroblast (MEF, Figure 30 e) do not proceed into S-phase but show apparent accumulation in the G2/M phase (64%), which may be related to the inability of mitomycin treated cells to separate the DNA strands at mitosis.

Example 24 Transfection Efficiency of ES cells vs EXPRES cells
[0263] A major limitation of genetic manipulation of hES is their relative resistance to conventional methods of transfection and viral transduction. In addition to their highly proliferative rates, EXPRES cells are easy to transfect in vitro. To compare transfection efficiency, in EXPRES and hES cells were transfected in culture with EGFP and analyzed by fluorescence microscopy and flow cytometric methods.
[0264] Methods: EXPRES 01 cells were seeded on human fibronectin coated (l0ug/ml) 6 well tissue culture plates in growth medium comprising 2% FBS in DMEM/F12, Activin-A
(100 ng/ml), wnt3a (10-20 ng/ml) and IGF (50 ng/ml). For cell clusters hES
cell were passaged by routine methods using collagenase into MATRIGEL coated 6 well culture plates, and grown in MEF conditioned hES medium. For single cells, hES cells were passaged by exposing cells to TRYPLE for 3 minutes at 37 C, followed by plating onto MATRIGEL coated 6 well culture plates. When cells achieved desired confluency (70-80%), cells were transfected with Lipofectamine 2000 according to the manufacturer's recommendations (Invitrogen, Carlsbad, CA). Briefly, 4 g of DNA
was diluted into 250 pl Opti-MEM I Reduced serum medium. Five microliters of Lipofectamine 200 was mixed into total of 250 pl Opti-MEM I medium for 5 minutes and gently mixed with diluted DNA. The DNA/Lipofectamine complexes were allowed to form at room temperature for 20 minutes, and then added to the respective wells with gentle swirling motions o f the plates for gentle mixing. Cells were incubated in presence of complexes for another 24 hrs followed by complete change of medium. Cells were analyzed by fluorescence microscopy and flow cytometry 48 hrs following transfection.
[0265] Results: The uptake and expression of eGFP was compared by transfection of EXPRES 01 cells and hES cells plated as single cell dispersion or cell clusters, and analyzed 48 hrs later. EXPRES 01 cell showed the highest level of eGFP protein expression, with 75% of cell expressing eGFP by flow cytometric analysis (Figure 31).
In contrast, hES were more resistant to transfection, with only 3% of cell expressing eGFP protein by FACS when cell clusters were used. Preparing a single cell dispersion of hES enhanced the level of DNA uptake and eGFP expression to about 20 %, but which is still by about three fold less the expression in EXPRES 01 cells.

Example 25 EXPRES Cells as a Versatile Tool for Screening
[0266] EXPRES cells were grown in DMEM:F12 medium containing 2% FBS, 100ng/ml recombinant human Activin-A (R&D Systems), and 20ng/ml recombinant mouse Wnt3a (R&D Systems). Growth medium for EXPRES 01 cells also contained 50ng/ml recombinant human IGF-1 (R&D Systems). Both cell lines were routinely grown at 37 C in an atmosphere of low oxygen (3%) and 5% CO2. EXPRES 01 and EXPRES
02 cells were released from culture as a single cell suspension using TrypLE
enzymatic digestion (Invitrogen, CA) then washed and counted to determine accurate cell numbers and viability (>95%). Aliquots ranging from 1,250 to 80,000 cells were distributed into human fibronectin-coated wells of a 96-well plate (Corning-Costar) in a final volume of 100 pl culture medium. Control wells were also fibronectin-coated and contained an equivalent volume of culture medium without cells. Plates were allowed to equilibrate overnight in a humidified chamber incubated under standard low oxygen, 5% CO2 at 37 C. During this time, the cells attached as monolayer cultures with varying degrees of confluency dependent upon the initial seeding density. After overnight culture, 20 1 of MTS reagent (CellTiter 96 Aqueous Assay; Promega) was added to each well.
MTS
is reduced to formazan and can be used as a measure of dehydrogenase enzyme activity directly proportional to the number of live cells. One plate was returned to low oxygen culture while an identical parallel plate was incubated in normal oxygen (20%). After 4 hours, absorbance was read at 490nm on a spectrophormetric plate reader (Molecular Devices). Statistical calculations for mean OD, standard deviation, and percent coefficient of variation (CV) were determined for replicate sample sets within each plate and then compared to similar wells between both plates.
[0267] Standard deviation and percent coefficient of variation values demonstrate that EXPRES cells can be evenly distributed between wells for high plating efficiency and good well-to-well reproducibility (Table VIII a-f). As seen with average OD490 readings for equivalent numbers of cells, the EXPRES 01 line has a higher metabolic activity than the EXPRES 02 line. For each EXPRES line, percent CV values between the two plates suggest there are no differences in metabolic activity for parallel conditions regardless of atmospheric oxygen levels in this short-term assay.
Optimal cell numbers per well within the linear range for this assay were determined by graphing average OD readings (Figure 32): less than 20,000 cells/well for and less than 40,000 cells/well for EXPRES 02. Again, atmospheric differences in oxygen levels did not affect optimal cell number results in this short-term assay. These results suggest that EXPRES cells are amenable to screening protocols that can measure toxicological effects of various agents on cell proliferation and/or metabolic rate.

Example 26 Expansion of DE-like Cells Derived from EXPRES Cells
[0268] Previous examples establish that EXPRES cells can be derived from embryonic stem cells and can be readily expanded on TCPS in various growth media. Most of these media formulation contain IGF as a supplement or insulin/IGF in 2% FBS used in the growth media. These factors have been shown to inhibit DE related genes through the PI-3 kinase pathway (Stem cells, 25:29-38, 2007). An alternative media was formulated based on DM-F12 + 0.5% FBS + 100 ng/ml AA + 20 ng/ml WNT3A + 100 nM GSK-3B inhibitor IX (further referred to as "growth media for DE cells").
EXPRES 01 at passage 27 cells cultured in the above media were able to propagate at the same rate as cells cultured in DM-F12 + 2% FBS + 100 ng/ml AA + 20 ng/ml WNT3A + 50 ng/ml IGF-I. Furthermore, cells cultured in the growth media for DE
cells expressed strong DE markers by real-time PCR (Figure 33) through three passages. Approximately 72% of cells expressed CXCR4 (Figure 34).

Example 27 siRNA Knockdown of Target Genes in EXPRES cells
[0269] Efficient knockdown of target genes in human embryonic stem cells using siRNA is severely limited by the ability to achieve high levels of transfection in human embryonic stem cells grown as cluster colonies. EXPRES cells are easily transfected with siRNA using conventional methods, and thus offer a valuable system to screen siRNA oligo sequences, as well as evaluate the role played by targeted genes.
[0270] Methods: EXPRES 03 cells were seeded on fibronectin coated (10pg/ml) 6 well tissue culture plates in growth medium comprising 2% FBS in DMEM/F12, Activin-A (100 ng/ml), wnt3a (10-20 ng/ml) and IGF (50 ng/ml). For 6 well plates, 200,000 cells were seeded 24 hrs prior to transfection with the siRNA oligo sequences.
[0271] To evaluate target gene knockdown, cells at 70-80% confluency cells were transfected using Lipofectamine 2000 according to the manufacturer's recommendations (Ambion (Applied Biosystems), Foster City, CA). Briefly, the appropriate amount of siRNA was diluted into 250 pl Opti-MEM I Reduced serum medium to achieve a final concentration of 100 nmol. Five microlitres of Lipofectamine 2000 was diluted in 250 pl Opti-MEM I medium and incubated for 5 minutes. The complexes were incubated for 15-20 min at room temperature, and then added to the cells with gentle swirling motions of the plates for gentle mixing. Cells were incubated in presence of siRNA for another 24 hrs followed by complete change of medium. Cells were visualized with fluorescence microscopy 24-48 hrs following transfection, and RNA harvested for analysis of target gene knockdown by quantitative RT-PCR methods. The following pre-validated siRNA oligo sequences, purchased from Ambion were tested: Beta-catenin (Id. No. 42816) and GSK3b (Id. No. 42839).
[0272] Results: Fluorescence microscopy revealed a very high level of siRNA
uptake by EXPRES cells (>80%) when using fluorescently labeled siRNA (Figure 35). RNA
harvested from the cells was analyzed by PCR for target gene knockdown, and compared with control siRNA oligo transfected cells. Beta-catenin and GSK3b siRNA
oligos achieved very high levels of gene knockdown in EXPRES cells, with greater than 93% gene knockdown. Other non-validated oligo sequences to other gene targets eg Hes-1, Oct-4 achieved lower and variable levels of target gene knockdown..
Specificity of oligo sequences was verified by analysis of other gene transcripts, which did not show any appreciable knockdown.

Example 28 Cytokine Antibody Array analysis for EXPRES 01 and 02 lines
[0273] EXPRES 01 and 02 lines at passage 22 and 23, respectively, were grown to approximately 70% confluency in their respective media and then cell lystaes was collected using mammalian cell lysis kit (Sigma-Aldrich, MO). Cytokine array analysis was completed using Cytokine Array panels provided by RayBiotech, GA
(http://www.raybiotech.com/). Table IX a-c lists cytokine, cytokine and growth factor receptor expression following normalization of the data and background subtraction.
For each panel, positive and negative controls are also included. The panels were run for two different samples per cell type.

Example 29 Karyotype Analysis The karyotype of EXPRES 01 cells at passage 20 and EXPRES 02 cells at passage was determined by G-band analysis. Cytogenetic analysis was performed on twenty-one G-banded cells from EXPRES 01 and on twenty G-banded cells from EXPRES 02.
Half of the G-banded EXPRES 01 cells showed a normal 46XX karyotype while the rest showed abnormal karyotype such as trisomy 17. The EXPRES 02 line also showed a chromosome rearrangement with a duplication of almost all of the chromosome short-arm.

Example 30 Derivation of EXPRES Cells from a Suspension of Single Human Embryonic Stem Cells in the Presence of a Rho-Kinase (ROCK) Inhibitor
[0274] Cells from the human embryonic stem cell line H9 at passage 35 lines were cultured under hypoxic conditions (approximately 3% 02) for at least three passages.
The cells were cultured in MEF-CM supplemented with 8 ng/ml of bFGF and plated on MATRIGEL coated plates according to Example 1. At approximately 60%
confluency, the cultures were exposed to TrypLETM Express solution (Invitrogen, CA) for 5 mins. Released cells were resuspended in DM-F 12 + 2% FBS medium, recovered by centrifugation, and counted using a hemocytometer. The released cells were seeded at 1000-10,000 cells/cm2 on tissue culture polystyrene (TCPS) flasks and cultured in DM-F 12 + 2% FBS + 100 ng/ml activin-A + 20 ng/ml WNT-3A + 50 ng/ml of IGF-I +
0.1 mM mercaptoethanol (Invitrogen, CA), non-essential amino acids (1X, NEAA
from Invitrogen, CA) +/- 10 pm ROCK inhibitor (Y-27632, Calbiochem, CA) under hypoxic conditions (approximately 3% 02) at 37 C in a standard tissue culture incubator. The TCPS flaks were not coated with MATRIGEL or other extracellular matrix proteins.
The media was changed daily. The first passage cells are referred to as P1. As shown in Figure 37, 24 hrs after seeding, addition of the ROCK inhibitor resulted in a significantly larger number of attached cells as compared to cultures derived in the absence of the ROCK inhibitor. EXPRES cells derived using the ROCK inhibitor, Y27632 were designated as EXPRES 15.

Example 31 Karyotype Analysis
[0275] The karyotype of EXPRES 15 cells at passage 5 and 12 were determined by G-band analysis. Cytogenetic analysis was performed on twenty-one G-banded cells from EXPRES 15 all of the cells showed a normal 46XX karyotype (Figure 38). FISH
analysis of chromosomes 12 and 17 also showed that all cells demonstrated a normal signal pattern for the ETV6 BAP (TEL) gene located on chromosome 12 and all cells demonstrated a normal signal pattern for the Her2/neu gene and 17 centromere on chromosome 17.

Example 32 EXPRES Cells can be Maintained in Media Containing a Range of Concentrations of IGF, WNT3A, activin-A, and GSK-3B inhibitors
[0276] EXPRES 11 cells were grown in DMEM/F12 (Invitrogen) containing 2% FBS, 100ng/ml activin-A, 20ng/ml Wnt3a and 50ng/ml IGF. At 80% confluency, cells were passed using TrypLE Express (Invitrogen) into 96-well plates at a density of cells/well in DMEM/F12 containing 2% FBS. Cells were allowed to adhere to the substrate for 1 hour in a humidified incubator held at 37 C with 5% CO2, prior to the addition of activin-A ranging from 50 to 100ng/ml, Wnt3a ranging from 10 to 20ng/ml, IGF ranging from 10 to 50ng/ml, and 50 to 100 nM GSK-3B inhibitor (IX). At 24, and 96 hours, cell viability was determined using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega). Briefly, MTS reagent was added to the 96-well plates and allowed to incubate with the cells for 1-4 hours and then reading the absorbance at 490nm on a plate reader. The absorbance reading was directly proportional to the number of living cells. Figure 39 a-c shows the absorbance readings at a) 24 hrs, b) 48 hrs, and c) 96 hrs post seeding.
[0277] Publications cited throughout this document are hereby incorporated by reference in their entirety. Although the various aspects of the invention have been illustrated above by reference to examples and preferred embodiments, it will be appreciated that the scope of the invention is defined not by the foregoing description but by the following claims properly construed under principles of patent law.

Table IA: List of primary antibodies used for FACS and immuno staining analysis.
Antibody Supplier Isotype Catalog#
SSEA-1 Chemicon (CA) Mouse IgM MAB4301 SSEA-3 Chemicon (CA) Mouse IgG3 MAB4303 SSEA-4 Chemicon (CA) Rat IgM MAB1435 TRA 1-60 Chemicon (CA) Mouse IgM MAB4360 TRA 1-81 Chemicon (CA) Mouse IgM MAB4381 TRA 1-85 Chemicon (CA) Mouse IgGI MAB4385 AP R&D Systems Mouse IgG1 FAB1448A
(MN) HNF3 R R&D Systems Goat IgG AF2400 PDX1 Santa Cruz Goat IgG
Biotechnology, INC
(CA) sc-14664 GATA4 R&D Systems Goat IgG AF2606 Sox 17 R&D Systems Goat IgG AF1924 CD 9 BD Bioscience Mouse IgG1 341647 (CA) CXCR4 R&D Systems Mouse IgG2A FAB 170A
SOX2 R&D Systems Goat IgG AF2018 Nanog R&D Systems Goat IgG AF1997 OCT4 R&D Systems Goat IgG AF1759 Gata6 R&D Systems Goat IgG AF 1700 Ecad R&D Systems Mouse IgG MAB1838 Ncam R&D Systems Mouse IgG MAB777 HNF1b R&D Systems Goat IgG AF3330 b-catenin R&D Systems Mouse IgG MAB13291 HNF1a BD Bioscience Mouse IgG 610902 CD99 Invitrogen (CA) Mouse IgG 18-0235 Cerebus Santa Cruz Goat IgG

Biotechnology, INC SC15131 Hex Santa Cruz Goat IgG

Biotechnology, INC SC15129 AFP R&D Systems Mouse IgG MAB1269 Antitrypsin DAKO (CA) Rabbit A0012 islet 1 R&D Systems Goat IgG AF1837 Table IB: List of secondary conjugated antibodies used for FACS and immuno staining analysis.

Secondary Conjugated Supplier Dilution Antibody Goat Anti-Mouse IgG APC Jackson ImmunoResearch 1:200 conjugated (PA) Goat Anti-Mouse IgG PE Jackson ImmunoResearch 1:200 conjugated (PA) Donkey anti-rabbit PE or - Jackson ImmunoResearch 1:200 APC conjugated (PA) Donkey anti-goat PE or - Jackson ImmunoResearch 1:200 APC conjugated (PA) Goat anti-mouse IgM PE SouthernBiotech (AL) 1:200 Goat anti-Rat IgM PE SouthernBiotech (AL) 1:200 Goat anti-mouse IgG3 PE SouthernBiotech (AL) 1:200 Table II List of primers used for real-time PCR analysis using TAQMAN probes Primer/Probe Catelog Number 18s 4310893E
ABCG2 Hs00184979m 1 AchE Hs00241307_ml AFP Hs00173490ml ALB Hs0060941 1 _m 1 alpha-antitrypsi n Hs02384981 _m 1 Amylase Hs00420710_g 1 AP Hs00240993_m 1 Atoh1 Hs00944192_sl B3Tubulin Hs00964962_gl B-Cate n i n Hs99999168_m 1 Barx1 Hs00222053m 1 Brachyury (T) Hs00610080_ml CCK Hs00174937_m 1 Cdx1 Hs00156451ml Cdx2 Hs00230919_ml CE B Pa Hs00269972s 1 CE B Pb Hs00942496_s 1 Cerberus Hs00193796ml CFC1 (Cripto) Hs00414425ml CGA H s00174938_m 1 CK19(KRT19) Hs00761767_s1 CLDN4 (claudin4) Hs00533616_sl C-Myc Binding Protein Hs00429315_gl Connexin32 (GJB-1) Hs00939759_s1 Connexin45 Hs00271416_sl CTN N (31 Hs00170025_m 1 CXCR4 Hs00237052_m 1 Cylcin-D1 Hs00277039_ml Dapper1 (DACT-1) Hs00420410_m1 DKK1 Hs00183740m 1 DKK4 Hs00205290m 1 Endoglin Hs00164438_m1 Exo1 Hs00243513_ml F3 Hs00175225_m 1 FAH Hs00164611 m 1 FGF4 H s00173564_m 1 FG F 10 H s00610298_m 1 FGFR1 Hs00241111ml FG F R3 H s00179839_m 1 FG F R4 H s00242558m 1 F I k1 Hs00911705_g 1 FOXA1 Hs00270129_m 1 FOXA3 Hs00270130_m 1 FOXD3 Hs00255287_s 1 FOXF 1 Hs00230962_m 1 GAPDH (human) 4310884E
Gastrin Hs00174945_m 1 GATA1 Hs00231112_ml GATA4 Hs00171403_m1 GATAS Hs00388359 m1 GATA6 Hs00232018_ml GCK Hs00175951_m1 GFAP Hs00157674_ml GIP H s00175030m 1 Gli Hs01110766ml Glucagon Hs00174967_ml Glut-2 Hs00165775ml Goosecoid Hs00418279_m 1 GS H s00374213m 1 Handyl Hs00231848_ml HB9 Hs00232128m 1 Hest Hs00172878_m1 Hex1 Hs00172696_ml HEYL Hs00232718ml HHIP (hedgehog interacting protein) Hs01011009_m1 hHIF1a Hs00153153ml HNF1 Hs00167041_m1 HNF1a Hs00167041ml HNF1(3 Hs00172123_m1 H N F3 R H s00232764m 1 H N F4a Hs00230853m 1 HNF6 (onecut) Hs00413554_ml HoxB1 Hs00157973_ml IBSP Hs00173720_ml Insulin II Hs00355773_ml Islet-1 Hs00158126m 1 Jagged-1 (JAG1) Hs00164982_m1 KDR Hs00176676m 1 KRT15 Hs00267035_m 1 MafA Hs00999118_m 1 MAML1 Hs00207373ml Map2 Hs00159041 _m 1 MapK14 Hs00176247_ml MapK8 Hs00177083_m1 MBP (myelin basic protein) Hs00921945_ml M ixl 1 Hs00430824_g 1 MMP1 (matrix metal loprotease1) Hs00233958_ml MOX1 Hs00793059ml MSX1 Hs00427183_m 1 M uci n 1 Hs00904328m 1 Mucin2 Hs00159374_ml MyfS Hs00271574_m 1 MyoD 1 Hs00159528_m 1 N-Cadherin (CDH2) Hs00169953_m1 N-Cam 1 Hs00169851 m 1 N E F H Hs00606024m 1 N E F L Hs00196245_m 1 Nestin Hs00707120_s1 NeuroD1 Hs00159598_m1 Ngn3 Hs00360700_gl N kx2.1 Hs00163037_m 1 N kx2.2 Hs00159616m 1 N kx6.1 Hs00232355m 1 Notch l Hs01062014_m 1 NTS Hs00175048_m1 02 Hs00377820m 1 Oct3/4 H s00742896_s 1 OTX2 Hs00222238ml Pax3 Hs00240950ml Pax4 Hs00173014 ml Pax6 Hs00240871_ml Pax8 Hs00247586_ml Pax9 Hs00196354ml PDX-1 (IPF1) Hs00236830_ml Ptch (Patched) Hs00970985ml PTF1a Hs00603586_gl PYY HsO1062281ml RA receptor alpha Hs00230907_ml RALDH Hs01125173ml RBPSUH Hs00794653ml Rexl (ZFP42) Hs00399279_ml SCGB1 Hs00171092ml Secretin Hs00360814_q 1 sFRP Hs00610060_m 1 sFRP5 Hs00169366ml S H H Hs00179843_m 1 SLC5A8 HsO1068911ml Snail Hs00195591_ml Snai2 Hs00161904ml Somatostatin Hs00174949_m 1 Soxl Hs00534426_sl Sox10 Hs00366918ml Soxl7 see "Soxl7" tab Sox2 Hs00602736sl Sox3 Hs00271627_sl Sox7 Hs00846731_sl Sox9 Hs00165814ml Sparc Hs00234160_m 1 SP-C Hs00161628m 1 TBX6 Hs00365539_ml Tert Hs00162669_ml TH B D Hs00264920s 1 Twistl Hs00361186_m 1 UtF1 Hs00747497_gl Vim Hs00185584_ml Wnt3a (human) Hs01055707ml Wnt3a (mouse) Mm00437337_ml WT1 HsO1103754m 1 Zicl Hs00604749m 1 Zic2 Hs00600845 m1 Table III List of EXPRES lines generated from Hl & H9 parent lines ID# ES Day of derivation Media used to propagate cells Parent during DE
line, differentiation Passage number EXPRES O1 H9P54 Day 4 Growth media + 50 ng/ml IGF-I
EXPRES 02 H9P54 Day 6 DM-F12-+ 2% FBS +100 ng/ml AA +20 ng/ml VVNT-3A (growth media) EXPRES 03 H9P39 Day 3 Growth media + 50 ng/ml IGF-I
EXPRES 04 H9P39 Day 4 Growth media + 50 ng/ml IGF-I
EXPRES 05 H9P39 Day 5 Growth media + 50 ng/ml IGF-I
EXPRES 06 H9P49 Day 5 Growth media EXPRES 07 H1P50 Day 5 Growth media EXPRES 08 H1P39 Day 4 Growth media + 50 ng/ml IGF-I + 0.1mM
mercaptoethanol EXPRES 09 H1P39 Day 6 Growth media + 50 ng/ml IGF-I + 0.1mM
mercaptoethanol EXPRES 10 H1P49 Day 4 Growth media EXPRES 11 H9P30 Day 4 Growth media + 50 ng/ml IGF-I + 0.1mM
mercaptoethanol EXPRES 12 H9P30 Day 6 Growth media + 50 ng/ml IGF-I + 0.1mM
mercaptoethanol Table IV Expression of cell surface markers by EXPRES 01 and 02 lines Marker EXPRES 01- % Expression EXPRES 02- % Expression SSEA-3 100 86(85-88) SSEA-4 100 87(83-88) CD56 (NCAM) <1 38(35-40) CXCR4 <1 20(10-25) SSEA-1 <1 26(9-32) E-cadherin 90 (85-95) 75 (72-79) CD9 99 66 (62-68) CD30 97 (96-98) 43 (40-46) LIF-receptor <1 20 (15-21) CD 117 92(90-95) 73 (67-75) Table V DIFFERENTIAL EXPRESSION OF GENES BETWEEN
UNDIFFERENTIATED EMBRYONIC STEM CELLS CULTURED ON
MATRIGELTM AND EXPRES 01 (A) AND 02 (B) CELLS CULTURED ON
TCPS
A) ES vs EXPRES 01- Intensity values are in Log2 format.

ES EXPRES Ratio Direction adj. p- Gene Gene Name 01 value Identifier -5.03662 3.037629 269.52 Up 8.34E-05 BG09943 ESTs -2.82645 3.094183 60.57 Up 3.88E-03 NM_0134 Homo sapiens glutamate 45 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 -4,71714 0,9,618 16 51,23 U p .\ O5 A4,7964,6,9 A`:-\ \ ,\\ prote-an, 3 _,a- .,..,.b :,v,=+ a 002051A

; b:: C ::307:.
-1.57973 4.092731 51 Up 6.13E-03 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 -2.24566 3.409815 50.4 Up 1.19E-03 NM_0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 -0.66473 4.897427 47.25 Up 1.97E-04 R06655 ESTs, Moderately similar to AF078844 1 hqp0376 protein (H.sapiens) -2.96204 2.589425 46.9 Up 1.79E-03 NM 0013 Homo sapiens cysteine-11 rich protein 1 (intestinal) (CRIP1), mRNA.
/PROD=cysteine-rich protein 1 (intestinal) /FL=gb:U58630.1 g b: 60002738.1 gb:NM_001311.1 g b: U09770.1 -0.08298 5.388254 44.36 Up 2.48E-04 NM_0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 -4,21,525 1,240929 ',3 ' U p 3 6 '\; 10=` H = n o sap, aen'w ' b o`0a'st 11 n .^ \i,=\'", 1 factor' a ndr'~~~ge (FGF `` a; R A.
r'o"w th factor ... U336, 23, a ate: ` '3. 2 .1 -3.11273 2.306225 42.78 Up 5.07E-03 AW44476 ESTs -4.05111 1.075159 34.93 Up 1.19E-03 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 -1.81534 3.025351 28.65 Up 7.00E-04 AW59092 ESTs -2.36335 2.448218 28.08 Up 1.62E-02 A1189359 mevalonate (diphospho) decarboxylase /F L=g b: N M_002461.1 g b: 60000011.1 g b: U49260.1 -3.00328 1.794842 27.82 Up 7.77E-03 A1571798 Rho GDP dissociation inhibitor (GDI) alpha -4.17258 0.510307 25.69 Up 2.29E-04 A1040887 ESTs -0.11332 4.420733 23.17 Up 8.78E-05 NM_0036 Homo sapiens basic helix-70 loop-helix domain containing, class B, 2 (BHLHB2), mRNA.
/PROD=differentiated embryo chondrocyte expressed genet /FL=gb:AB004066.1 g b: N M_003670.1 -1.94 2.590871 23.12 Up 3.90E-03 NM_0165 Homo sapiens TBX3-iso 69 protein (TBX3-iso), mRNA. /PROD=TBX3-iso protein /F L=g b: N M_016569.1 gb:AF216750.1 -2.18113 2.33099 22.82 Up 1.12E-02 NM_0040 Homo sapiens arrestin, 41 beta 1 (ARRB1), transcript variant 1, mRNA.
/PROD=arrestin beta 1, isoform A
/FL=gb:B0003636.1 gb:AF084040.1 g b: N M_004041.2 -2.85963 1.609384 22.15 Up 6.37E-03 80005961 Homo sapiens, parathyroid hormone-like hormone, clone MGC:14611, mRNA, complete cds.
/PROD= parathyroid hormone-like hormone /FL=gb:B0005961.1 0.044298 4.505436 22.03 Up 4.17E-05 W57613 ESTs -3.65051 0.757197 21.23 Up 7.11 E-04 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 -1.25226 2.990178 18.93 Up 2.70E-04 NM_0134 Homo sapiens glutamate 45 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 -0.63516 3.41866 16.61 Up 1.05E-03 AA149250 ESTs, Weakly similar to PROTEIN PRECURSOR
(R. norvegicus) -0.14916 3.880272 16.33 Up 8.45E-04 NM_0025 Homo sapiens natriuretic 21 peptide precursor B
(NPPB), mRNA.
/PROD=natriuretic peptide precursor B
/F L=g b: N M_002521.1 gb:M25296.1 -2.88485 1.143234 16.31 Up 2.83E-03 BF437711 ESTs -2.7136 1.194285 15.01 Up 2.14E-02 NM_0018 Homo sapiens cystatin SN
98 (CST1), mRNA.
/PROD=cystatin SN
/FL=gb:J03870.1 g b: N M_001898.1 -0.07353 3.816817 14.83 Up 1.62E-02 AF116616 Homo sapiens PR00998 mRNA, complete cds.
/PROD=PRO0998 /FL=gb:AF1 16616.1 -1.44577 2.422113 14.6 Up 1.34E-02 AL544576 ESTs 2.301255 6.091008 13.83 Up 6.50E-05 BC020935 Homo sapiens, Similar to otoconin 90, clone IMAGE:4277593, mRNA.
3.006559 6.79047 13.77 Up 8.80E-05 A1263909 ras homolog gene family, member B
/F L=g b: N M_004040.1 -0.512 3.268087 13.74 Up 2.96E-03 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 3.484047 7.24746 13.58 Up 4.12E-04 NM_0035 Homo sapiens transgelin 2 64 (TAGLN2), mRNA.
/PROD=transgelin 2 /FL=gb:D21261.1 g b: N M_003564.1 2.623145 6,382732 13,54 Up 7,32E-05 A s50*.. 66 no a mouse, i omo,oq 2.91184 6.66195 13.46 Up 1.44E-04 80002616 Homo sapiens, transgelin 2, clone MGC:2989, mRNA, complete cds.
/PROD=transgelin 2 /F L=g b: 60002616.1 -1.18027 2.546953 13.24 Up 1.42E-02 All23555 ESTs -0.92213 2.770179 12.93 Up 1.08E-04 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
-1.85154 1.840613 12.93 Up 6.40E-03 A1949760 ESTs, Weakly similar to unnamed protein product (H.sapiens) 0.899321 4.507212 12.19 Up 1.08E-04 AW19694 ESTs 1.651788 5.252439 12.13 Up 5.58E-05 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 -1.20347 2.387268 12.05 Up 2.76E-02 BF063186 ESTs 3.669215 7.251816 11.98 Up 2.01 E-05 NM_0007 Homo sapiens annexin Al 00 (ANXA1), mRNA.
/PROD=annexin I
/FL=gb:B0001275.1 g b: N M_000700.1 -3.52039 0.041471 11.81 Up 1.58E-02 AW16221 Homo sapiens cDNA
0 FLJ11490 fis, clone 3.006317 6.564471 11.78 Up 2.04E-04 NM_0061 Homo sapiens 83 neurotensin (NTS), mRNA.
/PROD=neurotensin precursor /F L=g b: N M_006183.2 gb:U91618.1 3.227575 6.777916 11.72 Up 2.01E-05 U15174 Homo sapiens BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3) mRNA, complete cds.
/PROD=BCL2adenovirus El B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 1.869893 5.411751 11.65 Up 2.01 E-05 NM _0018 Homo sapiens collagen, 54 type X1, alpha 1 (COL11A1), mRNA.
/PROD=collagen, type XI, alpha 1 /FL=gb:J04177.1 g b: N M_001854.1 2.851479 6.371229 11.47 Up 3.61 E-05 A1950472 ESTs -0.1081 3.393761 11.33 Up 1.39E-03 BG02859 ESTs 0.41954 3.911282 11.25 Up 1.42E-04 A1670948 ESTs -1.71451 1.771584 11.21 Up 7.77E-03 B1254089 Homo sapiens full length insert cDNA clone -1.66293 1.80547 11.07 Up 2.68E-02 NM_0008 Homo sapiens glutamate 17 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD67, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_000817.1 gb:M81883.1 gb:L16888.1 0.451086 3.904705 10.96 Up 5.45E-04 NM_0070 Homo sapiens a 38 disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) (ADAMTS5), mRNA.
/PROD=a disintegrin and metalloprotease withthrombospondin motifs-5 preproprotein /F L=g b: N M_007038.1 gb:AF14209 -1.44798 1.988376 10.83 Up 1.07E-02 AW37686 ESTs 1.19822 4.633038 10.81 Up 1.22E-04 NM_0169 Homo sapiens NADPH
31 oxidase 4 (NOX4), mRNA.
/PROD=NADPH oxidase 4 /FL=gb:AF261943.1 gb:NM_016931.1 gb:AF254621.1 gb:AB041035.1 1.552808 4.981033 10.76 Up 3.24E-04 NM_0006 Homo sapiens serine (or 02 cysteine) proteinase inhibitor, Glade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINEI), mRNA.
/PROD=serine (or cysteine) proteinase inhibitor, cladeE (nexin, plasminogen activator inhibitor type 1), membe -0.62725 2.792215 10.7 Up 3.24E-04 BC017942 Homo sapiens, Similar to otoconin 90, clone IMAGE:4285317, mRNA.
-1.22834 2.18828 10.68 Up 2.50E-02 BG40285 ESTs -0.85366 2.55067 10.59 Up 3.53E-04 N36408 hypothetical protein /F L=g b: N M_024530.1 1.55625 4.952105 10.53 Up 1.52E-03 BG16436 microtubule-associated protein 1 B
/F L=g b: N M_005909.1 0.93094 4.285883 10.23 Up 4.17E-05 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 -3.33551 0.008356 10.15 Up 9.88E-03 BF221850 ESTs -1.97569 1.35098 10.03 Up 2.12E-02 NM_0021 Homo sapiens 49 hippocalcin-like 1 (HPCAL1), mRNA.
/PROD=hippocalcin-like 1 /F L=g b: N M_002149.1 gb:D16227.1 0.624024 3.934756 9.92 Up 2.01 E-05 AF 154054 Homo sapiens DRM
(DRM) mRNA, complete cds. /PROD=DRM
/F L=g b: N M_013372.1 gb:AF110137.2 gb:AF045800.1 gb:AF154054.1 -2.37515 0.931587 9.9 Up 2.83E-02 NM_0251 Homo sapiens 36 hypothetical protein FLJ22187 (FLJ22187), mRNA.
/PROD=hypothetical protein FLJ22187 /FL=gb:B0005059.1 g b: N M_025136.1 0.906004 4.154799 9.51 Up 1.45E-04 NM _0133 Homo sapiens cysteine 72 knot superfamily 1, BMP
antagonist 1 (CKTSF1B1), mRNA. /PROD=cysteine knot superfamily 1, BMP
antagonist 1 /F L=g b: N M_013372.1 gb:AF110137.2 gb:AF045800.1 gb:AF154054.1 1.423659 4.64236 9.31 Up 2.01 E-05 AB019695 Homo sapiens mRNA for thioredoxin reductase II
beta, complete cds.
/PROD=thioredoxin reductase II beta /FL=gb:ABO19695.1 0.620478 3.822765 9.2 Up 6.53E-05 AL567376 G protein-coupled receptor 39 2.317589 5.509474 9.14 Up 1.02E-05 J04177 Cluster Incl.
J04177:Human alpha-1 type XI collagen (COL11A1) mRNA, complete cds /cds=(161,5581) /g b=J041 77 /g i=179729 /ug=Hs.82772 /len=6158 -0.01596 3.175621 9.14 Up 9.88E-03 L37033 Cluster Incl.
L37033:Human FK-506 binding protein homologue (FKBP38) mRNA, complete cds /cds=(140,1207) /gb=L37033 /gi=965469 /ug=Hs.173464 /len=1613 3.119777 6.302535 9.08 Up 5.07E-03 A1954041 F-box only protein 9 /F L=g b: N M_012347.1 0.891337 4.058968 8.99 Up 1.66E-04 NM_0003 Homo sapiens paired-like 25 homeodomain transcription factor 2 (PITX2), mRNA.
/PROD=paired-like homeodomain transcription factor 2 /F L=g b: N M_000325.1 gb:U69961.1 gb:AF048720.1 2.106895 5.247359 8.82 Up 2.13E-04 NM_0014 Homo sapiens filamin C, 58 gamma (actin-binding protein-280) (FLNC), mRNA. /PROD=gamma filamin /F L=g b:AF089841.1 g b: N M_001458.1 -1.42687 1.693258 8.69 Up 2.43E-02 AF243424 Homo sapiens SG2NA
beta isoform mRNA, partial cds.
/PROD=SG2NA beta isoform 0.657996 3.771559 8.66 Up 2.06E-02 AU 158380 Homo sapiens cDNA
FLJ13698 fis, clone 0.23287 3.334996 8.59 Up 2.01 E-05 R40917 phosphodiesterase 4D, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E3) /F L=g b: L20969.1 g b: N M_006203.1 g b: U02882.1 -0.06159 3.027095 8.51 Up 3.60E-04 U16797 Human LERK-5 (EPLG5) mRNA, complete cds.
/PROD=LERK-5 /FL=gb:U 16797.1 g b: N M_004093.1 gb:L38734.1 gb:U81262.1 4.07051 7.149479 8.45 Up 4.86E-05 M10943 Human metallothionein-If gene (hMT-If) -0.35204 2.705807 8.33 Up 1.09E-03 80004490 Homo sapiens, v-fos FBJ
murine osteosarcoma viral oncogene homolog, clone MGC:11074, mRNA, complete cds. /PROD=v-fos FBJ murine osteosarcoma viral oncogenehomolog /F L=g b: N M_005252.2 g b: 60004490.1 -2.0132 1.043139 8.32 Up 3.61 E-02 BE328496 hypothetical protein /FL=gb:AF1 16683.1 gb:NM_018615.1 -0.68954 2.36447 8.31 Up 8.94E-04 NM_0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 gb:NM_005181.2 -0.00953 3.031935 8.23 Up 9.88E-03 AA831438 Mad4 homolog 3.079271 6.1137 8.19 Up 4.17E-05 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 0.788995 3.806044 8.1 Up 6.41 E-05 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 0.9926 4.004698 8.07 Up 8.48E-05 A1202327 ESTs 0.051719 3.059444 8.04 Up 6.98E-04 NM_0073 Homo sapiens pleckstrin 50 homology-like domain, family A, member 1 (PHLDA1), mRNA.
/PROD=pleckstrin homology-like domain, family A, member 1 /F L=g b: N M_007350.1 -1.69103 1.312148 8.02 Up 1.82E-03 U32500 Human type 2 neuropeptide Y receptor mRNA, complete cds.
/PROD=type 2 neuropeptide Y receptor /FL=gb:U42766.1 gb:U36269.1 gb:U32500.1 -0.93931 2.060071 8 Up 6.51 E-03 AA004300 hypothetical protein D KFZp5661133 1.164666 4.161028 7.98 Up 2.51 E-03 80005807 Homo sapiens, clone MGC:10264, mRNA, complete cds.
/PROD=Unknown (protein for MGC:10264) /FL=gb:B0005807.1 2.462987 5.441963 7.88 Up 1.45E-04 NM_0166 Homo sapiens 51 heptacellular carcinoma novel gene-3 protein (LOC51339), mRNA.
/PROD=heptacellular carcinoma novel gene-3 protein /F L=g b: N M_016651.2 gb:AF251079.2 0.581498 3.560033 7.88 Up 1.07E-04 U38945 Human hypothetical 18.1 kDa protein (CDKN2A) mRNA, complete cds.
/FL=gb:U38945.1 gb:U26727.1 0.470814 3.417829 7.71 Up 8.26E-03 AF176039 Homo sapiens high mobility group protein-R
mRNA, complete cds.
/PROD=high mobility group protein-R
/F L=g b:AF 176039.1 -1.50663 1.438639 7.7 Up 7.38E-04 BF223214 ESTs -2.43082 0.495104 7.6 Up 1.71 E-02 BF508288 ESTs 1.084464 4.009912 7.6 Up 1.16E-03 80004865 Homo sapiens, cleft lip and palate associated transmembrane protein 1, clone MGC:10593, mRNA, complete cds.
/PROD=cleft lip and palate associated transmembraneprotein 1 /F L=g b: 60004865.1 4.232374 7.152167 7.57 Up 1.54E-03 BF971587 tubulin, beta polypeptide /F L=g b: 60001352.1 . ..
0 .1,29 `15 S,S.+'~. ~~~ 7,5,*,- D426.3 . Up 141 7E == 0 \ . NV n~M+~ 005~~~
Homo \:,3~i;3 ~'.~
..i-.1.... ..~. . L~4. ~:5.+..+

\eE opus k eev~s mRNA, 'PROD zeon esod~
Xe n,opu i 4s) i b: N~~ 0` 5 4 ti 2.
-0.20075 2.710846 7.52 Up 2.58E-02 NM_0033 Homo sapiens vascular 77 endothelial growth factor B (VEGFB), mRNA.
/PROD=vascular endothelial growth factor B /FL=gb:NM_003377.1 gb:U43368.1 gb:U52819.1 -0.45681 2.439084 7.44 Up 7.82E-03 A1417362 ESTs, Moderately similar to ALU1_HUMAN ALU
SUBFAMILY J
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.155309 3.037724 7.37 Up 8.78E-04 NM_0070 Homo sapiens serum 61 constituent protein (MSE55), mRNA.
/PROD=serum constituent protein /FL=gb:M88338.1 g b: N M_007061.1 1.506057 4.362244 7.24 Up 7.30E-05 NM_0014 Homo sapiens epithelial 25 membrane protein 3 (EMP3), mRNA.
/PROD=epithelial membrane protein 3 /F L=g b: U 52101.1 g b: N M_001425.1 gb:U87947.1 -1.75194 1.091177 7.18 Up 3.15E-02 NM_0215 Homo sapiens BarH-like 70 homeobox 1 (BARX1), mRNA. /PROD=BarH-like homeobox 1 /F L=g b: N M_021570.2 gb:AF213356.1 2.455614 5.294065 7.15 Up 9.88E-03 AF279899 Homo sapiens PNAS-145 mRNA, complete cds.
/PROD=PNAS-145 /FL=gb:U03105.1 g b: N M_006813.1 gb:AF279899.1 1.422626 4.257559 7.14 Up 2.01 E-05 NM_0063 Homo sapiens 65 transcriptional activator of the c-fos promoter (CROC4), mRNA.
/PROD=transcriptional activator of the c-fos promoter /F L=g b: N M_006365.1 gb:U49857.1 -2.40588 0.424388 7.11 Up 1.64E-02 NM_0024 Homo sapiens myelin 33 oligodendrocyte glycoprotein (MOG), mRNA. /PROD=myelin of igode nd rocyte g lycoprote i n /FL=gb:U 18798.1 gb:U64564.1 g b: N M_002433.1 -1.86904 0.959227 7.1 Up 4.35E-02 AB033831 Homo sapiens hSCDGF
mRNA for spinal cord-derived growth factor, complete cds.
/PROD=spinal cord-derived growth factor /F L=g b: N M_016205.1 gb:AB033831.1 gb:AF091434.1 gb:AF244813.1 1.811736 4.639749 7.1 Up 1.09E-03 M27830 Human 28S ribosomal RNA gene, complete cds.
-0.54131 2.28595 7.1 Up 3.63E-03 BE504838 ESTs 4.065536 6.887587 7.07 Up 4.08E-04 NM_0057 Homo sapiens nuclear 96 transport factor 2 (placental protein 15) (PP15), mRNA.
/PROD=nuclear transport factor 2 (placental protein 15) /F L=g b: 60002348.1 gb:NM_005796.1 gb:U43939.1 -0.4348 2.379408 7.03 Up 4.24E-03 BF686824 death-associated protein kinase 3 /FL=gb:AB007144.1 gb:AB022341.1 g b: N M_001348.1 1.448288 4.255531 7 Up 2.01 E-05 AF096296 Homo sapiens thymic stroma chemokine-1 precursor, mRNA, complete cds.
/PROD=thymic stroma chemokine-1 precursor /F L=g b:AF 142434.1 gb:AF096296.1 gb:AF124601.1 gb:ABO10447.1 g b: N M_006072.1 3.504052 6.307554 6.98 Up 4.05E-05 NM_0066 Homo sapiens serum-22 inducible kinase (SNK), mRNA. /PROD=serum-inducible kinase /FL=gb:AF059617.1 g b: N M_006622.1 gb:AF223574.1 2.124541 4.927935 6.98 Up 8.80E-05 J05008 Homo sapiens endothelin-1 (EDN1) gene, complete cds /FL=gb:NM_001955.1 1.872394 4.674078 6.97 Up 1.02E-05 AK022852 Homo sapiens cDNA
FLJ 12790 fis, clone NT2RP2001985, weakly similar to Homo sapiens high-risk human papilloma viruses E6 oncoproteins targeted protein E6TP1 alpha mRNA.
1.764338 4.563535 6.96 Up 1.43E-04 AA909044 tryptase, alpha 1.401293 4.178686 6.86 Up 1.66E-04 NM_0032 Homo sapiens tissue 56 inhibitor of metalloproteinase 4 (TIMP4), mRNA.
/PROD=tissue inhibitor of metal loprotei nase 4precursor /F L=g b: N M_003256.1 gb:U76456.1 0.767075 3.54446 6.86 Up 1.88E-03 AY029208 Homo sapiens type VI
collagen alpha 2 chain precursor (COL6A2) mRNA, complete cds, alternatively spliced.
/PROD=type VI collagen alpha 2 chain precursor /F L=g b:AY029208.1 -1.94468 0.831091 6.85 Up 1.92E-02 NM_1530 Homo sapiens 36 hypothetical protein FLJ32239 (FLJ32239), mRNA.
/F L=g b: N M_153036.1 0.586923 3.359675 6.83 Up 4.17E-05 NM_0000 Homo sapiens 47 arylsulfatase E
(chondrodysplasia punctata 1) (ARSE), mRNA.
/PROD=arylsulfatase E
precursor /FL=gb:X83573.1 g b: N M_000047.1 1.064878 3.834572 6.82 Up 2.41 E-04 NM_0026 Homo sapiens pyruvate dehydrogenase kinase, isoenzyme 1 (PDK1), nuclear gene encoding mitochondrial protein, mRNA. /PROD=pyruvate dehydrogenase kinase, isoenzyme 1 /F L=g b: N M_002610.2 g b: L42450.1 -0.11882 2.64743 6.8 Up 6.88E-04 A1702438 ESTs -0.34208 2.418198 6.78 Up 2.31 E-04 A1860150 ESTs, Weakly similar to A49134 Ig kappa chain V-1 region (H.sapiens) 4.156522 6.9125 6.76 Up 6.48E-05 NM_0032 Homo sapiens 40 endometrial bleeding associated factor (left-right determination, factor A;
transforming growth factor beta superfamily) (EBAF), mRNA.
/PROD=transforming growth factor, beta 4 /FL=gb:U81523.1 g b: N M_003240.1 gb:AF081513.1 -1.8911 0.860193 6.73 Up 2.83E-03 NM_0011 Homo sapiens BCL2-like 1 91 (BCL2L1), mRNA.
/PROD=BCL2-like 1 /F L=g b: N M_001191.1 -0.53771 2.208449 6.71 Up 1.41 E-02 A1806338 T-box 3 (ulnar mammary syndrome) /FL=gb:AF170708.2 g b: N M_005996.1 3.824397 6.568635 6.7 Up 1.66E-04 AL031602 Human DNA sequence from clone RP5-1174N9 on chromosome 1p34.1-35.3. Contains the gene for a novel protein with IBR domain, a (pseudo?) gene for a novel protein similar to MT1 E
(metallothionein 1 E
(functional)), ESTs, STSs, GSSs and two putative Cp...
0.001822 2.741586 6.68 Up 4.44E-05 NM_0049 Homo sapiens cAMP
04 response element-binding protein CRE-BPa (H_GS165L15.1), mRNA.
/PROD=cAMP response element-binding protein CRE-BPa /F L=g b: N M_004904.1 g b: L05911.1 0.301216 3.030236 6.63 Up 4.76E-04 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 4.63387 7.360687 6.62 Up 4.17E-05 BF217861 metallothionein 1E
(functional) 0.413191 3.124723 6.55 Up 5.00E-02 AL136925 Homo sapiens mRNA;
cDNA DKFZp586H1320 (from clone D KFZp586 H 1320);
complete cds.
/PROD=hypothetical protein /FL=gb:AL136925.1 -0.28056 2.427947 6.54 Up 1.39E-03 AW09018 dihydropyrimidinase-like 4 7 /FL=gb:NM_006426.1 gb:AB006713.1 1.095892 3.804014 6.53 Up 2.43E-04 NM_0011 Homo sapiens 46 angiopoietin 1 (ANGPT1), mRNA.
/PROD=angiopoietin 1 /F L=g b: N M_001146.1 gb:D13628.1 gb:U83508.1 -0.0845 2.62025 6.52 Up 2.59E-04 AA625683 ESTs 2.13274 4.835771 6.51 Up 2.01 E-04 AL574210 serine (or cysteine) proteinase inhibitor, Glade E (nexin, plasminogen activator inhibitor type 1), member 1 /F L=g b: N M_000602.1 g b: M 16006.1 -0.64252 2.055951 6.49 Up 2.10E-04 NM_0010 Homo sapiens ryanodine 35 receptor 2 (cardiac) (RYR2), mRNA.
/PROD=ryanodine receptor 2 (cardiac) /F L=g b: N M_001035.1 4.450364 7.144308 6.47 Up 3.61 E-05 BF246115 RNA helicase-related protein 0.405368 3.094055 6.45 Up 6.25E-05 AW18819 tumor necrosis factor, 8 alpha-induced protein 6 /F L=g b: N M_007115.1 -0.34351 2.332751 6.39 Up 5.54E-05 NM_0000 Homo sapiens cyclin-77 dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), mRNA. /PROD=cyclin-dependent kinase inhibitor 2A (melanoma,pl6, inhibits CDK4) /F L=g b: N M_000077.1 g b: L27211.1 -0.88122 1.790331 6.37 Up 1.37E-03 AA775681 hypothetical protein 3.508565 6.179917 6.37 Up 8.80E-05 NM_0001 Homo sapiens glucan 58 (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) (GBE1), mRNA.
/PROD=glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme) /FL=gb:L07956.1 g b: N M_000158.1 -1.84589 0.82486 6.37 Up 3.13E-03 AV705309 ESTs -0.18263 2.487276 6.36 Up 1.49E-02 A0006942 Homo sapiens chromosome 19, cosmid 3.759854 6.426778 6.35 Up 2.01 E-05 AF313413 Homo sapiens putative small membrane protein NID67 mRNA, complete cds. /PROD=putative small membrane protein /FL=gb:AF313413.1 2.4094 5.066795 6.31 Up 3.61 E-05 A1809870 HSKM-B protein -2.08089 0.570296 6.28 Up 7.70E-03 BC016043 Homo sapiens, hypothetical protein MGC2865, clone MGC:20246 IMAGE:4635389, mRNA, complete cds.
/FL=gb:BC016043.1 1.37641 4.004952 6.18 Up 1.20E-04 AU 148611 Human pTR7 mRNA for repetitive sequence 1.384716 4.012773 6.18 Up 4.52E-04 NM_0062 Homo sapiens splicing 75 factor, arginineserine-rich 6 (SFRS6), mRNA.
/PROD=splicing factor, arginineserine-rich 6 /F L=g b: U 30883.1 g b: N M_006275.1 2.979212 5.604053 6.17 Up 1.52E-04 M27830 Human 28S ribosomal RNA gene, complete cds.
0.310893 2.921559 6.11 Up 3.42E-04 NM_0072 Homo sapiens U2 small 79 nuclear ribonucleoprotein auxiliary factor (65kD) (U2AF65), mRNA.
/PROD=U2 small nuclear ribonucleoprotein auxiliaryfactor (65kD) /F L=g b: N M_007279.1 0.65284 3.256353 6.08 Up 2.49E-04 A1819043 ESTs 1.609773 4.213168 6.08 Up 1.35E-04 M29277 Human isolate JuSo MUC18 glycoprotein mRNA (3 variant), complete cds.
/PROD=MUC18 g lycoprote i n /FL=gb:M29277.1 -0.62167 1.968272 6.02 Up 4.11 E-04 A1963304 ESTs 4.459837 7.047717 6.01 Up 1.02E-04 NM_0040 Homo sapiens 52 BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3), nuclear gene encoding mitochondrial protein, mRNA.
/PROD=BCL2adenovirus El B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 3.178404 5.762898 6 Up 1.27E-04 AB037810 Homo sapiens mRNA for KIAA1389 protein, partial cds. /PROD=KIAA1389 protein -1.08931 1.494664 6 Up 2.35E-03 AB020683 Homo sapiens mRNA for KIAA0876 protein, partial cds. /PROD=KIAA0876 protein 1.9194 4.501184 5.99 Up 3.61 E-05 AK0001 62 Homo sapiens cDNA
FLJ20155 fis, clone COL08754, highly similar to ACSA_ECOLI
ACETYL-COENZYME A
SYNTHETASE.
0.671205 3.243641 5.95 Up 2.48E-04 AA463626 ESTs 0.091029 2.660133 5.93 Up 9.55E-04 AF277174 Homo sapiens PNAS-137 mRNA, complete cds.
/PROD=PNAS-1 37 /FL=gb:AF277174.1 1.479222 4.042679 5.91 Up 6.34E-05 NM_0054 Homo sapiens cerberus 1 54 (Xenopus laevis) homolog (cysteine knot superfamily) (CER1), mRNA. /PROD=cerberus 1 /FL=gb:NM_005454.1 -0.29455 2.259676 5.87 Up 2.79E-03 AF312393 Homo sapiens leucine-zipper protein FKSG13 (FKSG13) mRNA, complete cds.
/PROD=leucine-zipper protein FKSG13 /FL=gb:AF312393.1 -0.81321 1.740607 5.87 Up 3.72E-02 NM_0021 Homo sapiens 60 hexabrachion (tenascin C, cytotactin) (HXB), mRNA.
/PROD=hexabrachion (tenascin C, cytotactin) /FL=gb:M55618.1 g b: N M_002160.1 0.167058 2.720179 5.87 Up 1.02E-04 NM_0212 Homo sapiens myosin 23 light chain 2a (LOC58498), mRNA.
/PROD=myosin light chain 2a /FL=gb:NM_021223.1 0.901323 3.451092 5.86 Up 3.05E-05 NM_0057 Homo sapiens purinergic 67 receptor (family A group 5) (P2Y5), mRNA.
/PROD=purinergic receptor (family A group 5) /FL=gb:AF000546.1 g b: N M_005767.1 1.007578 3.543738 5.8 Up 2.13E-04 NM_0019 Homo sapiens endothelin 55 1 (EDN1), mRNA.
/PROD=endothelin 1 /F L=g b: N M_001955.1 1.327779 3.862686 5.8 Up 1.51 E-04 NM_0071 Homo sapiens tumor 15 necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA.
/PROD=tumor necrosis factor, alpha-induced protein 6 /F L=g b: N M_007115.1 -0.2077 2.32716 5.8 Up 1.52E-04 AA211909 ESTs 1.304257 3.835269 5.78 Up 3.02E-04 NM_0054 Homo sapiens enigma 51 (LIM domain protein) (ENIGMA), mRNA.
/PROD=enigma protein /F L=g b: 60001093.1 g b: N M_005451.2 gb:AF265209.1 -0.30113 2.227329 5.77 Up 4.58E-03 BE968750 Homo sapiens ryanodine receptor 2 (cardiac) (RYR2), mRNA
1.678635 4.204607 5.76 Up 9.75E-05 AA086229 enigma (LIM domain protein) 1.411335 3.932627 5.74 Up 1.58E-02 NM_0033 Homo sapiens vasodilator-70 stimulated phosphoprotein (VASP), mRNA.
/PROD=vasodilator-stimulated phosphoprotein /F L=g b: N M_003370.1 -1.32153 1.183922 5.68 Up 2.72E-02 AF217536 Homo sapiens truncated mevalonate kinase mRNA, partial cds, alternatively spliced. /PROD=truncated mevalonate kinase 1.058988 3.560886 5.66 Up 3.56E-03 H05812 insulin-like growth factor 1 receptor /F L=g b: N M_000875.2 4.435207 6.93459 5.65 Up 3.61 E-05 AF078844 Homo sapiens hqp0376 protein mRNA, complete cds. /PROD=hgp0376 protein /F L=g b:AF078844.1 2.418835 4.908301 5.62 Up 3.47E-03 NM_0122 Homo sapiens similar to 68 vaccinia virus Hindlll K4L
ORF (HU-K4), mRNA.
/PROD=similar to vaccinia virus Hindlll K4L ORF
/F L=g b: U 60644.1 gb:B0000553.1 g b: N M_012268.1 -0.56112 1.927121 5.61 Up 6.37E-03 AL041124 hypothetical protein -1.63462 0.844727 5.58 Up 4.98E-03 A1831874 ESTs -0.34446 2.130828 5.56 Up 3.75E-05 NM_0063 Homo sapiens sema 79 domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
(SEMA3C), mRNA.
/PROD=sema domain, immunoglobulin domain (Ig), shortbasic domain, secreted, (semaphorin) 3C
/F L=g b: N M_006379.1 gb:AB000220.1 4.143258 6.618477 5.56 Up 1.18E-05 AU146532 pyruvate dehydrogenase kinase, isoenzyme 1 -0.52233 1.950739 5.55 Up 1.54E-03 A1091047 solute carrier family 2 (facilitated glucose transporter), member 1 /F L=g b: K03195.1 g b: N M_006516.1 0.690529 3.155168 5.52 Up 9.91 E-04 BC033088 Homo sapiens, Similar to lamin AC, clone MGC:45654 IMAGE:3623265, mRNA, complete cds.
/PROD=Similar to lamin AC /FL=gb:BC033088.1 -0.00098 2.454314 5.48 Up 2.48E-04 NM_0132 Homo sapiens fibronectin 81 leucine rich transmembrane protein 3 (FLRT3), mRNA.
/PROD=fibronectin leucine rich transmembrane protein 3 /FL=gb:AF169677.1 g b: N M_013281.1 -0.87622 1.577138 5.48 Up 1.84E-02 M15329 Human interleukin 1-alpha (ILIA) mRNA, complete cds. /PROD=interleukin 1-alpha /FL=gb:M15329.1 5.117294 7.564809 5.45 Up 6.25E-05 M83248 Human nephropontin mRNA, complete cds.
/PROD=nephropontin /F L=g b: M83248.1 2.352834 4.796495 5.44 Up 4.17E-05 A1653107 ESTs 3.27933 5.719116 5.43 Up 3.24E-04 NM_0166 Homo sapiens type 1 39 transmembrane protein Fn14 (FN14), mRNA.
/PROD=type I
transmembrane protein Fn14 /F L=g b: N M_016639.1 g b: B0002718.1 gb:AB035480.1 gb:AF191148.1 -2.06232 0.368788 5.39 Up 6.40E-03 AA148534 pregnancy-associated plasma protein A
/F L=g b: N M_002581.1 gb:U28727.1 3.982825 6.413408 5.39 Up 7.48E-05 AA678241 stearoyl-CoA desaturase (delta-9-desaturase) /FL=gb:AB032261.1 gb:AF097514.1 g b: N M_005063.1 0.399566 2.809822 5.32 Up 7.81 E-04 AF 144103 Homo sapiens NJAC
protein (NJAC) mRNA, complete cds.
/PROD=NJAC protein /FL=gb:AF144103.1 gb:AF106911.1 gb:AF073957.1 gb:B0003513.1 g b: N M_004887.1 4.15299 6.560926 5.31 Up 6.59E-05 NM_0009 Homo sapiens 35 procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2 (PLOD2), mRNA.

/PROD=procollagen-lysine, 2-oxoglutarate 5-dioxygenase(lysine hydroxylase) 2 /F L=g b: N M_000935.1 gb:U84573.1 0.319769 2.724257 5.29 Up 8.94E-04 AL552534 Human mRNA for CD44 antigen, 5UTR (sequence from the 5cap to the start codon).
3.347359 5.750515 5.29 Up 5.27E-03 AF047002 Homo sapiens transcriptional coactivator ALY mRNA, partial cds.
/PROD=transcriptional coactivator ALY
4.571448 6.973787 5.29 Up 3.53E-04 A1631159 solute carrier family 2 (facilitated glucose transporter), member 3 /F L=g b: N M_006931.1 g b: M20681.1 1.93843 4.333496 5.26 Up 1.21 E-04 NM 0198 Homo sapiens 86 carbohydrate (N-acetylglucosamine 6-0) sulfotransferase 7 (CHST7), mRNA.
/PROD=carbohydrate (N-acetylglucosamine 6-O)sulfotransferase 7 /F L=g b: N M_019886.1 gb:AB037187.1 gb:AB04071 1.1 -0.3185 2.064012 5.21 Up 1.55E-03 U83508 Human angiopoietin-1 mRNA, complete cds.
/PRO D=ang iopoieti n-1 /F L=g b: N M_001146.1 gb:D13628.1 gb:U83508.1 1.484424 3.866551 5.21 Up 3.49E-04 80000076 Homo sapiens, cyclin D1 (PRAD1: parathyroid adenomatosis 1), clone MGC:2316, mRNA, complete cds.
/PROD=cyclin D1 (PRAD1: parathyroid adenomatosis 1) /FL=gb:M73554.1 g b: 60000076.1 4.465458 6.844763 5.2 Up 1.52E-04 AF003114 Homo sapiens CYR61 mRNA, complete cds.
/FL=gb:AF003114.1 -1.33756 1.041706 5.2 Up 8.51 E-03 BF196010 ESTs 3.747557 6.125638 5.2 Up 4.52E-04 AA554833 neuroendocrine secretory protein 55 -0.24196 2.129273 5.17 Up 2.80E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 2.657439 5.023981 5.16 Up 1.66E-04 NM_0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.

/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 1.275689 3.642133 5.16 Up 1.65E-04 BF982289 ESTs, Weakly similar to elastin like protein (D.melanogaster) 2.11271 4.458591 5.08 Up 1.97E-04 H15920 ESTs, Weakly similar to RTA RAT PROBABLE G
PROTEIN-COUPLED
RECEPTOR RTA
(R. norvegicus) 2.624088 4.968498 5.08 Up 1.45E-04 M28882 Human MUC18 glycoprotein mRNA, complete cds.
/PROD=MUC18 g lycoprote i n /F L=g b: M28882.1 4.046173 6.388326 5.07 Up 6.34E-05 NM 0156 Homo sapiens testin 41 (DKFZP586B2022), mRNA. /PROD=testin /FL=gb:B0001451.1 gb:AF245357.1 gb:AF245356.1 g b: N M_015641.1 0.946455 3.284436 5.06 Up 5.46E-04 BM97693 Homo sapiens cDNA
9 FLJ31611 fis, clone NT2R12002923.
1.389207 3.725552 5.05 Up 1.08E-04 AL136805 Homo sapiens mRNA;
cDNA DKFZp434J1521 (from clone DKFZp434J 1521);
complete cds.
/PROD=hypothetical protein /FL=gb:AL136805.1 0.710433 3.041407 5.03 Up 1.08E-03 NM 0044 Homo sapiens forkhead 72 box D1 (FOXD1), mRNA.
/PROD=forkhead box D1 /F L=g b: U 59832.1 gb:NM_004472.1 2.800881 5.127991 5.02 Up 6.53E-05 NM_0178 Homo sapiens 17 hypothetical protein FLJ20429 (FLJ20429), mRNA.
/PROD=hypothetical protein FLJ20429 /F L=g b: N M_017817.1 0.432778 2.759117 5.02 Up 2.50E-03 A1692523 ESTs -0.94056 1.385676 5.01 Up 4.17E-03 A1927458 Homo sapiens mRNA;
cDNA DKFZp434A196 (from clone DKFZp434A1 96);
complete cds 0.224112 2.550074 5.01 Up 4.11 E-04 BF060767 ESTs -0.47823 1.845598 5.01 Up 2.75E-03 AA489100 ESTs 4.590104 -3.36994 249.01 Down 2.26E-04 AA167449 nuclear receptor subfamily 1, group 1, member 3 6.024741 -1.32044 162.6 Down 1.79E-03 AF017987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF01 7987.1 gb:AF001900.1 1.940449 -5.04898 127.07 Down 3.05E-05 BE644917 nuclear receptor subfamily 1, group I, member 3 2.68759 -3.61621 79 Down 1.25E-03 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds 5.005827 -1.03397 65.79 Down 1.30E-04 NM_0030 Homo sapiens secretory 20 granule, neuroendocrine protein 1 (7B2 protein) (SGNE1), mRNA.
/PROD=secretory granule, neuroendocrine protein 1 (7B2protein) /F L=g b: 60005349.1 g b: N M_003020.1 0.357833 -5.67924 65.67 Down 2.26E-03 BG38978 Human mRNA
9 upregulated during ca m ptothec i n-induced apoptosis of U937 cells.
6.500961 0.756526 53.61 Down 4.17E-05 NM 0030 Homo sapiens secreted 12 frizzled-related protein 1 (SFRP1), mRNA.
/PROD=secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 2.077151 -3.59883 51.13 Down 3.75E-03 BF223193 nuclear receptor subfamily 1, group I, member 3 3.29779 -2.3376 49.71 Down 3.05E-05 U17496 Human proteasome subunit LMP7 (allele LMP7B) mRNA, complete cds. /PROD=proteasome subunit LMP7 /F L=g b: U 17497.1 g b: U 17496.1 4.803291 -0.78667 48.17 Down 3.75E-05 AA628440 nuclear receptor subfamily 1, group I, member 3 4.124115 -1.42293 46.75 Down 7.16E-04 AW26231 ESTs 2.437935 -3.10907 46.75 Down 2.41 E-04 BE672557 ESTs 4.276201 -1.19736 44.43 Down 9.47E-04 AV699347 nuclear receptor subfamily 1, group I, member 3 1.710253 -3.7619 44.39 Down 8.66E-05 NM_0161 Homo sapiens transient 79 receptor potential channel 4 (TRPC4), mRNA.
/PROD=transient receptor potential 4 /F L=g b: N M_016179.1 gb:AF175406.1 2.313549 -3.12747 43.44 Down 5.45E-04 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) 2.835599 -2.26295 34.26 Down 2.50E-03 A1735586 ESTs 0.588183 -4.50758 34.2 Down 2.89E-04 AU1 18882 endothelin receptor type A
/F L=g b: N M_001957.1 g b: L06622.1 0.349102 -4.73558 33.93 Down 2.50E-02 BM68235 Homo sapiens cDNA
2 FLJ37204 fis, clone BRALZ2006976.
-0.10303 -5.00884 29.98 Down 1.97E-04 NM 0221 Homo sapiens melanoma 68 differentiation associated protein-5 (MDAS), mRNA.
/PROD=melanoma differentiation associated protein-5 /FL=gb:AY017378.1 g b: N M_022168.1 gb:AF095844.1 2.325274 -2.506 28.47 Down 1.35E-04 AW19369 DKFZP566K1924 protein 0.252976 -4.55112 27.94 Down 2.54E-02 NM _0180 Homo sapiens 43 hypothetical protein FLJ10261(FLJ10261), mRNA.
/PROD=hypothetical protein FLJ10261 /F L=g b: N M_018043.1 2.719388 -2.08299 27.9 Down 1.72E-02 NM 0020 Homo sapiens growth 48 arrest-specific 1 (GAS1), mRNA. /PROD=growth arrest-specific 1 /F L=g b: N M_002048.1 g b: L 13698.1 3.257726 -1.54343 27.88 Down 6.25E-05 NM 0043 Homo sapiens bone 35 marrow stromal cell antigen 2 (BST2), mRNA.
/PROD=bone marrow stromal cell antigen 2 /F L=g b: N M_004335.2 gb:D28137.1 4.353788 -0.41404 27.24 Down 4.72E-04 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 4.387855 -0.27888 25.4 Down 6.82E-05 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 0.027478 -4.62508 25.15 Down 9.89E-03 NM 1526 Homo sapiens 47 hypothetical protein FLJ32800 (FLJ32800), mRNA.
/F L=g b: N M_152647.1 1.767203 -2.80617 23.81 Down 4.44E-04 A1742043 ESTs 1.665643 -2.69521 20.55 Down 1.08E-04 AF282250 Homo sapiens calneuron 1 (CALN 1) mRNA, complete cds.
/PROD=calneuron 1 /F L=g b:AF282250.1 0.414323 -3.84422 19.14 Down 3.42E-04 AF283777 Homo sapiens clone TCBAP0702 mRNA
sequence.
3.779853 -0.4664 18.98 Down 4.72E-04 AV646597 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.995324 -2.233 18.74 Down 1.01 E-03 NM 0148 Homo sapiens KIAA0307 62 gene product (KIAA0307), mRNA. /PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 1.946332 -2.24096 18.22 Down 2.40E-03 BG16670 small inducible cytokine subfamily B (Cys-X-Cys), member 5 (epithelial-derived neutrophil-activating peptide 78) 1.179963 -2.9904 18.01 Down 2.13E-04 U96136 Homo sapiens delta-catenin mRNA, complete cds. /PROD=delta-catenin /F L=g b: N M_001332.1 gb:U72665.1 gb:AB013805.1 gb:U96136.1 gb:AF035302.1 2.060687 -2.07873 17.62 Down 1.01 E-03 A1269290 solute carrier family 18 (vesicular monoamine), member 2 /F L=g b: L 14269.1 gb:L23205.1 gb:L09118.1 g b: N M_003054.1 2.480221 -1.64839 17.49 Down 1.22E-03 NM 0049 Homo sapiens phorbolin 00 (similar to apolipoprotein B
mRNA editing protein) (DJ742C19.2), mRNA.
/PROD=phorbolin (similar to apolipoprotein B
mRNAediting protein) /F L=g b: N M_004900.1 gb:U61083.1 0.971941 -3.12304 17.09 Down 1.07E-02 NM_0180 Homo sapiens 18 hypothetical protein FLJ10191 (FLJ10191), mRNA.
/PROD=hypothetical protein FLJ10191 /F L=g b: N M_018018.1 2.263194 -1.81469 16.89 Down 2.69E-03 AF052108 Homo sapiens clone 23687 mRNA sequence.

2.115848 -1.84267 15.55 Down 3.89E-02 AF213678 Homo sapiens HAI-2 related small protein (HAl-2) mRNA, complete cds.
/PROD=HAI-2 related small protein /FL=gb:AB038317.1 gb:AF213678.1 2.348373 -1.56046 15.02 Down 7.77E-03 NM 0163 Homo sapiens solute 54 carrier family 21 (organic anion transporter), member 12 (SLC21A12), mRNA. /PROD=organic anion transporter OATP-E
/FL=gb:AB031051.1 gb:NM_016354.1 gb:AF205072.1 gb:AF187817.1 1.910263 -1.99418 14.97 Down 3.77E-04 NM 0069 Homo sapiens 94 butyrophilin, subfamily 3, member A3 (BTN3A3), mRNA.
/PROD=butyrophilin, subfamily 3, member A3 /FL=gb:U90548.1 g b: N M_006994.2 2.699795 -1.16113 14.53 Down 5.07E-03 NM_0122 Homo sapiens potassium 81 voltage-gated channel, Shal-related subfamily, member 2 (KCND2), mRNA. /PROD=potassium voltage-gated channel, S ha l-re lated s u bfa m i l y, member 2 /F L=g b: N M_012281.1 gb:AB028967.1 gb:AF121104.1 2.172559 -1.66608 14.31 Down 7.83E-03 BE673445 Homo sapiens chromosome 19, cosmid 0.265765 -3.53873 13.97 Down 2.21 E-03 A1675836 Human DNA sequence from clone RP11-446H 13 on chromosome 10.
Contains the 3 end of the gene for a novel protein similar to KIAA1059 (ortholog of mouse VPS10 domain receptor protein SORCS), an RPL23A
(60S ribosmal protein 23A) pseudogene, ESTs, STSs an 5.440506 1.644236 13.89 Down 6.34E-05 M34455 Human interferon-gamma-inducible indoleamine 2,3-dioxygenase (IDO) mRNA, complete cds.
/F L=g b: N M_002164.1 gb:M34455.1 0.330556 -3.45471 13.79 Down 5.46E-04 BE972639 ESTs 0.437404 -3.31877 13.51 Down 4.52E-04 H05254 ESTs 1.32524 -2.42314 13.44 Down 1.57E-02 H29627 ESTs 1.673028 -2.06656 13.36 Down 5.30E-03 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 1.319614 -2.39234 13.1 Down 1.43E-02 NM_0043 Homo sapiens catenin 89 (cadherin-associated protein), alpha 2 (CTNNA2), mRNA.
/PROD=catenin (cadherin-associated protein), alpha 2 /FL=gb:NM_004389.1 gb:M94151.2 1.708627 -1.98647 12.95 Down 1.75E-02 NM _0175 Homo sapiens KIAA0449 96 protein (KIAA0449), mRNA.
/PROD=hypothetical protein DKFZp434J212 /F L=g b: N M_017596.1 2.777148 -0.8902 12.71 Down 4.36E-04 NM_0220 Homo sapiens estrogen 34 regulated gene 1 (ERG-1), mRNA. /PROD=estrogen regulated gene 1 /FL=gb:AF305835.1 g b: N M_022034.1 1.982765 -1.67669 12.64 Down 6.88E-04 BE672659 ESTs 0.457009 -3.18081 12.45 Down 3.30E-04 AW44981 KIAA0918 protein 0.510314 -3.12055 12.39 Down 1.71 E-02 AW78000 ESTs 0.536704 -3.05382 12.05 Down 1.92E-02 AL049250 Homo sapiens mRNA;
cDNA DKFZp564D1 13 (from clone DKFZp564D1 13).
2.294336 -1.27392 11.86 Down 1.66E-02 U11058 Homo sapiens large conductance calcium- and voltage-dependent potassium channel alpha subunit (MaxiK) mRNA, complete cds.
/PROD=large conductance calcium- and voltage-dependentpotassium channel alpha subunit /FL=gb:U23767.1 g b: N M_002247.1 gb:AF025999 2.177763 -1.38062 11.78 Down 8.80E-05 NM 0025 Homo sapiens 90 protocadherin 8 (PCDH8), mRNA.
/PROD=protocadherin 8 /F L=g b: N M_002590.2 gb:AF061573.2 -0.48821 -4.01809 11.55 Down 2.29E-02 AB040812 Homo sapiens mRNA for protein kinase PAK5, complete cds.
/PROD=protein kinase PAK5 /FL=gb:AB040812.1 1.785431 -1.74236 11.53 Down 2.18E-03 R15072 ESTs 1.459269 -2.00069 11 Down 3.74E-04 NM_0002 Homo sapiens 77 phenylalanine hydroxylase (PAH), mRNA.
/PROD=phenylalanine hydroxylase /FL=gb:U49897.1 g b: N M_000277.1 1.995493 -1.44407 10.85 Down 7.11 E-03 U91903 Human Fritz mRNA, complete cds.
/PROD=Fritz /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 0.679665 -2.7484 10.76 Down 5.57E-03 80000568 Homo sapiens, clone MGC:3040, mRNA, complete cds.
/PROD=Unknown (protein for MGC:3040) /F L=g b: 60000568.1 1.841888 -1.57619 10.69 Down 1.16E-03 AW07279 contactin 1 -0.42571 -3.8118 10.45 Down 1.58E-02 AK023699 Homo sapiens cDNA
FLJ13637 fis, clone PLACE 1011165.
1.923237 -1.4606 10.44 Down 4.11 E-04 AW07210 Homo sapiens mRNA;
2 cDNA DKFZp434H2O5 (from clone DKFZp434H2O5) 0.931661 -2.45074 10.43 Down 1.07E-02 AW14940 neurexin 1 /FL=gb:AB035356.1 0.781816 -2.56699 10.19 Down 2.50E-02 NM_0006 Homo sapiens 98 arachidonate 5-lipoxygenase (ALOX5), mRNA.
/PROD=arachidonate 5-l i poxyge nase /F L=g b: N M_000698.1 gb:J03600.1 gb:J03571.1 1.939598 -1.40726 10.17 Down 2.29E-03 AB014737 Homo sapiens mRNA for SMAP-2b, complete cds.
/PROD=SMAP-2b /FL=gb:AB014737.1 0.874376 -2.46854 10.15 Down 1.59E-02 U82671 Homo sapiens chromosome Xq28 melanoma antigen family A2a (MAGEA2A), melanoma antigen family A12 (MAGEA12), melanoma antigen family A2b (MAGEA2B), melanoma antigen family A3 (MAGEA3), caltractin (CALT), NAD(P)H
dehydrogenase-like protein (NSDHL), a...
3.315768 0.011663 9.88 Down 7.33E-04 AK098525 Homo sapiens cDNA

FLJ25659 fis, clone TST00427, highly similar to Mus musculus hedgehog-interacting protein (Hip) mRNA.
0.121165 -3.1782 9.84 Down 4.65E-03 A1985987 ESTs, Moderately similar to ALU1_HUMAN ALU
SUBFAMILY J
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.686587 -2.59339 9.71 Down 2.72E-02 NM_0004 Homo sapiens proprotein 39 convertase subtilisinkexin type 1 (PCSK1), mRNA.
/PROD=proprotein convertase subtilisinkexin type 1 /F L=g b: N M_000439.2 gb:M90753.1 3.113317 -0.0881 9.2 Down 7.30E-05 AL565745 ESTs, Weakly similar to 2108402A carnitine palmitoyltransferase I
(H.sapiens) 2.890305 -0.29832 9.12 Down 3.24E-04 NM 0154 Homo sapiens 74 DKFZP564AO32 protein (DKFZP564AO32), mRNA.
/PROD=DKFZP564AO32 protein /F L=g b:AF228421.1 gb:AL050267.1 gb:AB013847.1 g b: N M_015474.1 0.447048 -2.73882 9.1 Down 4.19E-02 BE645435 ESTs 3.142124 -0.03564 9.05 Down 3.76E-03 AL832535 Homo sapiens mRNA;
cDNA DKFZp547J1816 (from clone DKFZp547J 1816).
0.767101 -2.38787 8.91 Down 1.92E-02 80003517 Homo sapiens, clone IMAGE:3542589, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3542589) 4.315048 1.168713 8.85 Down 7.92E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 80003079.1 -0.47937 -3.61302 8.78 Down 2.49E-02 BE968773 Homo sapiens mRNA;
cDNA DKFZp564O1262 (from clone DKFZp564O1262) 3.26376 0.151239 8.65 Down 1.74E-04 BE644809 ESTs 0.384182 -2.72567 8.63 Down 3.02E-02 NM_0058 Homo sapiens RAS
25 guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), mRNA. /PROD=RAS
guanyl releasing protein 2 (calcium andDAG-regulated) /FL=gb:AF043723.1 g b: N M_005825.1 2.363587 -0.72928 8.53 Down 7.38E-04 NM_0246 Homo sapiens 45 hypothetical protein FLJ 13842 (F LJ 13842), mRNA.
/PROD=hypothetical protein FLJ13842 /F L=g b: N M_024645.1 4.756657 1.668488 8.5 Down 1.30E-04 AV715309 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.995551 -2.07915 8.43 Down 3.01 E-02 NM0053 Homo sapiens neuronatin 86 (NNAT), mRNA.
/PROD=neuronatin /F L=g b: N M_005386.1 gb:B0001768.1 gb:AB002392.1 gb:U25033.1 2.380226 -0.68921 8.39 Down 8.34E-05 NM 0165 Homo sapiens 46 complement C1 r-like proteinase precursor, (LOC51279), mRNA.
/PROD=complement C1 r-like proteinase precursor, /FL=gb:AF178985.1 g b: N M_016546.1 2.598916 -0.46577 8.37 Down 6.59E-05 AW05159 ESTs, Moderately similar 1 to unnamed protein product (H.sapiens) 1.045717 -2.01579 8.35 Down 1.44E-02 A1937060 KIAA1151 protein 3.009579 -0.04543 8.31 Down 7.08E-04 AB037730 Homo sapiens mRNA for KIAA1309 protein, partial cds. /PROD=KIAA1309 protein 1.440541 -1.60998 8.29 Down 1.58E-02 BE503640 ESTs 0.4785 -2.56291 8.23 Down 2.46E-02 BG53269 integrin, alpha 4 (antigen 0 CD49D, alpha 4 subunit of VLA-4 receptor) 5.84374 2.812887 8.17 Down 6.34E-05 80000069 Homo sapiens, retinoic acid receptor responder (tazarotene induced) 2, clone MGC:1544, mRNA, complete cds.
/PROD=retinoic acid receptor responder (tazaroteneinduced) 2 /F L=g b: 80000069.1 g b: N M_002889.2 gb:AB015632.1 gb:U77594.1 1.110683 -1.89628 8.04 Down 8.48E-04 AA557324 ESTs, Weakly similar to fatty acid omega-hydroxylase (H.sapiens) 1.386384 -1.61585 8.01 Down 3.53E-04 AF 196571 Homo sapiens Delta-like-1 protein (DLL1) mRNA, complete cds.
/PROD=Delta-like-1 protein /F L=g b: N M_005618.2 gb:AF196571.1 5.363884 2.372618 7.95 Down 7.30E-05 NM 0070 Homo sapiens 15 chondromodulin I
precursor (CHM-I), mRNA.
/PROD=chondromodulin I
precursor /F L=g b: N M_007015.1 g b:AB006000.1 1.364581 -1.62447 7.94 Down 2.16E-02 NM 1452 Homo sapiens similar to 80 hepatocellular carcinoma-associated antigen HCA557b (LOC151194), mRNA.
/F L=g b: 60009462.1 g b: N M_145280.1 2.628136 -0.35867 7.93 Down 1.22E-04 NM 0019 Homo sapiens endothelin 57 receptor type A (EDNRA), mRNA.
/PROD=endothelin receptor type A
/F L=g b: N M_001957.1 g b: L06622.1 1.712212 -1.25121 7.8 Down 8.48E-04 R62432 Cluster Incl.
R62432:yg52e11.s1 Homo sapiens cDNA, 3 end /clone=IMAGE-36023 /clone end=3 /gb=R62432 /gi=834311 /ug=Hs.12321 /len=487 1.443731 -1.51616 7.78 Down 4.37E-03 AJ272267 Homo sapiens partial mRNA for choline dehydrogenase (chdh gene). /PROD=choline dehydrogenase 3.106596 0.148375 7.77 Down 1.23E-02 NM 0023 Homo sapiens lectin, 05 galactoside-binding, soluble, 1 (galectin 1) (LGALS1), mRNA.
/PROD=beta-galactosidase binding lectin precursor /F L=g b: N M_002305.2 g b: 60001693.1 gb:J04456.1 1.961633 -0.98665 7.72 Down 8.93E-03 NM 0014 Homo sapiens frizzled-63 related protein (FRZB), mRNA. /PROD=frizzled-related protein /FL=gb:U24163.1 g b: U68057.1 g b: N M_001463.1 gb:U91903.1 2.38092 -0.54428 7.6 Down 6.34E-04 AF053712 Homo sapiens osteoprotegerin ligand mRNA, complete cds.
/PROD=osteoprotege ri n ligand /FL=gb:AF053712.1 gb:AF01 9047.1 0.685413 -2.22507 7.52 Down 2.98E-02 NM_0183 Homo sapiens 83 hypothetical protein FLJ11294(FLJ11294), mRNA.
/PROD=hypothetical protein FLJ11294 /F L=g b: N M_018383.1 -0.24717 -3.14972 7.48 Down 3.67E-04 AF429305 Homo sapiens C23up NORMS mRNA, partial sequence; alternatively spliced.
3.893148 0.997757 7.44 Down 1.29E-04 AU 144892 Homo sapiens cDNA
FLJ1 1569 fis, clone 0.82553 -2.06523 7.42 Down 4.10E-02 BC041933 Homo sapiens, clone IMAGE:5300703, mRNA.
0.728978 -2.13318 7.27 Down 1.25E-03 AL573058 complement component 1, r subcomponent 1.033324 -1.8148 7.2 Down 5.93E-03 N80918 Novel human gene mapping to chomosome 2.858719 0.013383 7.19 Down 4.37E-03 L10374 Human (clone CTG-A4) mRNA sequence.
2.260317 -0.57539 7.14 Down 1.02E-03 All 38603 ESTs 2.003902 -0.82254 7.09 Down 8.00E-03 BF109660 ESTs 3.85985 1.037668 7.07 Down 2.70E-04 R40892 ESTs 3.921983 1.12675 6.94 Down 3.53E-04 AA206141 ESTs -0.17018 -2.96268 6.93 Down 2.08E-02 AV741130 ESTs, Moderately similar to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.610685 -1.16078 6.83 Down 9.82E-04 AA886335 Homo sapiens serologically defined breast cancer antigen NY-BR-20 mRNA, partial cds 2.859538 0.089114 6.82 Down 2.22E-03 AW01473 ESTs 3.212409 0.467551 6.7 Down 2.69E-04 BG43417 Homo sapiens cDNA
4 FLJ13555 fis, clone 2.116702 -0.60252 6.59 Down 3.35E-03 AF107846 Homo sapiens ne u roe ndocri ne-specific Golgi protein p55 (XLalphas) gene, exon XL2 and complete cds 3.179908 0.462842 6.58 Down 3.24E-04 U82811 Human homeodomain-containing protein (HANF) mRNA, complete cds.

/PROD=HANF
/F L=g b: U 82811.1 g b: N M_003865.1 2.509452 -0.20066 6.54 Down 1.04E-03 NM _0016 Homo sapiens acyl-09 Coenzyme A
dehydrogenase, shortbranched chain (ACADSB), nuclear gene encoding mitochondrial protein, mRNA.
/PROD=acyl-Coenzyme A
dehydrogenase, shortbranchedchain precursor /FL=gb:U 12778.1 g b: N M_001609.1 2.596054 -0.10733 6.51 Down 1.39E-03 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) 0.559211 -2.13754 6.48 Down 2.20E-02 BF000203 ESTs 4.534853 1.872557 6.33 Down 9.75E-05 R38389 olfactomedin related ER
localized protein 2.068166 -0.59258 6.32 Down 1.69E-03 BF698797 ESTs 2.168796 -0.49174 6.32 Down 2.44E-04 NM_0025 Homo sapiens neuronal 22 pentraxin I (NPTX1), mRNA. /PROD=neuronal pentraxin I precursor /F L=g b: N M_002522.1 gb:U61849.1 -0.10024 -2.75761 6.31 Down 3.60E-02 BC033812 Homo sapiens, Similar to LOC1 55399, clone MGC:45477 IMAGE:5181460, mRNA, complete cds.
/PROD=Similar to /FL=gb:BC033812.1 0.994947 -1.65385 6.27 Down 7.39E-03 NM 0240 Homo sapiens 34 hypothetical protein MGC3129 similar to ganglioside-induced differentiation-associated protein (MGC3129), mRNA.
/PROD=hypothetical protein MGC3129 similar toga ng l ios ide-induced differentiation-associated protein /F L=g b: N M_024034.1 gb:BCO
3.758058 1.109291 6.27 Down 4.39E-04 NM 0053 Homo sapiens 56 lymphocyte-specific protein tyrosine kinase (LCK), mRNA.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 gb:NM_005356.1 gb:M36881.1 1.553207 -1.09181 6.26 Down 2.54E-02 A1653050 ESTs, Weakly similar to HPPD_HUMAN 4-HYDROXYPHENYLPYRU
VATE DIOXYGENASE
(H.sapiens) 3.702164 1.060081 6.24 Down 4.08E-04 U26662 Human neuronal pentraxin 11 (NPTX2) mRNA, partial cds. /PROD=neuronal pentraxin 11 4.260791 1.638346 6.16 Down 6.25E-05 AA603344 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 2.172331 -0.44991 6.16 Down 2.44E-04 NM_0038 Homo sapiens tumor 39 necrosis factor receptor superfamily, member 11a, activator of NFKB
(TNFRSF1 1A), mRNA.
/PROD=tumor necrosis factor receptor superfamily, member 11a, activator of NFKB
/F L=g b: N M_003839.1 gb:AF018253.1 4.981307 2.359848 6.15 Down 4.17E-05 NM 0051 Homo sapiens 03 fasciculation and elongation protein zeta 1 (zygin 1) (FEZ1), transcript variant 1, mRNA.
/PROD=zygin 1, isoform 1 /F L=g b: U 60060.1 gb:U69139.1 g b: N M_005103.2 3.826815 1.207679 6.14 Down 6.48E-05 BG40156 Homo sapiens mRNA;
8 cDNA DKFZp434H1235 (from clone DKFZp434H1235); partial cds 1.027188 -1.59055 6.14 Down 8.40E-03 BG16983 adenylate kinase 5 2 /FL=gb:NM_012093.1 gb:AF062595.1 2.054962 -0.54704 6.07 Down 2.86E-03 NM_0028 Homo sapiens 00 proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional protease 2) (PSMB9), mRNA.
/PROD=proteasome (prosome, macropain) subunit, betatype, 9 (large multifunctional protease 2) /FL=gb:U01025.1 g b: N M_002800.1 5.372736 2.7744 6.06 Down 8.80E-05 AA669799 Cluster Incl.
AA669799:ag 36c04.s l Homo sapiens cDNA, 3 end /clone=IMAGE-1118886 /clone end=3 /gb=AA669799 /gi=2631298 /ug=Hs.6315 /len=679 0.24636 -2.3444 6.02 Down 1.31 E-03 AW05758 ESTs 1.145878 -1.44369 6.02 Down 9.46E-03 A1056877 Human DNA sequence from clone RP4-530115 on chromosome 20. Contains the 3 end of the PTPN1 gene for protein tyrosine phosphatase, non-receptor type 1 (EC
3.1.3.48), the gene for a novel protein similar to placental protein DIFF40, an RPL36 (60S Ribos 0.976009 -1.61054 6.01 Down 5.39E-03 AW26420 ESTs 0.497515 -2.08762 6 Down 2.83E-02 AF052117 Homo sapiens clone 23809 mRNA sequence.
0.381933 -2.20139 5.99 Down 8.66E-04 A1913749 ESTs 0.528494 -2.05438 5.99 Down 4.17E-02 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 3.795925 1.232161 5.91 Down 2.20E-04 NM_0046 Homo sapiens N-myc (and 88 STAT) interactor (NMI), mRNA. /PROD=N-myc and STAT interactor /FL=gb:B0001268.1 g b: N M_004688.1 g b: U 32849.1 1.934415 -0.62283 5.89 Down 4.93E-04 NM 0013 Homo sapiens deleted in 51 azoospermia-like (DAZL), mRNA. /PROD=deleted in azoospermia-like /FL=gb:U66726.2 g b: N M_001351.1 gb:U65918.1 gb:U66078.1 1.805448 -0.75007 5.88 Down 1.88E-03 A1681917 ESTs, Highly similar to CLASS HOMEODOMAIN

(M.musculus) 2.788534 0.237692 5.86 Down 7.40E-03 AW45092 heterogeneous nuclear 9 ribonucleoprotein Al 2.99034 0.457208 5.79 Down 5.23E-04 NM_0029 Homo sapiens small 93 inducible cytokine subfamily B (Cys-X-Cys), member 6 (granulocyte chemotactic protein 2) (SCYB6), mRNA.
/PROD=small inducible cytokine subfamily B(Cys-X-Cys), member 6 (granulocyte chemotactic protein 2) /FL=gb:U81234.1 g b: N M_00299 0.362564 -2.17012 5.79 Down 1.28E-02 AB018580 Homo sapiens mRNA for hluPGFS, complete cds.
/PROD=hluPGFS
/F L=g b: N M_003739.2 gb:AF149416.2 gb:AB018580.1 gb:D17793.1 1.673874 -0.85315 5.76 Down 8.93E-03 NM_0059 Homo sapiens myosin, 65 light polypeptide kinase (MYLK), mRNA.
/PROD=myosin, light polypeptide kinase /FL=gb:AB037663.1 gb:AF069601.2 g b: N M_005965.1 1.858219 -0.66565 5.75 Down 2.13E-04 NM 0050 Homo sapiens 84 phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7), mRNA.
/PROD=phospholipase A2, group VII (platelet-activatingfactor acetylhydrolase, plasma) /FL=gb:U20157.1 gb:U24577.1 g b: N M_005084.1 3.016209 0.501482 5.71 Down 6.48E-05 AW02637 ESTs 3.692792 1.179422 5.71 Down 1.52E-04 N21096 ESTs 1.28245 -1.23083 5.71 Down 3.20E-04 AF063824 Homo sapiens trp-related protein 4 truncated variant delta mRNA, complete cds. /PROD=trp-related protein 4 truncated variant delta /FL=gb:AF063824.1 3.772564 1.260638 5.7 Down 3.53E-04 AA404269 ESTs 2.016986 -0.49385 5.7 Down 6.37E-03 A1741439 ESTs 2.453774 -0.04433 5.65 Down 1.01 E-03 NM_0071 Homo sapiens Wnt 91 inhibitory factor-1 (WIF-1), mRNA. /PROD=Wnt inhibitory factor-1 /F L=g b:AF 122922.1 gb:NM_007191.1 5.545158 3.061783 5.59 Down 1.71 E-04 BF057809 ESTs 5.219258 2.740374 5.57 Down 1.08E-04 AA974416 protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform 2.913327 0.434686 5.57 Down 2.99E-04 NM_0124 Homo sapiens regulator of 19 G-protein signalling 17 (RGS17), mRNA.
/PROD=regulator of G-protein signalling 17 /FL=gb:AF202257.2 gb:NM_012419.2 1.651332 -0.81962 5.54 Down 1.35E-02 NM_0071 Homo sapiens mitogen-81 activated protein kinase kinase kinase kinase 1 (MAP4K1), mRNA.
/PROD=mitogen-activated protein kinase kinase kinasekinase 1 /F L=g b: U 66464.1 gb:NM_007181.1 1.293775 -1.16956 5.51 Down 1.15E-02 BF593660 ESTs 1.417933 -1.04305 5.51 Down 4.93E-04 NM 0027 Homo sapiens protein 38 kinase C, beta 1 (PRKCB1), mRNA.
/PROD=protein kinase C, beta 1 /F L=g b: N M_002738.1 3.66812 1.207732 5.5 Down 1.97E-04 NM 1333 Homo sapiens potassium 29 voltage-gated channel, subfamily G, member 3 (KCNG3), transcript variant 1, mRNA.
/PROD=potassium voltage-gated channel, subfamily G,member 3 isoform 1 /F L=g b:AF454548.1 g b:AF348982.1 gb:AB070604.1 gb:NM_133329.4 3.002731 0.549124 5.48 Down 4.89E-04 R54042 ESTs 5.276628 2.824048 5.47 Down 6.48E-05 80005127 Homo sapiens, adipose differentiation-related protein, clone MGC:10598, mRNA, complete cds.
/PROD=adipose differentiation-related protein /FL=gb:B0005127.1 g b: N M_001122.1 3.380946 0.937118 5.44 Down 1.22E-04 AU151342 Homo sapiens cDNA
FLJ12935 fis, clone 2.01577 -0.42783 5.44 Down 1.92E-03 BE220341 casein kinase 2, alpha 1 polypeptide 1.307387 -1.12824 5.41 Down 1.08E-04 AK021452 Homo sapiens cDNA
FLJ11390 fis, clone HEMBA1000561, weakly similar to ZINC FINGER
PROTEIN 91.
0.36507 -2.02151 5.23 Down 4.98E-03 BF062244 ESTs 0.756663 -1.62346 5.21 Down 1.69E-03 BG53358 ESTs 3.876819 1.518834 5.13 Down 4.76E-04 A1651212 ESTs 0.619594 -1.73795 5.12 Down 1.18E-03 BE467611 ESTs 0.482843 -1.87385 5.12 Down 1.04E-03 BG28489 ESTs 1.048359 -1.30538 5.11 Down 8.93E-03 AA464273 ESTs 3.527039 1.198446 5.02 Down 2.69E-03 BG28379 ESTs 2.522705 0.194248 5.02 Down 3.09E-03 U07236 Human mutant lymphocyte-specific protein tyrosine kinase (LCK) mRNA, complete cds. /PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 g b: N M_005356.1 g b: M36881.1 2.356401 0.028606 5.02 Down 6.23E-04 NM 0248 Homo sapiens 93 hypothetical protein FLJ14220 (FLJ14220), mRNA.
/PROD=hypothetical protein FLJ14220 /F L=g b: N M_024893.1 4.587367 2.264046 5 Down 2.70E-04 AL049589 Human DNA sequence from clone 570L12 on chromosome Xq 13.1-21.1.
Contains the PGK1 gene for phosphoglycerate kinase 1, the gene for a novel protein similar to TAF2G (TATA box binding protein (TBP)-associated factor, RNA polymerase II, G, 32kD) (TAF...

B) ES vs EXPRES 02- Intensity values are in Log2 format.

ES EXPRES 02 Ratio Direction adj. p- Gene Gene Name value Identifier -2.7136 7.077563 886 Up 9.62E-04 NM_0018 Homo sapiens cystatin 98 SN (CST1), mRNA.
/PROD=cystatin SN
/FL=gb:J03870.1 g b: N M_001898.1 -2.3713 6.959692 644.03 Up 6.55E-05 R72286 microfibrillar-associated protein 4 -3.78394 5.172093 496.63 Up 1.06E-04 AW15754 insulin-like growth 8 factor binding protein 5 /FL=gb:M65062.1 g b: M62782.1 g b: N M_000599.1 gb:AF055033.1 -4.79257 3.432794 299.28 Up 1.81 E-03 AA352113 ESTs -5.16453 3.053666 297.8 Up 5.30E-03 NM_0023 Homo sapiens lumican 45 (LUM), mRNA.
/PROD=lumican /F L=g b: N M_002345.1 g b: U 18728.1 gb:U21128.1 290.65 Up E 0 2,55753 5,625595' 1.79,,-04 D87811 Hionno saqpiens& mRNA
for G..' + A..$, corn e :w.
PRO) G.A TA---$
. g k ,`F L bN1 7, 1 -5.03662 3.030028 268.1 Up 7.79E-05 BG09943 ESTs -2.97296 4.901727 234.7 Up 5.95E-05 A1821586 ESTs, Moderately similar to JE0284 Mm-1 cell derived transplantability-associated protein 1 b (H.sapiens) -3.06613 4.772945 228.98 Up 2.57E-03 A1422986 ESTs -4.37538 3.399327 218.99 Up 7.01 E-05 AA552969 ESTs -3.47045 4.200612 203.81 Up 4.26E-03 NM_0251 Homo sapiens 40 hypothetical protein FLJ22471 (FLJ22471), mRNA.
/PROD=hypothetical protein FLJ22471 /FL=gb:NM_025140.1 -4.82833 2.813842 199.77 Up 1.40E-04 BF064262 ESTs -5.1127 2.479359 192.95 Up 1.06E-04 NM_0026 Homo sapiens paired-53 like homeodomain transcription factor 1 (PITX1), mRNA.
/PROD=paired-like homeodomain transcription factor 1 /F L=g b: N M_002653.1 -3.4841 4.092799 190.93 Up 4.34E-04 BM12843 Homo sapiens full 2 length insert cDNA
clone YA81 B05 ..4 254 2,72-1,466 164.74 Up 2.38E401 5 .A1, 17 40 7 Ho o+ Sap ie ws hwnn-eobox p:w.eln goosecok1 :.:RNA.
omp+eti. '\t ROD=
prote n \ c .seco d iFL-,, ,b:A Y,7{=40j,i gx N \` 1 . 13 4$. i -3.40132 3.923976 160.37 Up 1.34E-02 BF589787 ESTs -1.20324 6.071574 154.86 Up 2.23E-04 NM_0016 Homo sapiens 43 apolipoprotein A-II
(APOA2), mRNA.
/PROD=a pol i poprote i n A-II precursor /FL=gb:M29882.1 g b: N M_001643.1 g b: 60005282.1 -3,4292 A. 8; 0a816 1:5 ;.89 p U 4,62E-04 AB02802 C:;i e::3," i;:a .
I 2 :e 2.1: omo ..ap!er H - beta RN 1 or =,. oq .- cle ;` cto 3 bei .
co-qp to cds !gb-ABO28 f g,.--,\S. +5565 u :ler:..i944 - .=' i i\ 2,37420," 13 6. 3 Usti 6.98,E405 AM)61 $ ) \:`+A i.A.b li\11inn rote in 3 IF .` - N M 4*32',5 ~~.B C0, 3O`0. i -2.26798 4.781861 132.5 Up 9.04E-05 NM_0013 Homo sapiens cystatin 22 SA (CST2), mRNA.
/PROD=cystatin SA
/F L=g b: N M_001322.1 -0.81321 6.174771 126.94 Up 1.57E-03 NM_0021 Homo sapiens 60 hexabrachion (tenascin C, cytotactin) (HXB), mRNA.
/PROD=hexabrachion (tenascin C, cytotactin) /FL=gb:M55618.1 g b: N M_002160.1 -2.38522 4.594021 126.17 Up 6.89E-05 AA502609 Homo sapiens ankyrin-like with trans membrane domains 1 (ANKTM1), mRNA
-3.75387 3.204091 124.32 Up 2.13E-04 A1991459 ESTs -4,21525 2.671776 1113.36 U;p 1.9.)E-04 H'iwnnc s pi i;\
19 iibro3a:at ;a Induced? (F GF8 ), R
D=fibro a3iast growth `acto 8 -2.02474 4.768631 110.92 Up 7.31 E-03 NM_0218 Homo sapiens 27 hypothetical protein FLJ23514 (FLJ23514), mRNA.
/PROD=hypothetical protein FLJ23514 /F L=g b: N M_021827.1 -2.38432 4.381798 108.84 Up 1.01 E-03 AL534095 hypothetical protein -2.25187 4.311095 94.55 Up 7.26E-03 AL136944 Homo sapiens mRNA;
cDNA
DKFZp586J0624 (from clone DKFZp586J0624);
complete cds.
/PROD=hypothetical protein /FL=gb:AF215636.1 g b: N M_014585.1 gb:AF231121.1 gb:AF226614.1 g b:AL 136944.1 1. 218\ 4,619M 93.1 Up, '9,02E-04 A,.7 07a4 GATA-;b~n2 :nq pro\emn `1 g ?:NM õ02521 c :,0_3$3 51 sib:0Th2$O 1 -3.42725 2.997778 85.93 Up 2.95E-03 NM_0224 Homo sapiens 69 hypothetical protein FLJ21195 similar to protein related to DAC
and cerberus (FLJ21195), mRNA.
/PROD=hypothetical protein FLJ21195 similar to proteinrelated to DAC
and cerberus /F L=g b: N M_022469.1 -3.14404 3.270152 85.28 Up 6.55E-05 AB028021 Homo sapiens HNF-3beta mRNA for hepatocyte nuclear factor-3 beta, complete cds.
/PROD=hepatocyte nuclear factor-3 beta /FL=gb:AB028021.1 g b: N M_021784.1 -0.88122 5.526622 84.91 Up 1.25E-04 AA775681 hypothetical protein -2.96204 3.439168 84.52 Up 1.08E-03 NM_0013 Homo sapiens 11 cysteine-rich protein 1 (intestinal) (CRIP1), mRNA.
/PROD=cysteine-rich protein 1 (intestinal) /FL=gb:U58630.1 g b: 60002738.1 g b: N M_001311.1 g b: U09770.1 -3.42819 2.876705 79.06 Up 2.31 E-04 AL 121722 Human DNA sequence from clone RP4-788L20 on chromosome 20 Contains the HNF3B
(hepatocyte nuclear factor 3, beta) gene. a novel gene based on ESTs, ESTs, STSs, GSSs and CpG
Islands -1.01231 5.27686 78.2 Up 1.85E-04 NM_0016 Homo sapiens 43 apolipoprotein A-II
(APOA2), mRNA.
/PROD=a pol i poprote i n A-II precursor /FL=gb:M29882.1 g b: N M_001643.1 g b: 60005282.1 . -., 134. '57 04 ? 5'. ^ U p .99 04 NM 0038 `sumo `. i. 1+. w l a txr nb a s growth factor m RNA, growth, factor 17 g NNI OO3867., b, AB009249i 1 -0.14916 6.052967 73.63 Up 2.30E-04 NM_0025 Homo sapiens 21 natriuretic peptide precursor B (NPPB), mRNA.
/PROD=natriuretic peptide precursor B
/F L=g b: N M_002521.1 g b: M25296.1 -2.9139 3.274181 72.91 Up 9.48E-04 NM_0051 Homo sapiens 43 haptoglobin (HP), mRNA.
/PROD=haptoglobin /F L=g b: K00422.1 g b: L29394.1 g b: N M_005143.1 -2.33028 3.85605 72.82 Up 2.04E-04 X02162 Human mRNA for apolipoprotein Al (apo AI)=.
/PROD=preproapolipo protein Al -4.75249 1.427636 72.51 Up 8.97E-04 AJ276395 Homo sapiens mRNA
for MSF-FN70 (FN
gene).
/PROD=migration stimulation factor -1.50663 4.672617 72.47 Up 9.82E-05 BF223214 ESTs -4.40099 1.778003 72.45 Up 8.87E-05 A1733179 ESTs -2.56553 3.594638 71.51 Up 4.24E-04 D31771 Homo sapiens mRNA
for MSX-2, complete cds. /PROD=MSX-2 /F L=g b: N M_002449.2 gb:D31771.1 -3.67415 2.447201 69.62 Up 1.97E-02 BC042378 Homo sapiens, clone I MAG E:5277693, mRNA.
-1.33141 4.770833 68.7 Up 2.36E-04 A1640307 protocadherin 10 -2.41293 3.673615 67.96 Up 8.00E-04 NM_0008 Homo sapiens 46 glutathione S-transferase A2 (GSTA2), mRNA.
/PROD=glutathione S-transferase A2 /F L=g b: 60002895.1 g b: M25627.1 g b: M 16594.1 gb:M14777.1 g b: M 15872.1 gb:M21758.1 g b: N M_000846.1 -2.95346 3.079949 65.5 Up 7.93E-05 NM_0004 Homo sapiens Kell 20 blood group (KEL), mRNA. /PROD=Kell blood group antigen /FL=gb:B0003135.1 g b: N M_000420.1 -3.41755 2.612638 65.35 Up 1.03E-02 A1808090 ESTs -4.08201 1.927438 64.42 Up 5.56E-04 AK000680 Homo sapiens cDNA
FLJ20673 fis, clone KAIA4464.
/FL=gb:AF240634.1 g b: N M_018440.1 -0.1416 5.830942 62.79 Up 6.89E-05 NM_0224 Homo sapiens 54 hypothetical protein FLJ22252 similar to SRY-box containing gene 17 (FLJ22252), mRNA.
/PROD=hypothetical protein FLJ22252 similar to SRY-boxcontaining gene 17 /F L=g b: N M_022454.1 -1.79329 4.15609 61.79 Up 7.58E-04 AL575177 noggin /FL=gb:NM_005450.1 -0.88683 5.039046 60.79 Up 8.36E-05 A1821669 ESTs -3.76697 2.141612 60.07 Up 2.25E-04 NM_0011 Homo sapiens 47 angiopoietin 2 (ANGPT2), mRNA.
/PROD=angiopoietin 2 /FL=gb:AB009865.1 gb:AF004327.1 g b: N M_001147.1 0.720535 6.617979 59.61 Up 5.95E-05 AW00753 Human insulin-like 2 growth factor binding protein 5 (IGFBP5) mRNA
-1.03589 4.784337 56.5 Up 2.23E-04 A1242583 Homo sapiens cDNA
FLJ1 1550 fis, clone M
2 885$ 3 3* O2 ti.= 1:`A." "` 4.54,,-0 .~, -s 89 'Hion-, no sapicns&
~ike pro,õe I (M L ^
n RN,A, con-ipk t ,e(Ab+' " e n ./e L::;g gb:we 1,1891 .`
-2.04403 3.759502 55.85 Up 2.17E-03 NM_0000 Homo sapiens 39 apolipoprotein A-1 (APOA1), mRNA.
/PROD=a pol i poprote i n A-1 precursor /FL=gb:M27875.1 gb:M11791.1 g b: N M_000039.1 g b: 60005380.1 0.129315 59201O2 55.36 Up 6.81.)E-05 = j.ti Hiwnno sapie'i:\
,e ,oderm4;

.:3 :opus 3a k.' v is (Eot B", ;:,RNA., n (Xe :o us '^aev s) hodaoa rF :::5b:A$ 3' O 8.
;,.N~^ 005442,", -1.57973 4.207564 55.23 Up 5.25E-03 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 -4.11172 1.670966 55.05 Up 4.57E-04 BG25667 interferon, gamma-7 inducible protein 16 /FL=gb:AF208043.1 -0.28789 5.482347 54.58 Up 6.89E-05 AW77219 Homo sapiens clone 2 23736 mRNA
sequence -1.44577 4.307421 53.94 Up 3.59E-03 AL544576 ESTs -3.9513 1.76416 52.54 Up 7.33E-05 NM_0163 Homo sapiens 41 pancreas-enriched phospholipase C
(LOC51196), mRNA.
/PROD=pancreas-enriched phospholipase C
/FL=gb:AF1 17948.1 g b: N M_016341.1 g b:AF 190642.2 0.05538 5.762108 52.23 Up 7.33E-05 A1817041 G protein-coupled receptor -3.52376 2.14189 50.76 Up 8.23E-05 AW30021 ESTs, Moderately 7 similar to C212 HUMAN 28.3 KD PROTEIN
C21 ORF2 (H.sapiens) -3.18877 2.469472 50.5 Up 7.47E-03 AF260333 Homo sapiens AD036 mRNA, complete cds.
/PROD=AD036 /FL=gb:AF260333.1 -1.973 3.674867 50.14 Up 1.91 E-04 AA772920 ESTs -2.30094 3.341814 49.96 Up 7.23E-03 A1806174 transcription factor 8 (represses interleukin 2 expression) -2.25531 3.356433 48.9 Up 6.63E-03 A1380207 ESTs -2.71676 2.892681 48.82 Up 5.25E-04 AU144167 Homo sapiens cDNA
FLJ1 1428 fis, clone HEMBA1001071, highly similar to PROCOLLAGEN
ALPHA 1(111) CHAIN
PRECURSOR
-0.16429 5.442379 48.73 Up 6.83E-04 L01639 Human (clone HSY3RR) neuropeptide Y
receptor (NPYR) mRNA, complete cds.
/PROD=neuropeptide Y receptor /FL=gb:L06797.1 g b: N M_003467.1 gb:AF025375.1 gb:AF147204.1 g b: M99293.1 g b: L01639.1 -4.03477 1.563749 48.45 Up 1.19E-02 U12170 Human zinc finger homeodomain protein mRNA, complete cds.
/PROD=zinc finger homeodomain protein /FL=gb:U12170.1 -0.08298 5.493663 47.72 Up 2.19E-04 NM_0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 -2.99405 2.552238 46.73 Up 4.78E-04 A1767388 Human DNA sequence from clone RP5-1024N4 on chromosome 1 p32.1-33. Contains the gene for a novel Sodium:solute symporter family member similar to SLC5A1 (SGLT1), a pseudogene similar to part of butyrophilin family members, a novel gene, ESTs, STSs, GS
-4.61432 0.925434 46.52 Up 2.53E-04 NM_0052 Homo sapiens distal-21 less homeo box 5 (DLX5), mRNA.
/PROD=distal-less homeo box 5 /F L=g b: N M_005221.3 -3.22309 2.302183 46.05 Up 4.60E-03 AW20724 ESTs -2.82645 2.655384 44.69 Up 4.60E-03 NM 0134 Homo sapiens 45 glutamate decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform GAD25 /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 0.533443 5.958927 42.98 Up 6.55E-05 NM_0018 Homo sapiens cystatin 99 S (CST4), mRNA.
/PROD=cystatin S
/F L=g b: N M_001899.1 0.116207 5.518477 42.29 Up 1.27E-04 NM_0005 Homo sapiens insulin-99 like growth factor binding protein 5 (IGFBP5), mRNA.
/PROD=insulin-like growth factor binding protein 5 /FL=gb:M65062.1 g b: M62782.1 g b: N M_000599.1 gb:AF055033.1 -2.1675 3.230235 42.16 Up 1.53E-04 NM_0218 Homo sapiens 04 angiotensin I
converting enzyme (pe ptidyl-d i peptidase A) 2 (ACE2), mRNA.
/PROD=angiotensin I
converting enzyme(peptidyl-dipeptidase A) 2 /F L=g b: N M_021804.1 gb:AF241254.1 gb:AB046569.1 gb:AF291820.1 -0.61985 4.752547 41.42 Up 3.54E-04 NM_0019 Homo sapiens 63 epidermal growth factor (beta-urogastrone) (EGF), mRNA.
/PROD=epidermal growth factor (beta-urogastrone) /F L=g b: N M_001963.2 -1.73746 3.627971 41.22 Up 3.35E-04 NM_0143 Homo sapiens cardiac 91 ankyrin repeat protein (CARP), mRNA.
/PROD=cardiac ankyrin repeat protein /FL=gb:NM_014391.1 -3.68848 1.657514 40.67 Up 2.86E-03 NM_0185 Homo sapiens low 57 density lipoprotein-related protein 1 B
(deleted in tumors) (LRP1 B), mRNA.
/PROD=low density lipoprotein-related protein 1 B(deleted in tumors) /FL=gb:AF1 76832.1 g b: N M_018557.1 -3.11273 2.220281 40.31 Up 5.02E-03 AW44476 ESTs -2.78886 2.517881 39.58 Up 7.89E-03 NM_0011 Homo sapiens 15 adenylate cyclase 8 (brain) (ADCY8), mRNA.
/PROD=adenylate cyclase 8 /FL=gb:NM_001115.1 -1.93668 3.348112 38.98 Up 7.23E-03 BE670361 G protein-coupled receptor 72 /FL=gb:NM_016540.1 g b:AF236081.1 -3.65051 1.595241 37.94 Up 3.80E-04 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /FL=gb:NM_005233.1 gb:M83941.1 gb:AF213459.1 0.767075 5.998268 37.56 Up 2.55E-04 AY029208 Homo sapiens type VI
collagen alpha 2 chain precursor (COL6A2) mRNA, complete cds, alternatively spliced.
/PROD=type VI
collagen alpha 2 chain precursor /FL=gb:AY029208.1 -2.34732 2.874499 37.32 Up 6.51 E-03 A1240545 glycophorin B
(includes Ss blood group) -2.41622 2.773394 36.49 Up 6.29E-04 NM_0019 Homo sapiens 77 glutamyl aminopeptidase (aminopeptidase A) (ENPEP), mRNA.
/PROD=glutamyl aminopeptidase (aminopeptidase A) /FL=gb:L12468.1 g b: N M_001977.1 gb:L14721.1 -1.58875 3.588854 36.19 Up 2.45E-03 NM_1525 Homo sapiens 06 hypothetical protein FLJ32835(FLJ32835), mRNA.
/FL=gb:NM_152506.1 -0.93849 4.238505 36.18 Up 1.38E-02 BE222344 splicing factor, arginineserine-rich 5 1.479222 6.611842 35.08 Up 5.95E-05 NM_0054 Homo sapiens 54 cerberus 1 (Xenopus laevis) homolog (cysteine knot superfamily) (CER1), mRNA.
/PROD=cerberus 1 /FL=gb:NM_005454.1 -0.46494 4.666106 35.04 Up 2.90E-04 A1141603 collagen, type VI, alpha 1 -2.23021 2.897749 34.97 Up 4.92E-04 NM_0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1 -3.12836 1.991299 34.77 Up 8.63E-04 NM_0027 Homo sapiens 70 protease, serine, 2 (trypsin 2) (PRSS2), mRNA.
/PROD=protease, serine, 2 (trypsin 2) /FL=gb:M27602.1 g b: N M_002770.1 -0.98659 4.115782 34.35 Up 1.19E-04 M65062 Human insulin-like growth factor binding protein 5 (IGFBP-5) mRNA, complete cds.
/PROD=insulin-like growth factor binding protein 5 /FL=gb:M65062.1 g b: M62782.1 g b: N M_000599.1 gb:AF055033.1 -2.50194 2.569744 33.63 Up 4.84E-03 AJ277914 Homo sapiens partial LHX9 gene for LIM-homeobox 9, 3UTR.
-1.27526 3.792158 33.53 Up 1.12E-03 A1688418 plexin A2 -3.34034 1.708137 33.09 Up 2.46E-03 AA781795 ESTs 1,339655 ;. : :.. 32,59 ? 7,93E-05 A J224869 onno n~ens C R, ene.odino re\.ep~to;
CXCR
-0.6944 4.326307 32.46 Up 7.33E-05 R73554 Human insulin-like growth factor binding protein 5 (IGFBP5) mRNA
-0.67187 4.337831 32.22 Up 7.54E-05 A1692659 heat shock 90kD
protein 1, alpha -0.46298 4.533319 31.92 Up 3.96E-04 S69738 MCP-1=monocyte chemotactic protein (human, aortic endothelial cells, mRNA, 661 nt).
/PROD=MCP-1 -2.56712 2.414446 31.59 Up 1.67E-03 A1813758 collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant) /F L=g b: N M_000090.1 -0.31684 4.651259 31.3 Up 7.83E-04 BF130943 ESTs -2.78124 2.184054 31.24 Up 8.36E-05 NM_0209 Homo sapiens 95 haptoglobin-related protein (HPR), mRNA.
/PROD=haptoglobin-related protein /F L=g b: N M_020995.1 -1.24179 3.719223 31.15 Up 4.92E-04 AL534095 hypothetical protein -0.35003 4.606618 31.05 Up 6.88E-03 NM_0017 Homo sapiens CD48 78 antigen (B-cell membrane protein) (CD48), mRNA.
/PROD=CD48 antigen (B-cell membrane protein) /FL=gb:NM_001 778.1 gb:M37766.1 g b: M59904.1 -1.81534 3.141104 31.05 Up 5.86E-04 AW59092 ESTs -1.93655 3.000448 30.63 Up 5.42E-03 NM_0133 Homo sapiens DNA
69 (cytosine-5-)-methyltransfe rase 3-like (DNMT3L), mRNA.
/PROD=DNA
(cytosine-5-)-methyltransfe rase 3-like /FL=gb:B0002560.1 g b: N M_013369.1 gb:AF194032.1 1.122063 6.03378 30.1 Up 7.33E-05 X58851 Human MLC1emb gene for embryonic myosin alkaline light chain, promoter and exon 1 -0.4721 4.436335 30.03 Up 7.93E-05 D89377 Homo sapiens mRNA
for MSX-2, complete cds. /PROD=MSX-2 /FL=gb:D89377.1 0.044298 4.952379 30.02 Up 6.89E-05 W57613 ESTs -0.59928 4.305866 29.96 Up 1.03E-03 AF020769 Homo sapiens cardiac ventricular troponin C
mRNA, complete cds.
/PROD=cardiac ventricular troponin C
/F L=g b: N M_003280.1 gb:AF020769.1 -1.04571 3.857701 29.93 Up 4.57E-03 NM0013 Homo sapiens 62 deiodinase, iodothyronine, type III
(D103), mRNA.
/PROD=thyroxine deiodinase type III
/F L=g b: N M_001362.1 gb:S79854.1 -3.24802 1.648226 29.78 Up 1.47E-03 A1694325 ESTs -2.50665 2.356234 29.1 Up 8.64E-03 BE222668 ESTs -2.27119 2.568908 28.64 Up 2.53E-03 NM0026 Homo sapiens platelet-08 derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) (PDGFB), mRNA.
/PROD=platelet-derived growth factor beta polypeptide(simian sarcoma viral (v-sis) oncogene homolog) /FL=gb:M12783.1 g b: N M_002 -4.34018 0.485509 28.36 Up 7.34E-05 AU144247 Homo sapiens cDNA
FLJ1 3443 fis, clone -1.02297 3.794799 28.2 Up 3.36E-03 AF208043 Homo sapiens IFI16b (IF116b) mRNA, complete cds.
/PROD=IF116b /FL=gb:AF208043.1 -2.79469 2.013598 28.02 Up 9.94E-05 A1700341 ESTs -2.73255 2.070789 27.92 Up 1.35E-03 X89271 H.sapiens mRNA for HG1 1 orphan receptor.
/PROD=HG11 orphan receptor /FL=gb:NM_005161.1 -3.05797 1.724772 27.53 Up 3.48E-04 A1801626 ESTs, Moderately similar to ALU4_HUMAN ALU

SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -2.83953 1.922194 27.13 Up 5.16E-04 BG29019 hypothetical protein /F L=g b: N M_025069.1 -4.60716 0.149736 27.04 Up 1.22E-02 NM_0046 Homo sapiens solute 96 carrier family 16 (monocarboxylic acid transporters), member 4 (SLC16A4), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 4 /FL=gb:U59185.1 g b: N M_004696.1 -1.57919 3.174205 26.97 Up 5.94E-04 AL524520 G protein-coupled receptor 49 -1.36626 3.37132 26.68 Up 2.16E-03 A1824037 ESTs, Weakly similar to FCE2 MOUSE LOW
AFFINITY
IMMUNOGLOBULIN
EPSILON FC
RECEPTOR
(M.musculus) 0.167058 4.895371 26.51 Up 6.90E-05 NM_0212 Homo sapiens myosin 23 light chain 2a (LOC58498), mRNA.
/PROD=myosin light chain 2a /F L=g b: N M_021223.1 -1.4009 3.316905 26.31 Up 6.35E-04 BC029835 Homo sapiens, clone IMAGE:5169759, mRNA.
-2.16518 2.549789 26.26 Up 1.77E-03 A1521166 ESTs, Moderately similar to MTR5_HUMAN
MYOTUBULARIN-(H.sapiens) -3.32235 1.375121 25.95 Up 2.00E-04 BC039433 Homo sapiens, clone IMAGE:5303550, mRNA.
-5.7338 -1.05152 25.67 Up 8.80E-03 NM_0201 Homo sapiens 30 chromosome 8 open reading frame 4 (C8ORF4), mRNA.
/PROD=chromosome 8 open reading frame /F L=g b: N M_020130.1 gb:AF268037.1 1.214325 5.878585 25.36 Up 7.93E-05 M36172 Human embryonic myosin alkali light chain (MLC1) mRNA, complete cds.
/FL=gb:M36172.1 gb:M24121.1 g b: N M_002476.1 -2.20104 2.461597 25.33 Up 4.67E-03 NM_0009 Homo sapiens 39 proopiomelanocortin (ad re nocorticotropi n beta-lipotropin alpha-melanocyte stimulating hormone beta-melanocyte stimulating hormone beta-endorphin) (POMC), mRNA.
/PROD=proopiomeIan ocorti n (ad re nocorticotropi n be ta-lipotropin alpha-melanocyt -0.2674 4.336009 24.31 Up 9.18E-05 N48299 ESTs, Moderately similar to NFY-C
(H.sapiens) 1.367677 5.968973 24.27 Up 1.00E-04 AF1 16676 Homo sapiens PRO1957 mRNA, complete cds.
/PROD=PRO1 957 /FL=gb:AF1 16676.1 -0.62697 3.974228 24.27 Up 4.69E-04 NM_0055 Homo sapiens 31 interferon, gamma-inducible protein 16 (IF116), mRNA.
/PROD=interferon, gamma-inducible protein 16 /FL=gb:M63838.1 gb:NM_005531.1 -3.90861 0.686447 24.17 Up 3.72E-03 BC022531 Homo sapiens, olfactomedin 3, clone MGC:26675 IMAGE:4812035, mRNA, complete cds.
/PROD=olfactomedin 3 /FL=gb:AF397394.1 g b: BC022531.1 -2.75089 1.840723 24.11 Up 2.60E-04 AL365343 Homo sapiens mRNA
full length insert cDNA
clone EUROIMAGE
32539.
-0.6097 3.975428 24 Up 1.05E-04 L12468 Homo sapiens aminopeptidase A
mRNA, complete cds.
/PROD=aminopeptidas e A /FL=gb:L12468.1 g b: N M_001977.1 gb:L14721.1 -3.18285 1.397334 23.92 Up 3.32E-04 BC041441 Homo sapiens, clone IMAGE:5167131, mRNA.
-1.92796 2.645248 23.81 Up 1.20E-02 BE551416 ESTs, Weakly similar to KIAA1330 protein (H.sapiens) -4.05111 0.51291 23.65 Up 1.05E-03 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 -2.79378 1.767388 23.61 Up 3.68E-02 AW29140 ESTs -2.80173 1.752943 23.5 Up 7.26E-03 AW08823 ESTs 0.422022 4.975085 23.48 Up 1.38E-04 D49958 Homo sapiens mRNA
for membrane glycoprotein M6, complete cds.
/PROD=membrane glycoprotein M6 /FL=gb:D49958.1 -1.20314 3.343061 23.36 Up 3.63E-04 M60721 Human homeobox gene, complete cds.
/FL=gb:M60721.1 g b: N M_021958.1 1.932439 6.477785 23.35 Up 7.33E-05 H92988 tyrosine 3-monooxygenasetrypto phan 5-monooxygenase activation protein, eta polypeptide -3.00328 1.524799 23.07 Up 8.50E-03 A1571798 Rho GDP dissociation inhibitor (GDI) alpha 0.526605 5.052252 23.03 Up 7.01 E-05 N71923 fibronectin leucine rich trans membrane protein 3 /FL=gb:AF169677.1 g b: N M_013281.1 -1.26047 3.239318 22.62 Up 5.12E-03 NM_0072 Homo sapiens 50 Kruppel-like factor 8 (KLF8), mRNA.
/PROD=Kruppel-like factor 8 /FL=gb:U28282.1 g b: N M_007250.1 -1.93118 2.556654 22.44 Up 2.34E-04 L33477 Human (clone 8B1) Br-cadherin mRNA, complete cds.
/PROD=Br-cadherin /FL=gb:L34057.1 gb:L33477.1 g b: N M_004061.1 0.005876 4.456564 21.87 Up 6.89E-05 AK023621 Homo sapiens cDNA
FLJ1 3559 fis, clone PLACE 1007852, highly similar to Homo sapiens mRNA for KIAA0878 protein.
-1.94 2.509492 21.85 Up 4.29E-03 NM_0165 Homo sapiens TBX3-69 iso protein (TBX3-iso), mRNA. /PROD=TBX3-iso protein /FL=gb:NM_016569.1 gb:AF216750.1 -3.44347 1.001698 21.78 Up 1.61 E-02 AF 187858 Homo sapiens angiopoietin-2 isoform-1 mRNA, complete cds, alternatively spliced.
/PROD=a ng iopoieti n-2 isoform-1 /FL=gb:AF187858.1 0.586923 5.027737 21.72 Up 6.55E-05 NM_0000 Homo sapiens 47 arylsulfatase E
(chondrodysplasia punctata 1) (ARSE), mRNA.
/PROD=arylsulfatase E precursor /FL=gb:X83573.1 g b: N M_000047.1 1.422626 5.860875 21.68 Up 5.95E-05 NM_0063 Homo sapiens 65 transcriptional activator of the c-fos promoter (CROC4), mRNA.
/PROD=transcriptional activator of the c-fos promoter /F L=g b: N M_006365.1 gb:U49857.1 -4.18575 0.241573 21.52 Up 7.54E-03 NM_0017 Homo sapiens 36 complement component 5 receptor 1 (C5a ligand) (C5R1), mRNA.
/PROD=complement component 5 receptor 1 (C5a ligand) /FL=gb:M62505.1 g b: N M_001736.1 2.301255 6.712959 21.28 Up 7.68E-05 BC020935 Homo sapiens, Similar to otoconin 90, clone IMAGE:4277593, mRNA.
-3.61192 0.788317 21.12 Up 1.71 E-03 R37101 ESTs -0.62474 3.768383 21.01 Up 6.55E-05 NM_0003 Homo sapiens protein 13 S (alpha) (PROS1), mRNA.
/PROD=protein S
(alpha) /FL=gb:M15036.1 g b: N M_000313.1 -0.62725 3.760374 20.93 Up 1.52E-04 BC017942 Homo sapiens, Similar to otoconin 90, clone I MAG E:4285317, mRNA.
-1.52261 2.858274 20.83 Up 2.98E-03 NM_0026 Homo sapiens PDZ
14 domain containing 1 (PDZK1), mRNA.
/PROD=PDZ domain containing 1 /F L=g b: N M_002614.1 gb:AF012281.1 -1.11347 3.25087 20.6 Up 4.26E-03 N69091 ESTs -0.11332 4.231933 20.33 Up 1.05E-04 NM_0036 Homo sapiens basic 70 helix-loop-helix domain containing, class B, 2 (BHLHB2), mRNA.
/PROD=differentiated embryo chondrocyte expressed genet /FL=gb:AB004066.1 g b: N M_003670.1 -1.69238 2.643704 20.2 Up 3.73E-03 W05495 ESTs -2.18113 2.138504 19.97 Up 1.23E-02 NM_0040 Homo sapiens 41 arrestin, beta 1 (ARRB1), transcript variant 1, mRNA.
/PROD=arrestin beta 1, isoform A
/FL=gb:B0003636.1 gb:AF084040.1 g b: N M_004041.2 1.306329 5.625069 19.96 Up 6.90E-05 NM_0012 Homo sapiens bone 00 morphogenetic protein 2 (BMP2), mRNA.
/PROD=bone morphogenetic protein 2 precursor /F L=g b: N M_001200.1 -1.23777 3.066156 19.75 Up 6.27E-04 A1917371 ESTs -0.00098 4.266076 19.25 Up 9.82E-05 NM_0132 Homo sapiens 81 fibronectin leucine rich trans membrane protein 3 (FLRT3), mRNA.
/PROD=fibronectin leucine rich trans membrane protein3 /FL=gb:AF169677.1 g b: N M_013281.1 -2.0132 2.250432 19.21 Up 1.37E-02 BE328496 hypothetical protein /FL=gb:AF1 16683.1 g b: N M_018615.1 1.758844 6.008618 19.02 Up 6.55E-05 N21138 KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 0.095309 4.341668 18.98 Up 8.55E-04 AA524250 deleted in liver cancer -0.96212 3.265791 18.74 Up 2.04E-04 AY1 13699 Homo sapiens presenilin stabilization factor b (PSF) mRNA, complete cds;
alternatively spliced.
/PROD=presenilin stabilization factor b /FL=gb:AY1 13699.1 0.502339 4.722511 18.64 Up 1.04E-04 A1676059 ESTs -1.74369 2.474001 18.61 Up 7.33E-05 NM_0018 Homo sapiens 82 corticotropin releasing hormone-binding protein (CRHBP), mRNA.
/PROD=corticotropin releasing hormone-binding protein /F L=g b: N M_001882.2 0.70975 4.924051 18.56 Up 1.64E-04 BF939489 glycoprotein M6A
/FL=gb:D49958.1 -2.40752 1.7892 18.34 Up 4.46E-03 A1738662 homeo box HB9 /FL=gb:NM_005515.1 -1.34609 2.844235 18.26 Up 7.33E-05 NM_0183 Homo sapiens 88 hypothetical protein FLJ11316 (FLJ11316), mRNA.
/PROD=hypothetical protein FLJ11316 /FL=gb:NM_018388.1 -0.74044 3.448679 18.24 Up 7.33E-05 N63706 ESTs -1.55229 2.611591 17.92 Up 4.34E-04 AU 158444 Homo sapiens cDNA
FLJ14216 fis, clone NT2RP3003672, weakly similar to T-CELL SURFACE

PRECURSOR
0.082922 4.230149 17.72 Up 1.63E-04 A1632223 hypothetical protein DKFZp434F2322 -1.66293 2.482886 17.7 Up 1.56E-02 NM_0008 Homo sapiens 17 glutamate decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD67, mRNA.
/PROD=glutamate decarboxylase 1, isoform GAD67 /F L=g b: N M_000817.1 g b: M81883.1 g b: L 16888.1 -1.82505 2.319685 17.69 Up 7.89E-03 T16257 G protein-coupled receptor 37 (endothelin receptor type B-like) /FL=gb:NM_005302.1 gb:AF017262.1 -3.11387 1.027176 17.64 Up 9.68E-03 U70370 Human hindlimb expressed homeobox protein backfoot (Bft) mRNA, complete cds.
/PROD=hindlimb expressed homeobox protein backfoot /FL=gb:U70370.1 g b: 60003685.1 -0.98938 3.143558 17.54 Up 6.04E-03 AF190725 Homo sapiens beta-site APP cleaving enzyme (BACE) mRNA, complete cds.
/PROD=beta-site APP
cleaving enzyme /FL=gb:AF200343.1 gb:AF204943.1 gb:AF190725.1 gb:AF201468.1 gb:NM_012104.1 -0.74839 3.363245 17.29 Up 5.33E-03 M17955 Human MHC class II
HLA-DQ-beta mRNA, complete cds.
/FL=gb:M33907.1 g b: M 17955.1 g b: M 16996.1 g b: M 17563.1 g b: M20432.1 g b: M26042.1 2.851479 6.958929 17.24 Up 5.95E-05 A1950472 ESTs -2.85963 1.242896 17.18 Up 7.55E-03 80005961 Homo sapiens, parathyroid hormone-like hormone, clone MGC:14611, mRNA, complete cds.
/PROD=parathyroid hormone-like hormone /FL=gb:B0005961.1 -1.18027 2.905057 16.97 Up 1.03E-02 AI123555 ESTs -1.53522 2.547506 16.94 Up 2.58E-03 NM0064 Homo sapiens 56 sialyltransferase (STHM), mRNA.
/PROD=sialyltransfera se /FL=gb:U14550.1 g b: N M_006456.1 1.620279 5.700292 16.91 Up 1.08E-04 A1583173 major histocompatibility complex, class II, DQ
beta 1 1.446234 5.516116 16.79 Up 6.55E-05 AF348491 Homo sapiens chemokine receptor CXCR4 mRNA, complete cds.
/PROD=chemokine receptor CXCR4 /FL=gb:AF348491.1 0.880085 4.948285 16.77 Up 6.90E-05 NM_0060 Homo sapiens N-myc 96 downstream regulated (NDRG1), mRNA.
/PROD=N-myc downstream regulated /FL=gb:AF004162.1 gb:B0003175.1 gb:D87953.1 g b: N M_006096.1 -1.11823 2.945099 16.72 Up 1.28E-02 NM_0021 Homo sapiens 00 glycophorin B
(includes Ss blood group) (GYPB), mRNA.
/PROD=glycophorin B
precursor /FL=gb:J02982.1 g b: N M_002100.2 -1.68075 2.377232 16.66 Up 4.35E-03 NM_0124 Homo sapiens sema 31 domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
(SEMA3E), mRNA.
/PROD=sema domain, immunoglobulin domain (Ig), shortbasic domain, secreted, (semaphorin) 3E
/FL=gb:NM_012431.1 gb:AB002329.1 0.70158 4.759011 16.65 Up 1.07E-04 U46768 Human stanniocalcin mRNA, complete cds.
/PROD=stanniocalcin /FL=gb:U25997.1 g b: N M_003155.1 g b: U46768.1 2.429693 6.487025 16.65 Up 6.89E-05 AA284532 tyrosine 3-monooxygenasetrypto phan 5-monooxygenase activation protein, eta polypeptide 1.964573 6.018949 16.61 Up 1.18E-04 NM_0307 Homo sapiens 81 scavenger receptor with C-type lectin (SRCL), mRNA.
/PROD=scavenger receptor with C-type lectin /FL=gb:NM_030781.1 0.399566 4.451136 16.58 Up 1.57E-04 AF144103 Homo sapiens NJAC
protein (NJAC) mRNA, complete cds.
/PROD=NJAC protein /FL=gb:AF144103.1 gb:AF106911.1 gb:AF073957.1 g b: 80003513.1 g b: N M_004887.1 4.590104 -3.21322 223.38 Down 7.77E-05 W67449 nuclear receptor subfamily 1, group I, member 3 1.940449 -5.370717 158.81 Down 8.36E-05 BE644917 nuclear receptor subfamily 1, group I, member 3 3.29779 -3.911445 147.98 Down 2.38E-05 U17496 Human proteasome subunit LMP7 (allele LMP7B) mRNA, complete cds.
/PROD=proteasome subunit LMP7 /FL=gb:U17497.1 g b: U 17496.1 4.124115 -2.85548 126.2 Down 2.99E-03 AW26231 ESTs 3.702164 -2.970402 102.01 Down 2.53E-03 U26662 Human neuronal pentraxin II (NPTX2) mRNA, partial cds.
/PROD=neuronal pentraxin II
1.785431 -4.509786 78.53 Down 1.45E-03 R15072 ESTs 5.545158 -0.710745 76.42 Down 7.01 E-05 BF057809 ESTs 1.946332 -3.865792 56.19 Down 7.43E-04 BG16670 small inducible cytokine subfamily B
(Cys-X-Cys), member 5 (epithelial-derived neutrophil-activating peptide 78) 1.717184 -3.902593 49.17 Down 1.30E-04 AF237813 Homo sapiens NPDO09 mRNA, complete cds.
/PROD=N PDO09 /F L=g b: N M_020686.1 gb:AF237813.1 3.179908 -2.381796 47.23 Down 9.96E-04 U82811 Human homeodomain-containing protein (HANF) mRNA, complete cds.
/PROD=HANF
/FL=gb:U8281 1.1 g b: N M_003865.1 2.359289 -3.177031 46.41 Down 1.72E-04 NM_0063 Homo sapiens 34 neuroblastoma (nerve tissue) protein (AMY), mRNA.
/PROD=neuroblastom a (nerve tissue) protein /FL=gb:NM_006334.1 g b: D82343.1 4.276201 -1.247561 46.01 Down 7.33E-05 AV699347 nuclear receptor subfamily 1, group I, member 3 2.435058 -2.963261 42.18 Down 1.36E-04 BF056204 Homo sapiens, clone I MAG E:3603836, mRNA, partial cds 2.348373 -2.98029 40.19 Down 7.34E-05 NM 0163 Homo sapiens solute 54 carrier family 21 (organic anion transporter), member 12 (SLC21A12), mRNA.
/PROD=organic anion transporter OATP-E
/FL=gb:AB031051.1 g b: N M_016354.1 gb:AF205072.1 gb:AF187817.1 4.315048 -0.819678 35.13 Down 3.33E-03 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA.
/PROD=16.7Kd protein /FL=gb:NM_016139.1 gb:AF078845.1 g b: 60003079.1 2.348717 -2.72835 33.76 Down 9.42E-04 NM0018 Homo sapiens 77 complement component (3dEpstein Barr virus) receptor 2 (CR2), mRNA.
/PROD=complement component (3dEpstein Barr virus)receptor 2 /FL=gb:NM_001877.1 g b: M26004.1 3.342331 -1.710595 33.2 Down 6.55E-05 AA876372 Homo sapiens mRNA;
cDNA DKFZp667DO95 (from clone DKFZp667DO95) 1.995324 -3.045119 32.91 Down 4.60E-03 NM 0148 Homo sapiens 62 KIAA0307 gene product (KIAA0307), mRNA.
/PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 2.890305 -2.133881 32.54 Down 1.71E-03 NM_0154 Homo sapiens protein (DKFZP564AO32), mRNA.
/PROD=DKFZP564AO
32 protein /FL=gb:AF228421.1 gb:AL050267.1 gb:ABO13847.1 g b: N M_015474.1 2.443445 -2.518495 31.17 Down 7.43E-03 NM_1523 Homo sapiens 32 chromosome 14 open reading frame 47 (C14orf47), mRNA.
/FL=gb:NM_152332.1 3.692792 -1.250743 30.77 Down 8.80E-04 N21096 ESTs 2.266312 -2.653405 30.27 Down 7.22E-03 NM0030 Homo sapiens SH3-26 domain GRB2-like 2 (SH3GL2), mRNA.
/PROD=SH3-domain GRB2-like 2 /FL=gb:AF036268.1 g b: N M_003026.1 2.453774 -2.402069 28.96 Down 7.93E-05 NM0071 Homo sapiens Wnt 91 inhibitory factor-1 (WIF-1), mRNA.
/PROD=Wnt inhibitory factor-1 /FL=gb:AF122922.1 g b: N M_007191.1 2.325274 -2.512615 28.6 Down 3.19E-05 AW19369 DKFZP566K1924 3 protein 1.982765 -2.836916 28.24 Down 1.21 E-04 BE672659 ESTs 0.997895 -3.793735 27.7 Down 3.97E-03 AW02592 ESTs, Weakly similar 8 to 138588 reverse transcriptase homolog (H.sapiens) 4.756657 0.005012 26.94 Down 6.55E-05 AV715309 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 4.803291 0.085342 26.32 Down 7.34E-05 AA628440 nuclear receptor subfamily 1, group 1, member 3 1.124153 -3.582082 26.1 Down 5.42E-03 W52934 ESTs, Weakly similar to similar to serinethreonine kinase (C.elegans) 0.874376 -3.810554 25.72 Down 2.24E-02 U82671 Homo sapiens chromosome Xq28 melanoma antigen family A2a (MAGEA2A), melanoma antigen family A12 (MAGEA1 2), melanoma antigen family A2b (MAGEA2B), melanoma antigen family A3 (MAGEA3), caltractin (CALT), NAD(P)H
dehydrogenase-like protein (NSDHL), a...
0.621075 -4.029928 25.12 Down 5.18E-03 BC028721 Homo sapiens, Similar to solute carrier family 1 (high affinity as pa rtateg l uta mate transporter), member 6, clone MGC:33092 I MAG E:5269300, mRNA, complete cds.
/PROD=Similar to solute carrier family 1 (highaffinity as pa rtateg l uta mate transporter), memb 1.49883 -3.130556 24.75 Down 7.87E-04 BF057784 ESTs 2.074855 -2.552806 24.72 Down 1.87E-03 A1420156 ESTs 3.2597 -1.357805 24.55 Down 1.05E-03 NM_0176 Homo sapiens 71 hypothetical protein FLJ20116(FLJ20116), mRNA.
/PROD=hypothetical protein FLJ20116 /FL=gb:NM_017671.1 -0.10303 -4.717227 24.49 Down 7.33E-05 NM_0221 Homo sapiens 68 melanoma differentiation associated protein-5 (MDAS), mRNA.
/PROD=melanoma differentiation associated protein-5 /FL=gb:AY017378.1 g b: N M_022168.1 gb:AF095844.1 2.688175 -1.908993 24.2 Down 2.73E-04 NM 0141 Homo sapiens 78 HSPC156 protein (HSPC156), mRNA.
/PROD=HSPC156 protein /FL=gb:NM_014178.1 gb:AF161505.1 1.24677 -3.309288 23.52 Down 2.54E-02 BC028359 Homo sapiens, clone I MAG E:4828836, mRNA.
0.686587 -3.862863 23.42 Down 1.28E-03 NM0004 Homo sapiens 39 proprotein convertase subtilisinkexin type 1 (PCSK1), mRNA.
/PROD=proprotein convertase subtilisinkexin type 1 /F L=g b: N M_000439.2 gb:M90753.1 5.363884 0.82261 23.28 Down 7.68E-05 NM0070 Homo sapiens 15 chondromodulin I
precursor (CHM-I), mRNA.
/PROD=chondromodul in I precursor /FL=gb:NM_007015.1 g b:AB006000.1 3.962328 -0.577927 23.27 Down 6.90E-05 AL533416 axonal transport of synaptic vesicles 2.086969 -2.410461 22.59 Down 9.65E-03 AL359055 Homo sapiens mRNA
full length insert cDNA
clone EUROIMAGE
2344436.
0.536704 -3.939442 22.26 Down 4.78E-03 AL049250 Homo sapiens mRNA;
cDNA DKFZp564D113 (from clone DKFZp564D1 13).
4.260791 -0.214844 22.25 Down 6.89E-05 AA603344 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.121165 -4.34837 22.15 Down 1.36E-04 A1985987 ESTs, Moderately similar to ALU1_HUMAN ALU
SUBFAMILY J
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.437404 -4.019211 21.96 Down 2.48E-02 H05254 ESTs 2.263194 -2.16575 21.54 Down 7.34E-04 AF052108 Homo sapiens clone 23687 mRNA
sequence.
4.055226 -0.3701 21.49 Down 1.16E-04 NM_0013 Homo sapiens claudin 07 7 (CLDN7), mRNA.
/PROD=claudin 7 /FL=gb:B0001055.1 g b: N M_001307.1 5.440506 1.023282 21.37 Down 1.02E-04 M34455 Human interferon-gamma-inducible indoleamine 2,3-dioxygenase (IDO) mRNA, complete cds.
/F L=g b: N M_002164.1 g b: M34455.1 2.169025 -2.207268 20.77 Down 3.41 E-03 NM0224 Homo sapiens N-67 acetylgalactosamine-4-0-s u Ifotra nsferase (GALNAC-4-ST1), mRNA. /PROD=N-acetylga lactosam i ne-4-0-s u Ifotra nsferase /F L=g b: N M_022467.1 gb:AF300612.1 0.252976 -4.116368 20.67 Down 3.36E-03 NM0180 Homo sapiens 43 hypothetical protein FLJ10261(FLJ10261), mRNA.
/PROD=hypothetical protein FLJ10261 /F L=g b: N M_018043.1 1.353776 -3.010836 20.6 Down 2.85E-02 AF147427 Homo sapiens full length insert cDNA
clone YP80A10.
2.437935 -1.918781 20.49 Down 1.70E-03 BE672557 ESTs 2.46341 -1.870689 20.17 Down 4.16E-04 NM0031 Homo sapiens 82 tachykinin, precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, neuromedin L, neurokinin alpha, neuropeptide K,neuropeptide gamma) (TAC1), transcript variant beta, mRNA.
/PROD=tachykinin 2 precursor, isoform beta /FL=gb:U3 2.294336 -2.028037 20.01 Down 7.10E-03 U11058 Homo sapiens large conductance calcium-and voltage-dependent potassium channel alpha subunit (MaxiK) mRNA, complete cds.
/PROD=large conductance calcium-and voltage-dependentpotassium channel alpha subunit /FL=gb:U23767.1 g b: N M_002247.1 gb:AF025999 4.534853 0.221559 19.88 Down 7.68E-05 R38389 olfactomedin related ER localized protein 3.142124 -1.136699 19.41 Down 1.73E-02 AL832535 Homo sapiens mRNA;
cDNA
DKFZp547J1816 (from clone DKFZp547J1816).
3.85985 -0.410223 19.29 Down 7.34E-05 R40892 ESTs 4.557488 0.304559 19.07 Down 1.43E-04 AK026546 Homo sapiens cDNA:
FLJ22893 fis, clone KAT04792.
5.966394 1.719122 18.99 Down 1.99E-04 AL117612 Homo sapiens mRNA;
cDNA
DKFZp564B1264 (from clone DKFZp564B1264).
1.212373 -3.013161 18.71 Down 5.22E-04 A1564075 ESTs 2.27629 -1.932316 18.49 Down 1.09E-04 BC044830 Homo sapiens, Similar to RIKEN cDNA

1700011 F14 gene, clone MGC:35062 IMAGE:5166167, mRNA, complete cds.
/PROD=Similar to RIKEN cDNA
1700011F14 gene /FL=gb:BC044830.1 3.18092 -1.007603 18.23 Down 1.29E-03 AJ01 1712 Homo sapiens TNNT1 gene, exons 1-11 (and joined CDS) 2.598916 -1.553059 17.78 Down 2.46E-03 AW05159 ESTs, Moderately 1 similar to unnamed protein product (H.sapiens) 2.003902 -2.139208 17.67 Down 4.71 E-03 BF109660 ESTs 1.905278 -2.229324 17.56 Down 5.05E-04 NM0189 Homo sapiens solute 64 carrier family 37 (glycerol-3-phosphate transporter), member 1 (SLC37A1), mRNA.
/PROD=solute carrier family 37 (glycerol-3-phosphatetransporter), member 1 /F L=g b: N M_018964.1 0.330556 -3.792993 17.43 Down 3.26E-04 BE972639 ESTs 1.044277 -3.067425 17.29 Down 1.23E-02 AL529104 ESTs 0.733534 -3.349221 16.94 Down 4.39E-03 BF061389 ESTs, Weakly similar to JC1405 6-pyruvoyltetrahydropteri n synthase (H.sapiens) 2.684281 -1.394654 16.9 Down 2.91 E-04 BF449063 collagen, type XIV, alpha 1 (undulin) 4.572354 0.512428 16.68 Down 5.89E-04 BF437747 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 2.313549 -1.734907 16.55 Down 6.84E-03 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K protein A
(H.sapiens) 0.679665 -3.355919 16.4 Down 1.43E-03 80000568 Homo sapiens, clone MGC:3040, mRNA, complete cds.
/PROD=Unknown (protein for MGC:3040) /FL=gb:B0000568.1 4.099873 0.092088 16.09 Down 6.90E-05 A1057619 ESTs, Highly similar to T42654 hypothetical protein DKFZp434G 1115.1 (H.sapiens) 1.459269 -2.519 15.76 Down 6.26E-03 NM0002 Homo sapiens 77 phenylalanine hydroxylase (PAH), mRNA.
/PROD=phenylalanine hyd roxylase /FL=gb:U49897.1 g b: N M_000277.1 2.220936 -1.733714 15.5 Down 1.34E-04 AF237813 Homo sapiens NPD009 mRNA, complete cds.
/PROD=N PD009 /F L=g b: N M_020686.1 gb:AF237813.1 2.81177 -1.140906 15.48 Down 6.89E-05 NM_0025 Homo sapiens 93 procollagen C-endopeptidase enhancer (PCOLCE), mRNA.
/PROD=procollagen C-endopeptidase enhancer /FL=gb:B0000574.1 g b: N M_002593.2 gb:AB008549.1 gb:L33799.1 1.529971 -2.399749 15.24 Down 2.29E-02 NM0247 Homo sapiens 89 hypothetical protein FLJ22529 (FLJ22529), mRNA.
/PROD=hypothetical protein FLJ22529 /FL=gb:NM_024789.1 0.255558 -3.655262 15.04 Down 4.26E-03 BC039509 Homo sapiens, clone IMAGE:5578073, mRNA.
0.970967 -2.921559 14.85 Down 4.46E-03 All 44156 ESTs 2.38092 -1.504443 14.78 Down 4.36E-04 AF053712 Homo sapiens osteoprotegerin ligand mRNA, complete cds.
/PROD=osteoprotegeri n ligand /FL=gb:AF053712.1 gb:AF019047.1 3.779853 -0.095194 14.67 Down 3.22E-04 AV646597 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.651332 -2.189895 14.33 Down 3.45E-03 NM0071 Homo sapiens 81 mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1), mRNA.
/PROD=mitogen-activated protein kinase kinase kinasekinase 1 /FL=gb:U66464.1 g b: N M_007181.1 3.786136 -0.030985 14.1 Down 1.49E-04 BF057731 ESTs 3.257726 -0.553697 14.04 Down 4.48E-04 NM_0043 Homo sapiens bone 35 marrow stromal cell antigen 2 (BST2), mRNA. /PROD=bone marrow stromal cell antigen 2 /FL=gb:NM_004335.2 gb:D28137.1 -0.33527 -4.146199 14.03 Down 4.21 E-03 BE968806 ESTs, Weakly similar to ALU4_HUMAN ALU

SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.349102 -3.450633 13.93 Down 1.30E-02 BM68235 Homo sapiens cDNA
2 FLJ37204 fis, clone BRALZ2006976.
2.172559 -1.624126 13.9 Down 2.32E-03 BE673445 Homo sapiens chromosome 19, cosmid R28379 0.381933 -3.390833 13.67 Down 1.84E-02 A1913749 ESTs 1.120467 -2.648498 13.63 Down 1.85E-03 BE672607 ESTs 1.924097 -1.801676 13.23 Down 8.92E-03 AW24292 ESTs 1.491527 -2.224633 13.14 Down 7.01 E-05 BG25813 ESTs 2.060687 -1.652733 13.12 Down 5.63E-03 A1269290 solute carrier family 18 (vesicular monoamine), member 2 /FL=gb:L14269.1 g b: L23205.1 g b: L09118.1 g b: N M_003054.1 2.886142 -0.811762 12.98 Down 4.93E-04 U83115 Human non-lens beta gamma-crystallin like protein (AIM1) mRNA, partial cds.
/PROD=non-lens beta gamma-crystallin like protein 0.626797 -3.063928 12.91 Down 4.51 E-02 AF393369 Homo sapiens sigma 1 C adaptin (AP1 S3) mRNA, complete cds.
/PROD=sigma 1C
adaptin /FL=gb:AF393369.1 1.575227 -2.112834 12.89 Down 1.85E-03 BE856544 hypothetical protein 0.4785 -3.197824 12.78 Down 1.72E-04 BG53269 integrin, alpha 4 0 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 1.707178 -1.969084 12.78 Down 1.84E-02 AF043179 Homo sapiens T cell receptor beta chain (TCRBV13S 1-TCRBJ2S1) mRNA, complete cds.
/PROD=T cell receptor beta chain /FL=gb:AF043179.1 0.47298 -3.177323 12.56 Down 8.00E-03 AF311324 Homo sapiens ubiquitin-like fusion protein mRNA, complete cds.
/PROD=ubiquitin-like fusion protein /FL=gb:AF311324.1 2.641731 -0.985721 12.36 Down 1.49E-04 AL133653 Homo sapiens mRNA;
cDNA
DKFZp434M2415 (from clone DKFZp434M2415).
2.913327 -0.707745 12.3 Down 3.70E-03 NM_0124 Homo sapiens 19 regulator of G-protein signalling 17 (RGS17), mRNA.
/PROD=regulator of G-protein signalling 17 /FL=gb:AF202257.2 g b: N M_012419.2 2.127724 -1.49095 12.28 Down 1.49E-03 NM0012 Homo sapiens 75 chromogranin A
(parathyroid secretory protein 1) (CHGA), mRNA.
/PROD=chromogranin A /FL=gb:B0001059.1 g b: N M_001275.2 gb:J03915.1 gb:J03483.1 0.80034 -2.81487 12.25 Down 4.62E-03 AW00310 ESTs 2.11511 -1.494168 12.2 Down 1.27E-03 NM_0005 Homo sapiens ATP-93 binding cassette, sub-family B (MDRTAP), member 2 (ABCB2), mRNA. /PROD=ATP-binding cassette, sub-family B, member 2 /F L=g b: N M_000593.2 g b: L21205.1 g b: L21206.1 g b: L21207.1 g b: L21204.1 g b: L21208.1 3.690675 0.086414 12.16 Down 1.85E-03 AW27401 ESTs 1.283746 -2.317044 12.13 Down 4.10E-03 NM_0140 Homo sapiens VLCS-31 H1 protein (VLCS-H1), mRNA. /PROD=very long-chain acyl-CoA
synthetase homolog 1 /FL=gb:AF064254.1 g b: N M_014031.1 0.467003 -3.132847 12.12 Down 4.39E-02 AL117530 Homo sapiens mRNA;

cDNA DKFZp434B172 (from clone DKFZp434B 172);
partial cds.
/PROD=hypothetical protein 2.6402 -0.955567 12.09 Down 3.80E-02 NM_0132 Homo sapiens breast 67 cell glutaminase (GA), mRNA. /PROD=breast cell glutaminase /FL=gb:AF1 10331.1 gb:AF110330.1 gb:AF223944.1 g b: N M_013267.1 1.858597 -1.724557 11.98 Down 5.91 E-04 AA757457 ESTs 0.945333 -2.635993 11.97 Down 2.41 E-03 BC040959 Homo sapiens, clone I MAG E:5242616, mRNA.
3.795925 0.223304 11.9 Down 1.71E-03 NM_0046 Homo sapiens N-myc 88 (and STAT) interactor (NMI), mRNA.
/PROD=N-myc and STAT interactor /FL=gb:B0001268.1 g b: N M_004688.1 g b: U 32849.1 2.074972 -1.490898 11.84 Down 2.94E-03 NM_0179 Homo sapiens 33 hypothetical protein FLJ20701 (FLJ20701), mRNA.
/PROD=hypothetical protein FLJ20701 /FL=gb:NM_017933.1 -0.42571 -3.975429 11.71 Down 1.54E-03 AK023699 Homo sapiens cDNA
FLJ1 3637 fis, clone PLACE 10 11165.
3.742964 0.195658 11.69 Down 1.19E-04 T62571 microtubule-associated protein 7 /F L=g b: N M_003980.1 1.621518 -1.924672 11.68 Down 2.63E-02 NM0037 Homo sapiens 25 oxidative 3 alpha hyd roxyste roid dehydrogenase; retinol dehydrogenase; 3-hydroxysteroid epimerase (RODH), mRNA.
/PROD=oxidative 3 alpha hydroxysteroid de hyd rogenase; reti nol dehydrogenase; 3-hydroxysteroid epimerase /FL=gb:AF016509.1 gb:A
6.076777 2.566425 11.4 Down 6.90E-05 AF229180 Homo sapiens alpha-a m i noad ipate semialdehyde synthase mRNA, complete cds.
/PROD=alpha-a m i noad ipate semialdehyde synthase /FL=gb:AF229180.1 3.758058 0.25238 11.36 Down 1.89E-04 NM_0053 Homo sapiens 56 lymphocyte-specific protein tyrosine kinase (LCK), mRNA.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 g b: N M_005356.1 g b: M36881.1 3.797019 0.297284 11.31 Down 2.69E-04 A1871745 ESTs 2.469508 -1.020673 11.24 Down 9.14E-04 W63754 Homo sapiens mRNA
for gycosyltransferase (ORF1) 1.048359 -2.438018 11.21 Down 1.39E-02 AA464273 ESTs 3.146674 -0.339455 11.21 Down 1.26E-04 BF435773 cortactin SH3 domain-binding protein 1.627801 -1.848139 11.13 Down 3.70E-03 L39833 Homo sapiens (clone hKvBeta3) K+ channel beta subunit mRNA, complete cds.
/PROD=K+ channel beta-subunit /FL=gb:U16953.1 gb:L39833.1 1.594689 -1.879508 11.11 Down 4.03E-02 AJ236915 Homo sapiens mRNA
for pak5 protein.
/PROD=pak5 protein /F L=g b: N M_020168.1 gb:AF276893.1 2.806504 -0.6571 11.03 Down 1.21E-04 NM_0036 Homo sapiens fatty-45 acid-Coenzyme A
ligase, very long-chain 1 (FACVL1), mRNA.
/PROD=very long-chain fatty-acid-Coenzyme A ligase 1 /FL=gb:AF096290.1 g b: D88308.1 g b: N M_003645.1 3.826815 0.364324 11.02 Down 6.55E-05 BG40156 Homo sapiens mRNA;
8 cDNA
DKFZp434H1235 (from clone DKFZp434H 1235);
partial cds 2.99034 -0.471936 11.02 Down 7.16E-04 NM0029 Homo sapiens small 93 inducible cytokine subfamily B (Cys-X-Cys), member 6 (granulocyte chemotactic protein 2) (SCYB6), mRNA.

/PROD=small inducible cytokine subfamily B(Cys-X-Cys), member 6 (granulocyte chemotactic protein 2) /FL=gb:U81234.1 g b: N M_00299 3.788599 0.329467 11 Down 8.58E-05 NM_0022 Homo sapiens 52 potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3 (KCNS3), mRNA.
/PROD=potassium voltage-gated channel,delayed-rectifier, subfamily S, member 3 /FL=gb:AF043472.1 g b: N M_002252.1 g b: 60004987.1 g b: 60004148.1 4.397278 0.939176 10.99 Down 1.22E-04 NM 0216 Homo sapiens 14 potassium intermediatesmall conductance calcium-activated channel, subfamily N, member 2 (KCNN2), mRNA.
/PROD=potassium intermediatesmall conductancecalcium-activated channel, subfamily N, member /FL=gb:NM_021614.1 gb:AF239613.1 1.027188 -2.423197 10.93 Down 1.22E-03 BG16983 adenylate kinase 5 2 /FL=gb:NM_012093.1 gb:AF062595.1 1.022495 -2.421211 10.88 Down 2.47E-02 80002832 Homo sapiens, Similar to butyrophilin, subfamily 3, member A2, clone MGC:3790, mRNA, complete cds.
/PROD=Similar to butyrophilin, subfamily 3, member A2 /FL=gb:U90144.1 g b: N M_007047.1 g b: U90546.1 g b: 60002832.1 0.311203 -3.122447 10.81 Down 1.70E-03 A1964053 ESTs 1.673874 -1.728682 10.57 Down 2.25E-03 NM_0059 Homo sapiens myosin, 65 light polypeptide kinase (MYLK), mRNA.
/PROD=myosin, light polypeptide kinase /FL=gb:AB037663.1 g b:AF069601.2 g b: N M_005965.1 1.443731 -1.955774 10.55 Down 1.43E-03 AJ272267 Homo sapiens partial mRNA for choline dehydrogenase (chdh gene). /PROD=choline dehydrogenase 0.383563 -3.004508 10.47 Down 2.48E-02 A1377688 ESTs 0.995551 -2.39165 10.46 Down 5.14E-03 NM_0053 Homo sapiens 86 neuronatin (NNAT), mRNA.
/PROD=neuronatin /FL=gb:NM_005386.1 g b: 60001768.1 gb:AB002392.1 gb:U25033.1 3.45531 0.070626 10.44 Down 1.94E-04 AV733308 integrin, alpha 6 3.527039 0.143408 10.44 Down 5.95E-05 BG28379 ESTs 2.950823 -0.418278 10.33 Down 1.38E-03 NM_0036 Homo sapiens fatty-45 acid-Coenzyme A
ligase, very long-chain 1 (FACVL1), mRNA.
/PROD=very long-chain fatty-acid-Coenzyme A ligase 1 /FL=gb:AF096290.1 g b: D88308.1 g b: N M_003645.1 1.55078 -1.80799 10.26 Down 3.70E-03 H28597 thymopoietin 5.005827 1.649812 10.24 Down 1.90E-04 NM0030 Homo sapiens 20 secretory granule, neuroendocrine protein 1 (7B2 protein) (SGNE1), mRNA.
/PROD=secretory granule, neuroendocrine protein 1 (7B2protein) /FL=gb:B0005349.1 g b: N M_003020.1 0.760646 -2.590248 10.2 Down 2.29E-02 AW58979 ESTs 2.209313 -1.126222 10.09 Down 5.95E-05 AA747379 calcitonin-related polypeptide, beta /FL=gb:NM_000728.1 -0.10418 -3.43217 10.04 Down 4.66E-03 NM_0176 Homo sapiens 55 hypothetical protein FLJ20075 (FLJ20075), mRNA.
/PROD=hypothetical protein FLJ20075 /FL=gb:NM_017655.1 2.598488 -0.722855 10 Down 2.03E-03 L08599 Human uvomorulin (E-cadherin) (UVO) mRNA, complete cds.
/PROD=uvomorulin /F L=g b: N M_004360.1 g b: L08599.1 1.858219 -1.457169 9.95 Down 1.81 E-03 NM0050 Homo sapiens 84 phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7), mRNA.
/PROD=phospholipase A2, group VII (platelet-activatingfactor acetylhydrolase, plasma) /FL=gb:U20157.1 gb:U24577.1 g b: N M_005084.1 1.910263 -1.3945 9.88 Down 1.27E-03 NM_0069 Homo sapiens 94 butyrophilin, subfamily 3, member A3 (BTN3A3), mRNA.
/PROD=butyrophil in, subfamily 3, member A3 /FL=gb:U90548.1 g b: N M_006994.2 2.001097 -1.297629 9.84 Down 1.19E-03 BC028721 Homo sapiens, Similar to solute carrier family 1 (high affinity as pa rtateg l uta mate transporter), member 6, clone MGC:33092 I MAG E:5269300, mRNA, complete cds.
/PROD=Similar to solute carrier family 1 (highaffinity as pa rtateg l uta mate transporter), memb 5.020283 1.723791 9.83 Down 1.63E-04 AK025084 Homo sapiens cDNA:
FLJ21431 fis, clone COL04214, highly similar to HSU80736 Homo sapiens CAGF9 mRNA.
2.474373 -0.811562 9.75 Down 5.94E-03 NM _0132 Homo sapiens solute 72 carrier family 21 (organic anion transporter), member 11 (SLC21A11), mRNA. /PROD=solute carrier family 21 (organic aniontransporter), member 11 /FL=gb:NM_013272.2 gb:AF205074.1 gb:AB031050.2 gb:AF187816.1 2.116702 -1.16308 9.71 Down 4.40E-02 AF107846 Homo sapiens neuroendocrine-specific Golgi protein p55 (XLalphas) gene, exon XL2 and complete cds 2.472358 -0.803312 9.68 Down 2.33E-03 NM_0003 Homo sapiens 63 troponin I, cardiac (TNN13), mRNA.
/PROD=troponin 1, cardiac /FL=gb:M64247.1 g b: N M_000363.1 0.384182 -2.880367 9.61 Down 4.26E-03 NM 0058 Homo sapiens RAS
25 guanyl releasing protein 2 (calcium and DAG-regulated) (RASGRP2), mRNA.
/PROD=RAS guanyl releasing protein 2 (calcium andDAG-regulated) /FL=gb:AF043723.1 g b: N M_005825.1 2.394742 -0.866876 9.59 Down 1.57E-04 A1733027 ESTs, Weakly similar to RET2_HUMAN
RETINOL-BINDING
PROTEIN 11, CELLULAR
(H.sapiens) 1.319792 -1.930717 9.52 Down 5.95E-05 M18767 Human complement subcomponent C1 s, alpha- and beta-chains, complete cds.
/FL=gb:J04080.1 g b: M 18767.1 g b: N M_001734.1 3.859451 0.610002 9.51 Down 5.73E-04 AJ242502 Homo sapiens mRNA
for E-MAP-1 15105 (MAP gene).
/PROD=epithelial microtubule-associated protein 3.009579 -0.239729 9.51 Down 5.22E-04 AB037730 Homo sapiens mRNA
for KIAA1 309 protein, partial cds.
/PROD=KIAA1309 protein 2.600702 -0.646217 9.49 Down 1.43E-02 AA740186 biliverdin reductase A
/FL=gb:NM_000712.1 gb:U34877.1 0.971941 -2.274152 9.49 Down 7.72E-04 NM_0180 Homo sapiens 18 hypothetical protein FLJ10191 (FLJ10191), mRNA.
/PROD=hypothetical protein FLJ10191 /FL=gb:NM_018018.1 0.414323 -2.829854 9.48 Down 6.30E-03 AF283777 Homo sapiens clone TCBAP0702 mRNA

sequence.
6.139688 2.900659 9.44 Down 4.48E-04 BC036488 Homo sapiens, clone MGC:43145 I MAG E:5261574, mRNA, complete cds.
/PROD=Unknown (protein for MGC:43145) /FL=gb:BC036488.1 1.569503 -1.668679 9.44 Down 1.24E-03 BF195118 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.665643 -1.567308 9.4 Down 8.63E-04 AF282250 Homo sapiens calneuron 1 (CALN1) mRNA, complete cds.
/PROD=calneuron 1 /FL=gb:AF282250.1 4.319584 1.104655 9.29 Down 5.53E-04 AA618420 Homo sapiens cDNA:
FLJ23597 fis, clone 4.436354 1.227541 9.25 Down 2.94E-04 A1912275 B-cell CLLlymphoma 1 1A (zinc finger protein) /F L=g b: N M_022893.1 g b: N M_018014.1 1.923237 -1.283751 9.23 Down 3.70E-03 AW0721 0 Homo sapiens mRNA;
2 cDNA DKFZp434H2O5 (from clone DKFZp434H2O5) 2.59299 -0.613677 9.23 Down 1.94E-04 NM0038 Homo sapiens 87 development and differentiation enhancing factor 2 (DDEF2), mRNA.
/PROD=ADP-ribosylation factor(arf)-d i rected GTPaseactivating protein /FL=gb:AB007860.1 g b: N M_003887.1 3.20248 0.002668 9.19 Down 5.80E-04 AF220153 Homo sapiens four and a half LIM
domains 1 protein isoform C (FHL1) mRNA, complete cds, alternatively spliced.
/PROD=four and a half LIM domains 1 protein isoform C
/FL=gb:AF220153.1 1.689335 -1.505873 9.16 Down 2.46E-03 NM0312 Homo sapiens testis 72 expressed sequence 14 (TEX14), mRNA.
/PROD=testis expressed sequence /FL=gb:NM_031272.1 3.026209 -0.167981 9.15 Down 6.90E-05 BC032302 Homo sapiens, similar to UDP-glucose ceramide g l ucosyltransferase-like 2, clone MGC:40268 IMAGE:5169731, mRNA, complete cds.
/PROD=similar to UDP-glucose cera m ideg l ucosyltra nsf erase-like 2 /FL=gb:BC032302.1 3.116245 -0.070826 9.11 Down 7.93E-05 NM_0179 Homo sapiens 47 hypothetical protein FLJ20733(FLJ20733), mRNA.
/PROD=hypothetical protein FLJ20733 /F L=g b: N M_017947.1 2.91664 -0.26326 9.06 Down 1.68E-03 AW00336 Homo sapiens clone 7 25237 mRNA
sequence 4.453662 1.27718 9.04 Down 7.33E-05 AV681807 v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 3.454075 0.278604 9.03 Down 1.86E-04 AV691491 Homo sapiens mRNA;
cDNA
DKFZp564D1462 (from clone DKFZp564D1462) 1.883578 -1.291525 9.03 Down 2.67E-02 BF970287 Human DNA sequence from clone RP1-310013 on chromosome 20g11.2.
Contains (part of) four novel genes, ESTs, STSs, GSSs and four putative CpG islands 2.326737 -0.838174 8.97 Down 2.61 E-03 NM_0159 Homo sapiens germ 82 cell specific Y-box binding protein (LOC51087), mRNA.
/PROD=germ cell specific Y-box binding protein /F L=g b: N M_015982.1 gb:AF096834.1 0.392456 -2.771428 8.96 Down 2.73E-02 NM 0030 Homo sapiens 07 semenogelin I
(SEMG1), mRNA.
/PROD=semenogelin I
/FL=gb:J04440.1 g b: N M_003007.1 3.116953 -0.041715 8.93 Down 3.90E-04 AA469071 Cluster Incl.

AA469071: ne 17fl 1.s l Homo sapiens cDNA, 3 end /clone=IMAGE-881517 /clone end=3 /gb=AA469071 /g i=2195605 /ug=Hs.180479 /len=758 3.113317 -0.040507 8.9 Down 2.36E-03 AL565745 ESTs, Weakly similar to 2108402A carnitine palmitoyltransferase I
(H.sapiens) 5.010828 1.86984 8.82 Down 3.28E-04 AK027006 Homo sapiens cDNA:
FLJ23353 fis, clone HEP14321, highly similar to HSU80736 Homo sapiens CAGF9 mRNA.
3.249727 0.113464 8.79 Down 2.14E-04 BC001 745 Homo sapiens, clone MGC:3328, mRNA, complete cds.
/PROD=Unknown (protein for MGC:3328) /FL=gb:B0001745.1 g b: N M_014392.1 1.532208 -1.601117 8.77 Down 3.19E-03 A1796813 advillin 5.063502 1.934512 8.75 Down 1.01 E-04 ABO18289 Homo sapiens mRNA
for KIAA0746 protein, partial cds.
/PROD=KIAA0746 protein 1.934415 -1.192238 8.73 Down 3.13E-03 NM_0013 Homo sapiens deleted 51 in azoospermia-like (DAZL), mRNA.
/PROD=deleted in azoospe rm is-like /FL=gb:U66726.2 g b: N M_001351.1 gb:U65918.1 g b: U66078.1 2.522705 -0.592752 8.67 Down 9.13E-03 U07236 Human mutant lymphocyte-specific protein tyrosine kinase (LCK) mRNA, complete cds.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 g b: N M_005356.1 g b: M36881.1 3.995648 0.881994 8.66 Down 6.55E-05 A1961231 KIAA0808 gene product /FL=gb:AB018351.1 g b: N M_014729.1 2.077151 -1.020617 8.56 Down 7.33E-05 BF223193 nuclear receptor subfamily 1, group I, member 3 6.650173 3.554864 8.55 Down 8.55E-04 NM0043 Homo sapiens 60 cadherin 1, type 1, E-cadherin (epithelial) (CDH1), mRNA.
/PROD=cadherin 1, type 1, E-cadherin (epithelial) /F L=g b: N M_004360.1 g b: L08599.1 1.440541 -1.650241 8.52 Down 1.11 E-03 BE503640 ESTs 1.344522 -1.721548 8.37 Down 1.97E-02 AW07170 dipeptidylpeptidase VI
4.319671 1.253603 8.37 Down 1.05E-04 AF063002 Homo sapiens LIM
protein SLIMMER
mRNA, complete cds.
/PROD=LIM protein SLIMMER
/FL=gb:AF063002.1 gb:AF098518.1 2.575606 -0.489298 8.37 Down 1.24E-03 BC016785 Homo sapiens, Similar to hypothetical protein PRO1722, clone I MAG E:4096414, mRNA.
1.070412 -1.992167 8.35 Down 7.29E-04 AF070642 Homo sapiens clone 24488 mRNA
sequence.
3.083054 0.021788 8.35 Down 2.33E-03 BC026969 Homo sapiens, clone IMAGE:5116073, mRNA, partial cds.
6.075972 3.015223 8.34 Down 1.35E-04 NM_0014 Homo sapiens four 49 and a half LIM
domains 1 (FHL1), mRNA. /PROD=four and a half LIM
domains 1 /FL=gb:U60115.1 g b: N M_001449.1 g b: U29538.1 0.779095 -2.27952 8.33 Down 1.58E-02 AF497717 Homo sapiens tissue-type lung unknown mRNA.
4.227241 1.173625 8.3 Down 3.47E-04 All 93252 ESTs, Weakly similar to AF133270 1 SLIT2 (H.sapiens) 1.139113 -1.908335 8.27 Down 1.40E-02 A1741469 ESTs 3.120689 0.079671 8.23 Down 6.27E-04 U01874 Human me20m mRNA, complete cds.
/PROD=me2Om /F L=g b: N M_006928.1 g b: 60001414.1 gb:U01874.1 3.499377 0.460367 8.22 Down 2.16E-03 NM0245 Homo sapiens 72 hypothetical protein FLJ12691 (FLJ12691), mRNA.
/PROD=hypothetical protein FLJ12691 /FL=gb:NM_024572.1 2.568736 -0.463022 8.18 Down 4.78E-03 AA531287 ESTs Table VI DIFFERENTIAL EXPRESSION OF GENES BETWEEN
UNDIFFERENTIATED EMBRYONIC STEM CELLS CULTURED ON
MATRIGELTM AND EXPRES 01 (A) AND 02 (B) CELLS CULTURED ON
TCPS
A) H9P39 at 2 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 2 HR DE Ratio Direction adj. p- Gene Gene Name 01 value Identifier -3.61621 3.301718 120.92 Up 0.001179 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds -1.32044 4.320344 49.89 Up 0.005081 AF01 7987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -3.12747 2.331072 43.97 Up 0.000718 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -2.3376 2.787516 34.9 Up 0.000229 U17496 Human proteasome subunit LMP7 (allele LMP7B) mRNA, complete cds. /PROD=proteasome subunit LMP7 /FL=gb:U 17497.1 gb:U17496.1 -0.27888 4.715023 31.86 Up 0.000339 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -1.56608 3.343812 30.06 Up 0.009753 NM_0007 Homo sapiens cytochrome 67 P450, subfamily IIB
(phenobarbital-inducible), polypeptide 6 (CYP2B6), mRNA.
/PROD=cytochrome P450, subfamily II B(phenobarbital-inducible), polypeptide 6 /F L=g b: N M_000767.2 gb:AF182277.1 gb:M29874.1 0.75652,6, 27,89 ,,, 0.000271 N 0030, Hon 12 prwe'4" I
(SFRPI rnR &
\ D--Vii`cre i s J 'F

g b: M X. O :...._ : b:AF^ ', g ` F 0',';90 ; , -1.03397 3.688335 26.4 Up 0.000308 NM_0030 Homo sapiens secretory 20 granule, neuroendocrine protein 1 (7B2 protein) (SGNE1), mRNA.
/PROD=secretory granule, neuroendocrine protein 1 (7B2protein) /F L=g b: 60005349.1 g b: N M_003020.1 -1.64839 2.654165 19.73 Up 0.000963 NM_0049 Homo sapiens phorbolin 00 (similar to apolipoprotein B
mRNA editing protein) (DJ742C19.2), mRNA.
/PROD=phorbolin (similar to apolipoprotein B
mRNAediting protein) /F L=g b: N M_004900.1 gb:U61083.1 -0.41404 3.88291 19.66 Up 0.00068 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -4.55112 -0.49607 16.62 Up 0.040292 NM_0180 Homo sapiens 43 hypothetical protein FLJ10261(FLJ10261), mRNA.
/PROD=hypothetical protein FLJ10261 /F L=g b: N M_018043.1 -2.38787 1.639634 16.31 Up 0.010236 80003517 Homo sapiens, clone IMAGE:3542589, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3542589) -2.506 1.482042 15.87 Up 0.000737 AW19369 DKFZP566K1924 protein -1.89835 2.076299 15.72 Up 0.000308 AL 122010 Human DNA sequence from clone RP5-997D16 on chromosome 1p34.1-35.3 Contains part of the gene for DAP-1 protein, STSs, GSSs and a CpG
island -2.80061 1.027087 14.2 Up 0.005931 NM_0146 Homo sapiens S100 24 calcium-binding protein A6 (calcyclin) (S100A6), mRNA. /PROD=S100 calcium-binding protein A6 /F L=g b: N M_014624.2 gb:B0001431.1 -1.56046 2.251934 14.05 Up 0.009772 NM_0163 Homo sapiens solute 54 carrier family 21 (organic anion transporter), member 12 (SLC21A12), mRNA. /PROD=organic anion transporter OATP-E
/FL=gb:AB031051.1 gb:NM_016354.1 gb:AF205072.1 gb:AF187817.1 1.109291 4.853054 13.4 Up 0.000308 NM_0053 Homo sapiens 56 lymphocyte-specific protein tyrosine kinase (LCK), mRNA.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 gb:NM_005356.1 gb:M36881.1 -2.69521 1.04038 13.32 Up 0.000271 AF282250 Homo sapiens calneuron 1 (CALN 1) mRNA, complete cds.
/PROD=calneuron 1 /F L=g b:AF282250.1 1.168713 4.897416 13.26 Up 0.001059 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 60003079.1 -3.05488 0.645316 13 Up 0.001719 A1569804 ESTs -0.10733 3.574485 12.83 Up 0.001042 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -3.12055 0.460578 11.97 Up 0.018849 AW78000 ESTs -0.8902 2.675714 11.84 Up 0.001172 NM_0220 Homo sapiens estrogen 34 regulated gene 1 (ERG-1), mRNA. /PROD=estrogen regulated gene 1 /FL=gb:AF305835.1 g b: N M_022034.1 -2.233 1.292642 11.52 Up 0.002196 NM_0148 Homo sapiens KIAA0307 62 gene product (KIAA0307), mRNA. /PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 -1.16113 2.362911 11.5 Up 0.007894 NM_0122 Homo sapiens potassium 81 voltage-gated channel, Shal-related subfamily, member 2 (KCND2), mRNA. /PROD=potassium voltage-gated channel, Shal-relatedsubfamily, member 2 /F L=g b: N M_012281.1 gb:AB028967.1 gb:AF121104.1 -2.7484 0.710709 11 Up 0.006544 80000568 Homo sapiens, clone MGC:3040, mRNA, complete cds.
/PROD=Unknown (protein for MGC:3040) /F L=g b: 60000568.1 -2.89467 0.509405 10.59 Up 0.0 10729 AW97120 ESTs -1.66608 1.669381 10.09 Up 0.01208 BE673445 Homo sapiens chromosome 19, cosmid -1.38062 1.947029 10.04 Up 0.000277 NM_0025 Homo sapiens 90 protocadherin 8 (PCDH8), mRNA.
/PROD=protocadherin 8 /F L=g b: N M_002590.2 gb:AF061573.2 1.12675 4.40089 9.67 Up 0.000277 AA206141 ESTs -0.04543 3.208344 9.54 Up 0.000875 AB037730 Homo sapiens mRNA for KIAA1309 protein, partial cds. /PROD=KIAA1309 protein -3.12304 0.081126 9.22 Up 0.025215 NM_0180 Homo sapiens 18 hypothetical protein FLJ10191 (FLJ10191), mRNA.
/PROD=hypothetical protein FLJ10191 /F L=g b: N M_018018.1 -2.26295 0.940715 9.21 Up 0.013376 A1735586 ESTs 3.061783 6.265115 9.21 Up 0.000149 BF057809 ESTs -1.57619 1.598447 9.03 Up 0.001707 AW07279 contactin 1 1.260638 4.356898 8.55 Up 0.000408 AA404269 ESTs -1.79406 1.19242 7.93 Up 0.023768 NM_0047 Homo sapiens solute 31 carrier family 16 (monocarboxylic acid transporters), member 7 (SLC16A7), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 7 /FL=gb:AF058056.1 g b: N M_004731.1 -1.25121 1.703716 7.75 Up 0.000875 R62432 Cluster Incl.
R62432:yg52el1.s1 Homo sapiens cDNA, 3 end /clone=IMAGE-36023 /clone end=3 /gb=R62432 /gi=834311 /ug=Hs.12321 /len=487 -2.01579 0.901094 7.55 Up 0.014339 A1937060 KIAA1151 protein 0.194248 3.083487 7.41 Up 0.002413 U07236 Human mutant lymphocyte-specific protein tyrosine kinase (LCK) mRNA, complete cds. /PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 g b: N M_005356.1 g b: M36881.1 -2.17012 0.714641 7.39 Up 0.0 11075 AB018580 Homo sapiens mRNA for hluPGFS, complete cds.
/PROD=hluPGFS
/F L=g b: N M_003739.2 gb:AF149416.2 gb:AB018580.1 gb:D17793.1 1.872557 4.741366 7.3 Up 0.000311 R38389 olfactomedin related ER
localized protein -1.81469 1.042382 7.25 Up 0.007408 AF052108 Homo sapiens clone 23687 mRNA sequence.
-1.51616 1.329372 7.19 Up 0.007084 AJ272267 Homo sapiens partial mRNA for choline dehydrogenase (chdh gene). /PROD=choline dehydrogenase -0.54428 2.289592 7.13 Up 0.000308 AF053712 Homo sapiens osteoprotegerin ligand mRNA, complete cds.
/PROD=osteoprotege ri n ligand /FL=gb:AF053712.1 gb:AF019047.1 -3.17826 -0.38807 6.92 Up 0.040995 A1798098 ESTs -1.88254 0.903098 6.9 Up 0.007894 BF694956 Human DNA sequence from clone RP1-187J11 on chromosome 6g11.1-22.33. Contains the gene for a novel protein similar to S. pombe and S.
cerevisiae predicted proteins, the gene for a novel protein similar to protein kinase C inhibitors, the 3 end of the -1.27392 1.501511 6.85 Up 0.036787 U11058 Homo sapiens large conductance calcium- and voltage-dependent potassium channel alpha subunit (MaxiK) mRNA, complete cds.
/PROD=large conductance calcium- and voltage-dependentpotassium channel alpha subunit /FL=gb:U23767.1 g b: N M_002247.1 gb:AF025999 -1.89628 0.858329 6.75 Up 0.001372 AA557324 ESTs, Weakly similar to fatty acid omega-hydroxylase (H.sapiens) -2.62694 0.10781 6.66 Up 0.017924 NM_0000 Homo sapiens 55 butyrylcholinesterase (BCHE), mRNA.
/PROD=butyrylcholinester ase precursor /FL=gb:M16541.1 gb:M16474.1 g b: N M_000055.1 -0.69028 2.041376 6.64 Up 0.001589 M16276 Human MHC class II HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 gb:M16276.1 g b: M60028.1 gb:M1 7564.1 gb:M81141.1 gb:M81140.1 1.037668 3.763873 6.62 Up 0.00068 R40892 ESTs -1.4606 1.25243 6.56 Up 0.001042 AW0721 0 Homo sapiens mRNA;
2 cDNA DKFZp434H2O5 (from clone DKFZp434H2O5) -2.07873 0.629421 6.53 Up 0.006819 A1269290 solute carrier family 18 (vesicular monoamine), member 2 /F L=g b: L 14269.1 gb:L23205.1 gb:L09118.1 g b: N M_003054.1 -1.17422 1.532018 6.53 Up 0.009466 A1962169 ESTs -1.85153 0.844198 6.48 Up 0.022892 AL359062 Homo sapiens mRNA full length insert cDNA clone EUROIMAGE 1913076.
-0.32746 2.355449 6.42 Up 0.000657 L39833 Homo sapiens (clone hKvBeta3) K+ channel beta subunit mRNA, complete cds. /PROD=K+
channel beta-subunit /FL=gb:U 16953.1 gb:L39833.1 -0.62283 2.054006 6.39 Up 0.000522 NM_0013 Homo sapiens deleted in 51 azoospermia-like (DAZL), mRNA. /PROD=deleted in azoospermia-like /FL=gb:U66726.2 g b: N M_001351.1 gb:U65918.1 gb:U66078.1 91 inM'`aiwry' fa,õ. o., (M
1) .?RNA. PRO ='Wn .,.,i3b to y factor-... `;.A,+' 1 2 `2.2. , .b:N`~~__ `"i ,9 1. , 0.462867 3.108247 6.26 Up 0.006847 A1807026 ESTs 1.37261 4.006097 6.21 Up 0.000311 BC040605 Homo sapiens, clone IMAGE:5271039, mRNA.
0.997757 3.610644 6.12 Up 0.000246 AU 144892 Homo sapiens cDNA
FLJ11569 fis, clone 2.214091 4.82397 6.1 Up 0.000277 N98595 ESTs ./FL=g `:eV16 891.1 -3.21441 -0.62151 6.03 Up 0.033157 NM_0219 Homo sapiens pre-TNK
81 cell associated protein (1 D12A), mRNA.
/PROD=pre-TNK cell associated protein /FL=gb:L17325.1 g b: N M_021981.1 -1.61054 0.964359 5.96 Up 0.005872 AW26420 ESTs -0.46577 2.083834 5.85 Up 0.00021 AW05159 ESTs, Moderately similar 1 to unnamed protein product (H.sapiens) -1.09181 1.45367 5.84 Up 0.027071 A1653050 ESTs, Weakly similar to HPPD_HUMAN 4-HYDROXYPHENYLPYRU
VATE DIOXYGENASE
(H.sapiens) -1.64801 0.893628 5.82 Up 0.000875 AW77991 ESTs -0.49174 2.041917 5.79 Up 0.005081 NM_0025 Homo sapiens neuronal 22 pentraxin I (NPTX1), mRNA. /PROD=neuronal pentraxin I precursor /F L=g b: N M_002522.1 gb:U61849.1 -0.7841 1.740263 5.75 Up 0.00111 BF672975 lipoprotein lipase /F L=g b: M 15856.1 g b: N M_000237.1 -0.75335 1.769582 5.75 Up 0.01551 AK023900 Homo sapiens cDNA
FLJ13838 fis, clone THYRO1000756, weakly similar to ALPHA-N-ACETYLGALACTOSAM IN
IDE ALPHA-2,6-SIALYLTRANSFERASE
(EC 2.4.99.-).
/F L=g b: N M_013443.1 gb:AB035173.1 1.174608 3.695562 5.74 Up 0.001082 A1659533 ArgAbl-interacting protein Arg B P2 -2.3444 0.162277 5.68 Up 0.00079 AW05758 ESTs -1.70607 0.798713 5.68 Up 0.006868 BC040321 Homo sapiens, Similar to LIM homeobox protein 8, clone IMAGE:4839343, mRNA.
-1.11642 1.371492 5.61 Up 0.016088 80000185 Homo sapiens, Similar to carnitine palmitoyltransferase 1, liver, clone MGC:1772, mRNA, complete cds.
/PROD=Similar to carnitine palmitoyltransferase I,liver /F L=g b: 60000185.1 2.631289 5.118301 5.61 Up 0.002033 AK026546 Homo sapiens cDNA:
FLJ22893 fis, clone KAT04792.
-1.99418 0.464132 5.5 Up 0.002048 NM_0069 Homo sapiens 94 butyrophilin, subfamily 3, member A3 (BTN3A3), mRNA.
/PROD=butyrophilin, subfamily 3, member A3 /F L=g b: U 90548.1 g b: N M_006994.2 -2.05438 0.400672 5.48 Up 0.047179 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -0.0881 2.345496 5.4 Up 0.001106 AL565745 ESTs, Weakly similar to 2108402A carnitine palmitoyltransferase I
(H.sapiens) -1.67442 0.753821 5.38 Up 0.004073 AW11745 neurotrimin -0.2823 2.124629 5.3 Up 0.006868 NM_0165 Homo sapiens peptide 82 transporter 3 (LOC51296), mRNA. /PROD=peptide transporter 3 /F L=g b: N M_016582.1 gb:AB020598.1 -0.08433 2.303971 5.24 Up 0.003841 NM_0007 Homo sapiens cytochrome 67 P450, subfamily IIB
(phenobarbital-inducible), polypeptide 6 (CYP2B6), mRNA.
/PROD=cytochrome P450, subfamily II B(phenobarbital-inducible), polypeptide 6 /F L=g b: N M_000767.2 gb:AF182277.1 gb:M29874.1 -0.49385 1.890277 5.22 Up 0.005872 A1741439 ESTs 2.372618 4.749882 5.2 Up 0.000339 NM_0070 Homo sapiens 15 chondromodulin I
precursor (CHM-I), mRNA.
/PROD=chondromodulin I
precursor /F L=g b: N M_007015.1 gb:AB006000.1 0.650035 3.011594 5.14 Up 0.011507 NM_0047 Homo sapiens lecithin 44 retinol acyltransferase (phosphatidylcholine--reti nol O-acyltra nsfe rase) (LRAT), mRNA.
/PROD=lecithin retinol acyltransferase(phosphati dylchol i ne--reti nol O-acyltransfe rase) /F L=g b: N M_004744.1 gb:AF071510.1 -1.60594 0.753467 5.13 Up 0.027018 AL050090 Homo sapiens mRNA;
cDNA DKFZp586F1018 (from clone DKFZp586F1018).
/PROD=hypothetical protein 4.239108 6.593362 5.11 Up 0.001589 BG54252 pyruvate dehydrogenase 1 phosphatase /F L=g b: N M_018444.1 gb:AF155661.1 0.040412 2.375678 5.05 Up 0.00034 AA960844 Homo sapiens, clone IMAGE:4081483, mRNA
1.986226 4.31181 5.01 Up 0.000576 NM_0184 Homo sapiens pyruvate 44 dehydrogenase phosphatase (PDP), mRNA. /PROD=pyruvate dehydrogenase phosphatase /F L=g b: N M_018444.1 gb:AF155661.1 3.409815 -3.01948 86.18 Down 0.000948 NM 0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 5.388254 -0.10197 44.95 Down 0.000308 NM 0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 3.094183 -2.07205 35.91 Down 0.000277 NM_0134 Homo sapiens glutamate 45 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 4.092731 -0.56561 25.25 Down 0.000149 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /F L=g b: U 81800.1 g b: N M_004207.1 2.990178 -1.65945 25.1 Down 0.012588 NM_0134 Homo sapiens glutamate 45 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 6.777916 2.398415 20.81 Down 0.000465 U15174 Homo sapiens BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3) mRNA, complete cds.
/PROD=BCL2adenovirus El B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 2.469646 -1.82868 19.68 Down 0.035416 N76327 ESTs, Highly similar to 101 1297A transferrin receptor (H.sapiens) 2.306111 -1.98162 19.53 Down 0.000324 A1632223 hypothetical protein DKFZp434F2322 3.834572 -0.18549 16.22 Down 0.001082 NM_0026 Homo sapiens pyruvate dehydrogenase kinase, isoenzyme 1 (PDK1), nuclear gene encoding mitochondrial protein, mRNA. /PROD=pyruvate dehydrogenase kinase, isoenzyme 1 /F L=g b: N M_002610.2 g b: L42450.1 1.790331 -2.19355 15.82 Down 0.001383 AA775681 hypothetical protein 2.770179 -1.16728 15.32 Down 0.000149 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
3.025351 -0.90644 15.26 Down 0.000718 AW59092 ESTs 4.505436 0.7876 13.16 Down 0.000277 W57613 ESTs 4.749034 1.283923 11.04 Down 0.001992 NM_0021 Homo sapiens 3-hydroxy-30 3-methylglutaryl-Coenzyme A synthase 1 (soluble) (HMGCS1), mRNA. /PROD=3-hyd roxy-3-methylg l uta ryl-Coenzyme A synthase 1(soluble) /F L=g b: N M_002130.1 gb:L25798.1 g b: 60000297.1 2.792215 -0.63797 10.78 Down 0.000308 BC017942 Homo sapiens, Similar to otoconin 90, clone IMAGE:4285317, mRNA.
1.80547 -1.58337 10.47 Down 0.003516 NM_0008 Homo sapiens glutamate 17 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD67, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_000817.1 gb:M81883.1 gb:L16888.1 5.095598 1.712881 10.43 Down 0.003841 NM_0055 Homo sapiens insulin 42 induced gene 1 (INSIG1), mRNA. /PROD=insulin induced gene 1 /F L=g b: N M_005542.1 3.268087 -0.094 10.28 Down 0.000308 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 4.161028 0.812032 10.19 Down 0.01551 80005807 Homo sapiens, clone MGC:10264, mRNA, complete cds.
/PROD=Unknown (protein for MGC:10264) /F L=g b: 60005807.1 2.62025 -0.70119 10 Down 0.002196 AA625683 ESTs 1.840613 -1.45068 9.79 Down 0.004024 A1949760 ESTs, Weakly similar to unnamed protein product (H.sapiens) 1.389794 -1.83973 9.38 Down 0.001383 BG49869 ESTs 1.075159 -2.15236 9.37 Down 0.002413 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 0.757197 -2.44574 9.21 Down 0.036787 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 0.831091 -2.3635 9.16 Down 0.026606 NM 1530 Homo sapiens 36 hypothetical protein FLJ32239 (FLJ32239), mRNA.
/F L=g b: N M_153036.1 4.507212 1.314761 9.14 Down 0.000772 AW19694 ESTs 1.194285 -1.99568 9.13 Down 0.018647 NM_0018 Homo sapiens cystatin SN
98 (CST1), mRNA.
/PROD=cystatin SN
/FL=gb:J03870.1 g b: N M_001898.1 3.030236 -0.13469 8.97 Down 0.001421 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 2.422113 -0.73175 8.9 Down 0.012832 AL544576 ESTs 6.091008 2.976341 8.66 Down 0.000149 BC020935 Homo sapiens, Similar to otoconin 90, clone IMAGE:4277593, mRNA.
5.023981 1.92526 8.57 Down 0.000702 NM_0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 4.285883 1.193881 8.53 Down 0.000308 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 6.371229 3.380355 7.95 Down 0.000277 A1950472 ESTs 3.953402 0.998399 7.75 Down 0.000728 80005369 Homo sapiens, chromosome 1 open reading frame 12, clone MGC:12484, mRNA, complete cds.
/PROD=chromosome 1 open reading frame 12 /FL=gb:AF277176.1 g b: N M_022051.1 gb:AF229245.1 g b: 60005369.1 2.759117 -0.13047 7.41 Down 0.000277 A1692523 ESTs 1.143234 -1.73889 7.37 Down 0.018647 BF437711 ESTs 2.36447 -0.49577 7.26 Down 0.000358 NM 0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 2.514693 -0.33184 7.19 Down 0.000412 NM 1450 Homo sapiens 32 hypothetical protein MGC21636 (MGC21636), mRNA.
/FL=gb:BC020572.1 gb:NM_145032.2 1.956681 -0.85067 7 Down 0.045693 NM_0052 Homo sapiens coagulation 42 factor 11 (thrombin) receptor-like 1 (F2RL1), mRNA.
/PROD=coagulation factor 11 (thrombin) receptor-like 1 precursor /FL=gb:U34038.1 g b: N M_005242.2 4.103964 1.313863 6.92 Down 0.000149 AA579773 ESTs 4.501184 1.716877 6.89 Down 0.000 149 AK000162 Homo sapiens cDNA
FLJ20155 fis, clone COL08754, highly similar to ACSA_ECOLI
ACETYL-COENZYME A
SYNTHETASE.
2.660133 -0.12206 6.88 Down 0.000412 AF277174 Homo sapiens PNAS-137 mRNA, complete cds.
/PROD=PNAS-1 37 /FL=gb:AF277174.1 4.560288 1.812725 6.72 Down 0.049122 BF979497 squalene epoxidase 0.300578 -2.4423 6.69 Down 0.047414 All 10886 prothymosin, alpha (gene sequence 28) 3.816817 1.093203 6.61 Down 0.008646 AR 16616 Homo sapiens PR00998 mRNA, complete cds.
/PROD=PRO0998 /FL=gb:AF1 16616.1 7.047717 4.332472 6.57 Down 6.33E-05 NM_0040 Homo sapiens 52 BCL2adenovirus E1 B
l9kD-interacting protein 3 (BNIP3), nuclear gene encoding mitochondrial protein, mRNA.
/PROD=B CL2ade novi rus El B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 4.897427 2.262649 6.21 Down 0.000149 R06655 ESTs, Moderately similar to AF078844 1 hqp0376 protein (H.sapiens) 4.424942 1.790634 6.21 Down 0.010942 AF493929 Homo sapiens regulator of G protein signalling 5 (RGS5) mRNA, complete cds. /PROD=regulator of G protein signalling 5 /F L=g b:AF493929.1 2.28595 -0.34058 6.18 Down 0.001421 BE504838 ESTs 2.276913 -0.33923 6.13 Down 0.045179 AK025909 Homo sapiens cDNA:
FLJ22256 fis, clone HRC02860.
2.33099 -0.27829 6.1 Down 0.020405 NM_0040 Homo sapiens arrestin, 41 beta 1 (ARRB1), transcript variant 1, mRNA.
/PROD=arrestin beta 1, isoform A
/FL=gb:B0003636.1 g b:AF084040.1 g b: N M_004041.2 5.319714 2.718977 6.07 Down 0.00034 AL117352 Human DNA sequence from clone RP5-876B10 on chromosome 1842.12-43. Contains the 3 end of the GNPAT gene for glyceronephosphate 0-acyltransferase (DHAPAT, DAPAT, dihydroxyacetone phosphate acyltransferase, EC
2.3.1.42), the gene for a novel protei...
6.618477 4.029022 6.02 Down 0.000267 AU 146532 pyruvate dehydrogenase kinase, isoenzyme 1 2.658828 0.094296 5.92 Down 0.000277 NM_0246 Homo sapiens 03 hypothetical protein FLJ1 1588 (FLJ1 1588), mRNA.
/PROD=hypothetical protein FLJ11588 /F L=g b: N M_024603.1 3.806044 1.246883 5.89 Down 0.001383 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 4.782763 2.225157 5.89 Down 0.000229 NM_0041 Homo sapiens 99 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide II (P4HA2), mRNA.

/PROD=procollagen-proline, 2-oxoglutarate4-dioxygenase (proline 4-hydroxylase), alpha polypeptidell /F L=g b: N M_004199.1 gb:U904 2.350127 -0.15742 5.69 Down 0.001603 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
5.979532 3.475949 5.67 Down 0.038914 U18197 Human ATP:citrate lyase mRNA, complete cds.
/PROD=ATP:citrate lyase /FL=gb:U 18197.1 2.322104 -0.13595 5.49 Down 0.001082 AW29136 ESTs 2.951696 0.4944 5.49 Down 0.004024 AB019562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
2.265595 -0.17155 5.42 Down 0.00303 NM_0221 Homo sapiens myodulin 44 protein (LOC64102), mRNA. /PROD=myodulin protein /FL=gb:AB055421.1 gb:AF191770.1 g b: N M_022144.1 gb:AF234259.1 5.606506 3.176643 5.39 Down 0.000149 NM 0134 Homo sapiens follistatin 09 (FST), transcript variant FST344, mRNA.
/PROD=follistatin isoform FST344 precursor /F L=g b: N M_013409.1 gb:B0004107.1 4.03305 1.617698 5.33 Down 0.000512 BE300521 insulin induced gene 1 /F L=g b: N M_005542.1 5.294065 2.87892 5.33 Down 0.01743 AF279899 Homo sapiens PNAS-145 mRNA, complete cds.
/PROD=PNAS-145 /FL=gb:U03105.1 g b: N M_006813.1 gb:AF279899.1 5.807319 3.40016 5.3 Down 0.000277 NM 0180 Homo sapiens 04 hypothetical protein FLJ10134 (FLJ10134), mRNA.
/PROD=hypothetical protein FLJ10134 /F L=g b: N M_018004.1 2.64743 0.242871 5.29 Down 0.00111 A1702438 ESTs 4.257559 1.873346 5.22 Down 0.00021 NM_0063 Homo sapiens 65 transcriptional activator of the c-fos promoter (CROC4), mRNA.
/PROD=transcriptional activator of the c-fos promoter /F L=g b: N M_006365.1 gb:U49857.1 B) H9P39 at 6 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 6 HR DE Ratio Direction adj. p- Gene Gene Name 01 value Identifier -3.61621 3.039489 100.82 Up 0.001521 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds -1.32044 4.397292 52.63 Up 0.005415 AF017987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -3.12747 2.554429 51.34 Up 0.000785 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -1.56608 3.285259 28.87 Up 0.010886 NM_0007 Homo sapiens cytochrome 67 P450, subfamily IIB
(phenobarbital-inducible), polypeptide 6 (CYP2B6), mRNA.
/PROD=cytochrome P450, subfamily IIB(phenobarbital-inducible), polypeptide 6 /F L=g b: N M_000767.2 gb:AF182277.1 g b: M29874.1 0,756526 44,2122 2573 SUp 11.01181 =13- ~* `w M:z3:-`Y;..r+'? at.vd Protein I
(SFRP rnR^ A.
PRO '-s ecr eted qb NM 003012,2 +- b`AFOOI9ad; 0 -1.03397 3.570137 24.32 Up 0.000451 NM_0030 Homo sapiens secretory 20 granule, neuroendocrine protein 1 (7B2 protein) (SGNE1), mRNA.
/PROD=secretory granule, neuroendocrine protein 1 (7B2protein) /F L=g b: 60005349.1 g b: N M_003020.1 -0.27888 4.229001 22.75 Up 0.000262 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.

/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -0.41404 4.064841 22.3 Up 0.000713 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF01 7987.1 gb:AF001900.1 -1.64839 2.511027 17.87 Up 0.001081 NM_0049 Homo sapiens phorbolin 00 (similar to apolipoprotein B
mRNA editing protein) (DJ742C19.2), mRNA.
/PROD=phorbolin (similar to apolipoprotein B
mRNAediting protein) /F L=g b: N M_004900.1 gb:U61083.1 -0.10733 3.921888 16.33 Up 0.001963 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -1.89835 2.08573 15.82 Up 0.000268 AL 122010 Human DNA sequence from clone RP5-997D16 on chromosome 1p34.1-35.3 Contains part of the gene for DAP-1 protein, STSs, GSSs and a CpG
island -2.38787 1.510394 14.91 Up 0.012419 80003517 Homo sapiens, clone IMAGE:3542589, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3542589) 1.168713 4.97383 13.98 Up 0.000908 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 80003079.1 1.109291 4.713388 12.16 Up 0.000639 NM_0053 Homo sapiens 56 lymphocyte-specific protein tyrosine kinase (LCK), mRNA.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 gb:NM_005356.1 gb:M36881.1 -0.69028 2.890465 11.96 Up 0.001335 M16276 Human MHC class 11 HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 gb:M16276.1 g b: M60028.1 gb:M1 7564.1 gb:M81141.1 gb:M81140.1 -2.89467 0.604102 11.3 Up 0.009629 AW97120 ESTs -1.66608 1.816524 11.18 Up 0.011253 BE673445 Homo sapiens chromosome 19, cosmid 3.061783 6.476101 10.66 Up 0.000192 BF057809 ESTs 1.495888 4.907617 10.64 Up 0.000719 NM_0021 Homo sapiens heme 33 oxygenase (decycling) 1 (HMOX1), mRNA.
/PROD=heme oxygenase (decyclizing) 1 /F L=g b: N M_002133.1 -3.05488 0.24579 9.85 Up 0.002819 A1569804 ESTs -2.233 1.058708 9.79 Up 0.002994 NM_0148 Homo sapiens KIAA0307 62 gene product (KIAA0307), mRNA. /PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 -3.588 -0.31418 9.67 Up 0.048375 A1743261 ESTs -2.01579 1.241268 9.56 Up 0.0 12905 A1937060 KIAA1151 protein -2.16864 1.08358 9.53 Up 0.053176 NM_0014 Homo sapiens galanin 80 receptor 1 (GALR1), mRNA. /PROD=galanin receptor 1 /F L=g b: N M_001480.2 gb:U23854.1 gb:L34339.1 gb:U5351 1.1 -1.39784 1.792634 9.13 Up 0.006895 BE222344 splicing factor, arginineserine-rich 5 -1.79406 1.292814 8.5 Up 0.025849 NM_0047 Homo sapiens solute 31 carrier family 16 (monocarboxylic acid transporters), member 7 (SLC16A7), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 7 /FL=gb:AF058056.1 g b: N M_004731.1 -0.04543 3.025604 8.4 Up 0.001481 AB037730 Homo sapiens mRNA for KIAA1309 protein, partial cds. /PROD=KIAA1309 protein -2.62694 0.426879 8.3 Up 0.015097 NM_0000 Homo sapiens 55 butyrylcholinesterase (BCHE), mRNA.
/PROD=butyrylcholinester ase precursor /FL=gb:M16541.1 gb:M16474.1 g b: N M_000055.1 -3.17826 -0.15901 8.11 Up 0.032029 A1798098 ESTs 1.875596 4.86264 7.93 Up 0.052512 M10098 Human 18S rRNA gene, complete.
-2.87679 0.053356 7.62 Up 0.045164 A1378647 ESTs -2.39234 0.513238 7.49 Up 0.032932 NM_0043 Homo sapiens catenin 89 (cadherin-associated protein), alpha 2 (CTNNA2), mRNA.
/PROD=catenin (cadherin-associated protein), alpha 2 /FL=gb:NM_004389.1 gb:M94151.2 -1.16113 1.724952 7.39 Up 0.016804 NM_0122 Homo sapiens potassium 81 voltage-gated channel, Shal-related subfamily, member 2 (KCND2), mRNA. /PROD=potassium voltage-gated channel, S ha l-re fated s u bfa m i l y, member 2 /F L=g b: N M_012281.1 gb:AB028967.1 gb:AF121104.1 0.194248 3.078427 7.38 Up 0.002349 U07236 Human mutant lymphocyte-specific protein tyrosine kinase (LCK) mRNA, complete cds. /PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 gb:NM_005356.1 gb:M36881.1 -1.57619 1.300336 7.34 Up 0.003836 AW07279 contactin 1 2.284174 5.158015 7.33 Up 0.031092 M10098 Human 18S rRNA gene, complete.
-1.51992 1.341829 7.27 Up 0.008657 AA460960 H.sapiens mRNA (clone ICRFp507L1876) 0.462867 3.324494 7.27 Up 0.005747 A1807026 ESTs -2.05438 0.78321 7.15 Up 0.031227 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.997757 3.818432 7.06 Up 0.000204 AU 144892 Homo sapiens cDNA
FLJ1 1569 fis, clone 2.013831 4.834052 7.06 Up 0.044501 M10098 Human 18S rRNA gene, complete.
-2.26295 0.550594 7.03 Up 0.018367 A1735586 ESTs -1.51616 1.294636 7.02 Up 0.005536 AJ272267 Homo sapiens partial mRNA for choline dehydrogenase (chdh gene). /PROD=choline dehydrogenase -2.13754 0.667215 6.99 Up 0.022696 BF000203 ESTs 0.466394 3.270039 6.98 Up 0.000736 NM_0031 Homo sapiens Spi-B
21 transcription factor (Spi-1 PU.1 related) (SPIB), mRNA. /PROD=Spi-B
transcription factor (Spi-1PU.1 related) /F L=g b: N M_003121.1 -2.17012 0.632675 6.98 Up 0.0112 AB018580 Homo sapiens mRNA for hluPGFS, complete cds.
/PROD=hluPGFS
/F L=g b: N M_003739.2 gb:AF149416.2 gb:AB018580.1 gb:D17793.1 -2.45074 0.326451 6.86 Up 0.021849 AW14940 neurexin 1 /FL=gb:AB035356.1 -0.8902 1.856598 6.71 Up 0.001423 NM_0220 Homo sapiens estrogen 34 regulated gene 1 (ERG-1), mRNA. /PROD=estrogen regulated gene 1 /FL=gb:AF305835.1 g b: N M_022034.1 -1.25121 1.488908 6.68 Up 0.001035 R62432 Cluster Incl.
R62432:yg52e11.s1 Homo sapiens cDNA, 3 end /clone=IMAGE-36023 /clone end=3 /gb=R62432 /gi=834311 /ug=Hs.12321 /len=487 -1.42062 1.315517 6.66 Up 0.053176 A1830490 glycerol kinase -1.85153 0.876867 6.63 Up 0.021533 AL359062 Homo sapiens mRNA full length insert cDNA clone EUROIMAGE 1913076.
-3.12055 -0.40125 6.59 Up 0.044501 AW78000 ESTs 1.037668 3.7519 6.56 Up 0.000736 R40892 ESTs -2.07873 0.630876 6.54 Up 0.00724 A1269290 solute carrier family 18 (vesicular monoamine), member 2 /F L=g b: L 14269.1 gb:L23205.1 gb:L09118.1 g b: N M_003054.1 -1.88254 0.821519 6.52 Up 0.006908 BF694956 Human DNA sequence from clone RP1-187J11 on chromosome 6811.1-22.33. Contains the gene for a novel protein similar to S. pombe and S.
cerevisiae predicted proteins, the gene for a novel protein similar to protein kinase C inhibitors, the 3 end of the -0.5392 2.15739 6.48 Up 0.00126 AA769438 ESTs, Moderately similar to ALU1_HUMAN ALU
SUBFAMILY J
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.872557 4.557858 6.43 Up 0.000315 R38389 olfactomedin related ER
localized protein -2.06656 0.610015 6.39 Up 0.01711 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 -1.4606 1.189801 6.28 Up 0.001394 AW07210 Homo sapiens mRNA;
2 cDNA DKFZp434H2O5 (from clone DKFZp434H2O5) -1.17422 1.42382 6.05 Up 0.007542 A1962169 ESTs -1.27392 1.293844 5.93 Up 0.042956 U11058 Homo sapiens large conductance calcium- and voltage-dependent potassium channel alpha subunit (MaxiK) mRNA, complete cds.
/PROD=large conductance calcium- and voltage-dependentpotassium channel alpha subunit /FL=gb:U23767.1 g b: N M_002247.1 gb:AF025999 -0,04433 2,4k56339 3$ 5,78 S S = . (30151 N ;'V! x=,071 n -o = Wn; ,H' o ;; :
."S~= a= tor- (* -`:'e RNA, AF R\ D',- r :

g b., N 0.= :' + i -1.38062 1.126483 5.68 Up 0.003297 NM_0025 Homo sapiens 90 protocadherin 8 (PCDH8), mRNA.
/PROD=protocadherin 8 /F L=g b: N M_002590.2 gb:AF061573.2 1.37261 3.87602 5.67 Up 0.000713 BC040605 Homo sapiens, clone IMAGE:5271039, mRNA.
-2.3444 0.156063 5.66 Up 0.002001 AW05758 ESTs -1.60594 0.882381 5.61 Up 0.016783 AL050090 Homo sapiens mRNA;
cDNA DKFZp586F1018 (from clone DKFZp586F1018).
/PROD=hypothetical protein -1.09181 1.384319 5.56 Up 0.030796 A1653050 ESTs, Weakly similar to HPPD_HUMAN 4-HYDROXYPHENYLPYRU
VATE DIOXYGENASE
(H.sapiens) -0.32746 2.147256 5.56 Up 0.001039 L39833 Homo sapiens (clone hKvBeta3) K+ channel beta subunit mRNA, complete cds. /PROD=K+
channel beta-subunit /FL=gb:U 16953.1 gb:L39833.1 -0.46577 2.00387 5.54 Up 0.000262 AW05159 ESTs, Moderately similar 1 to unnamed protein product (H.sapiens) -2.19527 0.241495 5.41 Up 0.017156 NM_0133 Homo sapiens EH
33 domain-binding mitotic phosphoprotein (EPSIN), mRNA. /PROD=EH
domain-binding mitotic phosphoprotein /FL=gb:NM_013333.1 gb:AF073727.1 1.684042 4.109252 5.37 Up 0.000924 BE504979 Wiskott-Aldrich syndrome-like /FL=gb:D88460.1 g b: N M_003941.1 2.7744 5.196982 5.36 Up 0.001859 AA669799 Cluster Incl.
AA669799:ag 36c04.s 1 Homo sapiens cDNA, 3 end /clone=IMAGE-1118886 /clone end=3 /gb=AA669799 /gi=2631298 /ug=Hs.6315 /len=679 0.623369 3.023579 5.28 Up 0.000791 NM_0063 Homo sapiens 34 neuroblastoma (nerve tissue) protein (AMY), mRNA.
/PROD=neuroblastoma (nerve tissue) protein /F L=g b: N M_006334.1 gb:D82343.1 -0.0881 2.307249 5.26 Up 0.000742 AL565745 ESTs, Weakly similar to 2108402A carnitine palmitoyltransferase I
(H.sapiens) 0.225505 2.619908 5.26 Up 0.000552 A1968440 ESTs -1.67442 0.713629 5.23 Up 0.008409 AW11745 neurotrimin 0.040412 2.394979 5.11 Up 0.000552 AA960844 Homo sapiens, clone IMAGE:4081483, mRNA
1.638346 3.992456 5.11 Up 0.000281 AA603344 ESTs, Weakly similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.923146 4.275361 5.11 Up 0.000799 BF057731 ESTs 1.398961 3.745146 5.08 Up 0.000972 NM_0240 Homo sapiens 36 hypothetical protein MGC3103 (MGC3103), mRNA.
/PROD=hypothetical protein MGC3103 /F L=g b: N M_024036.1 g b: 80000207.1 -0.2823 2.040956 5 Up 0.007542 NM_0165 Homo sapiens peptide 82 transporter 3 (LOC51296), mRNA. /PROD=peptide transporter 3 /F L=g b: N M_016582.1 gb:AB020598.1 3.409815 -2.62843 65.72 Down 0.0112 NM_0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 5.388254 0.009545 41.61 Down 0.000281 NM_0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 3.094183 -1.98643 33.84 Down 0.012905 NM_0134 Homo sapiens glutamate 45 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 3.025351 -1.81749 28.7 Down 0.004056 AW59092 ESTs 4.092731 -0.55563 25.08 Down 0.000627 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /F L=g b: U 81800.1 g b: N M_004207.1 6.777916 2.149128 24.74 Down 0.000281 U15174 Homo sapiens BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3) mRNA, complete cds.
/PROD=BCL2adenovirus El B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 0.959227 -3.66704 24.7 Down 0.001627 AB033831 Homo sapiens hSCDGF
mRNA for spinal cord-derived growth factor, complete cds.
/PROD=spinal cord-derived growth factor /F L=g b: N M_016205.1 gb:AB033831.1 gb:AF091434.1 gb:AF244813.1 1.470435 -3.07409 23.34 Down 0.029826 L49506 Homo sapiens cyclin G2 mRNA, complete cds.
/PROD=cyclin G2 /F L=g b: L49506.1 4.161028 -0.3587 22.94 Down 0.006316 80005807 Homo sapiens, clone MGC:10264, mRNA, complete cds.
/PROD=Unknown (protein for MGC:10264) /F L=g b: 60005807.1 2.446762 -1.7919 18.88 Down 0.029145 NM_0059 Homo sapiens S-phase 83 kinase-associated protein 2 (p45) (SKP2), mRNA.
/PROD=S-phase kinase-associated protein 2 (p45) /F L=g b: U 33761.1 g b: N M_005983.1 1.790331 -2.43995 18.77 Down 0.001074 AA775681 hypothetical protein 4.505436 0.27614 18.76 Down 0.000281 W57613 ESTs 2.792215 -1.38592 18.1 Down 0.013563 BC017942 Homo sapiens, Similar to otoconin 90, clone IMAGE:4285317, mRNA.
4.507212 0.470029 16.42 Down 0.000262 AW19694 ESTs 2.469646 -1.56158 16.35 Down 0.000649 N76327 ESTs, Highly similar to 101 1297A transferrin receptor (H.sapiens) 2.770179 -1.16077 15.25 Down 0.000181 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
3.834572 -0.07465 15.02 Down 0.000272 NM_0026 Homo sapiens pyruvate dehydrogenase kinase, isoenzyme 1 (PDK1), nuclear gene encoding mitochondrial protein, mRNA. /PROD=pyruvate dehydrogenase kinase, isoenzyme 1 /F L=g b: N M_002610.2 g b: L42450.1 2.306111 -1.49375 13.93 Down 0.004398 A1632223 hypothetical protein DKFZp434F2322 3.030236 -0.72689 13.52 Down 0.006371 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 3.268087 -0.40455 12.75 Down 0.000114 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 5.294065 1.68926 12.17 Down 0.001199 AF279899 Homo sapiens PNAS-145 mRNA, complete cds.
/PROD=PNAS-145 /FL=gb:U03105.1 g b: N M_006813.1 gb:AF279899.1 0.173113 -3.3673 11.64 Down 0.006169 NM_1524 Homo sapiens 90 hypothetical protein MGC39558 (MGC39558), mRNA.
/F L=g b: BC029564.1 g b: N M_152490.1 0.432613 -3.10597 11.62 Down 0.013508 80004884 Homo sapiens, clone MGC:11141, mRNA, complete cds.
/PROD=Unknown (protein for MGC:11141) /F L=g b: 60004884.1 6.371229 2.841928 11.55 Down 0.000432 A1950472 ESTs 5.023981 1.496597 11.53 Down 0.000207 NM_0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 2.036188 -1.4564 11.26 Down 0.023936 U55936 Human SNAP-23 mRNA, complete cds.
/PROD=SNAP-23 /F L=g b: U 55936.1 g b: 60000148.2 g b: 60003686.1 gb:Y09567.1 1.075159 -2.41498 11.24 Down 0.004979 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 6.091008 2.605414 11.2 Down 0.000741 BC020935 Homo sapiens, Similar to otoconin 90, clone IMAGE:4277593, mRNA.
0.783065 -2.6827 11.05 Down 0.030265 AB014486 Homo sapiens mRNA for RA70, complete cds.
/PROD=RA70 /FL=gb:AF051323.1 g b: 60002893.1 gb:AB014486.1 gb:AF072166.1 g b: N M_003930.1 2.505869 -0.95096 10.98 Down 0.001627 AV721177 phosphatidylinositol binding clathrin assembly protein 4.749034 1.297636 10.94 Down 0.000464 NM_0021 Homo sapiens 3-hydroxy-30 3-methylglutaryl-Coenzyme A synthase 1 (soluble) (HMGCS1), mRNA. /PROD=3-hyd roxy-3-methylg l uta ryl-Coenzyme A synthase 1(soluble) /F L=g b: N M_002130.1 gb:L25798.1 g b: 60000297.1 1.840613 -1.60133 10.87 Down 0.015976 A1949760 ESTs, Weakly similar to unnamed protein product (H.sapiens) 2.060071 -1.36259 10.72 Down 0.003053 AA004300 hypothetical protein DKFZp5661133 2.990178 -0.3979 10.47 Down 0.000924 NM_0134 Homo sapiens glutamate 45 decarboxylase 1 (brain, 67kD) (GAD1), transcript variant GAD25, mRNA.
/PROD=glutamate decarboxylase 1, isoform /F L=g b: N M_013445.1 gb:AF178853.1 g b: 60002815.1 1.143234 -2.23959 10.43 Down 0.00724 BF437711 ESTs 0.680039 -2.65005 10.06 Down 0.005452 AW26835 ESTs, Highly similar to antigen (H.sapiens) 0.757197 -2.55666 9.94 Down 0.012419 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 3.953402 0.655224 9.84 Down 0.000312 80005369 Homo sapiens, chromosome 1 open reading frame 12, clone MGC:12484, mRNA, complete cds.
/PROD=chromosome 1 open reading frame 12 /FL=gb:AF277176.1 g b: N M_022051.1 gb:AF229245.1 gb:B0005369.1 2.660133 -0.625 9.75 Down 0.000281 AF277174 Homo sapiens PNAS-1 37 mRNA, complete cds.
/PROD=PNAS-1 37 /FL=gb:AF277174.1 2.370141 -0.82549 9.16 Down 0.011076 BC020691 Homo sapiens, Similar to pre-B-cell colony-enhancing factor, clone MGC:22427 IMAGE:4717726, mRNA, complete cds.
/PROD=Similar to pre-B-cell colony-enhancing factor /FL=gb:BC020691.1 1.250277 -1.93752 9.11 Down 0.02358 BC035744 Homo sapiens, hypothetical protein HSPC129, clone MGC:46091 IMAGE:5744745, mRNA, complete cds.
/FL=gb:BC035744.1 2.62025 -0.48479 8.6 Down 0.002377 AA625683 ESTs 4.560288 1.479495 8.46 Down 0.000799 BF979497 squalene epoxidase 1.609384 -1.40302 8.07 Down 0.03374 80005961 Homo sapiens, parathyroid hormone-like hormone, clone MGC:14611, mRNA, complete cds.
/PROD=parathyroid hormone-like hormone /F L=g b: 60005961.1 2.422113 -0.58962 8.07 Down 0.035909 AL544576 ESTs 4.285883 1.280326 8.03 Down 0.000262 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 1.194285 -1.77245 7.82 Down 0.029849 NM_0018 Homo sapiens cystatin SN
98 (CST1), mRNA.
/PROD=cystatin SN
/FL=gb:J03870.1 g b: N M_001898.1 0.885541 -2.07053 7.76 Down 0.025326 AV721958 ESTs 4.501184 1.559254 7.68 Down 0.000 103 AK000162 Homo sapiens cDNA
FLJ20155 fis, clone COL08754, highly similar to ACSA_ECOLI
ACETYL-COENZYME A
SYNTHETASE.
2.264785 -0.65782 7.58 Down 0.000552 AF005037 Homo sapiens secretory carrier membrane protein (SCAMP1) mRNA, complete cds.
/PROD=secretory carrier membrane protein /F L=g b:AF038966.1 gb:AF005037.1 g b: N M_004866.1 5.095598 2.21166 7.38 Down 0.001394 NM_0055 Homo sapiens insulin 42 induced gene 1 (INSIG1), mRNA. /PROD=insulin induced gene 1 /F L=g b: N M_005542.1 5.979532 3.098176 7.37 Down 0.003586 U18197 Human ATP:citrate lyase mRNA, complete cds.
/PROD=ATP:citrate lyase /FL=gb:U 18197.1 4.782763 1.929757 7.23 Down 0.000451 NM 0041 Homo sapiens 99 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide II (P4HA2), mRNA.
/PROD=procollagen-proline, 2-oxoglutarate4-dioxygenase (proline 4-hydroxylase), alpha polypeptidell /F L=g b: N M_004199.1 gb:U904 5.356771 2.540614 7.04 Down 0.000587 W92036 ESTs 1.41468 -1.38083 6.94 Down 0.017389 NM_0184 Homo sapiens 70 uncharacterized hypothalamus protein HT009 (HT009), mRNA.
/PROD=uncharacterized hypothalamus protein /FL=gb:AF220183.1 g b: N M_018470.1 7.047717 4.25951 6.91 Down 0.000431 NM0040 Homo sapiens 52 BCL2adenovirus E1 B
19kD-interacting protein 3 (BNIP3), nuclear gene encoding mitochondrial protein, mRNA.
/PROD=BCL2adenovirus El B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 1.815339 -0.96912 6.89 Down 0.011253 BE206621 Homo sapiens mRNA;
cDNA DKFZp434P228 (from clone DKFZp434P228) 5.319714 2.54291 6.85 Down 0.000213 AL117352 Human DNA sequence from clone RP5-876B10 on chromosome 1g42.12-43. Contains the 3 end of the GNPAT gene for glyceronephosphate 0-acyltransferase (DHAPAT, DAPAT, dihydroxyacetone phosphate acyltransferase, EC
2.3.1.42), the gene for a novel protei...
4.010007 1.2423 6.81 Down 0.00398 NM 0065 Homo sapiens beta-1,3-N-77 acetylglucosaminyltransfer ase (BETA3GNT), mRNA.
/PROD= beta-1, 3-N-acetylglucosaminyltransfer ase /FL=gb:NM_006577.2 gb:AF288208.1 gb:AF092051.2 1.390174 -1.34692 6.67 Down 0.014402 80001224 Homo sapiens, clone MGC:982 IMAGE:3354306, mRNA, complete cds.
/PROD=Unknown (protein for MGC:982) /FL=gb:B0001224.1 0.831091 -1.89825 6.63 Down 0.025217 NM 1530 Homo sapiens 36 hypothetical protein FLJ32239 (FLJ32239), mRNA.
/F L=g b: N M_153036.1 2.33099 -0.39642 6.62 Down 0.000103 NM 0040 Homo sapiens arrestin, 41 beta 1 (ARRB1), transcript variant 1, mRNA.
/PROD=arrestin beta 1, isoform A
/FL=gb:B0003636.1 g b:AF084040.1 g b: N M_004041.2 1.389794 -1.32346 6.56 Down 0.006908 BG49869 ESTs 4.424942 1.717072 6.53 Down 0.000627 AF493929 Homo sapiens regulator of G protein signalling 5 (RGS5) mRNA, complete cds. /PROD=regulator of G protein signalling 5 /F L=g b:AF493929.1 1.987876 -0.71603 6.52 Down 0.032029 D84105 Human CD46 mRNA, complete cds.
/PROD=CD46 /FL=gb:D84105.1 2.224696 -0.43842 6.33 Down 0.003781 NM_0156 Homo sapiens 01 DKFZP564GO92 protein (DKFZP564GO92), mRNA.
/PROD=DKFZP564GO92 protein /F L=g b: N M_015601.1 0.366041 -2.27572 6.24 Down 0.017238 A1242583 Homo sapiens cDNA
FLJ11550 fis, clone 0.899011 -1.74189 6.24 Down 0.031092 NM 0028 Homo sapiens parathyroid 20 hormone-like hormone (PTHLH), mRNA.
/PROD=parathyroid hormone-like hormone /FL=gb:J03802.1 g b: N M_002820.1 -0.00139 -2.64223 6.24 Down 0.045323 NM 0028 Homo sapiens protein 37 tyrosine phosphatase, receptor type, B (PTPRB), mRNA. /PROD=protein tyrosine phosphatase, receptor type, B
/F L=g b: N M_002837.1 0.81216 -1.82788 6.23 Down 0.021836 NM_0177 Homo sapiens 63 hypothetical protein FLJ20315 (FLJ20315), mRNA.
/PROD=hypothetical protein FLJ20315 /F L=g b: N M_017763.1 5.600865 2.995377 6.09 Down 0.000713 All 83997 regulator of G-protein signalling 5 /FL=gb:AB008109.1 g b: N M_003617.1 gb:AF159570.1 2.350127 -0.2504 6.07 Down 0.030265 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
3.732985 1.134619 6.06 Down 0.001697 A1459194 early growth response 1 2.36447 -0.20141 5.92 Down 0.000552 NM_0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 3.621319 1.058823 5.91 Down 0.001394 AY072911 Homo sapiens coxsackie-adenovirus-receptor isoform CAR37 (CXADR) mRNA, complete cds;
alternatively spliced.
/PROD=coxsackie-adenovirus-receptor isoform CAR37 /F L=g b:AY072911.1 3.816817 1.261309 5.88 Down 0.000279 AF116616 Homo sapiens PR00998 mRNA, complete cds.
/PROD=PRO0998 /FL=gb:AF1 16616.1 2.003811 -0.52279 5.76 Down 0.012377 AK001291 Homo sapiens cDNA
FLJ 10429 fis, clone NT2RP1000413, highly similar to Homo sapiens mRNA for KIAA0587 protein.
2.951696 0.463484 5.61 Down 0.000268 AB019562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
4.654166 2.17714 5.57 Down 0.006161 H09085 Homo sapiens clone mRNA, complete cds 2.590871 0.126582 5.52 Down 0.00106 NM 0165 Homo sapiens TBX3-iso 69 protein (TBX3-iso), mRNA. /PROD=TBX3-iso protein /F L=g b: N M_016569.1 gb:AF216750.1 2.432066 -0.0298 5.51 Down 0.005455 NM 0070 Homo sapiens DnaJ-like 34 heat shock protein 40 (HLJ1), mRNA.
/PROD=DnaJ-like heat shock protein 40 /F L=g b: N M_007034.2 g b: U40992.2 5.807319 3.352042 5.48 Down 0.000612 NM 0180 Homo sapiens 04 hypothetical protein FLJ10134 (FLJ10134), mRNA.
/PROD=hypothetical protein FLJ10134 /F L=g b: N M_018004.1 2.006604 -0.43301 5.42 Down 0.000713 NM 0040 Homo sapiens discs, large 87 (Drosophila) homolog 1 (DLG1), mRNA.
/PROD=discs, large (Drosophila) homolog 1 /F L=g b: N M_004087.1 g b: U 13896.1 0.72592 -1.71056 5.41 Down 0.014643 AB050856 Homo sapiens beta3GaINAcT-1 mRNA
for globoside synthase, complete cds, clone:type 2. /PROD=globoside synthase /FL=gb:AB050856.1 3.805066 1.369345 5.41 Down 0.001099 BG33007 Human alpha-catenin 6 mRNA, partial cds.
3.70002 1.279892 5.35 Down 0.014262 NM_0065 Homo sapiens SEC10 (S.
44 cerevisiae)-like 1 (SEC10L1), mRNA.
/PROD=SEC10 (S.
cerevisiae)-like 1 /F L=g b: U 85946.1 g b: N M_006544.1 0.873551 -1.53444 5.31 Down 0.031228 AW29337 ESTs 5.850582 3.443167 5.31 Down 0.008657 AF394735 Homo sapiens MAD2 mitotic arrest deficient-like 1 variant (MAD2L1) mRNA, complete cds.
/PROD=MAD2 mitotic arrest deficient-like 1 variant /FL=gb:AF394735.1 5.252439 2.850969 5.28 Down 0.000192 NM 0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 1.275104 -1.11616 5.25 Down 0.031092 AU146738 Homo sapiens cDNA
FLJ11985 fis, clone 4.255531 1.866771 5.24 Down 0.001003 AF096296 Homo sapiens thymic stroma chemokine-1 precursor, mRNA, complete cds.
/PROD=thymic stroma chemokine-1 precursor /FL=gb:AF142434.1 gb:AF096296.1 gb:AF124601.1 gb:ABO10447.1 g b: N M_006072.1 4.075321 1.687619 5.23 Down 0.000791 A1652662 branched chain aminotransferase 1, cytosolic 3.806044 1.418363 5.23 Down 0.010886 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 2.276913 -0.10568 5.21 Down 0.042222 AK025909 Homo sapiens cDNA:
FLJ22256 fis, clone HRC02860.
3.264799 0.883433 5.21 Down 0.001003 NM_0160 Homo sapiens CGI-146 76 protein (LOC51029), mRNA. /PROD=CGI-146 protein /F L=g b: N M_016076.1 gb:AF151904.1 -0.70217 -3.08122 5.2 Down 0.046444 AV735100 ESTs, Weakly similar to ALU1_HUMAN ALU
SUBFAMILY J
SEQUENCE

CONTAMINATION
WARNING ENTRY
(H.sapiens) 2.28595 -0.08329 5.17 Down 0.001394 BE504838 ESTs 0.424388 -1.93597 5.13 Down 0.039624 NM_0024 Homo sapiens myelin 33 oligodendrocyte glycoprotein (MOG), mRNA. /PROD=myelin of igode nd rocyte g lycoprote i n /FL=gb:U 18798.1 gb:U64564.1 g b: N M_002433.1 5.450694 3.100148 5.1 Down 0.000281 AF095771 Homo sapiens PTH-responsive osteosarcoma B1 protein (B1) mRNA, complete cds.
/PROD=PTH-responsive osteosarcoma B1 protein /FL=gb:AF095771.1 2.176455 -0.15806 5.04 Down 0.000603 AB033281 Homo sapiens BTRCP2 mRNA for F-box and WD-repeats protein isoform C, complete cds. /PROD=F-box and WD-repeats protein beta-TRCP2 isoformC
/F L=g b:AF 176022.1 gb:AB033281.1 4.103964 1.770836 5.04 Down 0.000114 AA579773 ESTs 4.970228 2.637225 5.04 Down 0.005013 AF450454 Homo sapiens putative zinc finger protein 42 (ZFP42) mRNA, complete cds. /PROD=putative zinc finger protein 42 /F L=g b:AF450454.1 1.951234 -0.37257 5.01 Down 0.032802 NM 0162 Homo sapiens RAB23, 77 member RAS oncogene family (RAB23), mRNA.
/PROD=RAB23 protein /FL=gb:NM_016277.1 gb:AB034244.1 C) H9P39 at 24 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 24 HRS Ratio Direction adj. p- Gene Gene Name 01 DE value Identifier -3.61621 3.252949 116.9 Up 1.09E-03 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds -3.12747 2.81955 61.69 Up 5.09E-04 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -0.27888 4.796134 33.71 Up 2.25E-04 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -3.26893 1.684842 30.99 Up 1.95E-04 NM _0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1 -3.88742 0.690893 23.89 Up 2.83E-03 W80985 ESTs -1.32044 3.115913 21.65 Up 9.44E-03 AF017987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 1.168713 5.393939 18.7 Up 4.05E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 60003079.1 -2.69521 1.432079 17.48 Up 7.06E-05 AF282250 Homo sapiens calneuron 1 (CALN 1) mRNA, complete cds.
/PROD=calneuron 1 /F L=g b:AF282250.1 -2.506 1.523432 16.33 Up 2.66E-04 AW19369 DKFZP566K1924 protein -0.10733 3.827249 15.29 Up 5.09E-04 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -3.62742 0.232422 14.52 Up 1.32E-02 AA772920 ESTs -0.69028 3.077263 13.62 Up 8.84E-04 M16276 Human MHC class II HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 gb:M16276.1 g b: M60028.1 gb:M1 7564.1 gb:M81141.1 gb:M81140.1 -2.38787 1.308962 12.97 Up 1.24E-02 80003517 Homo sapiens, clone IMAGE:3542589, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3542589) -1.03397 2.650732 12.86 Up 4.41 E-04 NM_0030 Homo sapiens secretory 20 granule, neuroendocrine protein 1 (7B2 protein) (SGNE1), mRNA.
/PROD=secretory granule, neuroendocrine protein 1 (7B2protein) /F L=g b: 60005349.1 g b: N M_003020.1 2.05448 1,576656 12, 3,9 Up +.46E-02 80.2:090 E: Ts .Lo er::c; yS. ~...a;
_. 8 to A _UB HUMAN SL\
SW .AMNL, Y SX
SEQUENCE

Wti,AR*NG E N T R`' (F
0.756526 4.2504 11.27 Up 1.84E-04 NM_0030 Homo sapiens secreted 12 frizzled-related protein 1 (SFRP1), mRNA.
/PROD=secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -1.39784 2.037775 10.82 Up 4.58E-03 BE222344 splicing factor, arginineserine-rich 5 -3.12304 0.280186 10.58 Up 1.86E-02 NM_0180 Homo sapiens 18 hypothetical protein FLJ10191 (FLJ10191), mRNA.
/PROD=hypothetical protein FLJ10191 /F L=g b: N M_018018.1 -2.01579 1.387151 10.58 Up 7.46E-03 A1937060 KIAA1151 protein -2.19527 1.171426 10.32 Up 2.14E-03 NM 0133 Homo sapiens EH
33 domain-binding mitotic phosphoprotein (EPSIN), mRNA. /PROD=EH
domain-binding mitotic phosphoprotein /FL=gb:NM_013333.1 gb:AF073727.1 -1.16113 2.202477 10.29 Up 8.90E-03 NM_0122 Homo sapiens potassium 81 voltage-gated channel, Shal-related subfamily, member 2 (KCND2), mRNA. /PROD=potassium voltage-gated channel, S ha l-re fated s u bfa m i l y, member 2 /F L=g b: N M_012281.1 gb:AB028967.1 gb:AF121104.1 1.109291 4.425076 9.96 Up 3.72E-04 NM 0053 Homo sapiens 56 lymphocyte-specific protein tyrosine kinase (LCK), mRNA.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 gb:NM_005356.1 gb:M36881.1 -1.66608 1.62119 9.76 Up 1.29E-02 BE673445 Homo sapiens chromosome 19, cosmid -2.233 1.032915 9.62 Up 4.41 E-03 NM_0148 Homo sapiens KIAA0307 62 gene product (KIAA0307), mRNA. /PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 -3.17826 0.063512 9.46 Up 2.56E-02 A1798098 ESTs 42 ,c~+= e sot! ermir"
(XeE~opu ~ae1 i\) hon-x o (e_:O ES).
m R N.,A.
!PROD
(X op;as ho nnoko ~~ ="
R-1 =gb -2.62694 0.564089 9.13 Up 1.08E-02 NM 0000 Homo sapiens 55 butyrylcholinesterase (BCHE), mRNA.
/PROD=butyrylcholinester ase precursor /FL=gb:M16541.1 gb:M16474.1 g b: N M_000055.1 -3.588 -0.42279 8.97 Up 5.08E-02 A1743261 ESTs -1.75731 1.403919 8.95 Up 3.72E-02 80008992 Homo sapiens, clone MGC:16926 IMAGE:4183000, mRNA, complete cds.
/PROD=Unknown (protein for MGC:16926) /F L=g b: 60008992.1 -1.56608 1.492453 8.33 Up 3.48E-02 NM 0007 Homo sapiens cytochrome 67 P450, subfamily IIB
(phenobarbital-inducible), polypeptide 6 (CYP2B6), mRNA.
/PROD=cytochrome P450, subfamily II B(phenobarbital-inducible), polypeptide 6 /F L=g b: N M_000767.2 gb:AF182277.1 gb:M29874.1 -1.64839 1.373964 8.12 Up 2.63E-03 NM 0049 Homo sapiens phorbolin 00 (similar to apolipoprotein B
mRNA editing protein) (DJ742C19.2), mRNA.
/PROD=phorbolin (similar to apolipoprotein B
mRNAediting protein) /F L=g b: N M_004900.1 gb:U61083.1 -2.85395 0.154004 8.04 Up 3.89E-02 AY063451 Homo sapiens D21 52088E mRNA
sequence.

-1.61054 1.380575 7.95 Up 3.70E-03 AW26420 ESTs -3.12055 -0.14826 7.85 Up 3.16E-02 AW78000 ESTs -0.48291 2.475412 7.77 Up 6.01 E-04 NM_0002 Homo sapiens ocular 73 albinism 1 (Nettleship-Falls) (OA1), mRNA.
/PROD=ocular albinism 1 (Nettleship-Falls) protein /F L=g b: N M_000273.1 -0.01122 2.91624 7.61 Up 5.09E-04 A1356398 butyrate response factor 2 (EGF-response factor 2) /FL=gb:B0005010.1 g b: N M_006887.1 -0.41404 2.492138 7.5 Up 1.22E-03 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -0.04543 2.826104 7.32 Up 8.38E-04 AB037730 Homo sapiens mRNA for KIAA1309 protein, partial cds. /PROD=KIAA1309 protein 3.061783 5.932074 7.31 Up 2.39E-04 BF057809 ESTs 1.750623 4.603127 7.22 Up 3.35E-04 W76289 ESTs 1.37261 4.224545 7.22 Up 2.56E-04 BC040605 Homo sapiens, clone IMAGE:5271039, mRNA.
0.194248 2.977224 6.88 Up 1.76E-03 U07236 Human mutant lymphocyte-specific protein tyrosine kinase (LCK) mRNA, complete cds. /PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 g b: N M_005356.1 g b: M36881.1 -2.17012 0.571059 6.69 Up 1.11 E-02 ABO18580 Homo sapiens mRNA for hluPGFS, complete cds.
/PROD=hluPGFS
/F L=g b: N M_003739.2 gb:AF149416.2 gb:AB018580.1 gb:D17793.1 0.270429 2.998558 6.63 Up 2.01 E-02 AF493872 Homo sapiens guanine nucleotide binding protein gamma 4 (GNG4) mRNA, complete cds.
/PROD=guanine nucleotide binding protein gamma 4 /F L=g b:AF493872.1 0.462867 3.188675 6.62 Up 5.56E-03 A1807026 ESTs -2.3444 0.379948 6.61 Up 5.18E-04 AW05758 ESTs -2.06656 0.644395 6.55 Up 1.48E-02 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 -1.88254 0.823917 6.53 Up 5.94E-03 BF694956 Human DNA sequence from clone RP1-187J11 on chromosome 6g11.1-22.33. Contains the gene for a novel protein similar to S. pombe and S.
cerevisiae predicted proteins, the gene for a novel protein similar to protein kinase C inhibitors, the 3 end of the -2.14678 0.54813 6.48 Up 2.59E-02 AA143060 ESTs, Highly similar to 138945 melanoma ubiquitous mutated protein (H.sapiens) -1.09181 1.594917 6.44 Up 2.17E-02 A1653050 ESTs, Weakly similar to HPPD_HUMAN 4-HYDROXYPHENYLPYRU
VATE DIOXYGENASE
(H.sapiens) -1.57619 1.107388 6.42 Up 2.44E-03 AW07279 contactin 1 -1.42062 1.262234 6.42 Up 5.27E-02 A1830490 glycerol kinase -1.51992 1.159662 6.41 Up 4.58E-03 AA460960 H.sapiens mRNA (clone ICRFp507L1876) 0.828954 3.501807 6.38 Up 9.79E-04 AK026659 Homo sapiens cDNA:
FLJ23006 fis, clone LNO00414.
0.040412 2.69519 6.3 Up 3.16E-04 AA960844 Homo sapiens, clone IMAGE:4081483, mRNA
-0.0881 2.555378 6.25 Up 1.84E-04 AL565745 ESTs, Weakly similar to 2108402A carnitine palmitoyltransferase I
(H.sapiens) -0.66924 1.971531 6.24 Up 1.10E-02 A1986120 latent transforming growth factor beta binding protein 1 /FL=gb:M34057.1 g b: N M_000627.1 -1.25121 1.36043 6.11 Up 8.84E-04 R62432 Cluster Incl.
R62432:yg52el1.s1 Homo sapiens cDNA, 3 end /clone=IMAGE-36023 /clone end=3 /gb=R62432 /gi=834311 /ug=Hs.12321 /len=487 1.285793 3.892769 6.09 Up 1.84E-04 A1949827 ESTs -1.4606 1.131857 6.03 Up 1.46E-03 AW07210 Homo sapiens mRNA;
2 cDNA DKFZp434H2O5 (from clone DKFZp434H2O5) 1.037668 3.589262 5.86 Up 3.89E-04 R40892 ESTs -2.13754 0.412333 5.86 Up 2.35E-02 BF000203 ESTs 1.470195 4.017332 5.84 Up 1.93E-04 A1676059 ESTs 0.780689 3.30524 5.75 Up 2.66E-04 A1016316 ESTs -1.41031 1.100005 5.7 Up 2.17E-02 A1832477 serologically defined colon cancer antigen 43 -0.68225 1.819364 5.66 Up 3.04E-03 N48299 ESTs, Moderately similar to NFY-C (H.sapiens) 0.937118 3.415706 5.57 Up 2.66E-04 AU 151342 Homo sapiens cDNA
FLJ12935 fis, clone -0.41626 2.0614 5.57 Up 1.39E-03 BF110534 ESTs 2.167442 4.632856 5.52 Up 2.19E-04 NM_0015 Homo sapiens insulin-like 52 growth factor-binding protein 4 (IGFBP4), mRNA. /PROD=insulin-like growth factor-binding protein 4 /F L=g b: M62403.1 g b: N M_001552.1 -0.46577 1.990737 5.49 Up 1.62E-04 AW05159 ESTs, Moderately similar 1 to unnamed protein product (H.sapiens) -1.98038 0.474231 5.48 Up 1.22E-02 NM_0024 Homo sapiens Musashi 42 (Drosophila) homolog 1 (MS11), mRNA.
/PROD=Musashi (Drosophila) homolog 1 /FL=gb:ABO12851.1 g b: N M_002442.1 0.466394 2.917466 5.47 Up 6.01 E-04 NM_0031 Homo sapiens Spi-B
21 transcription factor (Spi-1 PU.1 related) (SPIB), mRNA. /PROD=Spi-B
transcription factor (Spi-1PU.1 related) /F L=g b: N M_003121.1 -2.73733 -0.30853 5.38 Up 1.36E-03 L41944 Homo sapiens interferon receptor ifnar2-1 (splice variant IFNAR2-1) mRNA, complete cds.
/PROD= interferon receptor /F L=g b: N M_000874.1 g b: L41944.1 0.923781 3.31197 5.23 Up 2.23E-04 BE897866 ESTs 1.198446 3.56619 5.16 Up 3.79E-03 BG28379 ESTs 0.013383 2.37551 5.14 Up 7.45E-03 L10374 Human (clone CTG-A4) mRNA sequence.
-1.39667 0.965049 5.14 Up 2.75E-03 A1018174 ESTs -3.38515 -1.06056 5.01 Up 3.31 E-02 NM_1723 Homo sapiens putative 68 protein LG30 (G30), mRNA. /PROD=putative protein LG30 /FL=gb:AY138548.1 g b: N M_172368.1 3.409815 -1.99672 42.42 Down 8.38E-04 NM _0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 4.092731 -0.75499 28.79 Down 3.57E-04 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 5.388254 0.591477 27.8 Down 4.11 E-05 NM_0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 2.306225 -2.24414 23.43 Down 1.14E-03 AW44476 ESTs 2.306111 -1.93483 18.91 Down 7.20E-04 A1632223 hypothetical protein DKFZp434F2322 3.025351 -1.21304 18.87 Down 6.42E-03 AW59092 ESTs 0.757197 -3.40795 17.94 Down 7.19E-03 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 0.959227 -3.03425 15.93 Down 1.27E-02 AB033831 Homo sapiens hSCDGF
mRNA for spinal cord-derived growth factor, complete cds.
/PROD=spinal cord-derived growth factor /F L=g b: N M_016205.1 gb:AB033831.1 gb:AF091434.1 gb:AF244813.1 4.505436 0.524918 15.79 Down 1.36E-04 W57613 ESTs 0.942774 -2.97701 15.13 Down 8.44E-04 AW95778 ESTs, Weakly similar to 6 S51797 vasodilator-stimulated phosphoprotein (H.sapiens) 1.1136 -2.73154 14.37 Down 1.61 E-02 Z70519 H.sapiens FASApo 1 mRNA for FAS soluble protein (clone FAS
Exo4Del). /PROD=FAS
soluble protein 1.389794 -2.42829 14.1 Down 1.11 E-02 BG49869 ESTs 1.312148 -2.42325 13.32 Down 5.09E-04 U32500 Human type 2 neuropeptide Y receptor mRNA, complete cds.
/PROD=type 2 neuropeptide Y receptor /FL=gb:U42766.1 gb:U36269.1 gb:U32500.1 2.62025 -1.04008 12.64 Down 1.04E-03 AA625683 ESTs 3.268087 -0.32148 12.04 Down 1.86E-04 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 4.152765 0.57732 11.92 Down 3.06E-04 AW00317 stanniocalcin 1 6.777916 3.231028 11.69 Down 3.37E-05 U15174 Homo sapiens BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3) mRNA, complete cds.
/PROD=BCL2adenovirus E1 B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 1.143234 -2.39818 11.64 Down 6.01 E-04 BF437711 ESTs 2.36447 -1.1716 11.6 Down 3.57E-04 NM_0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 4.285883 0.804811 11.17 Down 3.89E-04 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 5.023981 1.567701 10.98 Down 2.66E-04 NM 0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 2.590871 -0.83277 10.73 Down 2.00E-03 NM 0165 Homo sapiens TBX3-iso 69 protein (TBX3-iso), mRNA. /PROD=TBX3-iso protein /F L=g b: N M_016569.1 gb:AF216750.1 2.332751 -1.07983 10.65 Down 2.06E-02 NM_0000 Homo sapiens cyclin-77 dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), mRNA. /PROD=cyclin-dependent kinase inhibitor 2A (melanoma,pl6, inhibits CDK4) /F L=g b: N M_000077.1 g b: L27211.1 1.577138 -1.83389 10.64 Down 3.70E-03 M15329 Human interleukin 1-alpha (IL1A) mRNA, complete cds. /PROD=interleukin 1-alpha /FL=gb:M15329.1 0.831091 -2.57623 10.61 Down 1.77E-02 NM_1530 Homo sapiens 36 hypothetical protein FLJ32239 (FLJ32239), mRNA.
/F L=g b: N M_153036.1 2.350127 -1.04844 10.55 Down 2.83E-03 AK026106 Homo sapiens cDNA:

FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
4.927935 1.558948 10.33 Down 6.84E-04 J05008 Homo sapiens endothelin-1 (EDN1) gene, complete cds /FL=gb:NM_001955.1 2.951696 -0.34119 9.8 Down 5.52E-04 AB019562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
-0.42962 -3.66853 9.44 Down 3.14E-02 D28364 Human mRNA for annexin II, 5UTR (sequence from the 5cap to the start codon).
3.030236 -0.19682 9.36 Down 3.06E-04 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 4.528627 1.33908 9.12 Down 1.86E-04 NM_0031 Homo sapiens 55 stanniocalcin 1 (STC1), mRNA.
/PROD=stanniocalcin 1 /F L=g b: U 25997.1 g b: N M_003155.1 gb:U46768.1 2.660133 -0.51613 9.04 Down 3.37E-05 AF277174 Homo sapiens PNAS-137 mRNA, complete cds.
/PROD=PNAS-1 37 /FL=gb:AF277174.1 2.422113 -0.74259 8.97 Down 6.51 E-03 AL544576 ESTs 3.806044 0.684261 8.7 Down 3.17E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 3.953402 0.872354 8.46 Down 1.12E-03 80005369 Homo sapiens, chromosome 1 open reading frame 12, clone MGC:12484, mRNA, complete cds.
/PROD=chromosome 1 open reading frame 12 /FL=gb:AF277176.1 g b: N M_022051.1 gb:AF229245.1 gb:B0005369.1 3.437271 0.406885 8.17 Down 1.28E-04 AB029025 Homo sapiens mRNA for KIAA1102 protein, partial cds. /PROD=KIAA1102 protein 2.469646 -0.53314 8.02 Down 1.95E-03 N76327 ESTs, Highly similar to 101 1297A transferrin receptor (H.sapiens) 4.255531 1.305501 7.73 Down 2.22E-03 AF096296 Homo sapiens thymic stroma chemokine-1 precursor, mRNA, complete cds.
/PROD=thymic stroma chemokine-1 precursor /F L=g b:AF 142434.1 gb:AF096296.1 gb:AF124601.1 gb:AB010447.1 g b: N M_006072.1 1.609384 -1.3385 7.72 Down 3.57E-04 80005961 Homo sapiens, parathyroid hormone-like hormone, clone MGC:14611, mRNA, complete cds.
/PROD=parathyroid hormone-like hormone /F L=g b: 60005961.1 5.356771 2.475735 7.37 Down 2.39E-04 W92036 ESTs 4.055862 1.176103 7.36 Down 1.54E-04 AK026815 Homo sapiens cDNA:
FLJ23162 fis, clone LNG09734.
4.782763 1.926881 7.24 Down 2.56E-04 NM 0041 Homo sapiens 99 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide II (P4HA2), mRNA.
/PROD=procollagen-proline, 2-oxoglutarate4-dioxygenase (proline 4-hydroxylase), alpha polypeptidell /F L=g b: N M_004199.1 gb:U904 4.749034 1.911794 7.15 Down 6.01 E-04 NM_0021 Homo sapiens 3-hydroxy-30 3-methylglutaryl-Coenzyme A synthase 1 (soluble) (HMGCS1), mRNA. /PROD=3-hyd roxy-3-methylg l uta ryl-Coenzyme A synthase 1(soluble) /F L=g b: N M_002130.1 gb:L25798.1 g b: 60000297.1 4.501184 1.674786 7.09 Down 3.37E-05 AK000162 Homo sapiens cDNA
FLJ20155 fis, clone COL08754, highly similar to ACSA_ECOLI
ACETYL-COENZYME A
SYNTHETASE.
4.103964 1.279587 7.08 Down 1.86E-04 AA579773 ESTs 5.294065 2.498324 6.94 Down 3.17E-04 AF279899 Homo sapiens PNAS-145 mRNA, complete cds.
/PROD=PNAS-145 /FL=gb:U03105.1 g b: N M_006813.1 gb:AF279899.1 6.179917 3.394324 6.9 Down 2.56E-04 NM_0001 Homo sapiens glucan 58 (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) (GBE1), mRNA.
/PROD=glucan (1,4-alpha-), branching enzyme 1(glycogen branching enzyme) /FL=gb:L07956.1 g b: N M_000158.1 3.880272 1.125517 6.75 Down 2.25E-04 NM_0025 Homo sapiens natriuretic 21 peptide precursor B
(NPPB), mRNA.
/PROD=natriuretic peptide precursor B
/F L=g b: N M_002521.1 gb:M25296.1 1.075159 -1.64214 6.58 Down 2.88E-03 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 0.031255 -2.68323 6.56 Down 1.26E-02 AU142380 Homo sapiens cDNA
FLJ34825 fis, clone NT2NE2008785, weakly similar to ANTER-SPECIFIC PROLINE-RICH PROTEIN APG.
5.252439 2.540223 6.55 Down 1.93E-04 NM 0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 1.58166 -1.12925 6.55 Down 3.72E-02 AF207990 Homo sapiens fer-1 like protein 3 (FER1 L3) mRNA, complete cds.
/PROD=fer-1 like protein 3 /FL=gb:AF207990.1 3.732985 1.022527 6.55 Down 8.08E-04 A1459194 early growth response 1 6.1137 3.411176 6.51 Down 2.56E-04 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 4.507212 1.810296 6.48 Down 1.84E-04 AW19694 ESTs 2.770179 0.094942 6.39 Down 7.20E-04 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
4.633038 1.983552 6.27 Down 5.56E-04 NM_0169 Homo sapiens NADPH
31 oxidase 4 (NOX4), mRNA.
/PROD=NADPH oxidase 4 /FL=gb:AF261943.1 gb:NM_016931.1 gb:AF254621.1 gb:AB041035.1 5.099016 2.450575 6.27 Down 4.88E-04 NM 0181 Homo sapiens 92 hypothetical protein FLJ10718(FLJ10718), mRNA.
/PROD=hypothetical protein FLJ10718 /F L=g b: N M_018192.1 3.41866 0.772516 6.26 Down 1.05E-03 AA149250 ESTs, Weakly similar to PROTEIN PRECURSOR
(R. norvegicus) 4.506475 1.891343 6.13 Down 2.83E-04 A1300520 stanniocalcin 1 /F L=g b: U 25997.1 g b: N M_003155.1 gb:U46768.1 0.060743 -2.53505 6.05 Down 3.08E-02 NM_0147 Homo sapiens zinc finger 95 homeobox 1 B (ZFHX1 B), mRNA. /PROD=zinc finger homeobox 1 B
/FL=gb:NM_014795.1 gb:AB011141.1 1.470435 -1.11845 6.02 Down 1.04E-03 L49506 Homo sapiens cyclin G2 mRNA, complete cds.
/PROD=cyclin G2 /F L=g b: L49506.1 7.564809 4.992443 5.95 Down 2.36E-04 M83248 Human nephropontin mRNA, complete cds.
/PROD=nephropontin /F L=g b: M83248.1 3.508683 0.95049 5.89 Down 3.89E-04 AK027231 Homo sapiens cDNA:
FLJ23578 fis, clone LNG 12709.
3.543738 0.987655 5.88 Down 4.67E-04 NM_0019 Homo sapiens endothelin 55 1 (EDN1), mRNA.
/PROD=endothelin 1 /F L=g b: N M_001955.1 0.279226 -2.24474 5.75 Down 3.73E-02 AF278532 Homo sapiens beta-netrin mRNA, complete cds.
/PROD= beta-netri n /FL=gb:AF1 19916.1 gb:AF297711.1 g b: N M_021229.1 gb:AF278532.1 1.771584 -0.72454 5.64 Down 1.63E-03 B1254089 Homo sapiens full length insert cDNA clone 5.450694 2.958035 5.63 Down 1.84E-04 AF095771 Homo sapiens PTH-responsive osteosarcoma B1 protein (B1) mRNA, complete cds.
/PROD=PTH-responsive osteosarcoma B1 protein /FL=gb:AF095771.1 2.648874 0.166558 5.59 Down 1.84E-04 AW00753 Human insulin-like growth 2 factor binding protein 5 (IGFBP5) mRNA
4.420733 1.940312 5.58 Down 1.95E-04 NM0036 Homo sapiens basic helix-70 loop-helix domain containing, class B, 2 (BHLHB2), mRNA.
/PROD=differentiated embryo chondrocyte expressed genet /F L=g b:AB004066.1 gb:NM_003670.1 1.659275 -0.81556 5.56 Down 6.51 E-03 L16895 Human lysyl oxidase (LOX) gene, exon 7 3.334996 0.86328 5.55 Down 8.21 E-04 R40917 phosphodiesterase 4D, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E3) /F L=g b: L20969.1 g b: N M_006203.1 g b: U02882.1 2.886643 0.429864 5.49 Down 1.63E-03 NM_0220 Homo sapiens G protein-36 coupled receptor, family C, group 5, member C
(GPRC5C), transcript variant 1, mRNA.
/PROD=G protein-coupled receptor, family C, group 5,member C, isoform a, precursor /FL=gb:AF207989.1 g b: N M_022036.1 5.319714 2.870709 5.46 Down 1.84E-04 AL117352 Human DNA sequence from clone RP5-876B10 on chromosome 1842.12-43. Contains the 3 end of the GNPAT gene for glyceronephosphate 0-acyltransferase (DHAPAT, DAPAT, dihydroxyacetone phosphate acyltransferase, EC
2.3.1.42), the gene for a novel protei...
5.398488 2.949509 5.46 Down 3.37E-05 NM 0011 Homo sapiens alpha-34 fetoprotein (AFP), mRNA.
/PROD=alpha-fetoprotein /F L=g b: N M_001134.1 gb:J00077.1 3.904705 1.46154 5.44 Down 4.81 E-04 NM0070 Homo sapiens a 38 disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) (ADAMTS5), mRNA.
/PROD=a disintegrin and metalloprotease withthrombospondin motifs-5 preproprotein /F L=g b: N M_007038.1 gb:AF14209 2.001263 -0.41849 5.35 Down 2.30E-03 U46768 Human stanniocalcin mRNA, complete cds.
/PROD=stanniocalcin /F L=g b: U 25997.1 g b: N M_003155.1 gb:U46768.1 5.095598 2.679984 5.34 Down 3.06E-04 NM_0055 Homo sapiens insulin 42 induced gene 1 (INSIG1), mRNA. /PROD=insulin induced gene 1 /F L=g b: N M_005542.1 0.899011 -1.48844 5.23 Down 7.45E-03 NM_0028 Homo sapiens parathyroid 20 hormone-like hormone (PTHLH), mRNA.
/PROD=parathyroid hormone-like hormone /FL=gb:J03802.1 g b: N M_002820.1 2.933166 0.546859 5.23 Down 1.54E-04 NM_0057 Homo sapiens lipoma 80 HMGIC fusion partner (LHFP), mRNA.
/PROD=lipoma HMGIC
fusion partner /F L=g b: N M_005780.1 gb:AF098807.1 2.454314 0.080053 5.18 Down 3.37E-05 NM 0132 Homo sapiens fibronectin 81 leucine rich transmembrane protein 3 (FLRT3), mRNA.
/PROD=fibronectin leucine rich transmembrane protein 3 /FL=gb:AF169677.1 g b: N M_013281.1 4.981033 2.626098 5.12 Down 1.14E-03 NM 0006 Homo sapiens serine (or 02 cysteine) proteinase inhibitor, Glade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINEI), mRNA.
/PROD=serine (or cysteine) proteinase inhibitor, cladeE (nexin, plasminogen activator inhibitor type 1), membe 5.209052 2.857021 5.11 Down 2.66E-04 A1754404 procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2 /F L=g b: N M_000935.1 gb:U84573.1 7.251816 4.921229 5.03 Down 5.18E-04 NM_0007 Homo sapiens annexin Al 00 (ANXA1), mRNA.
/PROD=annexin I
/FL=gb:B0001275.1 g b: N M_000700.1 D) H9P39 at 30 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.

EXPRES 30 HR DE Ratio Direction adj. p- Gene Gene Name 01 value Identifier -3.61621 3.085829 104.12 Up 1.25E-03 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds -3.12747 2.633618 54.23 Up 5.47E-04 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -3.26893 2.480892 53.81 Up 3.52E-04 NM_0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1 -3.62742 1.93392 47.22 Up 3.24E-03 AA772920 ESTs -0.27888 4.672575 30.94 Up 2.20E-04 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -3.88742 0.719139 24.36 Up 2.32E-03 AA1 80985 ESTs 1.168713 5.535315 20.63 Up 4.09E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 60003079.1 -2.05438 2.234331 19.54 Up 9.02E-03 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -0.69028 3.350018 16.45 Up 8.76E-04 M16276 Human MHC class II HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 -1.32044 2.675867 15.96 Up 1.31 E-02 AF017987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 3,042634 $.981 1.26 5,33 U 3 -\ 4 111 as 0054 Ho. n o sap =ns . 42 cos'.,`õode r i?, (Xerlo su1 ea e:=''i1) ho'-('A'Og (EO^tiME )' 1:, RSSA.

,, . nopi iae s"' .
f.\ nnoo R-1 =gb g b.NM\l 005442.;

-0.41626 3.4773 14.86 Up 5.42E-04 BF110534 ESTs -2.69521 1.031628 13.24 Up 7.80E-05 AF282250 Homo sapiens calneuron 1 (CALN 1) mRNA, complete cds.
/PROD=calneuron 1 /F L=g b:AF282250.1 -2.38787 1.314022 13.01 Up 1.37E-02 80003517 Homo sapiens, clone IMAGE:3542589, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3542589) -2.45311 1.22951 12.84 Up 4.18E-02 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
-0.68225 2.956253 12.45 Up 2.72E-04 N48299 ESTs, Moderately similar to NFY-C (H.sapiens) -0.18256 3.454591 12.44 Up 2.72E-04 A1583173 major histocompatibility complex, class II, DQ beta -0.26005 3.330481 12.05 Up 1.37E-03 R72286 microfibrillar-associated protein 4 -1.75731 1.805232 11.81 Up 2.70E-02 80008992 Homo sapiens, clone MGC:16926 IMAGE:4183000, mRNA, complete cds.
/PROD=Unknown (protein for MGC:16926) /F L=g b: 60008992.1 -3.76077 -0.22572 11.59 Up 2.57E-02 A1040305 ESTs .v.<ac. ,8ti,. 5 .. . S; ..5 6 U 4. ..- ~ 9E 0 ~+ \* ` 0 _ \t ais3iu3;b secreted 0,756526 ~v. Y. 12 ...,_z. edrek t d pr e8 ( FR..,)mRN .
;;,"O,~__ ,,,.,.,,,,, ...,_.., i'dreik,ti l pr o e8 3:\ti 003012.2 :AF 7 a8:.' ",;,., F0019 0 0 -1.61054 1.918985 11.55 Up 2.71 E-03 AW26420 ESTs -2.30432 1.221219 11.52 Up 3.31 E-02 BC017958 Homo sapiens, clone IMAGE:4607409, mRNA.
-1.16113 2.306767 11.06 Up 6.77E-03 NM_0122 Homo sapiens potassium 81 voltage-gated channel, Shal-related subfamily, member 2 (KCND2), mRNA. /PROD=potassium voltage-gated channel, Shal-relatedsubfamily, member 2 /F L=g b: N M_012281.1 gb:AB028967.1 gb:AF121104.1 -1.03397 2.369328 10.58 Up 5.45E-04 NM_0030 Homo sapiens secretory 20 granule, neuroendocrine protein 1 (7B2 protein) (SGNE1), mRNA.
/PROD=secretory granule, neuroendocrine protein 1 (7B2protein) /F L=g b: 60005349.1 g b: N M_003020.1 GATA $, n p\ e cos, .'PROD[z;GAT ,\.'$

g b : ` V 0 t05 2 5 7, .
:Y) 8 7 B'1:+
-1.16952 2.129685 9.84 Up 4.80E-02 NM_0013 Homo sapiens disabled 43 (Drosophila) homolog 2 (mitogen-responsive phosphoprotein) (DAB2), mRNA. /PROD=disabled (Drosophila) homolog 2 /F L=g b: U 39050.1 g b: N M_001343.1 gb:U53446.1 g b: 60003064.1 -0.10733 3.157091 9.61 Up 2.31 E-03 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -0.70855 2.511903 9.32 Up 2.13E-03 A1917371 ESTs 1.109291 4.227073 8.68 Up 1.36E-03 NM_0053 Homo sapiens 56 lymphocyte-specific protein tyrosine kinase (LCK), mRNA.
/PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 gb:NM_005356.1 gb:M36881.1 -1.39784 1.697082 8.54 Up 1.04E-02 BE222344 splicing factor, arginineserine-rich 5 -2.23133 0.840905 8.41 Up 8.31 E-03 AA044140 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta -1.64839 1.38707 8.2 Up 2.49E-03 NM_0049 Homo sapiens phorbolin 00 (similar to apolipoprotein B
mRNA editing protein) (DJ742C19.2), mRNA.
/PROD=phorbolin (similar to apolipoprotein B
mRNAediting protein) /F L=g b: N M_004900.1 gb:U61083.1 0,50233,3- 3.532743 I.1 Up 1.88E-0,3- A+ 2I i 891 H !tip 1 ap i s NAix4ik ?,ome obox p otefr +4,LD1: mRN A +
\.or piete :+d:3.
TROD===*\0:xI ke horn obox prote n .
Fi gb' F 21 18`91 1.470195 4.487924 8.1 Up 4.48E-04 A1676059 ESTs -1.66608 1.305765 7.85 Up 1.61 E-02 BE673445 Homo sapiens chromosome 19, cosmid -2.17012 0.717557 7.4 Up 8.40E-03 AB018580 Homo sapiens mRNA for hluPGFS, complete cds.
/PROD=hluPGFS
/F L=g b: N M_003739.2 gb:AF149416.2 gb:AB018580.1 gb:D17793.1 -3.17826 -0.30252 7.34 Up 3.88E-02 A1798098 ESTs -2.62694 0.235765 7.27 Up 1.61 E-02 NM_0000 Homo sapiens 55 butyrylcholinesterase (BCHE), mRNA.
/PROD=butyrylcholinester ase precursor /FL=gb:M16541.1 gb:M16474.1 g b: N M_000055.1 -2.13754 0.709615 7.2 Up 1.59E-02 BF000203 ESTs 1.750623 4.592477 7.17 Up 3.86E-04 W76289 ESTs 0.923781 3.753533 7.11 Up 5.45E-04 BE897866 ESTs -1.51616 1.306468 7.07 Up 3.70E-03 AJ272267 Homo sapiens partial mRNA for choline dehydrogenase (chdh gene). /PROD=choline dehydrogenase -3.12304 -0.30584 7.05 Up 3.13E-02 NM_0180 Homo sapiens 18 hypothetical protein FLJ10191 (FLJ10191), mRNA.
/PROD=hypothetical protein FLJ10191 /F L=g b: N M_018018.1 0.828954 3.642692 7.03 Up 1.53E-03 AK026659 Homo sapiens cDNA:
FLJ23006 fis, clone LN000414.
3.061783 5.870643 7.01 Up 1.32E-04 BF057809 ESTs -0.20066 2.598953 6.96 Up 8.90E-04 NM_0016 Homo sapiens acyl-09 Coenzyme A
dehydrogenase, shortbranched chain (ACADSB), nuclear gene encoding mitochondrial protein, mRNA.
/PROD=acyl-Coenzyme A
dehydrogenase, shortbranchedchain precursor /FL=gb:U 12778.1 g b: N M_001609.1 -0.5777 2.186912 6.8 Up 2.34E-03 BC036592 Homo sapiens, clone IMAGE:4814184, mRNA.
-2.20139 0.556645 6.76 Up 1.88E-03 A1913749 ESTs -2.19527 0.555455 6.73 Up 3.02E-03 NM_0133 Homo sapiens EH
33 domain-binding mitotic phosphoprotein (EPSIN), mRNA. /PROD=EH
domain-binding mitotic phosphoprotein /FL=gb:NM_013333.1 gb:AF073727.1 0.194248 2.884093 6.45 Up 3.02E-03 U07236 Human mutant lymphocyte-specific protein tyrosine kinase (LCK) mRNA, complete cds. /PROD=lymphocyte-specific protein tyrosine kinase /FL=gb:U07236.1 g b: N M_005356.1 g b: M36881.1 -1.4606 1.195222 6.3 Up 1.88E-03 AW07210 Homo sapiens mRNA;
2 cDNA DKFZp434H2O5 (from clone DKFZp434H2O5) -0.41404 2.208672 6.16 Up 1.88E-03 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -1.98038 0.627155 6.09 Up 9.18E-03 NM_0024 Homo sapiens Musashi 42 (Drosophila) homolog 1 (MS11), mRNA.
/PROD=Musashi (Drosophila) homolog 1 /FL=gb:AB012851.1 g b: N M_002442.1 -3.12055 -0.51875 6.07 Up 4.51 E-02 AW78000 ESTs 2,428t'194 5.011314 5M UIp 8.90'E-04 E*~ 5'`071 f growth fact . (h~~
, par8n secretory transifornn~ng pro't&n K3pos: s rcor a ,,.\,1.7 4 0 :?b NN01_ \:0\ ,1 -2.06656 0.511613 5.97 Up 1.81 E-02 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 -1.18368 1.389404 5.95 Up 1.12E-03 AB011152 Homo sapiens mRNA for KIAA0580 protein, partial cds. /PROD=KIAA0580 protein 0.884916 3.44953 5.92 Up 2.61 E-04 NM_0001 Homo sapiens cytochrome 04 P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile) (CYP1 B1), mRNA.
/PROD=cytochrome P450, subfamily I (dioxin-inducible),polypeptide 1 /F L=g b: U 03688.1 g b: N M_000104.2 1.380324 3.936779 5.88 Up 4.48E-04 NM_0068 Homo sapiens histamine 95 N-methyltransferase (HNMT), mRNA.
/PROD=histamine N-methyltransferase /F L=g b: N M_006895.1 gb:D16224.1 gb:U08092.1 0.937118 3.476237 5.81 Up 5.45E-04 AU 151342 Homo sapiens cDNA
FLJ 12935 fis, clone -2.3444 0.189019 5.79 Up 3.32E-03 AW05758 ESTs -1.09181 1.43832 5.78 Up 2.62E-02 A1653050 ESTs, Weakly similar to HPPD_HUMAN 4-HYDROXYPHENYLPYRU
VATE DIOXYGENASE
(H.sapiens) 0.270429 2.788184 5.73 Up 2.50E-02 AF493872 Homo sapiens guanine nucleotide binding protein gamma 4 (GNG4) mRNA, complete cds.
/PROD=guanine nucleotide binding protein gamma 4 /F L=g b:AF493872.1 2.453593 4.950008 5.64 Up 4.67E-04 NM_0054 Homo sapiens selenoprotein P, plasma, 1 (SEPP1), mRNA.
/PROD=selenoprotein P
precursor /F L=g b: N M_005410.1 -1.88254 0.61166 5.63 Up 6.09E-03 BF694956 Human DNA sequence from clone RP1-187J11 on chromosome 6g11.1-22.33. Contains the gene for a novel protein similar to S. pombe and S.
cerevisiae predicted proteins, the gene for a novel protein similar to protein kinase C inhibitors, the 3 end of the 0.462867 2.940232 5.57 Up 8.05E-03 A1807026 ESTs -0.04543 2.430022 5.56 Up 1.88E-03 AB037730 Homo sapiens mRNA for KIAA1309 protein, partial cds. /PROD=KIAA1309 protein -0.01122 2.462282 5.55 Up 2.31 E-03 A1356398 butyrate response factor 2 (EGF-response factor 2) /FL=gb:B0005010.1 g b: N M_006887.1 1.285793 3.745524 5.5 Up 2.58E-03 A1949827 ESTs 1.37261 3.832097 5.5 Up 4.48E-04 BC040605 Homo sapiens, clone IMAGE:5271039, mRNA.
-0.67823 1.780805 5.5 Up 3.24E-04 AA040057 protocadherin 20 -1.41031 1.030229 5.43 Up 1.98E-02 A1832477 serologically defined colon cancer antigen 43 1.076427 3.500322 5.37 Up 1.17E-03 A1640307 protocadherin 10 -0.35323 2.051621 5.3 Up 2.59E-03 BM66601 Homo sapiens cDNA
0 FLJ23803 fis, clone HE P22811.
0.040412 2.442774 5.29 Up 3.56E-04 AA960844 Homo sapiens, clone IMAGE:4081483, mRNA

-1.51992 0.881919 5.28 Up 6.04E-03 AA460960 H.sapiens mRNA (clone ICRFp507L1876) -2.32443 0.069216 5.25 Up 3.43E-03 BC035759 Homo sapiens, clone IMAGE:5557641, mRNA.
4.072718 6.466193 5.25 Up 1.53E-03 AU144598 cell recognition molecule Caspr2 /FL=gb:AF193613.1 gb:NM_014141.1 0.143628 2.506522 5.14 Up 1.36E-02 AB037763 Homo sapiens mRNA for KIAA1342 protein, partial cds. /PROD=KIAA1342 protein /FL=gb:AF299075.1 -0.46577 1.883396 5.1 Up 6.92E-04 AW05159 ESTs, Moderately similar 1 to unnamed protein product (H.sapiens) 0.780689 3.126868 5.08 Up 7.58E-04 A1016316 ESTs 3.409815 -2.82988 75.57 Down 1.48E-02 NM_0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 0.757197 -4.3571 34.64 Down 4.81 E-03 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 5.388254 0.288621 34.29 Down 4.14E-05 NM 0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 4.092731 -0.8862 31.54 Down 7.12E-04 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 2.306111 -2.22732 23.16 Down 8.51 E-04 A1632223 hypothetical protein DKFZp434F2322 3.030236 -1.2974 20.08 Down 8.31 E-03 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 4.505436 0.504147 16.01 Down 1.23E-04 W57613 ESTs 3.025351 -0.90728 15.27 Down 2.53E-04 AW59092 ESTs 3.268087 -0.54228 14.03 Down 2.76E-05 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 2.62025 -1.1154 13.32 Down 1.12E-03 AA625683 ESTs 6.777916 3.123818 12.59 Down 6.00E-05 U15174 Homo sapiens BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3) mRNA, complete cds.
/PROD=BCL2adenovirus E1 B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 2.590871 -1.03729 12.36 Down 1.53E-03 NM 0165 Homo sapiens TBX3-iso 69 protein (TBX3-iso), mRNA. /PROD=TBX3-iso protein /F L=g b: N M_016569.1 gb:AF216750.1 4.152765 0.533234 12.29 Down 2.53E-04 AW00317 stanniocalcin 1 4.528627 0.921256 12.19 Down 7.80E-05 NM 0031 Homo sapiens 55 stanniocalcin 1 (STC1), mRNA.
/PROD=stanniocalcin 1 /F L=g b: U 25997.1 g b: N M_003155.1 gb:U46768.1 1.544409 -1.9767 11.48 Down 4.92E-02 NM 0005 Homo sapiens insulin-like 99 growth factor binding protein 5 (IGFBP5), mRNA. /PROD=insulin-like growth factor binding protein 5 /F L=g b: M65062.1 gb:M62782.1 g b: N M_000599.1 gb:AF055033.1 5.023981 1.530419 11.26 Down 2.80E-04 NM 0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 2.36447 -1.00627 10.34 Down 1.88E-03 NM 0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 4.285883 0.94478 10.13 Down 7.80E-05 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 4.782763 1.624946 8.92 Down 4.14E-05 NM_0041 Homo sapiens 99 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha polypeptide II (P4HA2), mRNA.
/PROD=procollagen-proline, 2-oxoglutarate4-dioxygenase (proline 4-hydroxylase), alpha polypeptidell /F L=g b: N M_004199.1 gb:U904 2.660133 -0.48383 8.84 Down 3.01 E-04 AF277174 Homo sapiens PNAS-1 37 mRNA, complete cds.
/PROD=PNAS-1 37 /FL=gb:AF277174.1 1.99849 -1.11713 8.67 Down 1.48E-02 NM_0023 Homo sapiens lysyl 17 oxidase (LOX), mRNA.
/PROD=lysyl oxidase /F L=g b:AF039291.1 g b: N M_002317.1 g b: M94054.1 4.927935 1.83445 8.54 Down 4.77E-04 J05008 Homo sapiens endothelin-1 (EDN1) gene, complete cds /FL=gb:NM_001955.1 5.356771 2.317383 8.22 Down 1.92E-05 W92036 ESTs 3.806044 0.77917 8.15 Down 1.32E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 2.350127 -0.67445 8.14 Down 1.86E-02 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
5.450694 2.473087 7.88 Down 2.35E-04 AF095771 Homo sapiens PTH-responsive osteosarcoma B1 protein (B1) mRNA, complete cds.
/PROD=PTH-responsive osteosarcoma B1 protein /FL=gb:AF095771.1 2.208449 -0.76852 7.87 Down 5.20E-03 A1806338 T-box 3 (ulnar mammary syndrome) /FL=gb:AF170708.2 g b: N M_005996.1 2.951696 -0.00873 7.78 Down 4.48E-04 AB019562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
3.953402 0.998843 7.75 Down 2.51 E-04 80005369 Homo sapiens, chromosome 1 open reading frame 12, clone MGC:12484, mRNA, complete cds.
/PROD=chromosome 1 open reading frame 12 /FL=gb:AF277176.1 g b: N M_022051.1 gb:AF229245.1 gb:B0005369.1 4.507212 1.576505 7.62 Down 2.04E-04 AW19694 ESTs 4.055862 1.195121 7.26 Down 5.45E-04 AK026815 Homo sapiens cDNA:
FLJ23162 fis, clone LNG09734.
4.103964 1.24922 7.23 Down 8.28E-05 AA579773 ESTs 2.001263 -0.84882 7.21 Down 3.24E-03 U46768 Human stanniocalcin mRNA, complete cds.
/PROD=stanniocalcin /F L=g b: U 25997.1 g b: N M_003155.1 gb:U46768.1 1.1136 -1.73388 7.2 Down 3.21 E-04 Z70519 H.sapiens FASApo 1 mRNA for FAS soluble protein (clone FAS
Exo4Del). /PROD=FAS
soluble protein 2.332751 -0.46123 6.94 Down 1.69E-04 NM_0000 Homo sapiens cyclin-77 dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), mRNA. /PROD=cyclin-dependent kinase inhibitor 2A (melanoma,pl6, inhibits CDK4) /F L=g b: N M_000077.1 gb:L2721 1.1 5.187988 2.402941 6.89 Down 3.52E-04 AA074145 proline oxidase homolog 4.255531 1.471522 6.89 Down 3.24E-04 AF096296 Homo sapiens thymic stroma chemokine-1 precursor, mRNA, complete cds.
/PROD=thymic stroma chemokine-1 precursor /F L=g b:AF 142434.1 gb:AF096296.1 gb:AF124601.1 gb:ABO10447.1 g b: N M_006072.1 4.501184 1.72274 6.86 Down 7.80E-05 AK000162 Homo sapiens cDNA
FLJ20155 fis, clone COL08754, highly similar to ACSA_ECOLI
ACETYL-COENZYME A
SYNTHETASE.
2.770179 0.000064 6.82 Down 2.31 E-03 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
6.1137 3.356776 6.76 Down 2.20E-04 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 4.506475 1.751272 6.75 Down 2.53E-04 A1300520 stanniocalcin 1 /F L=g b: U 25997.1 g b: N M_003155.1 gb:U46768.1 3.404056 0.670009 6.65 Down 4.14E-05 A1623211 lymphocyte-specific protein 1 2.469646 -0.26027 6.63 Down 4.40E-03 N76327 ESTs, Highly similar to 101 1297A transferrin receptor (H.sapiens) 5.252439 2.542675 6.54 Down 3.24E-04 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 5.294065 2.607826 6.44 Down 1.45E-03 AF279899 Homo sapiens PNAS-145 mRNA, complete cds.
/PROD=PNAS-145 /FL=gb:U03105.1 g b: N M_006813.1 gb:AF279899.1 1.312148 -1.30796 6.15 Down 2.85E-04 U32500 Human type 2 neuropeptide Y receptor mRNA, complete cds.
/PROD=type 2 neuropeptide Y receptor /FL=gb:U42766.1 gb:U36269.1 gb:U32500.1 6.179917 3.561259 6.14 Down 3.24E-04 NM_0001 Homo sapiens glucan 58 (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) (GBE1), mRNA.
/PROD=glucan (1,4-alpha-), branching enzyme 1(glycogen branching enzyme) /FL=gb:L07956.1 g b: N M_000158.1 0.959227 -1.64817 6.09 Down 2.57E-02 AB033831 Homo sapiens hSCDGF
mRNA for spinal cord-derived growth factor, complete cds.
/PROD=spinal cord-derived growth factor /F L=g b: N M_016205.1 gb:AB033831.1 gb:AF091434.1 gb:AF244813.1 0.579765 -1.99563 5.96 Down 2.00E-02 A1393930 ESTs 3.508683 0.978051 5.78 Down 4.14E-05 AK027231 Homo sapiens cDNA:
FLJ23578 fis, clone LNG 12709.
1.577138 -0.9435 5.74 Down 1.09E-02 M15329 Human interleukin 1-alpha (IL1A) mRNA, complete cds. /PROD=interleukin 1-alpha /FL=gb:M15329.1 2.982965 0.463474 5.73 Down 5.03E-04 AK026829 Homo sapiens cDNA:

FLJ23176 fis, clone LNG 10452.
3.86075 1.347537 5.71 Down 7.64E-04 U85995 Cluster Incl.
U85995:Human clone IMAGE-22181 unknown protein mRNA, partial cds /cds=(0,1291) /gb=U85995 /gi=1835749 /ug=Hs.79340 /len= 1696 2.64743 0.138623 5.69 Down 2.04E-04 A1702438 ESTs 3.437271 0.928673 5.69 Down 5.45E-04 AB029025 Homo sapiens mRNA for KIAA1102 protein, partial cds. /PROD=KIAA1102 protein 2.886643 0.386181 5.66 Down 1.25E-03 NM 0220 Homo sapiens G protein-36 coupled receptor, family C, group 5, member C
(GPRC5C), transcript variant 1, mRNA.
/PROD=G protein-coupled receptor, family C, group 5,member C, isoform a, precursor /FL=gb:AF207989.1 g b: N M_022036.1 5.099016 2.60798 5.62 Down 4.48E-04 NM 0181 Homo sapiens 92 hypothetical protein FLJ10718(FLJ10718), mRNA.
/PROD=hypothetical protein FLJ10718 /F L=g b: N M_018192.1 5.807319 3.321529 5.6 Down 3.21 E-04 NM_0180 Homo sapiens 04 hypothetical protein FLJ10134 (FLJ10134), mRNA.
/PROD=hypothetical protein FLJ10134 /F L=g b: N M_018004.1 1.659275 -0.80393 5.51 Down 2.08E-03 L16895 Human lysyl oxidase (LOX) gene, exon 7 2.060071 -0.40069 5.51 Down 5.45E-04 AA004300 hypothetical protein DKFZp566I133 3.094055 0.633797 5.5 Down 6.17E-04 AW18819 tumor necrosis factor, 8 alpha-induced protein 6 /F L=g b: N M_007115.1 1.865674 -0.57364 5.42 Down 1.88E-03 AU 156421 Homo sapiens cDNA
FLJ13457 fis, clone 5.207569 2.775215 5.4 Down 1.32E-04 AA083478 Homo sapiens mRNA full length insert cDNA clone 2.322104 -0.10923 5.39 Down 1.89E-03 AW29136 ESTs 3.862686 1.433656 5.39 Down 1.88E-03 NM_0071 Homo sapiens tumor 15 necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA.
/PROD=tumor necrosis factor, alpha-induced protein 6 /F L=g b: N M_007115.1 4.881197 2.470702 5.32 Down 1.33E-03 NM 0019 Homo sapiens enolase 2, 75 (gamma, neuronal) (EN02), mRNA.
/PROD=enolase 2, (gamma, neuronal) /FL=gb:NM_001975.1 gb:B0002745.1 gb:M22349.1 5.318139 2.908344 5.31 Down 4.67E-04 U87408 Cluster Incl.
U87408:Human clone IMAGE-74593 unknown protein mRNA, partial cds /cds=(0,1362) /gb=U87408 /gi=1842104 /ug=Hs.79340 /len= 1982 3.41866 1.024231 5.26 Down 1.40E-03 AA149250 ESTs, Weakly similar to PROTEIN PRECURSOR
(R. norvegicus) 2.28595 -0.10789 5.26 Down 1.74E-03 BE504838 ESTs 1.143234 -1.2451 5.24 Down 2.07E-03 BF437711 ESTs 2.164901 -0.22261 5.23 Down 2.00E-03 A1559300 ESTs 0.38149 -2.00456 5.23 Down 1.36E-02 Z25433 H.sapiens protein-serinethreonine kinase gene, complete CDS.
/PROD=protein-serinethreonine kinase /FL=gb:Z25433.1 2.271332 -0.11134 5.22 Down 1.88E-03 NM_0151 Homo sapiens KIAA0633 98 protein (COBL), mRNA.
/PROD=KIAA0633 protein /F L=g b: N M_015198.1 2.933166 0.558335 5.19 Down 1.04E-03 NM_0057 Homo sapiens lipoma 80 HMGIC fusion partner (LHFP), mRNA.
/PROD=lipoma HMGIC
fusion partner /F L=g b: N M_005780.1 gb:AF098807.1 3.77776 1.406437 5.17 Down 3.24E-04 BU729850 hypothetical protein 3.113698 0.751705 5.14 Down 7.12E-04 NM_0021 Homo sapiens insulinoma-96 associated 1 (INSM1), mRNA.
/PROD=insulinoma-associated 1 /F L=g b: N M_002196.1 gb:M93119.1 7.564809 5.218561 5.09 Down 5.70E-04 M83248 Human nephropontin mRNA, complete cds.
/PROD=nephropontin /F L=g b: M83248.1 5.209052 2.875305 5.04 Down 3.17E-04 A1754404 procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2 /F L=g b: N M_000935.1 gb:U84573.1 1.639038 -0.68383 5 Down 2.00E-03 AW02787 ESTs, Weakly similar to 9 NBHUC8 decorin precursor (H.sapiens) E) H9P39 at 48 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 48 HRS Ratio Direction adj. p- Gene Gene Name 01 DE value Identifier -3.62742 4.403382 261.52 Up 9.26E-04 AA772920 ESTs -3.26893 4.712617 252.75 Up 7.47E-05 NM_0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1 -4.01441 3.67249 206.06 Up 1.83E-04 AB028021 Cluster Incl.
AB028021:Homo sapiens HNF-3beta mRNA for hepatocyte nuclear factor-3 beta, complete cds /cds=(196,1569) /gb=AB028021 /gi=4958949 /ug=Hs.155651 /len=1944 -4,29896 3,38384 24'35,36 U a ...25 _:-\ 5 `Y "4:3 7 H omo ti ` ens ,\
':~~ .~>b .,+~>x ;asp>.:..:,+
e osecoid ; RNA, 'PROO
-zhorneobox pi':) ;:~oseci ~b,NO:?38 4:='. .

G A3`.A-61, compkkte cds, PROD-~:GA A.-6 ."L.gtA,U6$O75'1 .b,\ - 005257 -2,178 4.977566 1 42.5 Up 5.92E-04 M 01,44 H-1 o sapN mns c kopf 20 Xe;wpus :eev~s oi1'iAog 4 ` K4 r-RNA. ;'PR D -d vkk+opf (XeE~opua ,ael is) ho xA oe 4 MMJ)l M 54:2:.1 -3.61621 3.360873 125.98 Up 8.64E-04 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds ;`ti . 7 ,., 113 , 9 ,.~. ,p 2~~. "=ti02,0'2 Hon no, F
2 .~- e ._\.. ,_. ~ a..., ~ e _ .. 3 3beta i R \ for nucV e` r facto r-3 beta, compk t\

:: e r fa ctoi'--3 eta L::: =;,,, ~ e~ ,. U 02 IO2i .i ~' ... 'l.. \....6. ~?.ice .
62093 ' 95$O3 k95,47 Ups ;0 E- 5 MM 8224 , lc-m-mo Q

\.J,2252 z.,:,:;,. , to .R"1=-box Containing gene 17 (FLJ22252), . RN..A.
fl pr,,, 4,, F.. 4,..2'..`.x. rn Ia;
to SRY-box=%' ik*' `'aerie 1 F ._ .b~NNA 0.2245 -1,1115k9, 9O 52 Up 1,05E-04 * M OO38 l=>mo \ cibr bla"t 6' grOw t'i -ac or 17 (F GF 147 "RICA., g b:AE3 092 S. 1 -3.7558 2.70012 87.79 Up 1.88E-03 AW47365 ESTs -0.83997 5.315997 71.31 Up 2.36E-04 A1821669 ESTs -0.26005 5.721539 63.19 Up 1.82E-04 R72286 microfibrillar-associated protein 4 -1.32044 4.378147 51.93 Up 4.06E-03 AF017987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -3.12747 2.481837 48.82 Up 4.18E-04 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -0.69028 4.779809 44.33 Up 1.82E-04 M16276 Human MHC class II HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 gb:M16276.1 g b: M60028.1 gb:M1 7564.1 gb:M81141.1 gb:M81140.1 -4.79201 0.661683 43.83 Up 3.06E-04 NM_0124 Homo sapiens sema 31 domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
(SEMA3E), mRNA.
/PROD=sema domain, immunoglobulin domain (Ig), shortbasic domain, secreted, (semaphorin) 3E
/F L=g b: N M_012431.1 gb:AB002329.1 -1.55323 3.862277 42.68 Up 1.26E-04 A1821586 ESTs, Moderately similar to JE0284 Mm-1 cell derived transplantability-associated protein 1 b (H.sapiens) -5.25658 0.098569 40.93 Up 1.11 E-03 AW00557 putative 47 kDa protein -2.45311 2.87165 40.08 Up 1.40E-02 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
-3.10357 2.19103 39.25 Up 6.25E-05 NM_0014 Homo sapiens forkhead 53 box C1 (FOXC1), mRNA.
/PROD=forkhead box C1 /F L=g b: N M_001453.1 -0.27888 4.97765 38.23 Up 7.98E-05 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -0.81978 4.345795 35.89 Up 3.86E-04 A1824037 ESTs, Weakly similar to AFFINITY
IMMUNOGLOBULIN
EPSILON FC RECEPTOR
(M.musculus) -2.4051 2.697137 34.35 Up 6.25E-05 NM 0210 Homo sapiens 20 F37Esophageal cancer-related gene-coding leucine-zipper motif (FEZ1), mRNA.
/PROD=F37Esophageal cancer-related gene-codingleucine-zipper motif /FL=gb:AF123659.1 g b: N M_021020.1 0.756526 5.856918 34.31 Up 7.98E-05 NM_0030 Homo sapiens secreted 12 frizzled-related protein 1 (SFRP1), mRNA.
/PROD=secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -0.41626 4.620452 32.82 Up 2.24E-04 BF110534 ESTs 0,!10,2333 5,516306 32,31 U p 1,26E-04 AF2I 1891 s , ' s p:~ n M x- ke ~1~~~~=~1~~~~\~ 1i otci L01) R` n RN4 A, con" fetee cads.
J 'F
hor eo+box protein I
89 1., -2.39338 2.604622 31.96 Up 3.59E-03 M17955 Human MHC class 11 HLA-DQ-beta mRNA, complete cds. /FL=gb:M33907.1 gb:M17955.1 g b: M 16996.1 gb:M17563.1 gb:M20432.1 g b: M26042.1 -0.5292 4.348346 29.4 Up 1.25E-03 All 27440 ESTs -4.15276 0.716875 29.24 Up 1.59E-04 AA129444 Homo sapiens mRNA for KIAA1263 protein, partial cds -0.18256 4.556137 26.7 Up 5.90E-05 A1583173 major histocompatibility complex, class II, DQ beta -3.47945 1.255979 26.64 Up 2.39E-04 NM_0008 Homo sapiens glutathione 54 S-transferase theta 2 (GSTT2), mRNA.
/PROD=glutathione S-transferase theta 2 /F L=g b: L38503.1 g b: 60002415.1 g b: N M_000854.2 -3.39007 1.340459 26.55 Up 9.26E-03 NM_0066 Homo sapiens cell 14 adhesion molecule with homology to L1 CAM
(close homologue of L1) (CHL1), mRNA.
/PROD=cell adhesion molecule with homology to L1 CAM(close homologue of L1) /FL=gb:AF002246.1 g b: N M_006614.1 -1.61054 3.073011 25.7 Up 6.48E-04 AW26420 ESTs -0.68225 3.994036 25.57 Up 8.92E-05 N48299 ESTs, Moderately similar to NFY-C (H.sapiens) -2.69284 1.94677 24.93 Up 1.03E-02 R33964 Homo sapiens cDNA
FLJ11022 fis, clone -3.3099 1.316389 24.7 Up 4.00E-03 NM_1720 Homo sapiens retinol 37 dehydrogenase 10 (all-trans) (RDH10), mRNA.
/PROD=retinol dehydrogenase 10 /FL=gb:NM_172037.1 gb:AF456765.1 -2.23941 2.381967 24.61 Up 2.32E-03 NM_0054 Homo sapiens sine oculis 13 homeobox (Drosophila) homolog 3 (SIX3), mRNA.
/PROD=sine oculis homeobox (Drosophila) homolog 3 /F L=g b: N M_005413.1 -2.6422 1.964075 24.36 Up 8.92E-05 BF589787 ESTs -2.05438 2.54631 24.26 Up 6.59E-03 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.168713 5.686572 22.91 Up 2.60E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 60003079.1 -0.77864 3.712574 22.49 Up 5.77E-04 NM_0220 Homo sapiens reserved 55 (KCNK12), mRNA.
/PROD=tandem pore domain potassium channel THIK-2 /F L=g b: N M_022055.1 gb:AF287302.1 -0.70855 3.762307 22.17 Up 7.67E-04 A1917371 ESTs -2.06656 2.392721 22 Up 2.94E-03 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 3.042634 7.476267 21.61 Up 5.90E-05 NM_0054 Homo sapiens 42 eomesodermin (Xenopus laevis) homolog (EOMES), mRNA.
/PROD=eomesodermin (Xenopus laevis) homolog /FL=gb:AB031038.1 g b: N M_005442.1 -1.28224 3.131936 21.32 Up 2.22E-04 NM_0055 Homo sapiens LIM
68 homeobox protein 1 (LHX1), mRNA.
/PROD=LIM homeobox protein 1 /F L=g b: N M_005568.1 gb:U14755.1 -2.83906 1.564539 21.16 Up 4.15E-04 T15545 ESTs -0.5777 3.802538 20.82 Up 8.57E-04 BC036592 Homo sapiens, clone IMAGE:4814184, mRNA.
-3.88742 0.452273 20.25 Up 2.18E-03 W80985 ESTs -1.95127 2.384447 20.19 Up 2.26E-03 L12468 Homo sapiens aminopeptidase A mRNA, complete cds.
/PROD=aminopeptidase A
/F L=g b: L 12468.1 g b: N M_001977.1 gb:L14721.1 -4.63418 -0.31383 19.98 Up 2.41 E-02 BF112218 ESTs -2.30432 1.94413 19.01 Up 1.88E-02 BC017958 Homo sapiens, clone IMAGE:4607409, mRNA.
-2.9769 1.2531 18.77 Up 1.55E-02 AW61211 ESTs 0.420056 4.641313 18.65 Up 7.47E-05 NM_0122 Homo sapiens dickkopf 42 (Xenopus laevis) homolog 1 (DKK1), mRNA.
/PROD=dickkopf (Xenopus laevis) homolog 1 /FL=gb:AF177394.1 g b: N M_012242.1 gb:AF127563.1 -0.41404 3.780442 18.31 Up 4.24E-04 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF01 7987.1 gb:AF001900.1 -2.90798 1.272589 18.13 Up 1.07E-04 NM_0016 Homo sapiens 43 apolipoprotein A-11 (APOA2), mRNA.
/PROD=apolipoprotein A-II precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 60005282.1 -3.84662 0.311955 17.86 Up 2.27E-02 BF445031 ESTs -0.48487 3.656098 17.64 Up 7.98E-05 BG15053 ESTs 0.442286 4.570914 17.49 Up 1.50E-04 NM_0017 Homo sapiens CD48 78 antigen (B-cell membrane protein) (CD48), mRNA.
/PROD=CD48 antigen (B-cell membrane protein) /F L=g b: N M_001778.1 gb:M37766.1 g b: M59904.1 -2.0457 2.013773 16.67 Up 9.72E-04 A1422986 ESTs -1.37391 2.670539 16.5 Up 1.44E-02 NM_0066 Homo sapiens ret finger 05 protein-like 2 (RFPL2), mRNA. /PROD=ret finger protein-like 2 /F L=g b: N M_006605.1 -3.51429 0.527621 16.47 Up 2.50E-03 AA352113 ESTs -0.15629 3.869435 16.29 Up 4.57E-04 A1799018 ESTs -0.81856 3.176308 15.94 Up 8.74E-05 A1129628 ESTs -2.38787 1.575045 15.59 Up 9.00E-03 80003517 Homo sapiens, clone IMAGE:3542589, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3542589) -1.39784 2.47691 14.67 Up 2.38E-03 BE222344 splicing factor, arginineserine-rich 5 -2.20139 1.663866 14.57 Up 7.98E-05 A1913749 ESTs -3.18081 0.676419 14.49 Up 2.33E-04 AW44981 KIAA0918 protein -2.14545 1.70837 14.46 Up 3.27E-03 NM_0158 Homo sapiens 31 acetylcholinesterase (YT
blood group) (ACHE), transcript variant E4-E5, mRNA.
/PROD=acetylcholinestera se PI-linked form precursor /F L=g b: N M_015831.1 -2.233 1.502044 13.32 Up 1.33E-03 NM_0148 Homo sapiens KIAA0307 62 gene product (KIAA0307), mRNA. /PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 -0.21464 3.518576 13.3 Up 5.92E-04 NM_0050 Homo sapiens reelin 45 (RELN), mRNA.

/PROD=reelin /FL=gb:U79716.1 g b: N M_005045.1 -0.96765 2.760723 13.25 Up 1.83E-04 NM_0244 Homo sapiens Wilms 26 tumor 1 (WT1), transcript variant D, mRNA.
/PROD=Wilms tumor 1 isoform D
/F L=g b: N M_024424.1 g b: N M_024426.1 1.076427 4.796662 13.18 Up 6.25E-05 A1640307 protocadherin 10 1.197921 4.916826 13.17 Up 6.25E-05 AW15072 hypothetical protein 0.366041 4.082294 13.14 Up 1.82E-04 A1242583 Homo sapiens cDNA
FLJ1 1550 fis, clone eIe '.,ed \..~~.\; growth factor rice toO ipha oC pept:d e ( DG RA), \.;PROD:.pkt f ,``
\teri ed growth iaci eac.e?to;
F iph1.p,oq pep0 t d\
Me", 0 2 06 =i~\:M21 7 .1 -2.08299 1.631534 13.13 Up 3.64E-02 NM_0020 Homo sapiens growth 48 arrest-specific 1 (GAS1), mRNA. /PROD=growth arrest-specific 1 /F L=g b: N M_002048.1 g b: L 13698.1 0.502235 4.214192 13.1 Up 2.47E-04 NM_0148 Homo sapiens KIAA0878 99 protein (KIAA0878), mRNA. /PROD=KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 0.500662 4.2088 13.07 Up 4.57E-04 AB043703 Homo sapiens FZD8 mRNA for seven-transmembrane receptor Frizzled-8, complete cds.
/PROD=seven-transmembrane receptor Frizzled-8 /FL=gb:AB043703.1 -1.80959 1.846066 12.6 Up 2.72E-03 BF447246 KIAA0960 protein 0.804491 4.446299 12.48 Up 2.36E-04 AA583044 bone morphogenetic protein 2 /F L=g b: N M_001200.1 0.937118 4.57509 12.45 Up 7.47E-05 AU 151342 Homo sapiens cDNA
FLJ 12935 fis, clone 2.428694 6,06,2052 12,41 U,, 7,98E-05,13,F5107,15 4 ? :;ec:eiory.
trans','orn-dng protein Kaposi ,..,,Ae `' _,=_ ^,: M' '4$6.' b:N J 200 .
-4.25059 -0.61821 12.4 Up 2.17E-02 AL834407 Homo sapiens mRNA;
cDNA DKFZp547HO74 (from clone DKFZp547HO74).
-2.64131 0.98784 12.37 Up 4.22E-02 AU157303 ESTs 1.370117 4.998653 12.37 Up 2.02E-04 M33653 Human (clones HT-(125,133)) alpha-2 type IV
collagen (COL4A2) mRNA, complete cds.
/PROD=alpha-2 type IV
collagen /FL=gb:M33653.1 -0.05814 3.523836 11.98 Up 5.01 E-04 BF308645 KIAA1415 protein 0.85401 4.424822 11.88 Up 3.70E-04 NM 0017 Homo sapiens calcitonin 42 receptor (CALCR), mRNA.
/PROD=calcitonin receptor /FL=gb:AB022177.1 g b: N M_001742.1 gb:U26553.1 gb:U26554.1 -0.4843 3.086083 11.88 Up 1.07E-04 NM 0017 Homo sapiens CD1 D
66 antigen, d polypeptide (CD1 D), mRNA.
/PROD=CD1 D antigen, d polypeptide /F L=g b: N M_001766.1 gb:J04142.1 -3.03319 0.529885 11.82 Up 3.86E-02 A1378026 ESTs -0.45718 3.095926 11.74 Up 2.21 E-04 BF939489 glycoprotein M6A
/F L=g b: D49958.1 -1.35345 2.18761 11.64 Up 3.72E-03 AW15757 ESTs, Weakly similar to 1 T00331 hypothetical protein KIAA0555 (H.sapiens) 1.829497 5.364987 11.6 Up 2.65E-04 AA534817 ESTs, Weakly similar to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 0.828954 4.325235 11.28 Up 4.08E-04 AK026659 Homo sapiens cDNA:
FLJ23006 fis, clone LN000414.
-1.68521 1.795916 11.17 Up 5.31 E-03 NM_0027 Homo sapiens protease, 70 serine, 2 (trypsin 2) (PRSS2), mRNA.
/PROD=protease, serine, 2 (trypsin 2) /FL=gb:M27602.1 gb:NM_002770.1 -1.75731 1.71717 11.12 Up 2.72E-02 80008992 Homo sapiens, clone MGC:16926 IMAGE:4183000, mRNA, complete cds.
/PROD=Unknown (protein for MGC:16926) /F L=g b: 80008992.1 -0.33264 3.138536 11.09 Up 2.48E-04 NM_0203 Homo sapiens 53 phospholipid scramblase 4 (LOC57088), mRNA.
/PROD=phospholipid scramblase 4 /F L=g b: N M_020353.1 gb:AF199023.1 -2.84061 0.614927 10.97 Up 1.85E-03 All 23532 ESTs -0.11092 3.32528 10.82 Up 1.51 E-04 BF591483 ESTs -2.87916 0.555292 10.81 Up 6.20E-03 BF529886 Homo sapiens cDNA
FLJ39329 fis, clone OCBBF2015751.
0.378586 3.8114 10.8 Up 6.60E-05 BF109231 ESTs 0.53123 3.962218 10.79 Up 5.00E-04 BF112171 DKFZP56400423 protein -1.82351 1.607197 10.78 Up 1.13E-03 AA603467 ribosomal protein S11 56291 0,847807 10, 6 S SPA 1,68E-02 B` 5 26d.`,, B:F k gri,.t a`."':a (an:.3genu 0 C ,4 E), ; iph 4 ,,ub f u of VLA-4 receptor, 0.1187 3.529403 10.63 Up 1.31 E-04 N21184 Cluster Incl.
N21184:yx41 a10.sl Homo sapiens cDNA, 3 end /clone=IMAGE-264282 /clone end=3 /gb=N21184 /gi=1126354 /ug=Hs.93605 /len=619 -3.12055 0.266255 10.46 Up 1.87E-02 AW78000 ESTs -0.27888 3.087584 10.31 Up 1.05E-04 NM_0030 Homo sapiens SWISNF
78 related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 (SMARCD3), mRNA. /PROD=SWISNF
related, matrix associated, actindependent regulator of chromatin, subfamily d, member 3 /FL=gb:NM_003078.1 gb 1.223968 4.582504 10.26 Up 1.32E-04 AL574912 ESTs, Weakly similar to serine protease (H.sapiens) -0.52859 2.828373 10.25 Up 6.20E-03 AW59061 ESTs -1.20714 2.140319 10.18 Up 1.22E-03 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
1.59762 4.944335 10.17 Up 1.33E-03 NM_0186 Homo sapiens core 49 histone macroH2A2.2 (MACROH2A2), mRNA.
/PROD=core histone macroH2A2.2 /F L=g b:AF 151534.1 g b: N M_018649.1 -0.75724 2.582097 10.12 Up 5.49E-03 AL445192 Human DNA sequence from clone RP11-269H4 on chromosome 20 Contains the 3 end of the KIAA1415 gene similar to T-Lymphona invasion and metastasis inducing protein 1, ESTs, STSs and GSSs 0.884916 4.219652 10.09 Up 9.57E-05 NM_0001 Homo sapiens cytochrome 04 P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile) (CYP1 B1), mRNA.
/PROD=cytochrome P450, subfamily I (dioxin-inducible),polypeptide 1 /F L=g b: U 03688.1 g b: N M_000104.2 -2.62694 0.700178 10.04 Up 8.15E-03 NM_0000 Homo sapiens 55 butyrylcholinesterase (BCHE), mRNA.
/PROD=butyrylcholinester ase precursor /FL=gb:M16541.1 gb:M16474.1 g b: N M_000055.1 1.388898 4.709109 9.99 Up 1.48E-04 BE620739 ESTs 0.345528 3.626449 9.72 Up 6.25E-05 AW27618 major histocompatibility 6 complex, class II, DQ beta 1.563993 4.835093 9.65 Up 7.47E-05 NM_0024 Homo sapiens microsomal 13 glutathione S-transferase 2 (MGST2), mRNA.
/PROD=microsomal glutathione S-transferase 2 /FL=gb:NM_002413.1 gb:U77604.1 0.923781 4.188917 9.61 Up 7.47E-05 BE897866 ESTs -1.64839 1.585806 9.41 Up 1.44E-03 NM_0049 Homo sapiens phorbolin 00 (similar to apolipoprotein B
mRNA editing protein) (DJ742C19.2), mRNA.
/PROD=phorbolin (similar to apolipoprotein B
mRNAediting protein) /F L=g b: N M_004900.1 gb:U61083.1 0.829254 4.053354 9.34 Up 1.19E-04 AV697515 hypothetical protein -0.62897 2.594105 9.34 Up 2.12E-02 A1694545 ESTs 1.040647 4.25749 9.3 Up 6.25E-05 A1348094 KIAA0882 protein -2.10316 1.110711 9.28 Up 1.17E-02 H49805 ESTs -0.67823 2.5328 9.26 Up 1.82E-04 AA040057 protocadherin 20 -0.27302 2.923702 9.17 Up 3.58E-04 NM_0142 Homo sapiens interleukin 71 1 receptor accessory protein-like 1 (IL1RAPL1), mRNA. /PROD=interleukin 1 receptor accessory protein-like 1 /FL=gb:AF284435.1 gb:NM_014271.1 gb:AF181284.1 0.205308 3.376912 9.01 Up 1.73E-04 BF509230 ESTs -0.13427 3.027131 8.95 Up 1.71 E-04 D49958 Homo sapiens mRNA for membrane glycoprotein M6, complete cds.
/PROD=membrane glycoprotein M6 /F L=g b: D49958.1 -0.95386 2.202339 8.91 Up 5.60E-04 AF312769 Homo sapiens cryptic mRNA, complete cds.
/PROD=cryptic /FL=gb:AF312769.1 -1.39976 1.747599 8.86 Up 1.07E-04 NM_0052 Homo sapiens mitogen-04 activated protein kinase kinase kinase 8 (MAP3K8), mRNA.
/PROD=mitogen-activated protein kinase kinase kinase8 /F L=g b: N M_005204.1 gb:D14497.1 -1.12824 2.007285 8.79 Up 9.57E-05 AK021452 Homo sapiens cDNA
FLJ1 1390 fis, clone HEMBA1000561, weakly similar to ZINC FINGER
PROTEIN 91.
4.042679 7.170301 8.74 Up 2.33E-04 NM_0054 Homo sapiens cerberus 1 54 (Xenopus laevis) homolog (cysteine knot superfamily) (CER1), mRNA. /PROD=cerberus 1 /FL=gb:NM_005454.1 2.430238 5.551898 8.7 Up 7.47E-05 NM_0049 Homo sapiens calbindin 1, 29 (28kD) (CALB1), mRNA.
/PROD=calbindin 1 /F L=g b: N M_004929.2 -3.17826 -0.07573 8.59 Up 2.88E-02 A1798098 ESTs 0.424882 3.515001 8.52 Up 1.1 3E-03 A1692659 heat shock 90kD protein 1, alpha 2.19676 5.285103 8.51 Up 6.25E-05 AW26410 ESTs -1.16113 1.925599 8.5 Up 9.58E-03 NM_0122 Homo sapiens potassium 81 voltage-gated channel, Shal-related subfamily, member 2 (KCND2), mRNA. /PROD=potassium voltage-gated channel, Shal-relatedsubfamily, member 2 /F L=g b: N M_012281.1 gb:AB028967.1 gb:AF121104.1 1.071985 4.144927 8.41 Up 9.57E-05 NM_0045 Homo sapiens receptor 60 tyrosine kinase-like orphan receptor 2 (ROR2), mRNA.
/PROD=receptor tyrosine kinase-like orphan receptor 2 /FL=gb:M97639.1 g b: N M_004560.1 1.750623 4.809696 8.33 Up 2.20E-04 W76289 ESTs -1.25995 1.783805 8.25 Up 1.48E-03 AK026607 Homo sapiens cDNA:
FLJ22954 fis, clone KAT09813, highly similar to AF010315 Homo sapiens Pigl1 (PIG11) mRNA.
0.828899 3.847136 8.1 Up 6.55E-04 NM_0012 Homo sapiens bone 00 morphogenetic protein 2 (BMP2), mRNA.
/PROD=bone morphogenetic protein 2 precursor /F L=g b: N M_001200.1 1.690321 4.701963 8.06 Up 1.26E-04 NM_0140 Homo sapiens 45 DKFZP564C1940 protein (DKFZP564C1940), mRNA.
/PROD= DKFZP564C1 940 protein /F L=g b: 60000424.1 gb:AF131760.1 g b: N M_014045.1 1.979568 4.987789 8.05 Up 7.98E-05 M17565 Human MHC class II DQ-beta associated with DRw6, DQw1 protein, complete cds.
/FL=gb:M17565.1 -0.75007 2.251382 8.01 Up 1.88E-03 A1681917 ESTs, Highly similar to CLASS HOMEODOMAIN

(M.musculus) 2.109037 5.094219 7.92 Up 5.90E-05 AW01492 calbindin 1, (28kD) 7 /FL=gb:NM_004929.2 1.380324 4.364081 7.91 Up 2.74E-04 NM_0068 Homo sapiens histamine 95 N-methyltransferase (HNMT), mRNA.
/PROD=histamine N-methyltransfe rase /F L=g b: N M_006895.1 gb:D16224.1 gb:U08092.1 0.143628 3.121397 7.88 Up 7.94E-03 AB037763 Homo sapiens mRNA for KIAA1342 protein, partial cds. /PROD=KIAA1342 protein /FL=gb:AF299075.1 -0.20066 2.775234 7.87 Up 4.95E-04 NM_0016 Homo sapiens acyl-09 Coenzyme A
dehydrogenase, shortbranched chain (ACADSB), nuclear gene encoding mitochondrial protein, mRNA.
/PROD=acyl-Coenzyme A
dehydrogenase, shortbranchedchain precursor /FL=gb:U 12778.1 g b: N M_001609.1 -2.16611 0.806244 7.85 Up 2.70E-02 NM_0019 Homo sapiens glutamyl 77 aminopeptidase (aminopeptidase A) (ENPEP), mRNA.
/PROD=glutamyl aminopeptidase (aminopeptidase A) /F L=g b: L 12468.1 g b: N M_001977.1 gb:L14721.1 0.007601 2.978021 7.84 Up 3.96E-04 N63706 ESTs 1.186033 4.154093 7.82 Up 1.02E-04 A1627704 ESTs, Weakly similar to T17346 hypothetical protein D KFZp586O1624.1 (H.sapiens) 1.207341 4.163803 7.76 Up 7.98E-05 M31213 Human papillary thyroid carcinoma-encoded protein mRNA, complete cds. /FL=gb:M31213.1 0.106425 3.062268 7.76 Up 1.05E-04 NM_0183 Homo sapiens 71 hypothetical protein FLJ11264(FLJ11264), mRNA.
/PROD=hypothetical protein FLJ11264 /FL=gb:NM_018371.1 1.997597 4.940494 7.69 Up 8.49E-05 80005997 Homo sapiens, clone MGC:14801, mRNA, complete cds.
/PROD=Unknown (protein for MGC:14801) /FL=gb:B0005997.1 -0.29145 2.648165 7.67 Up 8.78E-04 A1197932 ESTs -1.20098 1.732939 7.64 Up 8.76E-03 NM_0017 Homo sapiens cadherin 4, 94 type 1, R-cadherin (retinal) (CDH4), mRNA.
/PROD=cadherin 4, type 1, R-cadherin (retinal) /FL=gb:L34059.1 g b: N M_001794.1 -0.96106 1.954749 7.55 Up 3.03E-04 AU 153412 Homo sapiens cDNA
FLJ13136 fis, clone 4.072718 6.987624 7.54 Up 3.42E-04 AU144598 cell recognition molecule Caspr2 /FL=gb:AF193613.1 gb:NM_014141.1 1.754933 4.669573 7.54 Up 1.40E-04 NM _0132 Homo sapiens fibronectin 31 leucine rich transmembrane protein 2 (FLRT2), mRNA.
/PROD=fibronectin leucine rich transmembrane protein2 /FL=gb:AB007865.1 gb:AF169676.1 gb:NM_013231.1 -2.81405 0.095993 7.52 Up 9.09E-03 A1694325 ESTs -1.80965 1.082014 7.42 Up 2.00E-02 NM_1525 Homo sapiens 06 hypothetical protein FLJ32835 (FLJ32835), mRNA.
/F L=g b: N M_152506.1 0.360809 3.246455 7.39 Up 7.76E-03 N47315 protein kinase C and casein kinase substrate in neurons 1 -0.10733 2.776046 7.38 Up 2.10E-03 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -1.44407 1.430083 7.33 Up 1.37E-02 U91903 Human Fritz mRNA, complete cds.
/PROD=Fritz /FL=gb:U24163.1 g b: U68057.1 g b: N M_001463.1 gb:U91903.1 2.383898 5.242759 7.25 Up 9.57E-05 BF476502 hypothetical protein -1.74597 1.112559 7.25 Up 3.28E-02 AW26981 hypothetical protein /F L=g b: N M_022068.1 -2.26295 0.569202 7.12 Up 1.70E-02 A1735586 ESTs -1.6164 1.213758 7.11 Up 2.52E-02 X00452 Human mRNA for DC
classll histocompatibility antigen alpha-chain.
/PROD=DC class II
histocompatibility antigenalpha-chain -0.13959 2.687835 7.1 Up 3.70E-04 BG10985 Homo sapiens clone TUA8 Cri-du-chat region mRNA
-0.88175 1.936253 7.05 Up 3.50E-03 A1650874 ESTs -1.37453 1.440655 7.04 Up 1.15E-02 AF1 26966 Homo sapiens voltage-dependent calcium channel alpha 1G subunit a isoform (CACNA1G) mRNA, complete cds.
/PROD=voltage-dependent calcium channel alpha 1 Gsubunit a isoform /F L=g b:AF 190860.1 g b:AF 126966.1 -3.09265 -0.28152 7.02 Up 9.07E-03 A1093492 ESTs -0.54935 2.252035 6.97 Up 1.12E-03 NM_0068 Homo sapiens guanosine 77 monophosphate reductase (GMPR), mRNA.
/PROD=guanosine monophosphate reductase /F L=g b: M24470.1 g b: N M_006877.1 1.956109 4.750668 6.94 Up 2.21 E-04 A1332979 potassium voltage-gated channel, subfamily G, member 1 /F L=g b: N M_002237.1 gb:AF033383.1 -1.26967 1.520668 6.92 Up 7.48E-03 AW16671 KIAA0403 protein -0.23726 2.551912 6.91 Up 3.23E-04 AA912476 Homo sapiens cDNA
FLJ13221 fis, clone 2.093848 4.875184 6.87 Up 5.90E-05 A0004010 Human BAC clone GS1--0.96264 1.812987 6.85 Up 6.20E-03 AB028998 Homo sapiens mRNA for KIAA1075 protein, partial cds. /PROD=KIAA1075 protein -2.33994 0.434528 6.84 Up 3.67E-02 AL134708 ESTs -2.08762 0.681751 6.82 Up 2.01 E-02 AF052117 Homo sapiens clone 23809 mRNA sequence.
0.323675 3.088394 6.8 Up 8.50E-03 M32577 Human MHC HLA-DQ
beta mRNA, complete cds. /FL=gb:M32577.1 3.287037 6.047807 6.78 Up 5.77E-04 A1633559 ESTs -2.02151 0.737644 6.77 Up 3.93E-03 BF062244 ESTs -1.66608 1.08864 6.75 Up 1.86E-02 BE673445 Homo sapiens chromosome 19, cosmid 0.449168 3.190138 6.69 Up 1.96E-04 A1688418 plexin A2 0.798972 3.539942 6.69 Up 4.35E-04 A1082827 hypothetical protein 0.83572 3.564527 6.63 Up 1.99E-03 N21138 KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 1.231172 3.958844 6.62 Up 2.36E-04 A1949419 ESTs -2.31389 0.411671 6.61 Up 1.05E-02 AF302494 Homo sapiens voltage-gated K+ channel subunit MIRP2 (KCNE3) mRNA, complete cds.
/PROD=voltage-gated K+
channel subunit MIRP2 /F L=g b: N M_005472.1 gb:AF076531.1 gb:AF302494.1 1.415513 4.132936 6.58 Up 3.18E-04 A1692703 potassium voltage-gated channel, Isk-related family, member 3 0.631332 3.346113 6.56 Up 5.92E-04 A1130705 ESTs, Weakly similar to A46302 PTB-associated splicing factor, long form (H.sapiens) 3.954335 6.666275 6.55 Up 7.98E-05 AB020675 Homo sapiens mRNA for KIAA0868 protein, partial cds. /PROD=KIAA0868 protein /FL=gb:AF193613.1 gb:NM_014141.1 -1.09181 1.620124 6.55 Up 2.00E-02 A1653050 ESTs, Weakly similar to HPPD_HUMAN 4-HYDROXYPHENYLPYRU
VATE DIOXYGENASE
(H.sapiens) 1.888188 4.581731 6.47 Up 3.37E-04 AW34031 ESTs -1.83503 0.855966 6.46 Up 6.85E-03 AA552969 ESTs -2.08627 0.604316 6.46 Up 1.75E-03 N50714 ESTs -1.2719 1.416234 6.44 Up 4.00E-03 NM_0204 Homo sapiens 06 polycythemia rubra vera 1;
cell surface receptor (PRV1), mRNA.
/PROD=polycythemia rubra vera 1; cell s u rface rece ptor /F L=g b: N M_020406.1 gb:AF146747.1 2.444644 5.126622 6.42 Up 2.48E-04 AA789332 ESTs, Moderately similar to KIAA1215 protein (H.sapiens) -1.10551 1.574234 6.41 Up 1.76E-02 AL136859 Homo sapiens mRNA;
cDNA DKFZp434P1735 (from clone DKFZp434P1735);
complete cds.
/PROD=hypothetical protein /FL=gb:AL136859.1 -1.30127 1.354641 6.3 Up 4.69E-04 A1003579 solute carrier family 6 (neurotransmitter transporter, GABA), member 1 /F L=g b: N M_003042.1 -0.22337 2.432405 6.3 Up 5.31 E-03 NM_0218 Homo sapiens phorbolin-22 like protein MDS019 (MDS019), mRNA.
/PROD= ph o rbol i n-like protein MDS019 /F L=g b:AF 182420.1 g b: N M_021822.1 -1.25121 1.403996 6.3 Up 1.13E-03 R62432 Cluster Incl.
R62432:yg52el1.s1 Homo sapiens cDNA, 3 end /clone=IMAGE-36023 /clone end=3 /gb=R62432 /gi=834311 /ug=Hs.12321 /len=487 -1.55104 1.102459 6.29 Up 7.99E-04 AU 157716 Homo sapiens cDNA
FLJ13585 fis, clone -2.47063 0.175591 6.26 Up 1.53E-02 H09657 ESTs 0.373467 3.018454 6.25 Up 1.79E-03 AU 151239 Homo sapiens cDNA
FLJ12927 fis, clone 1.861693 4.496649 6.21 Up 3.70E-04 A1374739 ESTs -1.73396 0.890885 6.17 Up 1.62E-02 AU 145336 Homo sapiens cDNA
FLJ1 1655 fis, clone 1.586056 4.195825 6.1 Up 4.67E-04 Z83851 Human DNA sequence from clone 989H1 1 on chromosome 22g13.1-13.2. Contains part of a novel gene, ESTs, GSSs and four putative CpG
islands 0.569298 3.178582 6.1 Up 3.18E-04 NM_0003 Homo sapiens tissue 62 inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) (TIMP3), mRNA.
/PROD=tissue inhibitor of metal loprotei nase 3precursor /F L=g b: N M_000362.2 gb:U14394.1 gb:U67195.1 gb:U02571.1 -2.13754 0.46922 6.09 Up 2.02E-02 BF000203 ESTs 0.013383 2.617624 6.08 Up 5.42E-03 L10374 Human (clone CTG-A4) mRNA sequence.
1.250788 3.85327 6.07 Up 1.09E-04 AF077040 Homo sapiens SIHOO3 mRNA, complete cds.
/PROD=SIH003 /FL=gb:AF077040.1 -1.09421 1.502221 6.05 Up 2.38E-03 AK023621 Homo sapiens cDNA
FLJ13559 fis, clone PLACE1007852, highly similar to Homo sapiens mRNA for KIAA0878 protein.
0.466394 3.059875 6.04 Up 5.79E-04 NM_0031 Homo sapiens Spi-B
21 transcription factor (Spi-1 PU.1 related) (SPIB), mRNA. /PROD=Spi-B
transcription factor (Spi-1PU.1 related) /F L=g b: N M_003121.1 -0.18863 2.401303 6.02 Up 3.85E-03 AV700724 GATA-binding protein 4 /F L=g b: N M_002052.1 gb:L34357.1 gb:D78260.1 2.182526 4.77117 6.02 Up 8.49E-05 NM_0040 Homo sapiens dystrophin (muscular dystrophy, Duchenne and Becker types), includes DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272 (DMD), transcript variant Dp427p2, mRNA.
/PROD=dystrophin Dp427p2 isoform /F L=g b: N M_004010.1 1.08211 3.666711 6 Up 9.72E-04 AF010314 Homo sapiens Pig10 (PIG10) mRNA, complete cds. /PROD=PiglO
/FL=gb:AF05961 1.1 gb:AF010314.1 g b: N M_003633.1 g b: 60000418.1 gb:AF005381.1 -1.4606 1.112751 5.95 Up 1.20E-03 AW07210 Homo sapiens mRNA;

2 cDNA DKFZp434H205 (from clone DKFZp434H205) 2.092702 4.657439 5.92 Up 6.25E-05 AA700440 ESTs 0.513482 3.076608 5.91 Up 3.96E-04 AU154504 cytochrome P450, subfamily I (dioxin-inducible), polypeptide 1 (glaucoma 3, primary infantile) /FL=gb:U03688.1 g b: N M_000104.2 -1.13676 1.422546 5.89 Up 6.80E-03 AB023144 Homo sapiens mRNA for KIAA0927 protein, partial cds. /PROD=KIAA0927 protein 1.297014 3.854685 5.89 Up 1.02E-04 NM_0057 Homo sapiens G protein-56 coupled receptor 64 (GPR64), mRNA.
/PROD=G protein-coupled receptor 64 /F L=g b: N M_005756.1 -0.68272 1.867351 5.86 Up 5.59E-03 AF1 59447 Homo sapiens Suppressor of Fused mRNA, alternatively spliced form 2, complete cds.
/PROD=Suppressor of Fused /F L=g b: N M_016169.1 gb:AF159447.1 gb:AF175770.1 -3.12304 -0.58481 5.81 Up 4.03E-02 NM_0180 Homo sapiens 18 hypothetical protein FLJ10191 (FLJ10191), mRNA.
/PROD=hypothetical protein FLJ10191 /F L=g b: N M_018018.1 1.163123 3.692873 5.77 Up 1.63E-04 NM_0027 Homo sapiens protein 42 kinase C, mu (PRKCM), mRNA. /PROD=protein kinase C, mu /F L=g b: N M_002742.1 -0.35867 2.162789 5.74 Up 1.69E-04 NM_0019 Homo sapiens endothelin 57 receptor type A (EDNRA), mRNA.
/PROD=endothelin receptor type A
/FL=gb:NM_001957.1 g b: L06622.1 2.405473 4.925144 5.73 Up 6.25E-05 A1283093 ESTs -1.58235 0.936512 5.73 Up 1.59E-03 NM_0184 Homo sapiens SRY (sex 19 determining region Y)-box 18 (SOX18), mRNA.
/PROD=SRY (sex determining region Y)-box 18 /FL=gb:AF270652.1 gb:AB033888.1 gb:NM_018419.1 -1.88254 0.627373 5.7 Up 6.20E-03 BF694956 Human DNA sequence from clone RP1-187J11 on chromosome 6g11.1-22.33. Contains the gene for a novel protein similar to S. pombe and S.
cerevisiae predicted proteins, the gene for a novel protein similar to protein kinase C inhibitors, the 3 end of the -0.68545 1.817815 5.67 Up 5.99E-03 BC035640 Homo sapiens, clone IMAGE:5547405, mRNA.
-1.92555 0.569805 5.64 Up 1.75E-03 BE856597 ESTs 3.313759 5.801354 5.61 Up 1.18E-04 AB020657 Homo sapiens mRNA for KIAA0850 protein, complete cds.
/PROD=KIAA0850 protein /FL=gb:AB020657.1 gb:AF161553.1 gb:AF205218.1 g b: N M_016389.1 4.49505 6.977964 5.59 Up 6.25E-05 AK093435 Homo sapiens cDNA
FLJ36116 fis, clone TEST12022338.
0.618056 3.100379 5.59 Up 1.33E-04 BG16533 ESTs -1.12392 1.354596 5.57 Up 2.50E-03 T82147 ESTs -1.17289 1.304294 5.57 Up 6.03E-03 AW02598 ESTs, Weakly similar to 0 A47582 B-cell growth factor precursor (H.sapiens) -0.66753 1.784294 5.47 Up 9.05E-04 AF284435 Homo sapiens TIGIRR-2 mRNA, complete cds.
/PROD=TIGIRR-2 /FL=gb:AF284435.1 g b: N M_014271.1 gb:AF181284.1 -0.04543 2.399112 5.44 Up 1.46E-03 AB037730 Homo sapiens mRNA for KIAA1309 protein, partial cds. /PROD=KIAA1309 protein -2.47478 -0.03132 5.44 Up 8.96E-03 NM_1526 Homo sapiens 87 hypothetical protein FLJ33641 (FLJ33641), mRNA.
/F L=g b: N M_152687.1 -1.89695 0.545787 5.44 Up 3.46E-03 AL136944 Homo sapiens mRNA;
cDNA DKFZp586J0624 (from clone DKFZp586J0624);
complete cds.
/PROD=hypothetical protein /FL=gb:AF215636.1 g b: N M_014585.1 gb:AF231121.1 gb:AF226614.1 g b:AL 136944.1 1.095538 3.529324 5.4 Up 1.59E-04 AF319520 Homo sapiens ARG99 mRNA, complete cds.

/PROD=ARG99 /FL=gb:AF319520.1 2.130365 4.562488 5.4 Up 8.49E-05 80005047 Homo sapiens, clone MGC:12852, mRNA, complete cds.
/PROD=Unknown (protein for MGC:12852) /F L=g b: N M_001946.1 gb:AB013382.1 gb:B0003562.1 gb:B0003143.1 gb:B0005047.1 3.686635 6.118029 5.39 Up 1.82E-04 AF205218 Homo sapiens NS1-binding protein-like protein mRNA, complete cds.
/PROD=NS1 -binding protein-like protein /FL=gb:AB020657.1 gb:AF161553.1 gb:AF205218.1 g b: N M_016389.1 1.298769 3.727597 5.38 Up 2.76E-04 A1123815 ESTs 1.182358 3.610132 5.38 Up 1.82E-04 AW27013 Homo sapiens mRNA for 8 KIAA1729 protein, partial cds -1.39667 1.02491 5.36 Up 6.51 E-03 A1018174 ESTs -0.47241 1.946888 5.35 Up 6.80E-03 NM_0066 Homo sapiens ret finger 04 protein-like 3 (RFPL3), mRNA. /PROD=ret finger protein-like 3 /F L=g b: N M_006604.1 -0.68921 1.725879 5.33 Up 1.34E-04 NM_0165 Homo sapiens 46 complement Cl r-like proteinase precursor, (LOC51279), mRNA.
/PROD=complement Cl r-like proteinase precursor, /FL=gb:AF178985.1 g b: N M_016546.1 -0.17505 2.238912 5.33 Up 1.05E-04 AA995925 Homo sapiens clone 23741 mRNA sequence -0.20099 2.21229 5.33 Up 1.55E-03 BF984830 retinoic acid induced 1 2.377335 4.79048 5.33 Up 4.69E-04 NM_0053 Homo sapiens hyaluronan 28 synthase 2 (HAS2), mRNA.
/PROD=hyaluronan synthase 2 /F L=g b: U 54804.1 g b: N M_005328.1 -0.98665 1.425455 5.32 Up 1.34E-02 NM_0014 Homo sapiens frizzled-63 related protein (FRZB), mRNA. /PROD=frizzled-related protein /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 2.264046 4.672118 5.31 Up 1.25E-04 AL049589 Human DNA sequence from clone 570L12 on chromosome Xq 13.1-21.1.
Contains the PGK1 gene for phosphoglycerate kinase 1, the gene for a novel protein similar to TAF2G (TATA box binding protein (TBP)-associated factor, RNA polymerase II, G, 32kD) (TAF...
-0.35323 2.046488 5.28 Up 2.37E-03 BM66601 Homo sapiens cDNA
0 FLJ23803 fis, clone HE P22811.
3.472109 5.867303 5.26 Up 7.98E-05 AW06972 Homo sapiens mRNA;
9 cDNA DKFZp434B2119 (from clone DKFZp434B2119); partial cds 0.977201 3.368558 5.25 Up 7.47E-05 A1656807 ESTs 2.732975 5.121756 5.24 Up 6.52E-04 A0005378 Homo sapiens PAC clone RP5-1137M13 from 7q33-q35 1.592667 3.976725 5.22 Up 6.48E-04 A1978754 ESTs 1.008383 3.391251 5.22 Up 8.23E-04 BE397715 pre-B-cell leukemia transcription factor 2 /F L=g b: N M_002586.1 0.134434 2.516313 5.21 Up 3.13E-04 AV758821 ESTs, Weakly similar to Z132_HUMAN ZINC

(H.sapiens) 1.496791 3.877324 5.21 Up 8.49E-05 BF338045 calumenin 0.329872 2.705019 5.19 Up 1.05E-04 A1652899 ESTs -0.39856 1.964554 5.14 Up 1.29E-03 BC019064 Homo sapiens, Similar to hypothetical protein FLJ14743, clone MGC:29781 IMAGE:4590587, mRNA, complete cds.
/PROD=Similar to hypothetical protein /F L=g b: BC019064.1 0.462867 2.81993 5.12 Up 8.02E-03 A1807026 ESTs 0.385307 2.742224 5.12 Up 4.37E-04 BF435123 bromodomain and PHD
finger containing, 3 -1.10371 1.252512 5.12 Up 9.04E-04 NM_0059 Homo sapiens snail 1 85 (drosophila homolog), zinc finger protein (SNA11), mRNA. /PROD=snail 1 (drosophila homolog), zinc fingerprotein /FL=gb:AF125377.1 g b: N M_005985.1 1.094591 3.449692 5.12 Up 1.02E-04 NM_0240 Homo sapiens 64 hypothetical protein MGC5363 (MGC5363), mRNA.
/PROD=hypothetical protein MGC5363 /FL=gb:B0001000.2 g b: N M_024064.1 2.167442 4.520183 5.11 Up 4.37E-04 NM_0015 Homo sapiens insulin-like 52 growth factor-binding protein 4 (IGFBP4), mRNA. /PROD=insulin-like growth factor-binding protein 4 /F L=g b: M62403.1 g b: N M_001552.1 2.49682 4.845096 5.09 Up 2.00E-04 NM_0149 Homo sapiens KIAA0854 43 protein (KIAA0854), mRNA. /PROD=KIAA0854 protein /F L=g b: N M_014943.1 g b:AB020661.1 0.089114 2.430633 5.07 Up 5.31 E-03 AW01473 ESTs 0.208844 2.544219 5.05 Up 4.90E-04 H09780 Human (clone CTG-A4) mRNA sequence 1.38879 3.721503 5.04 Up 1.05E-04 D21254 Human mRNA for OB-cadherin-1, complete cds.
/PROD=OB-cadherin-1 /FL=gb:L34056.1 g b: N M_001797.1 g b: D21254.1 -0.07494 2.251273 5.01 Up 8.04E-04 NM_0013 Homo sapiens dual 94 specificity phosphatase 4 (DUSP4), mRNA.
/PROD=dual specificity phosphatase 4 /F L=g b: N M_001394.2 g b: 60002671.1 gb:U48807.1 gb:U21108.1 2.115363 4.439619 5.01 Up 1.50E-04 NM_0187 Homo sapiens zinc-00 binding protein Rbcc728 (Rbcc728), mRNA.
/PROD=zinc-binding protein Rbcc728 /F L=g b: N M_018700.1 1.361153 -4.07391 43.26 Down 4.28E-04 NM_0143 Homo sapiens POU
52 transcription factor (OCT11), mRNA.
/PROD=POU transcription factor /F L=g b: N M_014352.1 gb:AF133895.1 gb:AF162278.1 1.312148 -3.67593 31.74 Down 2.15E-02 U32500 Human type 2 neuropeptide Y receptor mRNA, complete cds.
/PROD=type 2 neuropeptide Y receptor /FL=gb:U42766.1 gb:U36269.1 gb:U32500.1 3.409815 -1.40094 28.07 Down 4.88E-03 NM _0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 80002683.1 gb:AF136631.1 0.757197 -4.01309 27.29 Down 5.31 E-03 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 5.187988 0.925716 19.19 Down 1.82E-04 AA074145 proline oxidase homolog 3.862686 -0.33976 18.41 Down 1.79E-03 NM_0071 Homo sapiens tumor 15 necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA.
/PROD=tumor necrosis factor, alpha-induced protein 6 /F L=g b: N M_007115.1 0.579765 -3.61266 18.28 Down 1.63E-03 A1393930 ESTs 3.77776 -0.38219 17.88 Down 4.99E-04 BU729850 hypothetical protein 2.951696 -1.16992 17.41 Down 5.31 E-03 AB019562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
1.143234 -2.96901 17.29 Down 1.60E-04 BF437711 ESTs 3.268087 -0.81338 16.93 Down 1.82E-04 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 3.113698 -0.8325 15.41 Down 6.25E-05 NM_0021 Homo sapiens insulinoma-96 associated 1 (INSM1), mRNA.
/PROD=insulinoma-associated 1 /F L=g b: N M_002196.1 gb:M93119.1 4.927935 1.009599 15.12 Down 1.75E-04 J05008 Homo sapiens endothelin-1 (EDN1) gene, complete cds /FL=gb:NM_001955.1 4.897427 1.053368 14.36 Down 6.25E-05 R06655 ESTs, Moderately similar to AF078844 1 hqp0376 protein (H.sapiens) 2.271332 -1.54277 14.07 Down 1.21 E-02 NM_0151 Homo sapiens KIAA0633 98 protein (COBL), mRNA.
/PROD=KIAA0633 protein /F L=g b: N M_015198.1 3.025351 -0.68158 13.06 Down 6.25E-05 AW59092 ESTs 0.961816 -2.64027 12.14 Down 1.38E-02 A1796169 GATA-binding protein 3 /F L=g b: N M_002051.1 gb:M69106.1 g b: 60003070.1 1.840613 -1.75619 12.1 Down 1.31 E-02 A1949760 ESTs, Weakly similar to unnamed protein product (H.sapiens) 2.350127 -1.16435 11.43 Down 1.75E-03 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
2.36447 -1.11975 11.19 Down 1.26E-04 NM_0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 3.806044 0.35797 10.91 Down 5.32E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 5.023981 1.579769 10.88 Down 1.50E-04 NM_0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 7.564809 4.126951 10.84 Down 6.52E-04 M83248 Human nephropontin mRNA, complete cds.
/PROD=nephropontin /F L=g b: M83248.1 4.055862 0.664604 10.49 Down 9.57E-05 AK026815 Homo sapiens cDNA:
FLJ23162 fis, clone LNG09734.
3.437271 0.12475 9.94 Down 3.82E-04 AB029025 Homo sapiens mRNA for KIAA1102 protein, partial cds. /PROD=KIAA1102 protein 2.129273 -1.1448 9.67 Down 1.66E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 4.847114 1.573515 9.67 Down 1.73E-04 NM_0064 Homo sapiens lung type-I
74 cell membrane-associated glycoprotein (T1A-2), transcript variant 2, mRNA. /PROD=lung type-I cell membrane-associatedg lycoprotei n, isoform 2 precursor /F L=g b: N M_006474.1 gb:AF030428.1 1.577138 -1.67271 9.51 Down 7.76E-03 M15329 Human interleukin 1-alpha (IL1A) mRNA, complete cds. /PROD=interleukin 1-alpha /FL=gb:M15329.1 4.505436 1.287267 9.31 Down 9.57E-05 W57613 ESTs 3.508683 0.294832 9.28 Down 1.97E-04 AK027231 Homo sapiens cDNA:
FLJ23578 fis, clone LNG 12709.
2.62025 -0.53251 8.89 Down 5.60E-04 AA625683 ESTs 1.659275 -1.48435 8.84 Down 9.40E-04 L16895 Human lysyl oxidase (LOX) gene, exon 7 5.207569 2.064859 8.83 Down 2.72E-04 AA083478 Homo sapiens mRNA full length insert cDNA clone 2.306225 -0.8129 8.69 Down 2.76E-04 AW44476 ESTs 2.000419 -1.10961 8.63 Down 5.03E-03 NM_0312 Homo sapiens testis 72 expressed sequence 14 (TEX14), mRNA.
/PROD=testis expressed sequence 14 /FL=gb:NM_031272.1 5.450694 2.394209 8.32 Down 9.84E-05 AF095771 Homo sapiens PTH-responsive osteosarcoma B1 protein (B1) mRNA, complete cds.
/PROD=PTH-responsive osteosarcoma B1 protein /FL=gb:AF095771.1 5.252439 2.196404 8.32 Down 1.18E-03 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 4.507212 1.458704 8.27 Down 1.26E-04 AW19694 ESTs 3.543738 0.544705 7.99 Down 4.95E-04 NM_0019 Homo sapiens endothelin 55 1 (EDN1), mRNA.
/PROD=endothelin 1 /F L=g b: N M_001955.1 3.334996 0.337521 7.99 Down 1.34E-05 R40917 phosphodiesterase 4D, cAMP-specific (dunce (Drosophila)-homolog phosphodiesterase E3) /F L=g b: L20969.1 g b: N M_006203.1 g b: U02882.1 4.092731 1.098988 7.97 Down 7.83E-04 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /F L=g b: U 81800.1 g b: N M_004207.1 3.19487 0.215496 7.89 Down 2.37E-03 NM_1735 Homo sapiens 53 hypothetical protein FLJ25801 (FLJ25801), mRNA.
/FL=gb:NM_173553.1 5.388254 2.421904 7.82 Down 3.23E-04 NM 0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 3.094055 0.128818 7.81 Down 3.00E-04 AW18819 tumor necrosis factor, 8 alpha-induced protein 6 /F L=g b: N M_007115.1 2.332751 -0.63023 7.8 Down 9.35E-05 NM_0000 Homo sapiens cyclin-77 dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), mRNA. /PROD=cyclin-dependent kinase inhibitor 2A (melanoma,pl6, inhibits CDK4) /F L=g b: N M_000077.1 gb:L2721 1.1 1.10782 -1.84525 7.74 Down 3.46E-03 BC029425 Homo sapiens, Similar to KIAA1275 protein, clone IMAGE:4616553, mRNA.
3.655193 0.705514 7.73 Down 3.18E-04 A1659927 Homo sapiens cDNA:
FLJ22547 fis, clone 5.356771 2.412135 7.7 Down 1.86E-04 W92036 ESTs 2.28595 -0.65294 7.67 Down 2.78E-03 BE504838 ESTs 6.1137 3.198978 7.54 Down 2.22E-04 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 4.738703 1.825888 7.53 Down 1.59E-04 NM 0140 Homo sapiens 33 DKFZP586AO522 protein (DKFZP586A0522), mRNA.
/PROD=DKFZP586AO522 protein /F L=g b: N M_014033.1 4.633038 1.723613 7.51 Down 7.34E-05 NM _0169 Homo sapiens NADPH
31 oxidase 4 (NOX4), mRNA.
/PROD=NADPH oxidase 4 /FL=gb:AF261943.1 gb:NM_016931.1 gb:AF254621.1 gb:AB041035.1 0.831091 -2.07313 7.49 Down 1.64E-02 NM _1530 Homo sapiens 36 hypothetical protein FLJ32239 (FLJ32239), mRNA.
/F L=g b: N M_153036.1 3.030236 0.148098 7.37 Down 1.06E-03 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 5.715937 2.845518 7.31 Down 6.25E-05 U85658 Human transcription factor ERF-1 mRNA, complete cds. /PROD=ERF-1 /F L=g b: N M_003222.1 gb:U85658.1 2.597946 -0.264 7.27 Down 1.96E-04 AW13814 ESTs 2.798327 -0.06241 7.26 Down 1.59E-04 BF062943 protocadherin 18 2.590871 -0.2675 7.25 Down 5.03E-03 NM0165 Homo sapiens TBX3-iso 69 protein (TBX3-iso), mRNA. /PROD=TBX3-iso protein /F L=g b: N M_016569.1 gb:AF216750.1 2.967768 0.161666 6.99 Down 2.73E-03 AL 121753 Human DNA sequence from clone RP4-61404 on chromosome 20g11.1-12 Contains the 3 part of the MMP24 (matrix metalloproteinase 24 (membrane-inserted)) gene, the ITGB4BP
(integrin beta 4 binding protein) gene, the 3 end of a novel gene, the 3 end 0...
1.041706 -1.73204 6.84 Down 3.48E-02 BF196010 ESTs 0.424388 -2.34418 6.81 Down 3.04E-03 NM_0024 Homo sapiens myelin 33 oligodendrocyte glycoprotein (MOG), mRNA. /PROD=myelin of igode nd rocyte g lycoprote i n /FL=gb:U 18798.1 gb:U64564.1 g b: N M_002433.1 6.307554 3.554438 6.74 Down 3.96E-04 NM 0066 Homo sapiens serum-22 inducible kinase (SNK), mRNA. /PROD=serum-inducible kinase /FL=gb:AF059617.1 g b: N M_006622.1 gb:AF223574.1 3.876749 1.137352 6.68 Down 1.28E-03 AL574184 hydroxyprostaglandin dehydrogenase 15-(NAD) /F L=g b: N M_000860.1 gb:L76465.1 7.67265 4.935152 6.67 Down 3.86E-04 NM 0029 Homo sapiens S100 66 calcium-binding protein A10 (annexin II ligand, calpactin I, light polypeptide (p11)) (S100A10), mRNA.
/PROD=S100 calcium-binding protein A10 /FL=gb:M81457.1 gb:M38591.1 g b: N M_002966.1 3.127666 0.401912 6.62 Down 4.36E-04 NM 0035 Homo sapiens 77 undifferentiated embryonic cell transcription factor 1 (UTF1), mRNA.
/PROD=undifferentiated embryonic cell transcriptionfactor 1 /FL=gb:NM_003577.1 gb:ABO1 1076.1 2.677334 -0.04099 6.58 Down 4.48E-04 NM_0000 Homo sapiens collagen, 94 type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive) (COL7A1), mRNA. /PROD=collagen, type VII, alpha 1 (epidermolysisbullosa, dystrophic, dominant and recessive) /FL=gb:L02870.1 g b: N M_000094.1 4.796495 2.100178 6.48 Down 2.14E-05 A1653107 ESTs 1.075159 -1.6205 6.48 Down 2.02E-02 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 3.86075 1.187353 6.38 Down 1.59E-04 U85995 Cluster Incl.
U85995:Human clone IMAGE-22181 unknown protein mRNA, partial cds /cds=(0,1291) /gb=U85995 /gi=1835749 /ug=Hs.79340 /len= 1696 0.300578 -2.35535 6.3 Down 2.44E-02 All 10886 prothymosin, alpha (gene sequence 28) 0.182328 -2.47093 6.29 Down 1.88E-02 BC036917 Homo sapiens, clone MGC:46457 IMAGE:5201433, mRNA, complete cds.
/PROD=Unknown (protein for MGC:46457) /F L=g b: BC036917.1 6.568635 3.918368 6.28 Down 1.51 E-04 AL031602 Human DNA sequence from clone RP5-1174N9 on chromosome 1p34.1-35.3. Contains the gene for a novel protein with IBR domain, a (pseudo?) gene for a novel protein similar to MT1 E
(metallothionein 1 E
(functional)), ESTs, STSs, GSSs and two putative Cp...
1.639038 -1.00453 6.25 Down 5.77E-04 AW02787 ESTs, Weakly similar to 9 NBHUC8 decorin precursor (H.sapiens) 4.038177 1.406797 6.2 Down 1.02E-04 BF449053 ESTs 6.008797 3.380703 6.18 Down 1.64E-03 W72516 dihydropyrimidinase-like 3 /F L=g b: N M_001387.1 gb:D78014.1 2.098906 -0.52676 6.17 Down 2.78E-03 NM_0039 Homo sapiens cyclin Al 14 (CCNA1), mRNA.
/PROD=cyclin Al /F L=g b: N M_003914.1 g b: U66838.1 1.99849 -0.59877 6.05 Down 5.92E-04 NM_0023 Homo sapiens lysyl 17 oxidase (LOX), mRNA.
/PROD=lysyl oxidase /F L=g b:AF039291.1 g b: N M_002317.1 gb:M94054.1 2.982965 0.397911 6 Down 1.82E-04 AK026829 Homo sapiens cDNA:
FLJ23176 fis, clone LNG 10452.
3.08363 0.500579 5.99 Down 1.74E-04 U73778 Human collagen type XII
alpha-1 precursor (COL12A1) mRNA.
/PROD=collagen type XII
alpha-1 /F L=g b: N M_004370.3 0.857744 -1.71151 5.94 Down 4.12E-03 AB085901 Homo sapiens DBL mRNA
for DBL proto-oncogene splicing variant 1, complete cds.
/PROD=DBL proto-oncogene splicing variant 1 /FL=gb:AB085901.1 7.251816 4.700433 5.86 Down 3.86E-04 NM 0007 Homo sapiens annexin Al 00 (ANXA1), mRNA.
/PROD=annexin I
/FL=gb:B0001275.1 g b: N M_000700.1 5.318139 2.768691 5.85 Down 9.51 E-05 U87408 Cluster Incl.
U87408:Human clone IMAGE-74593 unknown protein mRNA, partial cds /cds=(0,1362) /gb=U87408 /gi=1842104 /ug=Hs.79340 /len= 1982 0.668218 -1.87886 5.84 Down 1.56E-02 BE048571 ESTs 4.103964 1.558115 5.84 Down 8.74E-05 AA579773 ESTs 0.549053 -1.9953 5.83 Down 4.41 E-02 A1825645 ESTs, Weakly similar to HOMEOBOX PROTEIN
GBX-2 (H.sapiens) 2.98904 0.457127 5.78 Down 7.98E-05 AW13814 ESTs 3.280973 0.749482 5.78 Down 2.21 E-04 AL 139377 Human DNA sequence from clone RP11-251J8 on chromosome 13 Contains ESTs, STSs, GSSs and a CpG island.
Contains two novel genes with two isoforms each and the KIAA0610 gene with two isoforms 2.750597 0.238017 5.71 Down 1.92E-02 NM 0069 Homo sapiens SRY (sex 42 determining region Y)-box 20 (SOX20), mRNA.
/PROD=SRY (sex determining region Y)-box 20 /FL=gb:NM_006942.1 g b: 80000985.1 gb:AB006867.1 3.880272 1.369596 5.7 Down 1.82E-04 NM0025 Homo sapiens natriuretic 21 peptide precursor B
(NPPB), mRNA.
/PROD=natriuretic peptide precursor B
/F L=g b: N M_002521.1 gb:M25296.1 2.324824 -0.18374 5.69 Down 2.00E-04 AL096771 Human DNA sequence from clone RP1-238D15 on chromosome 6g12-14.3 Contains part of COL12A1 (collagen, type XII, alpha 1) gene and STSs 6.179917 3.681421 5.65 Down 6.25E-05 NM_0001 Homo sapiens glucan 58 (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV) (GBE1), mRNA.
/PROD=glucan (1,4-alpha-), branching enzyme 1(glycogen branching enzyme) /FL=gb:L07956.1 g b: N M_000158.1 6.777916 4.283022 5.64 Down 3.42E-04 U15174 Homo sapiens BCL2adenovirus El B
19kD-interacting protein 3 (BNIP3) mRNA, complete cds.
/PROD=BCL2adenovirus E1 B 19kD-interacting protein 3 /FL=gb:AF002697.1 g b: N M_004052.2 gb:U15174.1 3.560033 1.066273 5.63 Down 4.18E-04 U38945 Human hypothetical 18.1 kDa protein (CDKN2A) mRNA, complete cds.
/F L=g b: U 38945.1 gb:U26727.1 2.64743 0.1565 5.62 Down 7.06E-03 A1702438 ESTs 4.981033 2.492173 5.61 Down 7.98E-05 NM_0006 Homo sapiens serine (or 02 cysteine) proteinase inhibitor, Glade E (nexin, plasminogen activator inhibitor type 1), member 1 (SERPINE1), mRNA.
/PROD=serine (or cysteine) proteinase inhibitor, cladeE (nexin, plasminogen activator inhibitor type 1), membe 5.13621 2.649783 5.6 Down 1.82E-04 BC013944 Homo sapiens, Similar to myosin, heavy polypeptide 7, cardiac muscle, beta, clone IMAGE:4064393, mRNA.
2.648874 0.170587 5.57 Down 2.39E-04 AW00753 Human insulin-like growth 2 factor binding protein 5 (IGFBP5) mRNA
4.285883 1.811154 5.56 Down 1.26E-04 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 3.41866 0.980192 5.42 Down 3.42E-04 AA149250 ESTs, Weakly similar to PROTEIN PRECURSOR
(R. norvegicus) 3.932141 1.49687 5.41 Down 6.25E-05 NM_0044 Homo sapiens growth 90 factor receptor-bound protein 14 (GRB14), mRNA. /PROD=growth factor receptor-bound protein 14 /F L=g b: L76687.1 g b: N M_004490.1 4.64236 2.208805 5.4 Down 4.99E-04 AB019695 Homo sapiens mRNA for thioredoxin reductase II
beta, complete cds.
/PROD=thioredoxin reductase II beta /FL=gb:ABO19695.1 2.256481 -0.17666 5.4 Down 2.51 E-03 NM_0184 Homo sapiens NAG22 95 protein (LOC55873), mRNA. /PROD=NAG22 protein /FL=gb:AF247820.3 g b: N M_018495.3 2.93223 0.515985 5.34 Down 1.40E-03 J05594 Homo sapiens NAD+-dependent 15-hyd roxyprostag land in dehydrogenase (PDGH) mRNA, complete cds.
/PROD=NAD+-dependent hydroxyprostaglandindehy drogenase /FL=gb:J05594.1 3.557525 1.145962 5.32 Down 1.74E-04 BF514079 Kruppel-like factor 4 (gut) 6.844763 4.45073 5.26 Down 5.92E-04 AF003114 Homo sapiens CYR61 mRNA, complete cds.
/FL=gb:AF003114.1 3.947271 1.57134 5.19 Down 3.82E-04 A1928035 ESTs 4.835771 2.460275 5.19 Down 1.74E-04 AL574210 serine (or cysteine) proteinase inhibitor, Glade E (nexin, plasminogen activator inhibitor type 1), member 1 /F L=g b: N M_000602.1 g b: M 16006.1 5.332534 2.96686 5.15 Down 2.34E-04 AW18988 protocadherin 18 5.43052 3.069652 5.14 Down 2.73E-04 AU154455 lung type-I cell membrane-associated glycoprotein 3.041407 0.703421 5.06 Down 1.48E-04 NM_0044 Homo sapiens forkhead 72 box D1 (FOXD1), mRNA.
/PROD=forkhead box D1 /FL=gb:U59832.1 gb:NM_004472.1 F) H9P39 at 72 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 72 HRS Ratio Direction adj. p- Gene Gene Name 01 DE value Identifier A Ã,<2 2' H ono :lien: HN==3be 2a m"UNNA for epato vte compete C'J's \' s (1 6,' 569 igb B '--02802-+
" ~ 49 i u :--H... 1 55+35 1 / en== ^ 9'44 -4.79201 3.675687 354.02 Up 7.11 E-05 NM_0124 Homo sapiens sema 31 domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
(SEMA3E), mRNA.
/PROD=sema domain, immunoglobulin domain (Ig), shortbasic domain, secreted, (semaphorin) 3E
/F L=g b: N M_012431.1 gb:AB002329.1 -5.25658 3.066715 320.3 Up 5.36E-05 AW00557 putative 47 kDa protein G: T'A--t , :3o piete c 1 .
iPRO G T `.$
3F ,:g':U'66075'1 :3..; 5;2 37. , q b:D 78 11.1 -3.8752 4.204423 270.53 Up 1.89E-05 AB028021 Homo sapiens HNF-3beta mRNA for hepatocyte nuclear factor-3 beta, complete cds.
/PROD=hepatocyte nuclear factor-3 beta /FL=gb:AB028021.1 g b: N M_021784.1 -3.26893 4.729085 255.65 Up 3.66E-05 NM_0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1 .q4.,.;- :~ =2$89x3 , 3,360647 202.2 ' .
~...1. Up +.8:~~~-=4j.5 .+~Y1 ,. :~.+.=a t' ~q1,~ :~D":'e~>:. ::,3;':;;x'.'3 ;oi;ieobox p rote n oo eco d mRNA, ^.
1,N' 0D w,~ `obo `: Erott) n qoos?+',' i .3"_"'g~...~a ; b:.AY' 77407,1 b::NM :'3 ,4>.
3,62O$ 6.953 "8ao . 9~ 0 6 7 U 3 ,85E-05 px'.__0224 Homo s pens 54 i F; J22252 ~~,. ...:.i-tic.
R box' 4'cnnt: +nm gene 17 'FL1 2a252', n-iRNA, pro-min FLJ22252,,,,,imiNr tip.. i\ .. +..+.\\... \+~... -4.50758 2.853368 164.39 Up 5.73E-05 AU1 18882 endothelin receptor type A

/FL=gb:NM_001957.1 g b: L06622.1 -1.11,159 6.244682 163,85 U 'p, 1.85E-05 . i 0038 H \ n'1 ,,p mn \ obigast 16 7 growth factor 17 ( \ Fj7i RNA.
/PR D- rob ast iro""vVf factor 17 ^b.. \8009249i -0.26005 7.057553 159.52 Up 8.58E-05 R72286 microfibrillar-associated protein 4 -3.62742 3.595825 149.42 Up 1.19E-03 AA772920 ESTs -3.61621 3.595293 148.21 Up 7.06E-04 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds -1.32044 5.888668 147.96 Up 1.62E-03 AF017987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -0.83997 6.288395 139.91 Up 1.06E-04 A1821669 ESTs -1.89695 5.066236 124.78 Up 5.04E-05 AL136944 Homo sapiens mRNA;
cDNA DKFZp586J0624 (from clone DKFZp586J0624);
complete cds.
/PROD=hypothetical protein /FL=gb:AF215636.1 g b: N M_014585.1 gb:AF231121.1 gb:AF226614.1 g b:AL 136944.1 -2.90798 4.005677 120.56 Up 7.41 E-05 NM_0016 Homo sapiens 43 apolipoprotein A-II
(APOA2), mRNA.
/PROD=apolipoprotein A-II precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 60005282.1 -3,39007 3,146077 UJp 2, 9 2 `" 0. 11 ay: ,0$6 Homo ap,aen=' c,0 U
a4 az hes on moaec k v t 3 3 i o3i'okgy to _ICA*v se:3 nmo~ogu (.',f L1,) i o;evk e with hs"rno: ogy to LICAiVl(c,Bose ho! ;o;o ue of ./FL=q :AF 0 2246.1 00661,4A
-4.63418 1.846961 89.33 Up 5.54E-03 BF112218 ESTs -2.0457 4.332524 83.18 Up 1.95E-04 A1422986 ESTs 0.756526 7.130796 82.96 Up 2.44E-05 NM_0030 Homo sapiens secreted 12 frizzled-related protein 1 (SFRP1), mRNA.
/PROD=secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -3.17056 3.112711 77.88 Up 5.66E-05 A1801626 ESTs, Moderately similar to ALU4_HUMAN ALU

SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -2.5679 3.691959 76.63 Up 1.85E-05 AL 121722 Human DNA sequence from clone RP4-788L20 on chromosome 20 Contains the HNF3B
(hepatocyte nuclear factor 3, beta) gene. a novel gene based on ESTs, ESTs, STSs, GSSs and CpG Islands -3.12184 3.093954 74.33 Up 1.27E-04 A1700341 ESTs -3.51429 2.6835 73.4 Up 7.26E-04 AA352113 ESTs 0.502235 6.679567 72.37 Up 8.17E-06 NM_0148 Homo sapiens KIAA0878 99 protein (KIAA0878), mRNA. /PROD=KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 -3.7619 2.400862 71.64 Up 4.61 E-05 NM 0161 Homo sapiens transient 79 receptor potential channel 4 (TRPC4), mRNA.
/PROD=transient receptor potential 4 /F L=g b: N M_016179.1 gb:AF175406.1 -1.66311 4.46486 69.94 Up 3.60E-04 S69738 MCP-1=monocyte chemotactic protein (human, aortic endothelial cells, mRNA, 661 nt).
/PROD=MCP-1 -2.26295 3.775709 65.74 Up 1.21 E-03 A1735586 ESTs -3.20091 2.823883 65.11 Up 8.22E-03 NM_0026 Homo sapiens PDZ
14 domain containing 1 (PDZK1), mRNA.
/PROD=PDZ domain containing 1 /F L=g b: N M_002614.1 gb:AF012281.1 -0.81978 5.17876 63.94 Up 1.52E-04 A1824037 ESTs, Weakly similar to AFFINITY
IMMUNOGLOBULIN
EPSILON FC RECEPTOR
(M.musculus) -3.10357 2.888163 63.63 Up 1.85E-05 NM_0014 Homo sapiens forkhead 53 box C1 (FOXC1), mRNA.
/PROD=forkhead box C1 /F L=g b: N M_001453.1 -0.41404 5.48675 59.75 Up 1.39E-04 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -4.29055 1.60372 59.48 Up 5.86E-05 A1337300 Homo sapiens, clone MGC:4604, mRNA, complete cds /FL=gb:B0004219.1 -1.70149 4.121658 56.62 Up 6.46E-04 AF225426 Homo sapiens HT016 mRNA, complete cds.
/PROD=HT016 /FL=gb:AF225426.1 -2.07937 3.707398 55.21 Up 2.52E-03 NM_0016 Homo sapiens 43 apolipoprotein A-11 (APOA2), mRNA.
/PROD=apolipoprotein A-ll precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 80005282.1 0.800949 6.56634 54.39 Up 2.72E-07 NM_0307 Homo sapiens scavenger 81 receptor with C-type lectin (SRCL), mRNA.
/PROD=scavenger receptor with C-type lectin /F L=g b: N M_030781.1 -2.72686 2.973219 51.99 Up 1.82E-04 A1692180 PTPRF interacting protein, binding protein 2 (liprin beta 2) -1.55323 4.113731 50.81 Up 2.92E-05 A1821586 ESTs, Moderately similar to JE0284 Mm-1 cell derived transplantability-associated protein 1 b (H.sapiens) -3.53873 2.127137 50.77 Up 4.17E-04 A1675836 Human DNA sequence from clone RP11-446H 13 on chromosome 10.
Contains the 3 end of the gene for a novel protein similar to KIAA1059 (ortholog of mouse VPS10 domain receptor protein SORCS), an RPL23A
(60S ribosmal protein 23A) pseudogene, ESTs, STSs an -2.45311 3.17372 49.41 Up 1.17E-02 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
-2.91295 2.704851 49.1 Up 5.98E-03 AW00557 putative 47 kDa protein -1.44407 4.173723 49.1 Up 1.23E-03 U91903 Human Fritz mRNA, complete cds.
/PROD=Fritz /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 -0.77864 4.836717 49.02 Up 2.61 E-04 NM_0220 Homo sapiens reserved 55 (KCNK12), mRNA.
/PROD=tandem pore domain potassium channel THIK-2 /F L=g b: N M_022055.1 gb:AF287302.1 -3.90126 1.704039 48.68 Up 2.65E-04 A1004009 ESTs, Moderately similar to ALU7_HUMAN ALU
SUBFAMILY SQ
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.388898 6.98175 48.26 Up 1.85E-05 BE620739 ESTs -3.91992 1.582406 45.33 Up 1.28E-04 AL553774 KIAA1462 protein -2.50168 2.984782 44.83 Up 6.69E-03 X16468 Human mRNA for alpha-1 type 11 collagen.
-1.71797 3.748284 44.21 Up 2.10E-03 AL524520 G protein-coupled receptor 49 -0.5292 4.934946 44.14 Up 7.15E-04 A1127440 ESTs -0.69028 4.756395 43.61 Up 1.42E-04 M16276 Human MHC class 11 HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 gb:M16276.1 g b: M60028.1 gb:M17564.1 gb:M81141.1 gb:M81140.1 0.83572 6.263504 43.05 Up 8.83E-05 N21138 KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 -2.61405 2.778049 41.99 Up 4.08E-05 U71207 Human eyes absent homolog (Eab1) mRNA, complete cds.
/PROD=Eab1 /F L=g b: N M_005244.1 gb:U71207.1 -3.54017 1.841563 41.69 Up 9.86E-04 NM_0020 Homo sapiens gastrin-91 releasing peptide (GRP), mRNA. /PROD=gastrin-releasing peptide /F L=g b: N M_002091.1 g b: K02054.1 g b: 60004488.1 -2.39338 2.964195 41 Up 2.62E-03 M17955 Human MHC class II HLA-DQ-beta mRNA, complete cds. /FL=gb:M33907.1 gb:M1 7955.1 g b: M 16996.1 gb:M1 7563.1 gb:M20432.1 g b: M26042.1 -1.77041 3.564655 40.37 Up 1.48E-03 NM_0039 Homo sapiens sema 66 domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
(SEMA5A), mRNA.
/PROD=sema domain, seven thrombospondin repeats (typel and type 1-like), transmem -0.27888 5.053648 40.29 Up 4.00E-05 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -2.4051 2.925248 40.23 Up 2.25E-05 NM_0210 Homo sapiens 20 F37Esophageal cancer-related gene-coding leucine-zipper motif (FEZ1), mRNA.
/PROD=F37Esophageal cancer-related gene-codingleucine-zipper motif /FL=gb:AF123659.1 g b: N M_021020.1 -2.16079 3.152396 39.76 Up 4.00E-05 NM_0005 Homo sapiens von 52 Willebrand factor (VWF), mRNA. /PROD=von Willebrand factor precursor /F L=g b: N M_000552.2 -2.6422 2.666218 39.63 Up 1.85E-05 BF589787 ESTs -1.09421 4.204596 39.36 Up 7.37E-05 AK023621 Homo sapiens cDNA
FLJ13559 fis, clone PLACE1007852, highly similar to Homo sapiens mRNA for KIAA0878 protein.
-3.7558 1.527474 38.94 Up 3.02E-03 AW47365 ESTs -3.21708 2.015336 37.59 Up 1.57E-04 NM_0044 Homo sapiens EphA4 38 (EPHA4), mRNA.

/PROD=EphA4 /F L=g b: L36645.1 g b: N M_004438.1 -0.18256 5.019816 36.82 Up 1.85E-05 A1583173 major histocompatibility complex, class II, DQ beta -0.1886,3- 5.007893 36 6 7 U, P 3.26E-04 AC,' 9072 GATA-bbiding pro efr 4 AAA:`_ 0 \ 205 , -2.69284 2.499705 36.57 Up 6.77E-03 R33964 Homo sapiens cDNA
FLJ11022 fis, clone 0.804491 5.966318 35.8 Up 4.00E-05 AA583044 bone morphogenetic protein 2 /F L=g b: N M_001200.1 0.828899 5.985645 35.67 Up 4.40E-05 NM_0012 Homo sapiens bone 00 morphogenetic protein 2 (BMP2), mRNA.
/PROD=bone morphogenetic protein 2 precursor /F L=g b: N M_001200.1 0.663834 5.813725 35.5 Up 7.23E-05 A1817041 G protein-coupled receptor -2.83906 2.291355 35.03 Up 8.28E-05 T15545 ESTs -3.25309 1.849989 34.37 Up 1.65E-03 AL050154 Homo sapiens mRNA;
cDNA DKFZp586LO120 (from clone DKFZp586LO120).
0.713597 5.813528 34.3 Up 2.17E-04 BF508344 ESTs -1.61054 3.372801 31.63 Up 6.80E-04 AW26420 ESTs -3.31261 1.666545 31.54 Up 5.69E-04 BG39785 major histocompatibility 6 complex, class 11, DQ
alpha 1 -1.35345 3.621423 31.45 Up 7.05E-04 AW15757 ESTs, Weakly similar to 1 T00331 hypothetical protein KIAA0555 (H.sapiens) -0.81856 4.154852 31.42 Up 2.94E-05 A1129628 ESTs -0.45718 4.48679 30.78 Up 6.26E-05 BF939489 glycoprotein M6A
/F L=g b: D49958.1 0.424882 5.366945 30.74 Up 1.58E-04 A1692659 heat shock 90kD protein 1, alpha -0.95386 3.986146 30.7 Up 7.87E-05 AF312769 Homo sapiens cryptic mRNA, complete cds.
/PROD=cryptic /FL=gb:AF312769.1 -1.39784 3.506506 29.95 Up 9.97E-04 BE222344 splicing factor, arginineserine-rich 5 -0.47614 4.408298 29.54 Up 3.38E-05 BF508639 Homo sapiens mRNA;
cDNA DKFZp434EO82 (from clone DKFZp434EO82) -3.12747 1.716365 28.72 Up 9.08E-04 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -2.81405 2.019329 28.51 Up 9.96E-04 A1694325 ESTs 1.829497 6.661623 28.48 Up 3.89E-05 AA534817 ESTs, Weakly similar to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -1.42034 3.409373 28.44 Up 4.12E-04 BE737251 Homo sapiens cDNA:
FLJ22482 fis, clone HRC1 0859, highly similar to IR0180147 Homo sapiens mRNA full length insert cDNA clone 1.563993 6.383462 28.24 Up 1.85E-05 NM_0024 Homo sapiens microsomal 13 glutathione S-transferase 2 (MGST2), mRNA.
/PROD=microsomal glutathione S-transferase 2 /FL=gb:NM_002413.1 g b: U 77604.1 1.314051 6.126464 28.1 Up 1.89E-05 80000740 Homo sapiens, cholecystokinin B
receptor, clone MGC:2199, mRNA, complete cds.
/PROD=cholecystokinin B
receptor /FL=gb:L07746.1 gb:L08112.1 gb:S70057.1 g b: 80000740.1 gb:L04473.1 g b: N M_000731.1 0.420056 5.197721 27.43 Up 1.85E-05 NM_0122 Homo sapiens dickkopf 42 (Xenopus laevis) homolog 1 (DKK1), mRNA.
/PROD=dickkopf (Xenopus laevis) homolog 1 /FL=gb:AF177394.1 g b: N M_012242.1 gb:AF127563.1 -1.54464 3.22856 27.34 Up 5.11 E-05 A1743534 Homo sapiens mRNA;
cDNA DKFZp564B1 162 (from clone D KFZp564 B 1162);
complete cds /FL=gb:AL136646.1 -4.15276 0.598294 26.93 Up 1.83E-04 AA1 29444 Homo sapiens mRNA for KIAA1263 protein, partial cds -1.83503 2.912585 26.86 Up 8.60E-04 AA552969 ESTs 0.442286 5.16846 26.47 Up 1.85E-05 NM_0017 Homo sapiens CD48 78 antigen (B-cell membrane protein) (CD48), mRNA.
/PROD=CD48 antigen (B-cell membrane protein) /F L=g b: N M_001778.1 gb:M37766.1 g b: M59904.1 -2.05438 2.666454 26.37 Up 5.65E-03 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -3.25961 1.457558 26.3 Up 1.49E-02 NM 0163 Homo sapiens pancreas-41 enriched phospholipase C
(LOC51196), mRNA.
/PROD=pancreas-enriched phospholipase C
/F L=g b:AF 117948.1 gb:NM_016341.1 g b:AF 190642.2 -0.68225 4.022195 26.07 Up 4.08E-05 N48299 ESTs, Moderately similar to NFY-C (H.sapiens) -0.37709 4.293707 25.47 Up 5.32E-05 AU 152102 Homo sapiens cDNA
FLJ 12993 fis, clone -0.13959 4.521681 25.3 Up 5.89E-05 BG10985 Homo sapiens clone TUA8 Cri-du-chat region mRNA
-1.80965 2.799751 24.41 Up 4.74E-03 NM_1525 Homo sapiens 06 hypothetical protein FLJ32835 (FLJ32835), mRNA.
/F L=g b: N M_152506.1 1.275191 5.879425 24.32 Up 3.33E-05 A1587307 hypothetical protein /F L=g b: N M_024641.1 -3.79684 0.804733 24.28 Up 2.78E-04 AK026720 Homo sapiens cDNA:
FLJ23067 fis, clone LNG04993.
-0.13427 4.467037 24.27 Up 2.87E-05 D49958 Homo sapiens mRNA for membrane glycoprotein M6, complete cds.
/PROD=membrane glycoprotein M6 /F L=g b: D49958.1 1.997597 6.595913 24.22 Up 2.84E-05 80005997 Homo sapiens, clone MGC:14801, mRNA, complete cds.
/PROD=Unknown (protein for MGC:14801) /FL=gb:B0005997.1 -2.9769 1.607498 23.99 Up 1.19E-02 AW61211 ESTs -3.10679 1.463399 23.76 Up 3.41 E-04 N59476 ESTs -2.06656 2.502146 23.73 Up 2.55E-03 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 0.007601 4.558709 23.44 Up 1.02E-04 N63706 ESTs -0.15629 4.385668 23.3 Up 2.61 E-04 A1799018 ESTs -3.10838 1.4221 23.11 Up 3.43E-04 N50412 ESTs -2.50006 1.997519 22.59 Up 1.83E-03 U66061 Human germline T-cell receptor beta chain TCRBV17S1AlT, TCRBV2S1, TCRBV10S1 P, TCRBV29S1 P, TCRBV19S1 P, TCRBV15S1, TCRBV11 S1 Al T, HVB
relic, TCRBV28S1 P, TCRBV34S1, TCRBV14S1, TCRBV3S1, TCRBV4S1A1T, TRY4, TRY5, TRY6, TRY7, TRY8, TCRBD1, TCRBJISI, TCRB...
-0.98665 3.469502 21.95 Up 1.93E-03 NM_0014 Homo sapiens frizzled-63 related protein (FRZB), mRNA. /PROD=frizzled-related protein /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 -0.62897 3.790333 21.4 Up 7.95E-03 A1694545 ESTs 0.500662 4.91845 21.37 Up 1.92E-04 AB043703 Homo sapiens FZD8 mRNA for seven-transmembrane receptor Frizzled-8, complete cds.
/PROD=seven-transmembrane receptor Frizzled-8 /FL=gb:AB043703.1 -0.10733 4.302037 21.25 Up 2.88E-04 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -0.70855 3.6919 21.12 Up 4.93E-04 A1917371 ESTs -3.53207 0.857843 20.97 Up 1.12E-03 NM_0027 Homo sapiens protease, 69 serine, 1 (trypsin 1) (PRSS1), mRNA.
/PROD=protease, serine, 1 (trypsin 1) /F L=g b: M22612.1 g b: N M_002769.1 1.168713 5.556831 20.94 Up 2.43E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 60003079.1 -1.68521 2.69622 20.84 Up 2.06E-03 NM_0027 Homo sapiens protease, 70 serine, 2 (trypsin 2) (PRSS2), mRNA.
/PROD=protease, serine, 2 (trypsin 2) /FL=gb:M27602.1 gb:NM_002770.1 -2.14813 2.233148 20.84 Up 2.55E-04 NM_0060 Homo sapiens p53-34 induced protein (PIG11), mRNA. /PROD=p53-induced protein /FL=gb:AF010315.1 g b: 60000443.1 gb:BO003010.1 g b: N M_006034.1 -0.5982 3.780076 20.8 Up 1.63E-02 A1806510 putative 47 kDa protein 0.449168 4.82657 20.78 Up 2.33E-05 A1688418 plexin A2 1.223968 5.565279 20.27 Up 1.85E-05 AL574912 ESTs, Weakly similar to serine protease (H.sapiens) 2,'3,68939 17 1,7 20M)I Up 3.09E-05 A,1224869 o. o1~p t,'2~ CXCR4 gene enc zd in :r ce,; for \.XC R4 -1.83333 2.487663 19.99 Up 2.10E-03 NM_0065 Homo sapiens myelin-01 associated oligodendrocyte basic protein (MOBP), mRNA.
/PROD= myel i n-associated oligodendrocyte basic protein /FL=gb:D28113.1 g b: N M_006501.1 -2.16064 2.095432 19.11 Up 1.23E-02 NM_0004 Homo sapiens nuclear 75 receptor subfamily 0, group B, member 1 (NROB1), mRNA.
/PROD=adrenal hypoplasia protein /F L=g b: N M_000475.2 1.861693 6.103583 18.92 Up 2.59E-05 A1374739 ESTs -3.47945 0.755598 18.83 Up 5.51 E-04 NM_0008 Homo sapiens glutathione 54 S-transferase theta 2 (GSTT2), mRNA.
/PROD=glutathione S-transferase theta 2 /F L=g b: L38503.1 g b: 60002415.1 g b: N M_000854.2 -1.25995 2.973193 18.81 Up 2.98E-04 AK026607 Homo sapiens cDNA:
FLJ22954 fis, clone KAT09813, highly similar to AF010315 Homo sapiens Pigl1 (PIG11) mRNA.
-0.27888 3.946435 18.7 Up 2.46E-05 NM_0030 Homo sapiens SWISNF
78 related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 (SMARCD3), mRNA. /PROD=SWISNF
related, matrix associated, actindependent regulator of chromatin, subfamily d, member 3 /FL=gb:NM_003078.1 gb 1.740607 5.961556 18.65 Up 2.25E-05 NM_0021 Homo sapiens 60 hexabrachion (tenascin C, cytotactin) (HXB), mRNA.
/PROD=hexabrachion (tenascin C, cytotactin) /FL=gb:M55618.1 g b: N M_002160.1 -2.84061 1.378474 18.62 Up 7.18E-04 All 23532 ESTs 3.042634 7.250084 18.47 Up 2.33E-05 NM_0054 Homo sapiens 42 eomesodermin (Xenopus laevis) homolog (EOMES), mRNA.
/PROD=eomesodermin (Xenopus laevis) homolog /FL=gb:AB031038.1 g b: N M_005442.1 1.192657 5.39941 18.47 Up 1.18E-04 NM_0246 Homo sapiens 41 hypothetical protein FLJ12838(FLJ12838), mRNA.
/PROD=hypothetical protein FLJ12838 /F L=g b: N M_024641.1 -2.81453 1.375898 18.26 Up 3.27E-02 BC014585 Homo sapiens, clone IMAGE:4047715, mRNA.
0.476688 4.64635 18 Up 1.14E-04 NM_0245 Homo sapiens 81 hypothetical protein FLJ 13942 (F LJ 13942), mRNA.
/PROD=hypothetical protein FLJ13942 /F L=g b: N M_024581.1 -2.14545 2.018966 17.93 Up 2.47E-03 NM_0158 Homo sapiens 31 acetylcholinesterase (YT
blood group) (ACHE), transcript variant E4-E5, mRNA.
/PROD=acetylcholinestera se PI-linked form precursor /F L=g b: N M_015831.1 -2.24406 1.891442 17.58 Up 4.96E-05 NM_0032 Homo sapiens 75 tropomodulin (TMOD), mRNA.
/PROD=tropomodulin /F L=g b: N M_003275.1 gb:M77016.1 g b: 80002660.1 -0.5777 3.557171 17.57 Up 5.59E-04 BC036592 Homo sapiens, clone IMAGE:4814184, mRNA.
-0.05814 4.076316 17.56 Up 1.83E-04 BF308645 KIAA1415 protein -1.27748 2.846094 17.43 Up 1.96E-04 D78260 Homo sapiens mRNA for GATA-4 transcription factor, complete cds.
/PROD=GATA-4 transcription factor /F L=g b: N M_002052.1 gb:L34357.1 gb:D78260.1 -2.64131 1.466395 17.24 Up 2.99E-02 AU157303 ESTs -1.82351 2.283948 17.24 Up 3.95E-04 AA603467 ribosomal protein S11 1.59762 5.701737 17.2 Up 5.72E-04 NM_0186 Homo sapiens core 49 histone macroH2A2.2 (MACROH2A2), mRNA.

/PROD=core histone macroH2A2.2 /FL=gb:AF151534.1 g b: N M_018649.1 -0.20099 3.88744 17.01 Up 1.99E-04 BF984830 retinoic acid induced 1 -0.41626 3.652079 16.78 Up 2.69E-04 BF110534 ESTs 2.377335 6.437231 16.68 Up 1.89E-05 NM_0053 Homo sapiens hyaluronan 28 synthase 2 (HAS2), mRNA.
/PROD=hyaluronan synthase 2 /F L=g b: U 54804.1 g b: N M_005328.1 -0.29145 3.768186 16.68 Up 2.40E-04 A1197932 ESTs -3.88742 0.162889 16.57 Up 2.95E-03 W80985 ESTs -0.75724 3.289214 16.52 Up 2.66E-03 AL445192 Human DNA sequence from clone RP11-269H4 on chromosome 20 Contains the 3 end of the KIAA1415 gene similar to T-Lymphona invasion and metastasis inducing protein 1, ESTs, STSs and GSSs -2.30432 1.732166 16.41 Up 2.23E-02 BC017958 Homo sapiens, clone IMAGE:4607409, mRNA.
-3.30412 0.716129 16.23 Up 3.22E-02 AU 157224 Homo sapiens cDNA
FLJ1 1570 fis, clone -3.4744 0.544234 16.21 Up 8.79E-03 L32867 Homo sapiens alpha 2,8-sialyltransfe rase mRNA, complete cds.
/PROD=alpha 2,8-sialyltransferase /F L=g b: L43494.1 gb:D26360.1 gb:L32867.1 g b: N M_003034.1 -3.09265 0.925475 16.2 Up 2.03E-03 A1093492 ESTs -1.39277 2.622602 16.17 Up 2.73E-04 A1629041 ESTs 0.366041 4.354631 15.87 Up 8.71 E-05 A1242583 Homo sapiens cDNA
FLJ1 1550 fis, clone -0.35867 3.62672 15.84 Up 3.71 E-05 NM_0019 Homo sapiens endothelin 57 receptor type A (EDNRA), mRNA.
/PROD=endothelin receptor type A
/FL=gb:NM_001957.1 g b: L06622.1 -0.66587 3.318505 15.83 Up 9.18E-05 NM_0013 Homo sapiens deiodinase, 62 iodothyronine, type III
(D103), mRNA.
/PROD=thyroxine deiodinase type III
/F L=g b: N M_001362.1 gb:S79854.1 -1.80959 2.172774 15.81 Up 1.70E-03 BF447246 KIAA0960 protein -3.95752 0.007632 15.62 Up 1.52E-02 NM_0014 Homo sapiens epiregulin 32 (EREG), mRNA.

/PROD=epiregulin precursor /FL=gb:D30783.1 g b: N M_001432.1 -0.22337 3.730539 15.5 Up 9.97E-04 NM_0218 Homo sapiens phorbolin-22 like protein MDS019 (MDS019), mRNA.
/PROD= ph o rbol i n-like protein MDS019 /F L=g b:AF 182420.1 g b: N M_021822.1 -2.56291 1.390726 15.49 Up 1.14E-02 BG53269 integrin, alpha 4 (antigen 0 CD49D, alpha 4 subunit of VLA-4 receptor) -2.89467 1.029195 15.18 Up 4.69E-03 AW97120 ESTs -1.16952 2.748825 15.12 Up 2.94E-02 NM_0013 Homo sapiens disabled 43 (Drosophila) homolog 2 (mitogen-responsive phosphoprotein) (DAB2), mRNA. /PROD=disabled (Drosophila) homolog 2 /F L=g b: U 39050.1 g b: N M_001343.1 gb:U53446.1 g b: 60003064.1 0.798972 4.674672 14.68 Up 5.97E-05 A1082827 hypothetical protein -0.33264 3.541617 14.66 Up 3.49E-05 NM_0203 Homo sapiens 53 phospholipid scramblase 4 (LOC57088), mRNA.
/PROD=phospholipid scramblase 4 /F L=g b: N M_020353.1 gb:AF199023.1 -0.88175 2.988123 14.62 Up 1.30E-03 A1650874 ESTs -0.11092 3.758565 14.62 Up 4.96E-05 BF591483 ESTs 1.370117 5.237165 14.59 Up 7.39E-05 M33653 Human (clones HT-(125,133)) alpha-2 type IV
collagen (COL4A2) mRNA, complete cds.
/PROD=alpha-2 type IV
collagen /FL=gb:M33653.1 0.041468 3.902142 14.53 Up 9.62E-04 BF1 30943 ESTs -0.41994 3.432925 14.45 Up 1.98E-03 A1686957 KIAA1494 protein -3.44709 0.392958 14.32 Up 3.27E-02 H39185 ESTs 1.071985 4.903249 14.23 Up 1.89E-05 NM_0045 Homo sapiens receptor 60 tyrosine kinase-like orphan receptor 2 (ROR2), mRNA.
/PROD=receptor tyrosine kinase-like orphan receptor 2 /FL=gb:M97639.1 g b: N M_004560.1 -0.60671 3.220921 14.2 Up 2.49E-03 NM_0004 Homo sapiens 58 transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor (TCF2), transcript variant a, mRNA.
/PROD=transcription factor 2, isoform a /F L=g b: N M_000458.1 1.186033 5.004503 14.11 Up 5.86E-05 A1627704 ESTs, Weakly similar to T17346 hypothetical protein DKFZp586O1624.1 (H.sapiens) -2.69521 1.121263 14.09 Up 5.32E-05 AF282250 Homo sapiens calneuron 1 (CALN1) mRNA, complete cds.
/PROD=calneuron 1 /F L=g b:AF282250.1 -2.70961 1.095539 13.98 Up 2.03E-02 AK055534 Homo sapiens cDNA
FLJ30972 fis, clone H EART2000492.
-0.65009 3.149996 13.93 Up 2.55E-04 NM_0179 Homo sapiens 31 hypothetical protein FLJ20699 (FLJ20699), mRNA.
/PROD=hypothetical protein FLJ20699 /F L=g b: N M_017931.1 -1.6164 2.173017 13.83 Up 9.97E-03 X00452 Human mRNA for DC
classll histocompatibility antigen alpha-chain.
/PROD=DC class II
h istocom pati b i l ity antigenalpha-chain -3.47125 0.312463 13.77 Up 3.91 E-02 BF114815 ESTs -2.17973 1.59463 13.68 Up 1.03E-03 BE379542 chromodomain helicase DNA binding protein 3 /FL=gb:U91543.1 -1.95127 1.804379 13.51 Up 3.31 E-03 L12468 Homo sapiens aminopeptidase A mRNA, complete cds.
/PROD=aminopeptidase A
/F L=g b: L 12468.1 g b: N M_001977.1 gb:L14721.1 0,449933 x. =.\ 3\3.3 13,49 U 6.13E-04 1533 HEX gene re :Sep: Protein-'PROD
ate `rwted 0.502333 4.255116 13.48 Up 3.46E-04 AF211891 Homo sapiens Mix-like homeobox protein 1 (MILD1) mRNA, complete cds. /PROD=Mix-like homeobox protein 1 /FL=gb:AF211891.1 0.151239 3.88836 13.33 Up 5.61 E-05 BE644809 ESTs 0.631332 4.364524 13.3 Up 8.23E-05 A1130705 ESTs, Weakly similar to A46302 PTB-associated splicing factor, long form (H.sapiens) -1.83999 1.892454 13.29 Up 2.17E-04 AK074453 Homo sapiens cDNA
FLJ23873 fis, clone LNG12941.
-0.28951 3.441091 13.27 Up 2.34E-04 NM_0183 Homo sapiens 88 hypothetical protein FLJ11316 (FLJ11316), mRNA.
/PROD=hypothetical protein FLJ11316 /F L=g b: N M_018388.1 0.120924 3,842731 13A 9 Up 4,04E-05 M,"V" 0015 kllomo sap~ens 29 h ; i.YD: oietBcai3Y
expressed homeobox *=' expressed ho meoboa R-1 =gb .. - b:M'vI 001529,1 S,b: L'164991' b:N 0,02729A
-0.4843 3.220215 13.04 Up 2.66E-05 NM_0017 Homo sapiens CD1 D
66 antigen, d polypeptide (CD1 D), mRNA.
/PROD=CD1 D antigen, d polypeptide /F L=g b: N M_001766.1 gb:J04142.1 -3.18081 0.521542 13.02 Up 3.11 E-04 AW44981 KIAA0918 protein -1.17885 2.522906 13.01 Up 7.75E-04 AB002155 Homo sapiens mRNA for human uroplakin Ib, complete cds.
/PROD=human uroplakin Ib /FL=gb:NM_006952.1 gb:AB015234.1 gb:AF042331.1 gb:AB002155.1 2.383898 6.070755 12.88 Up 2.59E-05 BF476502 hypothetical protein 3.2061 6.89075 12.86 Up 2.73E-05 NM_0066 Homo sapiens 81 neuromedin U (NMU), mRNA.
/PROD=neuromedin U
/F L=g b: N M_006681.1 0.454394 4.138042 12.85 Up 2.43E-04 AL036088 KIAA1479 protein -2.233 1.436726 12.73 Up 1.41 E-03 NM_0148 Homo sapiens KIAA0307 62 gene product (KIAA0307), mRNA. /PROD=KIAA0307 gene product /FL=gb:AB002305.1 g b: N M_014862.1 -2.50335 1.160623 12.68 Up 4.71 E-04 AA781795 ESTs 0.414809 4.075067 12.64 Up 3.71 E-05 NM_0161 Homo sapiens transient 79 receptor potential channel 4 (TRPC4), mRNA.
/PROD=transient receptor potential 4 /F L=g b: N M_016179.1 gb:AF175406.1 -0.40798 3.250175 12.62 Up 3.66E-05 AI143879 phosphodiesterase 10A

/FL=gb:AB020593.1 gb:AF127479.1 g b: N M_006661.1 -1.20714 2.448878 12.61 Up 9.04E-04 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
0.999053 4.64687 12.53 Up 3.66E-05 AW12959 tudor repeat associator 3 with PCTAIRE 2 -1.0335 2.604062 12.45 Up 4.91 E-04 AL553774 KIAA1462 protein -1.78964 1.842967 12.4 Up 1.49E-02 NM_0048 Homo sapiens 61 cerebroside (3-phosphoadenylylsulfate:g alactosylceramide 3) sulfotransferase (CST), mRNA.
/PROD=galactosylceramid e sulfotransferase /F L=g b: N M_004861.1 gb:D88667.1 0.81871 4.448452 12.38 Up 9.04E-05 X06268 Human mRNA for pro-alpha 1 (II) collagen 3end C-term. triple helical and C-terminal non-helical domain. /PROD=pro-alpha 1 (11) collagen (313 AA; AA
975-271 c) /F L=g b: N M_001844.2 1.040647 4.667276 12.35 Up 2.25E-05 A1348094 KIAA0882 protein -2.2316 1.390239 12.31 Up 1.38E-02 AA757630 ESTs 1.076427 4.696942 12.3 Up 3.12E-05 A1640307 protocadherin 10 -1.28224 2.327697 12.21 Up 3.34E-04 NM_0055 Homo sapiens LIM
68 homeobox protein 1 (LHX1), mRNA.
/PROD=LIM homeobox protein 1 /F L=g b: N M_005568.1 gb:U14755.1 -1.99136 1.617733 12.2 Up 4.20E-03 AL 109653 Human DNA sequence from clone GS1-115M3 on chromosome Xq27.1-28 Contains a gene for a novel protein, CXorf1 (chromosome X open reading frame 1), ESTs, STSs, GSSs and a CpG
Island -3.12055 0.469175 12.04 Up 1.54E-02 AW78000 ESTs 0.1187 3.707767 12.03 Up 5.97E-05 N21184 Cluster Incl.
N21184:yx4lalO.sl Homo sapiens cDNA, 3 end /clone=IMAGE-264282 /clone end=3 /gb=N21184 /gi=1126354 /ug=Hs.93605 /len=619 -1.40826 2.177544 12.01 Up 7.18E-04 AB046770 Homo sapiens mRNA for KIAA1550 protein, partial cds. /PROD=KIAA1550 protein 1.316429 4.899037 11.98 Up 7.87E-05 A1769688 Homo sapiens clone 23664 and 23905 mRNA
sequence -1.08244 2.498502 11.97 Up 1.67E-03 X75208 X75208 /FEATURE=cds /DEFINITION=HSPTKR
H.sapiens HEK2 mRNA
for protein tyrosine kinase receptor -2.68947 0.886703 11.93 Up 4.38E-02 AW29140 ESTs 1.438639 5.011903 11.9 Up 2.06E-04 BF223214 ESTs -0.10881 3.452952 11.81 Up 2.39E-04 AA701657 hypothetical protein -2.33994 1.211956 11.73 Up 1.74E-02 AL 134708 ESTs -0.52859 3.016773 11.68 Up 4.43E-03 AW59061 ESTs -1.77455 1.768056 11.65 Up 1.17E-02 AF140507 Homo sapiens Ca2+calmodulin-dependent protein kinase kinase beta (CAMKKB) mRNA, complete cds.
/PROD =Ca2+ca l m od u l i n-dependent protein kinase kinasebeta /FL=gb:AF140507.1 -2.84187 0.695267 11.61 Up 1.89E-03 NM_0022 Homo sapiens potassium 44 inwardly-rectifying channel, subfamily J, inhibitor 1 (KCNJN1), mRNA. /PROD=potassium inwardly-rectifying channel, subfamilyJ, inhibitor 1 /F L=g b: N M_002244.1 4.042679 7.571956 11.55 Up 2.86E-05 NM_0054 Homo sapiens cerberus 1 54 (Xenopus laevis) homolog (cysteine knot superfamily) (CER1), mRNA. /PROD=cerberus 1 /FL=gb:NM_005454.1 0.581614 4.103441 11.49 Up 1.82E-04 AF005775 Homo sapiens caspase-like apoptosis regulatory protein 2 (clarp) mRNA, alternatively spliced, complete cds.
/PROD=caspase-like apoptosis regulatory protein 2 /FL=gb:AF005775.1 3.287037 6.806239 11.47 Up 3.78E-05 A1633559 ESTs 0.661121 4.174547 11.42 Up 4.53E-05 AA502609 Homo sapiens ankyrin-like with transmembrane domains 1 (ANKTM1), mRNA
1.888188 5.396458 11.38 Up 4.53E-05 AW34031 ESTs -1.24923 2.257525 11.37 Up 1.03E-03 R42166 ESTs, Weakly similar to AXO1_HUMAN AXONIN-(H.sapiens) -0.21464 3.287026 11.33 Up 1.37E-03 NM_0050 Homo sapiens reelin 45 (RELN), mRNA.
/PROD=reelin /FL=gb:U79716.1 g b: N M_005045.1 2,.3`> e ~`ti~:`,: 77 ,tA,Y:_>.,_;2.., ,+p ,~..1~5~~. - 0~ . ;e ,3 :a .
a,..;,.- . ..,_. ~..~~ ~=1.;. vd:3 .--.%2 , :~ ~`: r in e~ :~ ~3 ~:a ..\

z i4"e.. arc-' n .'ira *'dfi e,RNA. ; - R ``-- -, ft.
Sarcon"a bE.c do nwo one ; n: o~og;
precursor =' ` +b: N NA 00 0.2.2 1 4.897427 -1.39089 78.16 Down 7.30E-04 R06655 ESTs, Moderately similar to AF078844 1 hqp0376 protein (H.sapiens) 3.409815 -2.69915 69.02 Down 1.89E-05 NM_0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 2.62025 -2.80479 42.96 Down 6.27E-03 AA625683 ESTs 0.757197 -4.55188 39.65 Down 2.02E-04 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 3.113698 -2.03811 35.55 Down 2.91 E-04 NM_0021 Homo sapiens insulinoma-96 associated 1 (INSM1), mRNA.
/PROD=insulinoma-associated 1 /F L=g b: N M_002196.1 gb:M93119.1 2.36447 -2.49724 29.08 Down 2.24E-03 NM 0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 3.77776 -1.04395 28.28 Down 5.05E-05 BU729850 hypothetical protein 3.862686 -0.6228 22.4 Down 5.05E-05 NM_0071 Homo sapiens tumor 15 necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA.
/PROD=tumor necrosis factor, alpha-induced protein 6 /F L=g b: N M_007115.1 0.579765 -3.59498 18.06 Down 5.51 E-04 A1393930 ESTs 0.300578 -3.86457 17.94 Down 5.00E-04 All 10886 prothymosin, alpha (gene sequence 28) 2.28595 -1.84349 17.5 Down 2.27E-02 BE504838 ESTs 4.507212 0.466223 16.46 Down 1.27E-04 AW19694 ESTs 3.025351 -0.89578 15.15 Down 8.71 E-05 AW59092 ESTs 6.568635 2.65029 15.12 Down 6.26E-05 AL031602 Human DNA sequence from clone RP5-1174N9 on chromosome 1p34.1-35.3. Contains the gene for a novel protein with IBR domain, a (pseudo?) gene for a novel protein similar to MT1 E
(metallothionein 1 E
(functional)), ESTs, STSs, GSSs and two putative Cp...
2.000419 -1.85226 14.45 Down 1.06E-02 NM 0312 Homo sapiens testis 72 expressed sequence 14 (TEX14), mRNA.
/PROD=testis expressed sequence 14 /F L=g b: N M_031272.1 1.361153 -2.47081 14.24 Down 6.49E-03 NM_0143 Homo sapiens POU
52 transcription factor (OCT1 1), mRNA.
/PROD=POU transcription factor /F L=g b: N M_014352.1 gb:AF133895.1 gb:AF162278.1 2.350127 -1.47399 14.16 Down 7.74E-03 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
7.360687 3.631772 13.26 Down 4.64E-05 BF217861 metallothionein 1E
(functional) 0.372329 -3.25088 12.32 Down 3.04E-02 AV648405 polymerase (RNA) III
(DNA directed) (32kD) 0.82229 -2.77919 12.14 Down 1.29E-02 AB017269 Homo sapiens TMEFF2 mRNA, complete cds.
/FL=gb:ABO17269.1 gb:NM_016192.2 gb:AF179274.2 g b:AF242222.1 3.806044 0.220062 12.01 Down 7.25E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 2.967768 -0.60775 11.92 Down 1.42E-02 AL 121753 Human DNA sequence from clone RP4-61404 on chromosome 20811.1-12 Contains the 3 part of the MMP24 (matrix metalloproteinase 24 (membrane-inserted)) gene, the ITGB4BP
(integrin beta 4 binding protein) gene, the 3 end of a novel gene, the 3 end 0...
2.129273 -1.43763 11.85 Down 1.15E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 2.951696 -0.61466 11.85 Down 8.28E-05 AB019562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
0.860464 -2.69824 11.78 Down 2.25E-02 NM_0030 Homo sapiens 07 semenogelin I (SEMG1), mRNA.
/PROD=semenogelin I
/F L=g b:J04440.1 g b: N M_003007.1 3.557525 0.063117 11.27 Down 1.07E-03 BF514079 Kruppel-like factor 4 (gut) 3.094055 -0.35326 10.91 Down 4.64E-05 AW18819 tumor necrosis factor, 8 alpha-induced protein 6 /F L=g b: N M_007115.1 4.847114 1.490225 10.25 Down 6.76E-05 NM_0064 Homo sapiens lung type-I
74 cell membrane-associated glycoprotein (T1A-2), transcript variant 2, mRNA. /PROD=lung type-I cell membrane-associatedg lycoprotei n, isoform 2 precursor /F L=g b: N M_006474.1 gb:AF030428.1 6.426778 3.157882 9.64 Down 1.85E-05 AF313413 Homo sapiens putative small membrane protein NID67 mRNA, complete cds. /PROD=putative small membrane protein /FL=gb:AF313413.1 4.927935 1.661339 9.62 Down 8.71 E-05 J05008 Homo sapiens endothelin-1 (EDN1) gene, complete cds /FL=gb:NM_001955.1 3.268087 0.027916 9.45 Down 1.05E-03 AF345910 Homo sapiens NYD-SP14 mRNA, complete cds.
/PROD=NYD-SP14 /FL=gb:AF345910.1 3.655193 0.425727 9.38 Down 2.88E-04 A1659927 Homo sapiens cDNA:
FLJ22547 fis, clone 7.149479 3.957802 9.14 Down 3.56E-05 M10943 Human metallothionein-If gene (hMT-If) 1.143234 -2.04451 9.11 Down 1.25E-02 BF437711 ESTs 1.588735 -1.59544 9.09 Down 4.64E-02 AF279774 Homo sapiens clone N4 NTera2D1 teratocarcinoma mRNA.
7.144308 3.960669 9.09 Down 2.18E-05 BF246115 RNA helicase-related protein 3.437271 0.276071 8.95 Down 4.74E-05 AB029025 Homo sapiens mRNA for KIAA1102 protein, partial cds. /PROD=KIAA1102 protein 7.224807 4.073278 8.89 Down 2.46E-05 NM_0059 Homo sapiens 51 metallothionein 1H
(MT1 H), mRNA.
/PROD=metallothionein 1 H /F L=g b: N M_005951.1 2.367534 -0.77672 8.84 Down 3.10E-03 AF098641 Homo sapiens CD44 isoform RC (CD44) mRNA, complete cds.
/PROD=CD44 isoform RC
/F L=g b:AF098641.1 4.253624 1.120681 8.77 Down 4.72E-05 NM 0033 Homo sapiens visinin-like 85 1 (VSNL1), mRNA.
/PROD=visinin-like 1 /FL=gb:AF039555.1 gb:U14747.1 gb:AB001104.1 g b: N M_003385.1 5.398488 2.316218 8.47 Down 6.93E-05 NM _0011 Homo sapiens alpha-34 fetoprotein (AFP), mRNA.
/PROD=alpha-fetoprotein /F L=g b: N M_001134.1 gb:J00077.1 3.947271 0.8794 8.39 Down 2.51 E-04 A1928035 ESTs 7.768254 4.72435 8.25 Down 2.44E-05 NM 0059 Homo sapiens 53 metallothionein 2A
(MT2A), mRNA.
/PROD=metallothionein 2A /FL=gb:NM_005953.1 6.813053 3.774649 8.22 Down 2.87E-05 NM 0059 Homo sapiens 50 metallothionein 1G
(MT1G), mRNA.
/PROD=metallothionein 1G /FL=gb:NM_005950.1 7.426418 4.406989 8.11 Down 1.89E-05 NM 0059 Homo sapiens 52 metallothionein 1X
(MT1X), mRNA.
/PROD=metallothionein ix /FL=gb:NM_005952.1 2.332751 -0.66491 7.99 Down 5.08E-03 NM_0000 Homo sapiens cyclin-77 dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), mRNA. /PROD=cyclin-dependent kinase inhibitor 2A (melanoma,p16, inhibits CDK4) /F L=g b: N M_000077.1 gb:L27211.1 4.738703 1.752163 7.93 Down 4.08E-05 NM 0140 Homo sapiens 33 DKFZP586AO522 protein (DKFZP586A0522), mRNA.
/PROD=DKFZP586A0522 protein /F L=g b: N M_014033.1 5.601289 2.627505 7.86 Down 1.20E-04 AF039555 Homo sapiens visinin-like protein 1 (VSNL1) mRNA, complete cds.
/PROD=visinin-like protein 1 /FL=gb:AF039555.1 gb:U14747.1 gb:AB001104.1 g b: N M_003385.1 7.564809 4.595208 7.83 Down 2.94E-05 M83248 Human nephropontin mRNA, complete cds.
/PROD=nephropontin /F L=g b: M83248.1 3.602406 0.633934 7.83 Down 5.32E-05 A1493245 CD44 antigen (homing function and Indian blood group system) 3.08363 0.127792 7.76 Down 9.96E-04 U73778 Human collagen type XII
alpha-1 precursor (COL12A1) mRNA.
/PROD=collagen type XII
alpha-1 /F L=g b: N M_004370.3 3.030236 0.074899 7.76 Down 9.24E-03 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 7.493544 4.550383 7.69 Down 2.85E-05 NM 0024 Homo sapiens 50 metallothionein 1L
(MT1 L), mRNA.
/PROD=metallothionein 1 L /FL=gb:NM_002450.1 3.19487 0.252626 7.69 Down 1.19E-04 NM 1735 Homo sapiens 53 hypothetical protein FLJ25801 (FLJ25801), mRNA.
/FL=gb:NM_173553.1 3.127666 0.186544 7.68 Down 5.32E-05 NM 0035 Homo sapiens 77 undifferentiated embryonic cell transcription factor 1 (UTF1), mRNA.
/PROD=undifferentiated embryonic cell transcriptionfactor 1 /FL=gb:NM_003577.1 gb:ABO1 1076.1 2.514693 -0.40391 7.56 Down 4.74E-05 NM 1450 Homo sapiens 32 hypothetical protein MGC21636 (MGC21636), mRNA.
/FL=gb:BC020572.1 gb:NM_145032.2 5.207569 2.290724 7.55 Down 5.33E-05 AA083478 Homo sapiens mRNA full length insert cDNA clone 0.041471 -2.87232 7.54 Down 4.34E-02 AW16221 Homo sapiens cDNA
0 FLJ11490 fis, clone 5.13621 2.236529 7.46 Down 5.86E-05 BC013944 Homo sapiens, Similar to myosin, heavy polypeptide 7, cardiac muscle, beta, clone IMAGE:4064393, mRNA.

4.255531 1.357834 7.45 Down 6.54E-05 AF096296 Homo sapiens thymic stroma chemokine-1 precursor, mRNA, complete cds.
/PROD=thymic stroma chemokine-1 precursor /F L=g b:AF 142434.1 gb:AF096296.1 g b:AF 124601.1 gb:AB010447.1 g b: N M_006072.1 4.055862 1.169817 7.39 Down 1.10E-04 AK026815 Homo sapiens cDNA:
FLJ23162 fis, clone LNG09734.
4.715355 1.834956 7.36 Down 6.18E-04 AA788946 ESTs, Moderately similar to CA1C RAT COLLAGEN
ALPHA 1(XI1) CHAIN
(R. norvegicus) 2.597946 -0.27094 7.31 Down 6.26E-05 AW13814 ESTs 4.796495 1.938561 7.25 Down 1.82E-04 A1653107 ESTs 3.508683 0.663662 7.19 Down 1.82E-04 AK027231 Homo sapiens cDNA:
FLJ23578 fis, clone LNG 12709.
5.441963 2.62358 7.05 Down 3.09E-05 NM 0166 Homo sapiens 51 heptacellular carcinoma novel gene-3 protein (LOC51339), mRNA.
/PROD=heptacellular carcinoma novel gene-3 protein /F L=g b: N M_016651.2 gb:AF251079.2 1.389794 -1.42311 7.03 Down 4.34E-03 BG49869 ESTs 2.194683 -0.60003 6.94 Down 3.56E-02 U63296 Human 15-hyd roxyprostag land in dehydrogenase mRNA, complete cds. /PROD=15-hyd roxyprostag land in dehydrogenase /F L=g b: U 63296.1 5.450694 2.658196 6.93 Down 1.85E-05 AF095771 Homo sapiens PTH-responsive osteosarcoma B1 protein (B1) mRNA, complete cds.
/PROD=PTH-responsive osteosarcoma B1 protein /FL=gb:AF095771.1 0.907338 -1.88392 6.92 Down 3.84E-02 NM 0252 Homo sapiens solute 43 carrier (SLC19A3), mRNA.
/PROD=solute carrier /F L=g b: N M_025243.1 gb:AF271633.1 6.93459 4.14838 6.9 Down 9.04E-05 AF078844 Homo sapiens hqp0376 protein mRNA, complete cds. /PROD=hgp0376 protein /F L=g b:AF078844.1 2.724257 -0.05687 6.87 Down 7.43E-04 AL552534 Human mRNA for CD44 antigen, 5UTR (sequence from the 5cap to the start codon).
3.86075 1.090793 6.82 Down 1.89E-05 U85995 Cluster Incl.
U85995:Human clone IMAGE-22181 unknown protein mRNA, partial cds /cds=(0,1291) /gb=U85995 /gi=1835749 /ug=Hs.79340 /len= 1696 2.982965 0.222537 6.78 Down 1.19E-03 AK026829 Homo sapiens cDNA:
FLJ23176 fis, clone LNG10452.
0.873551 -1.88238 6.75 Down 5.65E-03 AW29337 ESTs 5.023981 2.272773 6.73 Down 8.41 E-05 NM 0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 3.932141 1.1878 6.7 Down 3.66E-05 NM_0044 Homo sapiens growth 90 factor receptor-bound protein 14 (GRB14), mRNA. /PROD=growth factor receptor-bound protein 14 /FL=gb:L76687.1 g b: N M_004490.1 5.356771 2.61556 6.69 Down 4.40E-05 W92036 ESTs 2.770179 0.05935 6.55 Down 1.17E-04 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
3.462851 0.769123 6.47 Down 2.19E-04 BE673800 ESTs, Moderately similar to KIAA1238 protein (H.sapiens) 7.424722 4.734219 6.46 Down 7.86E-05 AF333388 Homo sapiens metallothionein 1 H-like protein mRNA, complete cds.
/PROD=metallothionein 1 H-like protein /FL=gb:AF333388.1 3.610367 0.921088 6.45 Down 4.21 E-05 80004372 Homo sapiens, Similar to CD44 antigen (homing function and Indian blood group system), clone MGC:10468, mRNA, complete cds.
/PROD=Similar to CD44 antigen (homing function andlndian blood group system) /FL=gb:B0004372.1 2.798327 0.114281 6.43 Down 4.31 E-04 BF062943 protocadherin 18 2.387268 -0.26492 6.29 Down 2.59E-04 BF063186 ESTs 4.622217 1.982686 6.23 Down 4.40E-05 AL537457 neurofilament, light polypeptide (68kD) /F L=g b: N M_006158.1 5.295204 2.664042 6.2 Down 5.37E-04 D32039 Human pgH3 mRNA for proteoglycan PG-M(V3), complete cds.
/PROD=proteoglycan PG-M(V3) /FL=gb:D32039.1 -0.55251 -3.18076 6.18 Down 2.91 E-02 A1277662 ESTs, Weakly similar to TRP7_HUMAN
TRANSIENT RECEPTOR

(H.sapiens) 2.060071 -0.56473 6.17 Down 8.28E-05 AA004300 hypothetical protein D KFZp5661133 1.892794 -0.71503 6.1 Down 5.25E-04 AL138349 KIAA0367 protein 3.822765 1.223367 6.06 Down 2.86E-04 AL567376 G protein-coupled receptor 39 0.803559 -1.78647 6.02 Down 8.07E-04 BF673779 ESTs 4.038177 1.461889 5.96 Down 1.52E-04 BF449053 ESTs 3.280973 0.707817 5.95 Down 1.37E-03 AL139377 Human DNA sequence from clone RP11-251J8 on chromosome 13 Contains ESTs, STSs, GSSs and a CpG island.
Contains two novel genes with two isoforms each and the KIAA0610 gene with two isoforms 3.059444 0.490104 5.94 Down 3.30E-02 NM_0073 Homo sapiens pleckstrin 50 homology-like domain, family A, member 1 (PHLDA1), mRNA.
/PROD=pleckstrin homology-like domain, family A, member 1 /F L=g b: N M_007350.1 3.876749 1.313133 5.91 Down 1.25E-03 AL574184 hydroxyprostaglandin dehydrogenase 15-(NAD) /F L=g b: N M_000860.1 gb:L76465.1 5.318139 2.762676 5.88 Down 2.55E-04 U87408 Cluster Incl.
U87408:Human clone IMAGE-74593 unknown protein mRNA, partial cds /cds=(0,1362) /gb=U87408 /gi=1842104 /ug=Hs.79340 /len= 1982 1.99849 -0.55448 5.87 Down 1.01 E-03 NM_0023 Homo sapiens lysyl 17 oxidase (LOX), mRNA.
/PROD=lysyl oxidase /F L=g b:AF039291.1 g b: N M_002317.1 g b: M94054.1 1.312148 -1.23479 5.84 Down 1.36E-04 U32500 Human type 2 neuropeptide Y receptor mRNA, complete cds.
/PROD=type 2 neuropeptide Y receptor /FL=gb:U42766.1 gb:U36269.1 gb:U32500.1 2.64743 0.101711 5.84 Down 6.52E-04 A1702438 ESTs 2.918001 0.408444 5.69 Down 5.51 E-04 BF674052 cathepsin D (lysosomal aspartyl protease) 4.64236 2.137119 5.68 Down 3.09E-05 AB019695 Homo sapiens mRNA for thioredoxin reductase 11 beta, complete cds.
/PROD=thioredoxin reductase 11 beta /FL=gb:ABO19695.1 4.505436 2.001428 5.67 Down 9.04E-05 W57613 ESTs 2.98904 0.488717 5.66 Down 2.78E-04 AW13814 ESTs 0.424388 -2.06318 5.61 Down 2.92E-02 NM_0024 Homo sapiens myelin 33 oligodendrocyte glycoprotein (MOG), mRNA. /PROD=myelin of igode nd rocyte g lycoprote i n /FL=gb:U 18798.1 g b: U64564.1 g b: N M_002433.1 3.560033 1.077194 5.59 Down 1.52E-04 U38945 Human hypothetical 18.1 kDa protein (CDKN2A) mRNA, complete cds.
/FL=gb:U38945.1 gb:U26727.1 1.840613 -0.62498 5.52 Down 9.50E-05 A1949760 ESTs, Weakly similar to unnamed protein product (H.sapiens) 4.178686 1.713153 5.52 Down 1.61 E-04 NM_0032 Homo sapiens tissue 56 inhibitor of metalloproteinase 4 (TIMP4), mRNA.
/PROD=tissue inhibitor of metalloproteinase 4precursor /F L=g b: N M_003256.1 gb:U76456.1 2.324824 -0.13601 5.51 Down 2.39E-04 AL096771 Human DNA sequence from clone RP1-238D15 on chromosome 6g12-14.3 Contains part of COL12A1 (collagen, type X11, alpha 1) gene and STSs 5.041032 2.59268 5.46 Down 2.25E-05 AK022686 Homo sapiens cDNA
FLJ 12624 fis, clone NT2RM4001754.
1.294482 -1.14923 5.44 Down 2.97E-02 AA723810 cDNA for differentially expressed C016 gene /FL=gb:B0001291.1 3.732985 1.29318 5.43 Down 4.32E-03 A1459194 early growth response 1 1.117304 -1.32124 5.42 Down 1.63E-02 AL046992 G protein-coupled receptor 1 /F L=g b: N M_005279.1 6.120177 3.682667 5.42 Down 1.93E-04 NM_0017 Homo sapiens caveolin 1, 53 caveolae protein, 22kD

(CAV1), mRNA.
/PROD=caveolin 1 /F L=g b: N M_001753.2 3.365852 0.931215 5.41 Down 8.41 E-05 NM_0033 Homo sapiens wingless-92 type MMTV integration site family, member 5A
(WNT5A), mRNA.
/PROD=wingless-type MMTV integration site family, member 5A
/F L=g b: N M_003392.1 g b: L20861.1 5.752704 3.318587 5.4 Down 5.75E-04 R94644 Homo sapiens versican Vint isoform, mRNA, partial cds 2.256481 -0.17157 5.38 Down 1.10E-04 NM_0184 Homo sapiens NAG22 95 protein (LOC55873), mRNA. /PROD=NAG22 protein /FL=gb:AF247820.3 g b: N M_018495.3 5.522456 3.095555 5.38 Down 9.25E-05 BG05484 ras homolog gene family, 4 member E
/F L=g b: N M_005168.1 3.660753 1.237109 5.37 Down 1.10E-04 BE903880 zinc finger protein 6 (CMPX1) 2.418198 0.007534 5.32 Down 9.96E-04 A1860150 ESTs, Weakly similar to A49134 Ig kappa chain V-1 region (H.sapiens) 1.659275 -0.74924 5.31 Down 2.40E-03 L16895 Human lysyl oxidase (LOX) gene, exon 7 5.715937 3.314142 5.28 Down 1.74E-04 U85658 Human transcription factor ERF-1 mRNA, complete cds. /PROD=ERF-1 /F L=g b: N M_003222.1 gb:U85658.1 2.572851 0.172113 5.28 Down 2.43E-04 AW59256 KIAA0455 gene product 5.807319 3.410152 5.27 Down 6.54E-05 NM_0180 Homo sapiens 04 hypothetical protein FLJ10134 (FLJ10134), mRNA.
/PROD=hypothetical protein FLJ10134 /F L=g b: N M_018004.1 4.138808 1.745346 5.25 Down 1.40E-03 AW59019 lung type-I cell membrane-6 associated glycoprotein 6.003141 3.615412 5.23 Down 7.14E-04 M25915 Human complement cytolysis inhibitor (CLI) mRNA, complete cds.
/F L=g b:J02908.1 gb:NM_001831.1 gb:M64722.1 gb:M25915.1 1.05854 -1.32898 5.23 Down 1.59E-03 A1703321 wingless-type MMTV
integration site family, member 5A
4.285883 1.901821 5.22 Down 6.26E-05 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 6.959783 4.576665 5.22 Down 1.85E-05 NM 0143 Homo sapiens 67 hypothetical protein, estradiol-induced (E21G5), mRNA.
/PROD=hypothetical protein, estradiol-induced /FL=gb:NM_014367.1 gb:AF191020.1 1.10782 -1.27174 5.2 Down 1.99E-04 BC029425 Homo sapiens, Similar to KIAA1275 protein, clone IMAGE:4616553, mRNA.
5.252439 2.877592 5.19 Down 5.32E-05 NM_0015 Homo sapiens insulin-like 53 growth factor binding protein 7 (IGFBP7), mRNA. /PROD=insulin-like growth factor binding protein 7 /F L=g b: N M_001553.1 gb:L19182.1 6.881969 4.510778 5.17 Down 1.85E-05 AF201944 Homo sapiens HGTD-P
(HGTD-P) mRNA, complete cds.
/PROD=HGTD-P
/FL=gb:AF201944.1 gb:AF250321.1 3.543738 1.178007 5.15 Down 2.51 E-05 NM_0019 Homo sapiens endothelin 55 1 (EDN1), mRNA.
/PROD=endothelin 1 /F L=g b: N M_001955.1 4.229884 1.871489 5.13 Down 1.55E-04 BC032716 Homo sapiens, clone MGC:45425 IMAGE:5518697, mRNA, complete cds.
/PROD=Unknown (protein for MGC:45425) /FL=gb:BC032716.1 3.035594 0.680769 5.12 Down 1.37E-03 A1963605 ESTs 6.307554 3.95342 5.11 Down 7.03E-05 NM 0066 Homo sapiens serum-22 inducible kinase (SNK), mRNA. /PROD=serum-inducible kinase /FL=gb:AF059617.1 g b: N M_006622.1 gb:AF223574.1 2.271332 -0.08272 5.11 Down 1.59E-03 NM _0151 Homo sapiens KIAA0633 98 protein (COBL), mRNA.
/PROD=KIAA0633 protein /F L=g b: N M_015198.1 3.584234 1.244979 5.06 Down 7.30E-04 AF232772 Homo sapiens hyaluronan synthase 3 (HAS3) mRNA, complete cds.
/PROD=hyaluronan synthase 3 /F L=g b: N M_005329.1 gb:AF232772.1 6.883803 4.552208 5.03 Down 3.09E-05 AF107495 Homo sapiens FWP001 and putative FWP002 mRNA, complete cds.

/PROD=FWP001 /FL=gb:AF107495.1 3.931505 1.606097 5.01 Down 5.32E-05 NM_0006 Homo sapiens CD44 antigen (homing function and Indian blood group system) (CD44), mRNA.
/PROD=CD44 antigen (homing function and Indian bloodgroup system) /FL=gb:U40373.1 g b: N M_000610.1 g b: M59040.1 gb:M24915.1 G) H9P39 at 96 hr DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 96 HRS Ratio Direction adj. p- Gene Gene Name 01 DE value Identifier -4,01441 4,891626-1, $81.26 1,67E-04 AB 2 8 . C?u .te icL
,A O2 O2 1 . Homo ,sapiens N -3binla fn,RNA for h patoc to *.o:n:p e`te c.,=
!~?1~ I
6,1,569) 1gbA 3 2802 ~
g "4$5 X949 ?ug:::KP , $5651 .';e ,-:i 944 -4.79201 3.803312 386.77 Up 1.32E-04 NM 0124 Homo sapiens sema 31 domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
(SEMA3E), mRNA.
/PROD=sema domain, immunoglobulin domain (Ig), shortbasic domain, secreted, (semaphorin) 3E
/F L=g b: N M_012431.1 g b:AB002329.1 -5.25658 3.205654 352.69 Up 1.07E-04 AW00557 putative 47 kDa protein -0.80C14,3- 3251 91 \A ;. 6 `-0 $ 0 8 7811 Homo s qp 4n'',\ n ',RNA
for .fiA0 -6, co ap3ete e 1.
a' R\ D[-] G,\TA.,j ,~'b :U6$ 5 EMI 005'257.1 D'8781 1 .1 -4.50758 3.451939 248.92 Up 8.69E-05 AU1 18882 endothelin receptor type A
/F L=g b: N M_001957.1 g b: L06622.1 -3.8752 4.026704 239.17 Up 2.39E-05 AB028021 Homo sapiens HNF-3beta mRNA for hepatocyte nuclear factor-3 beta, complete cds.
/PROD=hepatocyte nuclear factor-3 beta /F L=g b:AB028021.1 g b: N M_021784.1 -2.90798 4.967321 234.8 Up 2.99E-05 NM_0016 Homo sapiens 43 apolipoprotein A-II
(APOA2), mRNA.
/PROD=apolipoprotein A-II precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 60005282.1 429896 3,16 6O$ 176,26 Up 3,54E-05 AY1 7t' 407 Homo sap~ens hoine0box prote i doe s:ed `id rnRNA, prote r goo eco 'Fk Jr. -=gb,:AYI 7740,7,1 g b: N" ' 173849,1 -3.61621 3.736424 163.44 Up 7.81 E-04 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds *. 5p` 6.1..9 9 9 152.33 Up 2.) n - 5 NM\'O038 Ho mo pk ens fib S
r" t . .
nq, - - 16 7 growth factor 17 (FGFI7S mR A.
IPR .'i`ro,ast Yxvvth ;actor 17 Jr. gb:4M 003,1' gb:'A ( '24$. , -3.26893 3.979011 152 Up 7.78E-05 NM _0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1 -2.0457 5.103681 141.96 Up 2.15E-04 A1422986 ESTs 2093 6,499027 139.1 Up 2,99E-05 M ,"v" 02'2 4 Homo sap~ens 54 Protein q ,e 17 (F J ?2 ti:
nn RZI NA, ;.~
Wj\:\~ln:., "\~.a. a,A..~..v ; ` 22 5A- tit gene 17 t~ =gb,, 1 022 , 54 ' -0.26005 6.792541 132.75 Up 1.17E-04 R72286 microfibrillar-associated protein 4 -3.62742 3.409798 131.34 Up 1.36E-03 AA772920 ESTs -1.89695 5.127766 130.21 Up 8.40E-05 AL136944 Homo sapiens mRNA;
cDNA DKFZp586J0624 (from clone DKFZp586J0624);
complete cds.
/PROD=hypothetical protein /FL=gb:AF215636.1 g b: N M_014585.1 gb:AF231121.1 gb:AF226614.1 g b:AL 136944.1 -1.32044 5.59755 120.93 Up 2.06E-03 AF01 7987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -0.83997 5.897601 106.71 Up 1.78E-04 A1821669 ESTs -3.51429 3.198717 104.91 Up 1.10E-03 AA352113 ESTs -2.5679 4.132538 104 Up 7.31 E-05 AL 121722 Human DNA sequence from clone RP4-788L20 on chromosome 20 Contains the HNF3B
(hepatocyte nuclear factor 3, beta) gene. a novel gene based on ESTs, ESTs, STSs, GSSs and CpG Islands -3.53873 2.87541 85.28 Up 7.65E-04 A1675836 Human DNA sequence from clone RP11-446H 13 on chromosome 10.
Contains the 3 end of the gene for a novel protein similar to KIAA1059 (ortholog of mouse VPS10 domain receptor protein SORCS), an RPL23A
(60S ribosmal protein 23A) pseudogene, ESTs, STSs an -3,390,07 3,0'12Z85,1, 84,62 U p 3,25E-03 Nfl','01 0066 Homo ,e,aen COae i hes>on moaecuk w W, h*~-okogy to , 1CAM
(c~ose of L1,) mo ecu e w th 91:
to t..'3 Cry (d_ Bose ho! ok' guea of F
FL=g :AF Oa246.1 g`~:+~\`_ it? ems.':
A -E 'C
66, 3 4,666455 80,42 ~Jp 4,61 -04 'S 9738;

(human, : ort 66 nt) 0.502235 6.820772 79.81 Up 1.83E-05 NM_0148 Homo sapiens KIAA0878 99 protein (KIAA0878), mRNA. /PROD=KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 -2.07937 4.232685 79.45 Up 1.97E-03 NM_0016 Homo sapiens 43 apolipoprotein A-II

(APOA2), mRNA.
/PROD=apolipoprotein A-II precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 60005282.1 -3.17056 3.136032 79.15 Up 8.69E-05 A1801626 ESTs, Moderately similar to ALU4_HUMAN ALU

SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -3.54017 2.747179 78.11 Up 6.80E-04 NM_0020 Homo sapiens gastrin-91 releasing peptide (GRP), mRNA. /PROD=gastrin-releasing peptide /F L=g b: N M_002091.1 g b: K02054.1 g b: 80004488.1 . A 6 7,035708 7 7, *6; Up 3 90E 05 NM 0030 ~. .\ a.;pkm c eta:d 0,756526' 12 frizxred-ris de=l p3"'At A=
~`~~\.f`=+ mRN A.
'PROD
--:secreted pro te:1, I

003012.2 `,jb:AFOI 7987.1 \ b A OO 900 0 -1.44407 4.79513 75.54 Up 9.78E-04 U91903 Human Fritz mRNA, complete cds.
/PROD=Fritz /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 -2.72686 3.495506 74.67 Up 2.07E-04 A1692180 PTPRF interacting protein, binding protein 2 (liprin beta 2) -3.20091 3.013879 74.27 Up 7.33E-03 NM_0026 Homo sapiens PDZ
14 domain containing 1 (PDZK1), mRNA.
/PROD=PDZ domain containing 1 /F L=g b: N M_002614.1 gb:AF012281.1 -3.7619 2.33669 68.53 Up 7.27E-05 NM_0161 Homo sapiens transient 79 receptor potential channel 4 (TRPC4), mRNA.
/PROD=transient receptor potential 4 /F L=g b: N M_016179.1 gb:AF175406.1 -3.12184 2.909781 65.42 Up 1.61 E-04 A1700341 ESTs 0.800949 6.787852 63.42 Up 2.39E-05 NM_0307 Homo sapiens scavenger 81 receptor with C-type lectin (SRCL), mRNA.
/PROD=scavenger receptor with C-type lectin /F L=g b: N M_030781.1 -4.29055 1.624099 60.32 Up 2.39E-04 A1337300 Homo sapiens, clone MGC:4604, mRNA, complete cds /F L=g b: 60004219.1 -2.91295 2.987854 59.75 Up 5.35E-03 AW00557 putative 47 kDa protein -1.70149 4.156198 57.99 Up 7.75E-04 AF225426 Homo sapiens HT016 mRNA, complete cds.
/PROD=HT016 /FL=gb:AF225426.1 -1.71797 4.089548 56.01 Up 2.11 E-03 AL524520 G protein-coupled receptor 49 -2.50168 3.192473 51.77 Up 6.18E-03 X16468 Human mRNA for alpha-1 type 11 collagen.
-1.55323 4.102505 50.41 Up 6.30E-05 A1821586 ESTs, Moderately similar to JE0284 Mm-1 cell derived transplantability-associated protein 1 b (H.sapiens) 1.388898 7.006012 49.08 Up 2.00E-05 BE620739 ESTs 0.663834 6.273873 48.84 Up 1.42E-04 A1817041 G protein-coupled receptor -0.41404 5.168897 47.93 Up 2.80E-04 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -0.77864 4.801921 47.85 Up 3.26E-04 NM_0220 Homo sapiens reserved 55 (KCNK12), mRNA.
/PROD=tandem pore domain potassium channel THIK-2 /F L=g b: N M_022055.1 gb:AF287302.1 -3.10357 2.474935 47.79 Up 1.14E-04 NM_0014 Homo sapiens forkhead 53 box C1 (FOXC1), mRNA.
/PROD=forkhead box C1 /F L=g b: N M_001453.1 -0.81978 4.721279 46.56 Up 2.62E-04 A1824037 ESTs, Weakly similar to AFFINITY
IMMUNOGLOBULIN
EPSILON FC RECEPTOR
(M.musculus) -2.26295 3.255855 45.85 Up 1.71E-03 A1735586 ESTs -2.45311 3.005889 43.99 Up 1.26E-02 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.

b,. d 002052:1, q b: 04357,1 -0.27888 5.117281 42.11 Up 1.28E-04 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -1.83503 3.514396 40.77 Up 1.00E-03 AA552969 ESTs 0.83572 6.138202 39.46 Up 1.51 E-04 N21138 KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 -3.79684 1.484084 38.88 Up 7.14E-05 AK026720 Homo sapiens cDNA:
FLJ23067 fis, clone LNG04993.
-1.77041 3.498637 38.56 Up 1.69E-03 NM_0039 Homo sapiens sema 66 domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
(SEMA5A), mRNA.
/PROD=sema domain, seven thrombospondin repeats (typel and type 1-like), transmem -3.31261 1.945323 38.26 Up 5.68E-04 BG39785 major histocompatibility 6 complex, class II, DQ
alpha 1 0.804491 6.016482 37.07 Up 6.98E-05 AA583044 bone morphogenetic protein 2 /F L=g b: N M_001200.1 -3.10838 2.083703 36.56 Up 3.89E-04 N50412 ESTs -2.61405 2.571666 36.4 Up 7.27E-05 U71207 Human eyes absent homolog (Eab1) mRNA, complete cds.
/PROD=Eabl /F L=g b: N M_005244.1 gb:U71207.1 -3.12747 2.048588 36.15 Up 6.25E-04 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) -2.81405 2.361598 36.14 Up 1.28E-03 A1694325 ESTs -0.69028 4.475046 35.89 Up 2.18E-04 M16276 Human MHC class II HLA-DR2-Dw12 mRNA DQw1-beta, complete cds.
/F L=g b: N M_002123.1 gb:M16276.1 g b: M60028.1 gb:M1 7564.1 gb:M81141.1 gb:M81140.1 0.713597 5.840181 34.93 Up 2.79E-04 BF508344 ESTs 0.828899 5.924976 34.2 Up 7.27E-05 NM_0012 Homo sapiens bone 00 morphogenetic protein 2 (BMP2), mRNA.
/PROD=bone morphogenetic protein 2 precursor /F L=g b: N M_001200.1 -0.47614 4.618034 34.16 Up 6.98E-05 BF508639 Homo sapiens mRNA;
cDNA DKFZp434EO82 (from clone DKFZp434EO82) -0.5292 4.497879 32.61 Up 9.90E-04 All 27440 ESTs 7.391'327 32,51 U 3 5...1 -\ E5 A. 2 24 $:' Homo sap CXCR\
\enneelnco\,'+n:n1 receptor CX\ti F 4 -3.7558 1.259886 32.35 Up 4.07E-03 AW47365 ESTs -0.98665 4.021785 32.19 Up 1.71 E-03 NM_0014 Homo sapiens frizzled-63 related protein (FRZB), mRNA. /PROD=frizzled-related protein /FL=gb:U24163.1 g b: U68057.1 g b: N M_001463.1 gb:U91903.1 -4.30972 0.685002 31.88 Up 7.81 E-04 A1911379 hypothetical protein -3.25309 1.716276 31.33 Up 2.03E-03 AL050154 Homo sapiens mRNA;
cDNA DKFZp586LO120 (from clone DKFZp586LO120).
-0.45718 4.508664 31.25 Up 1.56E-04 BF939489 glycoprotein M6A
/FL=gb:D49958.1 -2.39338 2.572327 31.25 Up 3.48E-03 M17955 Human MHC class II HLA-DQ-beta mRNA, complete cds. /FL=gb:M33907.1 gb:M17955.1 g b: M 16996.1 gb:M17563.1 g b: M20432.1 g b: M26042.1 1.314051 6.278914 31.23 Up 2.39E-05 80000740 Homo sapiens, cholecystokinin B
receptor, clone MGC:2199, mRNA, complete cds.
/PROD=cholecystokinin B
receptor /FL=gb:L07746.1 gb:L08112.1 gb:S70057.1 g b: 60000740.1 gb:L04473.1 g b: N M_000731.1 -2.16079 2.736566 29.8 Up 2.47E-04 NM_0005 Homo sapiens von 52 Willebrand factor (VWF), mRNA. /PROD=von Willebrand factor precursor /F L=g b: N M_000552.2 -1.39784 3.483531 29.47 Up 1.14E-03 BE222344 splicing factor, arginineserine-rich 5 -3.25961 1.618799 29.41 Up 1.38E-02 NM_0163 Homo sapiens pancreas-41 enriched phospholipase C
(LOC51196), mRNA.
/PROD=pancreas-enriched phospholipase C
/F L=g b:AF 117948.1 gb:NM_016341.1 g b:AF 190642.2 -4.15276 0.707307 29.04 Up 1.84E-04 W29444 Homo sapiens mRNA for KIAA1263 protein, partial cds -0.13959 4.718875 29.01 Up 6.98E-05 BG10985 Homo sapiens clone TUA8 Cri-du-chat region mRNA
1.829497 6.66646 28.58 Up 6.58E-05 AA534817 ESTs, Weakly similar to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -1.09421 3.740217 28.53 Up 8.67E-04 AK023621 Homo sapiens cDNA
FLJ13559 fis, clone PLACE1007852, highly similar to Homo sapiens mRNA for KIAA0878 protein.
-0.37709 4.429943 27.99 Up 7.27E-05 AU 152102 Homo sapiens cDNA
FLJ 12993 fis, clone -3.4744 1.320969 27.77 Up 5.88E-03 L32867 Homo sapiens alpha 2,8-sialyltransfe rase mRNA, complete cds.
/PROD=alpha 2,8-sialyltransferase /F L=g b: L43494.1 gb:D26360.1 gb:L32867.1 g b: N M_003034.1 -2.4051 2.382948 27.63 Up 7.27E-05 NM_0210 Homo sapiens 20 F37Esophageal cancer-related gene-coding leucine-zipper motif (FEZ1), mRNA.
/PROD=F37Esophageal cancer-related gene-codingleucine-zipper motif /FL=gb:AF123659.1 g b: N M_021020.1 1.563993 6.348869 27.57 Up 2.99E-05 NM_0024 Homo sapiens microsomal 13 glutathione S-transferase 2 (MGST2), mRNA.
/PROD=microsomal glutathione S-transferase 2 /FL=gb:NM_002413.1 gb:U77604.1 -4.63418 0.150462 27.56 Up 1.41 E-02 BF112218 ESTs -2.83906 1.924807 27.17 Up 1.51 E-04 T15545 ESTs -0.18256 4.580673 27.16 Up 2.39E-05 A1583173 major histocompatibility complex, class II, DQ beta -1.80965 2.891679 26.02 Up 4.11 E-03 NM_1525 Homo sapiens 06 hypothetical protein FLJ32835 (FLJ32835), mRNA.
/F L=g b: N M_152506.1 -0.10733 4.583423 25.83 Up 3.29E-04 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -1.42034 3.260135 25.64 Up 5.35E-04 BE737251 Homo sapiens cDNA:
FLJ22482 fis, clone HRC1 0859, highly similar to IR0180147 Homo sapiens mRNA full length insert cDNA clone -2.6422 2.00977 25.14 Up 2.92E-05 BF589787 ESTs -2.50335 2.123365 24.7 Up 3.11 E-04 AA781795 ESTs -2.68947 1.923908 24.48 Up 2.10E-02 AW29140 ESTs -2.14813 2.455272 24.31 Up 7.80E-04 NM_0060 Homo sapiens p53-34 induced protein (PIG11), mRNA. /PROD=p53-induced protein /FL=gb:AF010315.1 g b: 60000443.1 gb:B0003010.1 g b: N M_006034.1 -1.35345 3.203459 23.54 Up 9.11 E-04 AW15757 ESTs, Weakly similar to 1 T00331 hypothetical protein KIAA0555 (H.sapiens) 0.424882 4.980575 23.52 Up 2.79E-04 A1692659 heat shock 90kD protein 1, alpha -2.05438 2.485242 23.26 Up 6.59E-03 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -0.35867 4.178782 23.22 Up 4.79E-05 NM_0019 Homo sapiens endothelin 57 receptor type A (EDNRA), mRNA.
/PROD=endothelin receptor type A
/FL=gb:NM_001957.1 g b: L06622.1 -0.13427 4.37209 22.73 Up 3.30E-04 D49958 Homo sapiens mRNA for membrane glycoprotein M6, complete cds.
/PROD=membrane glycoprotein M6 /F L=g b: D49958.1 -1.54464 2.95955 22.69 Up 1.14E-04 A1743534 Homo sapiens mRNA;
cDNA DKFZp564B1 162 (from clone DKFZp564B1 162);
complete cds /F L=g b:AL 136646.1 -2.16064 2.33987 22.64 Up 1.03E-02 NM_0004 Homo sapiens nuclear 75 receptor subfamily 0, group B, member 1 (NR0B1), mRNA.
/PROD=adrenal hypoplasia protein /F L=g b: N M_000475.2 1.168713 5.649978 22.34 Up 3.27E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 60003079.1 1.740607 6.204585 22.07 Up 3.94E-05 NM_0021 Homo sapiens 60 hexabrachion (tenascin C, cytotactin) (HXB), mRNA.
/PROD=hexabrachion (tenascin C, cytotactin) /FL=gb:M55618.1 g b: N M_002160.1 -3.95062 0.506384 21.96 Up 3.04E-03 AU 144247 Homo sapiens cDNA
FLJ13443 fis, clone -2.49959 1.953408 21.9 Up 2.53E-03 NM_0006 Homo sapiens bradykinin 23 receptor B2 (BDKRB2), mRNA. /PROD=bradykinin receptor B2 /FL=gb:M88714.1 g b: N M_000623.1 1.997597 6.394209 21.06 Up 7.27E-05 80005997 Homo sapiens, clone MGC:14801, mRNA, complete cds.
/PROD=Unknown (protein for MGC:14801) /FL=gb:B0005997.1 0.476688 4.86637 20.96 Up 1.84E-04 NM_0245 Homo sapiens 81 hypothetical protein FLJ13942(FLJ13942), mRNA.
/PROD=hypothetical protein FLJ13942 /F L=g b: N M_024581.1 -0.5982 3.789814 20.94 Up 1.67E-02 A1806510 putative 47 kDa protein 1.275191 5.659185 20.88 Up 2.29E-04 A1587307 hypothetical protein /F L=g b: N M_024641.1 -0.81856 3.56477 20.87 Up 6.98E-05 A1129628 ESTs -1.25995 3.108032 20.65 Up 5.74E-04 AK026607 Homo sapiens cDNA:
FLJ22954 fis, clone KAT09813, highly similar to AF010315 Homo sapiens Pigl1 (PIG11) mRNA.
-2.69284 1.656461 20.38 Up 1.26E-02 R33964 Homo sapiens cDNA
FLJ11022 fis, clone 0.449168 4.77336 20.03 Up 2.99E-05 A1688418 plexin A2 -3.9115 0.399609 19.85 Up 2.57E-03 NM_0057 Homo sapiens RAS
39 guanyl releasing protein 1 (calcium and DAG-regulated) (RASGRPI), mRNA. /PROD=RAS
guanyl releasing protein 1 /FL=gb:AF081195.1 g b: N M_005739.2 gb:AF106071.1 -1.61054 2.680455 19.58 Up 1.10E-03 AW26420 ESTs -1.40826 2.851659 19.16 Up 6.31 E-04 AB046770 Homo sapiens mRNA for KIAA1550 protein, partial cds. /PROD=KIAA1550 protein 0.007601 4.206081 18.36 Up 8.27E-05 N63706 ESTs -0.15629 4.036024 18.28 Up 5.42E-04 A1799018 ESTs -0.95386 3.225705 18.12 Up 2.80E-04 AF312769 Homo sapiens cryptic mRNA, complete cds.
/PROD=cryptic /FL=gb:AF312769.1 -1.16952 2.986121 17.82 Up 2.56E-02 NM_0013 Homo sapiens disabled 43 (Drosophila) homolog 2 (mitogen-responsive phosphoprotein) (DAB2), mRNA. /PROD=disabled (Drosophila) homolog 2 /F L=g b: U 39050.1 g b: N M_001343.1 gb:U53446.1 g b: 60003064.1 -0.68225 3.470947 17.79 Up 9.21 E-05 N48299 ESTs, Moderately similar to NFY-C (H.sapiens) 1.861693 6.008305 17.71 Up 2.22E-04 A1374739 ESTs 0.366041 4.503789 17.6 Up 2.15E-04 A1242583 Homo sapiens cDNA
FLJ1 1550 fis, clone 0.420056 4.533726 17.31 Up 7.27E-05 NM_0122 Homo sapiens dickkopf 42 (Xenopus laevis) homolog 1 (DKK1), mRNA.
/PROD=dickkopf (Xenopus laevis) homolog 1 /FL=gb:AF177394.1 g b: N M_012242.1 gb:AF127563.1 -2.64131 1.459191 17.15 Up 3.06E-02 AU 157303 ESTs -1.39277 2.690011 16.94 Up 1.61 E-04 A1629041 ESTs -0.88175 3.200899 16.94 Up 1.09E-03 A1650874 ESTs -2.14545 1.935001 16.92 Up 3.05E-03 NM_0158 Homo sapiens 31 acetylcholinesterase (YT
blood group) (ACHE), transcript variant E4-E5, mRNA.
/PROD=acetylcholinestera se PI-linked form precursor /F L=g b: N M_015831.1 -0.5777 3.489676 16.76 Up 7.55E-04 BC036592 Homo sapiens, clone IMAGE:4814184, mRNA.
-3.18582 0.860182 16.52 Up 1.89E-03 A1991033 heparan sulfate proteoglycan 2 (perlecan) /F L=g b: M85289.1 g b: N M_005529.2 0.041468 4.081945 16.46 Up 6.89E-04 BF130943 ESTs -1.6164 2.402639 16.21 Up 8.12E-03 X00452 Human mRNA for DC
classll histocompatibility antigen alpha-chain.

/PROD=DC class II
h istocom pati b i l ity antigenalpha-chain -0.70855 3.310445 16.21 Up 8.09E-04 A1917371 ESTs 1.186033 5.204849 16.21 Up 2.18E-04 A1627704 ESTs, Weakly similar to T17346 hypothetical protein DKFZp586O1624.1 (H.sapiens) -2.70961 1.305453 16.17 Up 1.75E-02 AK055534 Homo sapiens cDNA
FLJ30972 fis, clone H EART2000492.
1.192657 5.206164 16.15 Up 6.23E-04 NM_0246 Homo sapiens 41 hypothetical protein FLJ12838(FLJ12838), mRNA.
/PROD=hypothetical protein FLJ12838 /F L=g b: N M_024641.1 -0.41626 3.581554 15.98 Up 4.74E-04 BF110534 ESTs -0.29145 3.703489 15.94 Up 3.27E-04 A1197932 ESTs -0.20099 3.787591 15.87 Up 4.75E-04 BF984830 retinoic acid induced 1 -0.62897 3.35485 15.82 Up 1.12E-02 A1694545 ESTs 3042634 7,019598 15,75 , Up 39E-05 N +005$ sz p^e ns ~-.\Ke ,+\ pu*
..:RNA, k ME

1b:N~N4 005442A
0.500662 4.465346 15.61 Up 5.59E-04 AB043703 Homo sapiens FZD8 mRNA for seven-transmembrane receptor Frizzled-8, complete cds.
/PROD=seven-transmembrane receptor Frizzled-8 /FL=gb:AB043703.1 -2.81453 1.143479 15.54 Up 4.26E-02 BC014585 Homo sapiens, clone IMAGE:4047715, mRNA.
-0.27888 3.6716 15.46 Up 7.27E-05 NM_0030 Homo sapiens SWISNF
78 related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 (SMARCD3), mRNA. /PROD=SWISNF
related, matrix associated, actindependent regulator of chromatin, subfamily d, member 3 /FL=gb:NM_003078.1 gb 2.377335 6.2969 15.13 Up 7.27E-05 NM_0053 Homo sapiens hyaluronan 28 synthase 2 (HAS2), mRNA.
/PROD=hyaluronan synthase 2 /F L=g b: U 54804.1 g b: N M_005328.1 -2.84061 1.073185 15.07 Up 1.33E-03 A1123532 ESTs 0.81871 4.722909 14.97 Up 2.18E-04 X06268 Human mRNA for pro-alpha 1 (II) collagen 3end C-term. triple helical and C-terminal non-helical domain. /PROD=pro-alpha 1 (11) collagen (313 AA; AA
975-271 c) /F L=g b: N M_001844.2 3.2061 7.080736 14.67 Up 2.00E-05 NM_0066 Homo sapiens 81 neuromedin U (NMU), mRNA.
/PROD=neuromedin U
/F L=g b: N M_006681.1 -0.60671 3.260587 14.59 Up 2.39E-03 NM_0004 Homo sapiens 58 transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor (TCF2), transcript variant a, mRNA.
/PROD=transcription factor 2, isoform a /F L=g b: N M_000458.1 -3.75063 0.097574 14.4 Up 2.53E-03 AW24315 ESTs -0.66587 3.17829 14.36 Up 2.94E-04 NM_0013 Homo sapiens deiodinase, 62 iodothyronine, type III
(D103), mRNA.
/PROD=thyroxine deiodinase type III
/F L=g b: N M_001362.1 gb:S79854.1 -2.17973 1.654509 14.26 Up 7.81 E-04 BE379542 chromodomain helicase DNA binding protein 3 /FL=gb:U91543.1 -0.40798 3.424074 14.24 Up 3.78E-04 A1143879 phosphodiesterase 10A
/FL=gb:AB020593.1 gb:AF127479.1 g b: N M_006661.1 1.194285 5.026057 14.24 Up 4.81 E-04 NM_0018 Homo sapiens cystatin SN
98 (CST1), mRNA.
/PROD=cystatin SN
/FL=gb:J03870.1 g b: N M_001898.1 -0.22337 3.603991 14.2 Up 1.24E-03 NM_0218 Homo sapiens phorbolin-22 like protein MDS019 (MDS019), mRNA.
/PROD= ph o rbol i n-like protein MDS019 /F L=g b:AF 182420.1 g b: N M_021822.1 -3.47125 0.352559 14.16 Up 3.65E-02 BF114815 ESTs -3.95752 -0.14384 14.06 Up 1.63E-02 NM_0014 Homo sapiens epiregulin 32 (EREG), mRNA.
/PROD=epiregulin precursor /FL=gb:D30783.1 g b: N M_001432.1 -1.83999 1.973187 14.06 Up 2.96E-04 AK074453 Homo sapiens cDNA
FLJ23873 fis, clone LNG 12941.
-2.9769 0.834997 14.04 Up 2.11 E-02 AW61211 ESTs -1.92059 1.887684 14.01 Up 1.43E-03 A1738662 homeo box HB9 /F L=g b: N M_005515.1 1.868094 5.672805 13.97 Up 7.78E-05 H92988 tyrosine 3-monooxygenasetryptopha n 5-monooxygenase activation protein, eta polypeptide -1.42171 2.367519 13.83 Up 1.18E-04 NM_0050 Homo sapiens neuronal cell adhesion molecule (NRCAM), mRNA.
/PROD=neuronal cell adhesion molecule /FL=gb:AB002341.1 g b: N M_005010.1 -3.18081 0.59108 13.66 Up 6.34E-04 AW44981 KIAA0918 protein -0.11092 3.655377 13.61 Up 1.43E-04 BF591483 ESTs -1.74597 2.018156 13.59 Up 1.45E-02 AW26981 hypothetical protein /F L=g b: N M_022068.1 1.59762 5.358013 13.55 Up 9.35E-04 NM_0186 Homo sapiens core 49 histone macroH2A2.2 (MACROH2A2), mRNA.
/PROD=core histone macroH2A2.2 /FL=gb:AF151534.1 g b: N M_018649.1 -2.85208 0.904726 13.52 Up 4.53E-03 A1423201 ESTs -1.68521 2.068725 13.49 Up 3.53E-03 NM 0027 Homo sapiens protease, 70 serine, 2 (trypsin 2) (PRSS2), mRNA.
/PROD=protease, serine, 2 (trypsin 2) /FL=gb:M27602.1 g b: N M_002770.1 0.753353 4.506029 13.48 Up 1.83E-05 NM _0218 Homo sapiens 27 hypothetical protein FLJ23514 (FLJ23514), mRNA.
/PROD=hypothetical protein FLJ23514 /F L=g b: N M_021827.1 -1.54589 2.19498 13.37 Up 7.14E-03 AW08823 ESTs -2.06656 1.672721 13.35 Up 5.12E-03 AF 141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 1.696658 5.415977 13.17 Up 8.38E-04 L01639 Human (clone HSY3RR) neuropeptide Y receptor (NPYR) mRNA, complete cds. /PROD=neuropeptide Y receptor /FL=gb:L06797.1 g b: N M_003467.1 gb:AF025375.1 gb:AF147204.1 gb:M99293.1 gb:L01639.1 1.633768 5.346711 13.11 Up 2.39E-05 A1733465 collagen, type IX, alpha 2 /F L=g b: N M_001852.1 -0.65009 3.058078 13.07 Up 1.17E-04 NM_0179 Homo sapiens 31 hypothetical protein FLJ20699 (FLJ20699), mRNA.
/PROD=hypothetical protein FLJ20699 /F L=g b: N M_017931.1 0.661121 4.360957 12.99 Up 1.08E-04 AA502609 Homo sapiens ankyrin-like with transmembrane domains 1 (ANKTM1), mRNA
1.048741 4.74741 12.98 Up 4.60E-04 NM_0018 Homo sapiens cystatin S
99 (CST4), mRNA.
/PROD=cystatin S
/F L=g b: N M_001899.1 -2.19527 1.501137 12.96 Up 1.06E-03 NM_0133 Homo sapiens EH
33 domain-binding mitotic phosphoprotein (EPSIN), mRNA. /PROD=EH
domain-binding mitotic phosphoprotein /FL=gb:NM_013333.1 gb:AF073727.1 -2.89467 0.794807 12.9 Up 7.39E-03 AW97120 ESTs -3.30412 0.383694 12.89 Up 3.93E-02 AU 157224 Homo sapiens cDNA
FLJ1 1570 fis, clone 1.223968 4.90936 12.87 Up 8.70E-05 AL574912 ESTs, Weakly similar to serine protease (H.sapiens) -2.30432 1.381011 12.86 Up 3.92E-02 BC017958 Homo sapiens, clone IMAGE:4607409, mRNA.
2.593137 6.238337 12.51 Up 2.99E-05 NM_0018 Homo sapiens 73 carboxypeptidase E
(CPE), mRNA.
/PROD=carboxypeptidase E precursor /FL=gb:NM_001873.1 -1.43446 2.199521 12.41 Up 9.27E-03 AW29148 ESTs 0.151239 3.777599 12.35 Up 1.16E-04 BE644809 ESTs -0.07494 3.527775 12.15 Up 9.39E-05 NM_0013 Homo sapiens dual 94 specificity phosphatase 4 (DUSP4), mRNA.
/PROD=dual specificity phosphatase 4 /F L=g b: N M_001394.2 g b: 60002671.1 gb:U48807.1 gb:U21108.1 -2.56291 1.033178 12.09 Up 1.48E-02 BG53269 integrin, alpha 4 (antigen
278 0 CD49D, alpha 4 subunit of VLA-4 receptor) -3.10679 0.486734 12.07 Up 8.34E-04 N59476 ESTs -1.71673 1.874627 12.05 Up 9.46E-04 NM_0004 Homo sapiens Kell blood 20 group (KEL), mRNA.
/PROD=Kell blood group antigen /FL=gb:B0003135.1 g b: N M_000420.1 1.071985 4.656957 12 Up 6.98E-05 NM_0045 Homo sapiens receptor 60 tyrosine kinase-like orphan receptor 2 (ROR2), mRNA.
/PROD=receptor tyrosine kinase-like orphan receptor 2 /FL=gb:M97639.1 g b: N M_004560.1 -0.05814 3.51961 11.94 Up 8.07E-04 BF308645 KIAA1415 protein 0.581614 4.158253 11.93 Up 1.95E-04 AF005775 Homo sapiens caspase-like apoptosis regulatory protein 2 (clarp) mRNA, alternatively spliced, complete cds.
/PROD=caspase-like apoptosis regulatory protein 2 /FL=gb:AF005775.1 -3.51603 0.057356 11.9 Up 2.99E-02 AV724769 ESTs -1.99136 1.57545 11.85 Up 8.72E-03 AL 109653 Human DNA sequence from clone GS1-115M3 on chromosome Xq27.1-28 Contains a gene for a novel protein, CXorfl (chromosome X open reading frame 1), ESTs, STSs, GSSs and a CpG
Island 0.454394 4.013479 11.79 Up 3.30E-04 AL036088 KIAA1479 protein -0.41994 3.13818 11.78 Up 2.73E-03 A1686957 KIAA1494 protein 1.355965 4.912341 11.76 Up 2.16E-04 A1141603 collagen, type VI, alpha 1 -2.33835 1.203342 11.65 Up 2.16E-02 L33477 Human (clone 8B1) Br-cadherin mRNA, complete cds. /PROD=Br-cadherin /F L=g b: L34057.1 gb:L33477.1 g b: N M_004061.1 2.453593 5.992042 11.62 Up 5.24E-05 NM_0054 Homo sapiens selenoprotein P, plasma, 1 (SEPP1), mRNA.
/PROD=selenoprotein P
precursor /F L=g b: N M_005410.1 0.240245 3.777926 11.61 Up 8.44E-04 BF940761 ESTs -0.28951 3.242447 11.57 Up 3.11 E-04 NM_0183 Homo sapiens 88 hypothetical protein FLJ11316 (FLJ11316), mRNA.
/PROD=hypothetical
279 protein FLJ11316 /F L=g b: N M_018388.1 -0.10881 3.416108 11.51 Up 3.44E-04 AA701657 hypothetical protein -1.17666 2.334376 11.4 Up 7.27E-04 NM_0246 Homo sapiens 33 hypothetical protein FLJ21276(FLJ21276), mRNA.
/PROD=hypothetical protein FLJ21276 /F L=g b: N M_024633.1 2.59334 6.102285 11.38 Up 6.58E-05 AA045184 ribosomal protein L14 0.451744 3.95936 11.37 Up 2.79E-04 NM_0013 Homo sapiens ectodermal 99 dysplasia 1, anhidrotic (ED1), mRNA.
/PROD=ectodermal dysplasia 1, anhidrotic /F L=g b:AF060999.1 g b: N M_001399.1 gb:AF040628.1 gb:AF061189.1 1.040647 4.542431 11.33 Up 6.98E-05 A1348094 KIAA0882 protein -1.24923 2.248992 11.3 Up 1.02E-03 R42166 ESTs, Weakly similar to AX01_HUMAN AXONIN-(H.sapiens) 0.414809 3.908697 11.27 Up 2.78E-04 NM_0161 Homo sapiens transient 79 receptor potential channel 4 (TRPC4), mRNA.
/PROD=transient receptor potential 4 /F L=g b: N M_016179.1 gb:AF175406.1 -2.9904 0.493882 11.19 Up 2.79E-04 U96136 Homo sapiens delta-catenin mRNA, complete cds. /PROD=delta-catenin /F L=g b: N M_001332.1 gb:U72665.1 gb:ABO13805.1 gb:U96136.1 gb:AF035302.1 1.076427 4.559689 11.18 Up 1.88E-04 A1640307 protocadherin 10 -1.08244 2.395089 11.14 Up 2.32E-03 X75208 X75208 /FEATURE=cds /DEFINITION=HSPTKR
H.sapiens HEK2 mRNA
for protein tyrosine kinase receptor -1.25121 2.224638 11.13 Up 3.78E-04 R62432 Cluster Incl.
R62432:yg52el1.s1 Homo sapiens cDNA, 3 end /clone=IMAGE-36023 /clone end=3 /gb=R62432 /gi=834311 /ug=Hs.12321 /len=487 0.631332 4.097155 11.05 Up 3.78E-04 A1130705 ESTs, Weakly similar to A46302 PTB-associated splicing factor, long form (H.sapiens) 1.438639 4.903827 11.04 Up 9.39E-05 BF223214 ESTs
280 0.120924 3.584799 11.03 Up 9.41 E-05 NM_0015 Homo sapiens 29 hematopoietically expressed homeobox (HHEX), mRNA.
/PROD=hematopoietically expressed homeobox /F L=g b: N M_001529.1 gb:L16499.1 g b: N M_002729.1 1.316429 4.768005 10.94 Up 1.37E-04 A1769688 Homo sapiens clone 23664 and 23905 mRNA
sequence 0.449933 3.898646 10.92 Up 3.56E-03 Z21533 H.sapiens HEX gene encoding homeobox related protein.
/PROD=homeobox related protein 2.383898 5.826754 10.87 Up 2.39E-05 BF476502 hypothetical protein -2.21968 1.214412 10.81 Up 2.00E-02 AA946876 ESTs 0.999053 4.427902 10.77 Up 2.39E-04 AW12959 tudor repeat associator 3 with PCTAIRE 2 1.750623 5.17881 10.76 Up 7.27E-05 W76289 ESTs 0.502333 3.925314 10.73 Up 2.47E-03 AF211891 Homo sapiens Mix-like homeobox protein 1 (MILD1) mRNA, complete cds. /PROD=Mix-like homeobox protein 1 /FL=gb:AF211891.1 -2.15454 1.256699 10.64 Up 4.44E-02 NM_0120 Homo sapiens Friend of 82 GATA2 (FOG2), mRNA.
/PROD=Friend of GATA2 /F L=g b: N M_012082.2 gb:AF1 19334.1 -0.23726 3.166937 10.59 Up 3.27E-04 AA912476 Homo sapiens cDNA
FLJ13221 fis, clone -2.38435 1.018436 10.58 Up 1.74E-03 A1743137 ESTs -1.83333 1.555259 10.47 Up 5.26E-03 NM_0065 Homo sapiens myelin-01 associated oligodendrocyte basic protein (MOBP), mRNA.
/PROD= myel i n-associated oligodendrocyte basic protein /FL=gb:D28113.1 g b: N M_006501.1 2.168853 5.557183 10.47 Up 2.75E-04 AA284532 tyrosine 3-monooxygenasetryptopha n 5-monooxygenase activation protein, eta polypeptide -1.0335 2.347369 10.42 Up 9.35E-04 AL553774 KIAA1462 protein -1.78964 1.575618 10.3 Up 2.04E-02 NM_0048 Homo sapiens 61 cerebroside (3-phosphoadenylylsulfate:g alactosylceramide 3) sulfotransferase (CST), mRNA.
/PROD=galactosylceramid
281 e sulfotransferase /F L=g b: N M_004861.1 gb:D88667.1 -3.12055 0.243075 10.29 Up 2.31 E-02 AW78000 ESTs 2.194421 5.519803 10.02 Up 8.38E-04 AF348491 Homo sapiens chemokine receptor CXCR4 mRNA, complete cds.
/PROD=chemokine receptor CXCR4 /F L=g b:AF348491.1 -0.75724 2.561949 9.98 Up 5.19E-03 AL445192 Human DNA sequence from clone RP11-269H4 on chromosome 20 Contains the 3 end of the KIAA1415 gene similar to T-Lymphona invasion and metastasis inducing protein 1, ESTs, STSs and GSSs -0.92287 2.395505 9.98 Up 3.26E-04 AA443280 ESTs, Highly similar to AF229172 1 class III
myosin (H.sapiens) -0.38837 2.924326 9.94 Up 6.37E-04 BE551088 ESTs -1.06796 2.241523 9.91 Up 3.97E-02 AW66417 hypothetical protein /F L=g b: N M_024329.1 gb:BC003033.1 -0.65031 2.656212 9.89 Up 1.16E-04 A1760630 ESTs -0.2425 3.063759 9.89 Up 1.10E-04 NM_0182 Homo sapiens 86 hypothetical protein FLJ10970(FLJ10970), mRNA.
/PROD=hypothetical protein FLJ10970 /F L=g b: N M_018286.1 54 , (X:a.
horn > '<'=ysae'' ne k4-1o ..:RNA,,='PRO `._,c(r ?erus 0.561438 3.86147 9.85 Up 3.49E-04 BF968270 ESTs -2.62694 0.672523 9.85 Up 8.33E-03 NM_0000 Homo sapiens 55 butyrylcholinesterase (BCHE), mRNA.
/PROD=butyrylcholinester ase precursor /FL=gb:M16541.1 gb:M16474.1 g b: N M_000055.1 -1.75731 1.539959 9.83 Up 3.37E-02 80008992 Homo sapiens, clone MGC:16926 IMAGE:4183000, mRNA, complete cds.
/PROD=Unknown (protein for MGC:16926) /F L=g b: 80008992.1 3.287037 6.580588 9.81 Up 7.27E-05 A1633559 ESTs
282 -1.20714 2.08291 9.78 Up 3.66E-03 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
0.937118 4.225755 9.77 Up 7.27E-05 AU 151342 Homo sapiens cDNA
FLJ12935 fis, clone 0.447082 3.734688 9.76 Up 1.61 E-04 NM_0149 Homo sapiens KIAA0957 42 protein (KIAA0957), mRNA. /PROD=KIAA0957 protein /FL=gb:AB023174.1 g b: N M_014942.1 -3.09265 0.191299 9.74 Up 6.04E-03 A1093492 ESTs -2.20597 1.071614 9.7 Up 1.05E-02 A1968904 ESTs 1.370117 4.641246 9.65 Up 7.27E-05 M33653 Human (clones HT-(125,133)) alpha-2 type IV
collagen (COL4A2) mRNA, complete cds.
/PROD=alpha-2 type IV
collagen /FL=gb:M33653.1 0.205308 3.457432 9.53 Up 1.55E-04 BF509230 ESTs 1.380324 4.628332 9.5 Up 3.46E-04 NM_0068 Homo sapiens histamine 95 N-methyltransferase (HNMT), mRNA.
/PROD=histamine N-methyltransfe rase /F L=g b: N M_006895.1 gb:D16224.1 gb:U08092.1 0.1187 3.354157 9.42 Up 2.39E-05 N21184 Cluster Incl.
N21184:yx41 a10.sl Homo sapiens cDNA, 3 end /clone=IMAGE-264282 /clone end=3 /gb=N21184 /gi=1126354 /ug=Hs.93605 /len=619 -0.30596 2.924622 9.39 Up 1.42E-03 BC029835 Homo sapiens, clone IMAGE:5169759, mRNA.
1.008383 4.233261 9.35 Up 1.84E-04 BE397715 pre-B-cell leukemia transcription factor 2 /F L=g b: N M_002586.1 -1.28081 1.941655 9.33 Up 1.10E-03 NM_0017 Homo sapiens 35 complement component 5 (C5), mRNA.
/PROD=complement component 5 /FL=gb:M57729.1 g b: N M_001735.1 -1.80959 1.41238 9.33 Up 3.47E-03 BF447246 KIAA0960 protein 0.378586 3.596764 9.31 Up 3.90E-05 BF109231 ESTs -1.17885 2.035986 9.28 Up 1.34E-03 AB002155 Homo sapiens mRNA for human uroplakin Ib, complete cds.
/PROD=human uroplakin Ib /FL=gb:NM_006952.1 gb:ABO1 5234.1 gb:AF042331.1 gb:AB002155.1 -2.84187 0.3707 9.27 Up 2.06E-03 NM_0022 Homo sapiens potassium 44 inwardly-rectifying
283 channel, subfamily J, inhibitor 1 (KCNJN1), mRNA. /PROD=potassium inwardly-rectifying channel, subfamilyJ, inhibitor 1 /F L=g b: N M_002244.1 0.442286 3.651458 9.25 Up 6.22E-04 NM_0017 Homo sapiens CD48 78 antigen (B-cell membrane protein) (CD48), mRNA.
/PROD=CD48 antigen (B-cell membrane protein) /F L=g b: N M_001778.1 gb:M37766.1 g b: M59904.1 -1.58477 1.612357 9.17 Up 3.93E-03 NM _0163 Homo sapiens pancreas-41 enriched phospholipase C
(LOC51196), mRNA.
/PROD=pancreas-enriched phospholipase C
/F L=g b:AF 117948.1 gb:NM_016341.1 g b:AF 190642.2 0.798972 3.993241 9.15 Up 2.02E-05 A1082827 hypothetical protein -1.39976 1.793953 9.15 Up 8.10E-04 NM 0052 Homo sapiens mitogen-04 activated protein kinase kinase kinase 8 (MAP3K8), mRNA.
/PROD=mitogen-activated protein kinase kinase kinase8 /F L=g b: N M_005204.1 gb:D14497.1 -1.2719 1.918316 9.13 Up 2.22E-03 NM 0204 Homo sapiens 06 polycythemia rubra vera 1;
cell surface receptor (PRV1), mRNA.
/PROD=polycythemia rubra vera 1; cell su rface rece ptor /F L=g b: N M_020406.1 gb:AF146747.1 -1.20098 1.986443 9.11 Up 7.28E-03 NM_0017 Homo sapiens cadherin 4, 94 type 1, R-cadherin (retinal) (CDH4), mRNA.
/PROD=cadherin 4, type 1, R-cadherin (retinal) /F L=g b: L34059.1 g b: N M_001794.1 0.270283 3.456007 9.1 Up 1.24E-03 A1690433 Homo sapiens mRNA;
cDNA DKFZp434KO621 (from clone DKFZp434KO621); partial cds -3.14727 0.038057 9.1 Up 4.46E-02 NM_0011 Homo sapiens 47 angiopoietin 2 (ANGPT2), mRNA.
/PROD=angiopoietin 2
284 /FL=gb:AB009865.1 gb:AF004327.1 g b: N M_001147.1 -2.65285 0.529695 9.08 Up 5.20E-04 BE549700 ESTs -0.70603 2.476147 9.08 Up 2.75E-04 X02162 Human mRNA for apolipoprotein Al (apo AI)=.
/PROD= pre proa pol i poprot ein Al 0.134434 3.31354 9.06 Up 7.31 E-05 AV758821 ESTs, Weakly similar to Z132_HUMAN ZINC

(H.sapiens) 1.488455 4.666225 9.05 Up 2.39E-05 NM_0001 Homo sapiens gelsolin 77 (amyloidosis, Finnish type) (GSN), mRNA.
/PROD=gelsolin (amyloidosis, Finnish type) /F L=g b: N M_000177.1 0.37879 3.553097 9.03 Up 2.87E-04 BC039295 Homo sapiens, Similar to down-regulated by Ctnnbl, a, clone MGC:39518 IMAGE:5267063, mRNA, complete cds.
/PROD=Similar to down-regulated by Ctnnbl, a /F L=g b: BC039295.1 -2.03929 1.12953 8.99 Up 1.03E-02 NM_0038 Homo sapiens interleukin 55 18 receptor 1 (IL18R1), mRNA. /PROD=interleukin 18 receptor 1 /F L=g b: N M_003855.1 gb:U43672.1 -1.95127 1.210788 8.95 Up 6.65E-03 L12468 Homo sapiens aminopeptidase A mRNA, complete cds.
/PROD=aminopeptidase A
/F L=g b: L 12468.1 g b: N M_001977.1 gb:L14721.1 -3.03451 0.120756 8.91 Up 1.30E-03 BF432875 ESTs 0.219552 3.367037 8.86 Up 1.61 E-04 BE856336 Homo sapiens mRNA;
cDNA DKFZp761 G151 (from clone DKFZp761G151); partial cds 1.091867 4.237655 8.85 Up 3.97E-03 NM_0047 Homo sapiens B-cell 65 CLLlymphoma 7C
(BCL7C), mRNA.
/PROD=B-cell CLLlymphoma 7C
/F L=g b: N M_004765.1 -1.37872 1.766362 8.85 Up 2.81 E-03 AF063825 Homo sapiens trp-related protein 4 truncated variant gamma mRNA, complete cds. /PROD=trp-related protein 4 truncated variant gamma
285 /FL=gb:AF063825.1 -0.88126 2.263541 8.84 Up 1.10E-03 BC014364 Homo sapiens, clone MG0:24252 IMAGE:3932604, mRNA, complete cds.
/PROD=Unknown (protein for MGC:24252) /FL=gb:BC014364.1 0.345528 3.488906 8.84 Up 1.32E-04 AW27618 major histocompatibility 6 complex, class II, DQ beta -1.23083 1.909333 8.82 Up 3.54E-05 AF063824 Homo sapiens trp-related protein 4 truncated variant delta mRNA, complete cds. /PROD=trp-related protein 4 truncated variant delta /FL=gb:AF063824.1 -0.95126 2.187719 8.81 Up 8.38E-04 NM_0211 Homo sapiens bHLH
70 factor Hes4 (LOC57801), mRNA. /PROD=bHLH
factor Hes4 /F L=g b: N M_021170.1 gb:AB048791.1 1.979568 5.115328 8.79 Up 1.83E-05 M17565 Human MHC class II DQ-beta associated with DRw6, DQw1 protein, complete cds.
/FL=gb:M17565.1 1.425392 4.555892 8.76 Up 1.10E-03 AB018195 Homo sapiens ca xi mRNA for carbonic anhydrase-related protein XI, complete cds.
/PROD=carbonic anhydrase-related protein XI /FL=gb:NM_001217.2 gb:ABO18195.1 g b: 60002662.1 gb:AF067662.1 -0.94697 2.181933 8.75 Up 8.53E-03 BG20809 Homo sapiens cDNA
1 FLJ37414 fis, clone BRAWH1000157.
-2.29059 0.832807 8.71 Up 1.45E-03 NM_0001 Homo sapiens dihydropyrimidine dehydrogenase (DPYD), mRNA.
/PROD=dihydropyrimidine dehydrogenase /FL=gb:AB003063.1 gb:U09178.1 g b: N M_000110.2 g b: U20938.1 1.409091 4.531365 8.71 Up 3.78E-04 AF026219 Homo sapiens HP protein (HP) mRNA, complete cds. /PROD=HP protein /FL=gb:AF026219.1 gb:AF035119.1 g b: N M_006094.2 0.038661 3.158562 8.69 Up 1.38E-02 AL831967 Homo sapiens mRNA;
cDNA DKFZp451 H072
286 (from clone DKFZp451 H072);
complete cds.
/FL=gb:AL831967.1 -0.75335 2.363345 8.67 Up 7.05E-03 AK023900 Homo sapiens cDNA
FLJ13838 fis, clone THYRO1000756, weakly similar to ALPHA-N-ACETYLGALACTOSAM IN
IDE ALPHA-2,6-SIALYLTRANSFERASE
(EC 2.4.99.-).
/F L=g b: N M_013443.1 gb:AB035173.1 -3.56757 -0.45104 8.67 Up 3.25E-03 R43486 ESTs or:cs)gene ;ho3ixAog S T; mRN , IPR+ Y --v kit 4 h tm ise p: ex-u k:ti or `+,F ", M 004*3 2 2 1 3.409815 -4.69755 275.78 Down 7.78E-05 NM 0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 2.62025 -3.04157 50.63 Down 2.62E-04 AA625683 ESTs 4.897427 -0.73179 49.5 Down 3.89E-04 R06655 ESTs, Moderately similar to AF078844 1 hqp0376 protein (H.sapiens) 3.77776 -1.65937 43.32 Down 9.82E-04 BU729850 hypothetical protein 0.757197 -4.31965 33.75 Down 9.91 E-03 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 3.025351 -1.38311 21.24 Down 1.78E-03 AW59092 ESTs 2.350127 -1.99242 20.29 Down 2.82E-04 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
0.860464 -3.44694 19.8 Down 1.25E-02 NM 0030 Homo sapiens 07 semenogelin I (SEMG1), mRNA.
/PROD=semenogelin I
/F L=g b:J04440.1
287 g b: N M_003007.1 0.579765 -3.42804 16.09 Down 1.83E-03 A1393930 ESTs 4.507212 0.732117 13.69 Down 6.09E-05 AW19694 ESTs 3.862686 0.237876 12.34 Down 1.03E-03 NM 0071 Homo sapiens tumor 15 necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA.
/PROD=tumor necrosis factor, alpha-induced protein 6 /F L=g b: N M_007115.1 2.36447 -1.22861 12.07 Down 2.57E-04 NM 0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 3.113698 -0.4652 11.95 Down 1.17E-04 NM_0021 Homo sapiens insulinoma-96 associated 1 (INSM1), mRNA.
/PROD=insulinoma-associated 1 /F L=g b: N M_002196.1 gb:M93119.1 1.05854 -2.46305 11.48 Down 2.94E-02 A1703321 wingless-type MMTV
integration site family, member 5A
3.557525 0.041029 11.44 Down 2.62E-04 BF514079 Kruppel-like factor 4 (gut) 3.806044 0.419409 10.46 Down 7.75E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 2.64743 -0.69932 10.17 Down 2.48E-03 A1702438 ESTs 3.030236 -0.17175 9.2 Down 4.80E-03 AA812232 upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 5.023981 1.931575 8.53 Down 1.95E-04 NM 0064 Homo sapiens 72 upregulated by 1,25-dihydroxyvitamin D-3 (VDUP1), mRNA.
/PROD=upregulated by 1,25-dihydroxyvitamin D-3 /F L=g b: N M_006472.1 gb:S73591.1 6.426778 3.371755 8.31 Down 2.62E-04 AF313413 Homo sapiens putative small membrane protein NID67 mRNA, complete cds. /PROD=putative small membrane protein /FL=gb:AF313413.1 -0.42962 -3.45743 8.16 Down 2.90E-02 D28364 Human mRNA for annexin 11, 5UTR (sequence from the 5cap to the start codon).
2.367534 -0.64534 8.07 Down 2.77E-02 AF098641 Homo sapiens CD44 isoform RC (CD44)
288 mRNA, complete cds.
/PROD=CD44 isoform RC
/F L=g b:AF098641.1 5.13621 2.189627 7.71 Down 2.78E-03 BC013944 Homo sapiens, Similar to myosin, heavy polypeptide 7, cardiac muscle, beta, clone IMAGE:4064393, mRNA.
2.951696 0.005808 7.71 Down 1.79E-02 ABO19562 Homo sapiens mRNA
expressed only in placental villi, clone SMAP41.
6.568635 3.642312 7.6 Down 2.61 E-04 AL031602 Human DNA sequence from clone RP5-1174N9 on chromosome 1p34.1-35.3. Contains the gene for a novel protein with IBR domain, a (pseudo?) gene for a novel protein similar to MT1 E
(metallothionein 1 E
(functional)), ESTs, STSs, GSSs and two putative Cp...
0.237018 -2.68848 7.6 Down 1.69E-02 NM 0028 Homo sapiens pentaxin-52 related gene, rapidly induced by IL-1 beta (PTX3), mRNA.
/PROD= pe ntaxi n- related gene, rapidly induced by IL-1 beta /FL=gb:M31166.1 g b: N M_002852.1 3.094055 0.187515 7.5 Down 7.78E-05 AW18819 tumor necrosis factor, 8 alpha-induced protein 6 /F L=g b: N M_007115.1 0.510307 -2.36971 7.36 Down 5.02E-02 A1040887 ESTs 2.514693 -0.35098 7.29 Down 5.77E-05 NM_1450 Homo sapiens 32 hypothetical protein MGC21636 (MGC21636), mRNA.
/FL=gb:BC020572.1 gb:NM_145032.2 5.356771 2.49399 7.27 Down 2.39E-04 W92036 ESTs 4.622217 1.771706 7.21 Down 4.89E-05 AL537457 neurofilament, light polypeptide (68kD) /F L=g b: N M_006158.1 7.360687 4.513462 7.2 Down 5.28E-04 BF217861 metallothionein 1 E
(functional) 5.388254 2.562722 7.09 Down 4.27E-04 NM 0042 Homo sapiens solute 07 carrier family 16 (monocarboxylic acid transporters), member 3 (SLC16A3), mRNA.
/PROD=solute carrier family 16 (monocarboxylic acidtransporters), member 3 /FL=gb:U81800.1 g b: N M_004207.1 3.462851 0.655394 7 Down 5.00E-04 BE673800 ESTs, Moderately similar
289 to KIAA1238 protein (H.sapiens) 4.749034 1.960178 6.91 Down 1.18E-02 NM_0021 Homo sapiens 3-hydroxy-30 3-methylglutaryl-Coenzyme A synthase 1 (soluble) (HMGCS1), mRNA. /PROD=3-hyd roxy-3-methylg l uta ryl-Coenzyme A synthase 1(soluble) /F L=g b: N M_002130.1 gb:L25798.1 g b: 60000297.1 4.738703 1.971781 6.81 Down 7.81 E-04 NM_0140 Homo sapiens 33 DKFZP586AO522 protein (DKFZP586A0522), mRNA.
/PROD=DKFZP586A0522 protein /F L=g b: N M_014033.1 2.28595 -0.4498 6.66 Down 2.03E-03 BE504838 ESTs 1.10782 -1.62775 6.66 Down 9.81 E-04 BC029425 Homo sapiens, Similar to KIAA1275 protein, clone IMAGE:4616553, mRNA.
4.092731 1.365462 6.62 Down 2.70E-04 AL513917 solute carrier family 16 (monocarboxylic acid transporters), member 3 /F L=g b: U 81800.1 g b: N M_004207.1 3.437271 0.717704 6.59 Down 1.77E-04 AB029025 Homo sapiens mRNA for KIAA1102 protein, partial cds. /PROD=KIAA1102 protein 2.129273 -0.56464 6.47 Down 9.35E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 3.508683 0.85988 6.27 Down 4.89E-05 AK027231 Homo sapiens cDNA:
FLJ23578 fis, clone LNG 12709.
4.285883 1.64868 6.22 Down 4.39E-04 AL038787 6-phosphofructo-2-kinasefructose-2,6-biphosphatase 4 4.847114 2.216008 6.2 Down 6.18E-03 NM_0064 Homo sapiens lung type-I
74 cell membrane-associated glycoprotein (T1A-2), transcript variant 2, mRNA. /PROD=lung type-I cell membrane-associatedg lycoprotei n, isoform 2 precursor /F L=g b: N M_006474.1 gb:AF030428.1 5.095598 2.488937 6.09 Down 5.96E-03 NM 0055 Homo sapiens insulin 42 induced gene 1 (INSIG1), mRNA. /PROD=insulin induced gene 1 /F L=g b: N M_005542.1 0.547626 -2.03638 6 Down 2.43E-03 A1632015 solute carrier family 12 (sodiumpotassiumchloride
290 transporters), member 1 /F L=g b: U 58130.1 g b: N M_000338.1 3.127666 0.546103 5.99 Down 1.23E-03 NM_0035 Homo sapiens 77 undifferentiated embryonic cell transcription factor 1 (UTF1), mRNA.
/PROD=undifferentiated embryonic cell transcriptionfactor 1 /FL=gb:NM_003577.1 gb:ABO1 1076.1 1.389794 -1.18154 5.94 Down 7.75E-04 BG49869 ESTs 2.098906 -0.46916 5.93 Down 5.35E-03 NM_0039 Homo sapiens cyclin Al 14 (CCNA1), mRNA.
/PROD=cyclin Al /F L=g b: N M_003914.1 g b: U66838.1 1.361153 -1.18056 5.82 Down 5.68E-04 NM_0143 Homo sapiens POU
52 transcription factor (OCT1 1), mRNA.
/PROD=POU transcription factor /F L=g b: N M_014352.1 gb:AF133895.1 gb:AF162278.1 4.308564 1.770347 5.81 Down 3.89E-04 NM 1719 Homo sapiens sal-like 3 99 (Drosophila) (SALL3), mRNA. /PROD=sal-like 3 /F L=g b: N M_171999.1 2.798327 0.284755 5.71 Down 7.29E-03 BF062943 protocadherin 18 4.255531 1.77831 5.57 Down 8.19E-04 AF096296 Homo sapiens thymic stroma chemokine-1 precursor, mRNA, complete cds.
/PROD=thymic stroma chemokine-1 precursor /F L=g b:AF 142434.1 gb:AF096296.1 gb:AF124601.1 gb:ABO10447.1 g b: N M_006072.1 3.602406 1.138163 5.52 Down 2.16E-04 A1493245 CD44 antigen (homing function and Indian blood group system) 1.892794 -0.57116 5.52 Down 8.90E-04 AL138349 KIAA0367 protein 4.253624 1.806392 5.45 Down 2.55E-03 NM_0033 Homo sapiens visinin-like 85 1 (VSNL1), mRNA.
/PROD=visinin-like 1 /FL=gb:AF039555.1 gb:U14747.1 gb:AB001104.1 g b: N M_003385.1 4.055862 1.616613 5.42 Down 1.30E-03 AK026815 Homo sapiens cDNA:
FLJ23162 fis, clone LNG09734.
5.441963 3.012923 5.39 Down 5.89E-03 NM_0166 Homo sapiens 51 heptacellular carcinoma
291 novel gene-3 protein (LOC51339), mRNA.
/PROD=heptacellular carcinoma novel gene-3 protein /F L=g b: N M_016651.2 gb:AF251079.2 7.149479 4.725219 5.37 Down 2.79E-04 M10943 Human metallothionein-If gene (hMT-If) 4.590778 2.174965 5.34 Down 5.10E-04 BF055311 hypothetical protein 4.560288 2.150773 5.31 Down 4.80E-02 BF979497 squalene epoxidase 5.807319 3.418163 5.24 Down 4.84E-04 NM 0180 Homo sapiens 04 hypothetical protein FLJ10134 (FLJ10134), mRNA.
/PROD=hypothetical protein FLJ10134 /F L=g b: N M_018004.1 7.224807 4.842369 5.21 Down 6.39E-04 NM 0059 Homo sapiens 51 metallothionein 1H
(MT1 H), mRNA.
/PROD=metallothionein 1 H /F L=g b: N M_005951.1 7.144308 4.773705 5.17 Down 4.79E-04 BF246115 RNA helicase-related protein 3.56272 1.19687 5.15 Down 2.14E-04 NM_0032 Homo sapiens 47 thrombospondin 2 (THBS2), mRNA.
/PROD=thrombospondin 2 /F L=g b: N M_003247.1 gb:L12350.1 3.280973 0.92641 5.11 Down 8.07E-04 AL139377 Human DNA sequence from clone RP11-251J8 on chromosome 13 Contains ESTs, STSs, GSSs and a CpG island.
Contains two novel genes with two isoforms each and the KIAA0610 gene with two isoforms 2.770179 0.433532 5.05 Down 1.14E-04 AK000345 Homo sapiens cDNA
FLJ20338 fis, clone HEP12179.
3.947271 1.623385 5.01 Down 6.54E-04 A1928035 ESTs H) H9P39 at 5 day DE stage vs EXPRES 01- Intensity values are in Log2 format.
EXPRES 5D DE Ratio Direction adj. p- Gene Gene Name 01 value Identifier -4,01441 5,1241,76 5C, 3.62 Ui.~ 2,04E-04 AB 283.._ moo: uste3 ~n~,: .
.,A 3132 02i . Homo ,sapiens N -3binla ftn RNA for h patoc to co:n:p e`te c., , 1C du =:\ .i 96' 1569 { qb=A B t 8\ 2 1
292 -2.90798 5.80468 419.54 Up 6.31 E-05 NM_0016 Homo sapiens 43 apolipoprotein A-II
(APOA2), mRNA.
/PROD=apolipoprotein A-II precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 60005282.1 -3.8752 4.686662 377.9 Up 9.07E-05 AB028021 Homo sapiens HNF-3beta mRNA for hepatocyte nuclear factor-3 beta, complete cds.
/PROD=hepatocyte nuclear factor-3 beta /F L=g b:AB028021.1 g b: N M_021784.1 -5.25658 3.291398 374.28 Up 1.45E-04 AW00557 putative 47 kDa protein -4.79201 3.696679 359.21 Up 1.91 E-04 NM_0124 Homo sapiens sema 31 domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E
(SEMA3E), mRNA.
/PROD=sema domain, immunoglobulin domain (Ig), shortbasic domain, secreted, (semaphorin) 3E
/F L=g b: N M_012431.1 C gb:AB002329.1 =2989x, 3,55326 '2'-'1 07 Up 6-3,1 E-05 Y'177X0,7 H .
nom obox p rote i oo eco +! nRNA, a. q :;t3d'5t3i~~~~a :'~,si.
';'SRO D :3 C ;: Ã ob p Erott) n goosie?+';' i , 'b AY', ~.. AtiSq17' +" t.~"~, gin.. ~ a 1 .
g bõN 173849A
.3.,Y. õ9 202. U *\ D87811 ~,~1 1 ~; .: ~1:)~*`>:. .......~~< Y: ~3 S~\~:==S`OA ~.YD t ~ a:i ;+;R\r\ for GA 4 v*i-6. compk to eds.
t3:U661 U661075 A
ib:N`,0 00525. : , q\2~0'8781 1.1 -2.0457 5.432491 178.3 Up 3.17E-04 A1422986 ESTs 3J,32093 82 Up * = 22, Homo sap~ens 54 hypoi3'etk"'M Protein' FL. x.22..: 3.2 sirniiar to gt'ne 17 (F J22 5:
nRINM A.

;.~ ; ` J22=5 3 Wj\:\~ln:, "\~.a. a,A..~..v A- tit -" i.
t~ =, b: 1 022 , 54 ' -3.20091 4.115748 159.42 Up 4.55E-03 NM0026 Homo sapiens PDZ
293 14 domain containing 1 (PDZK1), mRNA.
/PROD=PDZ domain containing 1 /F L=g b: N M_002614.1 gb:AF012281.1 -1.55323 5.756709 158.68 Up 1.18E-04 A1821586 ESTs, Moderately similar to JE0284 Mm-1 cell derived transplantability-associated protein 1 b (H.sapiens) -1.32044 5.931596 152.43 Up 1.87E-03 AF01 7987 Homo sapiens secreted apoptosis related protein 2 (SARP2) mRNA, complete cds. /PROD=secreted apoptosis related protein 2 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 -2.07937 5.100657 145.01 Up 1.38E-03 NM_0016 Homo sapiens 43 apolipoprotein A-II
(APOA2), mRNA.
/PROD=apolipoprotein A-II precursor /F L=g b: M29882.1 g b: N M_001643.1 g b: 60005282.1 -1.44407 5.698139 141.26 Up 7.86E-04 U91903 Human Fritz mRNA, complete cds.
/PROD=Fritz /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 -1.89695 5.224062 139.2 Up 2.36E-04 AL136944 Homo sapiens mRNA;
cDNA DKFZp586J0624 (from clone DKFZp586J0624);
complete cds.
/PROD=hypothetical protein /FL=gb:AF215636.1 g b: N M_014585.1 gb:AF231121.1 gb:AF226614.1 g b:AL 136944.1 -1.39784 5.68934 135.97 Up 4.88E-04 BE222344 splicing factor, arginineserine-rich 5 -0.77864 6.281843 133.48 Up 2.22E-04 NM_0220 Homo sapiens reserved 55 (KCNK12), mRNA.
/PROD=tandem pore domain potassium channel THIK-2 /F L=g b: N M_022055.1 gb:AF287302.1 -4.50758 2.549475 133.16 Up 2.17E-04 AU1 18882 endothelin receptor type A
/FL=gb:NM_001957.1 g b: L06622.1
294 -3.51429 3.503914 129.63 Up 4.95E-04 AA352113 ESTs -3.66072 3.328123 127.01 Up 3.78E-04 A1240545 glycophorin B (includes Ss blood group) i 59 5, 7 2 = 1 $'` ~ 16 63 Up . O .O * * 05,.38 H o fi brob,.'.,,t ?> gr"'Ml' iacto3r 17 lFGF n RNA, J 'F

`0 3 `$7.
i b: `O9 2$$.
-3.61621 3.217076 114.03 Up 1.27E-03 AL569326 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds -1.66311 5.134985 111.28 Up 4.22E-04 S69738 MCP-1=monocyte chemotactic protein (human, aortic endothelial cells, mRNA, 661 nt).
/PROD=MCP-1 -0.83997 5.93144 109.24 Up 2.98E-04 A1821669 ESTs -0.98665 5.726104 104.89 Up 5.59E-04 NM_0014 Homo sapiens frizzled-63 related protein (FRZB), mRNA. /PROD=frizzled-related protein /FL=gb:U24163.1 gb:U68057.1 g b: N M_001463.1 gb:U91903.1 -2.5679 4.137457 104.36 Up 7.79E-05 AL 121722 Human DNA sequence from clone RP4-788L20 on chromosome 20 Contains the HNF3B
(hepatocyte nuclear factor 3, beta) gene. a novel gene based on ESTs, ESTs, STSs, GSSs and CpG Islands -1.80965 4.847846 100.95 Up 1.46E-03 NM_1525 Homo sapiens 06 hypothetical protein FLJ32835 (FLJ32835), mRNA.
/F L=g b: N M_152506.1 0.502235 7.009369 90.96 Up 6.31 E-05 NM_0148 Homo sapiens KIAA0878 99 protein (KIAA0878), mRNA. /PROD=KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 -2.72686 3.743779 88.69 Up 2.40E-04 A1692180 PTPRF interacting protein, binding protein 2 (liprin beta 2) -3.53873 2.900762 86.79 Up 7.01 E-04 A1675836 Human DNA sequence from clone RP11-446H 13 on chromosome 10.
Contains the 3 end of the gene for a novel protein similar to KIAA1059 (ortholog of mouse VPS10 domain receptor protein
295 SORCS), an RPL23A
(60S ribosmal protein 23A) pseudogene, ESTs, STSs an 0.756526 7.184293 86.09 Up 1.32E-04 NM_0030 Homo sapiens secreted 12 frizzled-related protein 1 (SFRP1), mRNA.
/PROD=secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1 gb:AF001900.1 1.194285 7.539085 81.28 Up 1.91 E-04 NM_0018 Homo sapiens cystatin SN
98 (CST1), mRNA.
/PROD=cystatin SN
/FL=gb:J03870.1 g b: N M_001898.1 -3.13458 3.167207 78.89 Up 3.78E-04 A1767388 Human DNA sequence from clone RP5-1024N4 on chromosome 1p32.1-33. Contains the gene for a novel Sodium:solute symporter family member similar to SLC5A1 (SGLT1), a pseudogene similar to part of butyrophilin family members, a novel gene, ESTs, STSs, GS
-2.16064 4.140592 78.86 Up 3.71 E-03 NM_0004 Homo sapiens nuclear 75 receptor subfamily 0, group B, member 1 (NROB1), mRNA.
/PROD=adrenal hypoplasia protein /F L=g b: N M_000475.2 -3.54017 2.700772 75.63 Up 7.42E-04 NM_0020 Homo sapiens gastrin-91 releasing peptide (GRP), mRNA. /PROD=gastrin-releasing peptide /F L=g b: N M_002091.1 g b: K02054.1 g b: BC004488.1 -0.10733 6.129363 75.41 Up 1.89E-04 80005107 Homo sapiens, clone IMAGE:3840937, mRNA, partial cds.
/PROD=Unknown (protein for IMAGE:3840937) -0.70603 5.511093 74.39 Up 1.32E-04 X02162 Human mRNA for apolipoprotein Al (apo Al)=.
/PROD= pre proa pol i poprot ein Al -1.71797 4.462566 72.53 Up 1.82E-03 AL524520 G protein-coupled receptor 49 -2.6422 3.482776 69.79 Up 1.32E-04 BF589787 ESTs -2.55363 3.5449 68.52 Up 7.88E-04 NM_0051 Homo sapiens 43 haptoglobin (HP), mRNA.
296 /PROD=haptoglobin /F L=g b: K00422.1 gb:L29394.1 g b: N M_005143.1 -1.68521 4.368534 66.43 Up 8.61 E-04 NM_0027 Homo sapiens protease, 70 serine, 2 (trypsin 2) (PRSS2), mRNA.
/PROD=protease, serine, 2 (trypsin 2) /FL=gb:M27602.1 gb:NM_002770.1 -0.81978 5.225222 66.03 Up 2.29E-04 A1824037 ESTs, Weakly similar to AFFINITY
IMMUNOGLOBULIN
EPSILON FC RECEPTOR
(M.musculus) -3.86227 2.17108 65.5 Up 3.68E-03 000178 Homo sapiens glycophorin Erik STA (GPErik) gene complete cds.
/PROD=glycophorin Erik (STA) /FL=gb:000178.1 -1.09421 4.938977 65.49 Up 6.31 E-05 AK023621 Homo sapiens cDNA
FLJ13559 fis, clone PLACE1007852, highly similar to Homo sapiens mRNA for KIAA0878 protein.
0.663834 6.652281 63.49 Up 1.91 E-04 A1817041 G protein-coupled receptor -0.58181 5.375577 62.14 Up 1.45E-04 NM_0000 Homo sapiens 39 apolipoprotein A-1 (APOA1), mRNA.
/PROD=apolipoprotein A-1 precursor /FL=gb:M27875.1 gb:M11791.1 g b: N M_000039.1 gb:BC005380.1 -1.54589 4.362835 60.08 Up 1.73E-03 AW08823 ESTs -0.07494 5.828115 59.84 Up 1.54E-04 NM_0013 Homo sapiens dual 94 specificity phosphatase 4 (DUSP4), mRNA.
/PROD=dual specificity phosphatase 4 /F L=g b: N M_001394.2 g b: 80002671.1 gb:U48807.1 gb:U21108.1 -4.56294 1.310101 58.61 Up 1.11 E-03 NM_0024 Homo sapiens 43 microseminoprotein, beta-(MSMB), mRNA.
/PROD=microseminoprote in, beta-/F L=g b: N M_002443.1 -3.4744 2.363586 57.2 Up 2.68E-03 L32867 Homo sapiens alpha 2,8-sialyltransfe rase mRNA, complete cds.
/PROD=alpha 2,8-
297 sialyltransferase /F L=g b: L43494.1 gb:D26360.1 gb:L32867.1 g b: N M_003034.1 -2.46443 3.369728 57.05 Up 1.45E-04 AL450314 Novel human gene mapping to chomosome 22. /PROD=hypothetical protein 1.388898 7.19192 55.83 Up 8.20E-05 BE620739 ESTs -4.00586 1.787905 55.48 Up 2.21 E-04 A1032108 hepatocyte nuclear factor 4, alpha -3.79684 1.959873 54.07 Up 2.17E-04 AK026720 Homo sapiens cDNA:
FLJ23067 fis, clone LNG04993.
-0.66587 5.083659 53.8 Up 1.91 E-04 NM_0013 Homo sapiens deiodinase, 62 iodothyronine, type III
(D103), mRNA.
/PROD=thyroxine deiodinase type III
/F L=g b: N M_001362.1 gb:S79854.1 -01,18863 5.551911 53,47 Up 3.,52E-04 .AV700724 j * T-b .. o 002052,1 _; b: L343571' 0.800949 6.531642 53.1 Up 1.02E-04 NM_0307 Homo sapiens scavenger 81 receptor with C-type lectin (SRCL), mRNA.
/PROD=scavenger receptor with C-type lectin /F L=g b: N M_030781.1 -1.61054 4.10541 52.56 Up 5.56E-04 AW26420 ESTs -2.91295 2.78771 52.01 Up 6.07E-03 AW00557 putative 47 kDa protein -2.50006 3.186935 51.52 Up 8.45E-04 U66061 Human germline T-cell receptor beta chain TCRBV17S1AlT, TCRBV2S1, TCRBV10S1 P, TCRBV29S1 P, TCRBV19S1 P, TCRBV15S1, TCRBV11 S1 Al T, HVB
relic, TCRBV28S1 P, TCRBV34S1, TCRBV14S1, TCRBV3S1, TCRBV4S1A1T, TRY4, TRY5, TRY6, TRY7, TRY8, TCRBD1, TCRBJISI, TCRB...
-1.70149 3.97514 51.15 Up 1.10E-03 AF225426 Homo sapiens HT016 mRNA, complete cds.
/PROD=HT016 /FL=gb:AF225426.1 -2.50335 3.151666 50.39 Up 2.47E-04 AA781795 ESTs -3.2144 2.380089 48.32 Up 4.61 E-03 NM_0209 Homo sapiens 95 haptoglobin-related protein (HPR), mRNA.
298 /PROD=haptoglobin-related protein /F L=g b: N M_020995.1 0.83572 6.417467 47.89 Up 1.94E-04 N21138 KIAA0878 protein /F L=g b: N M_014899.1 gb:AB020685.1 -2.4051 3.170689 47.7 Up 1.32E-04 NM_0210 Homo sapiens 20 F37Esophageal cancer-related gene-coding leucine-zipper motif (FEZ1), mRNA.
/PROD=F37Esophageal cancer-related gene-codingleucine-zipper motif /FL=gb:AF123659.1 g b: N M_021020.1 -3.91992 1.65452 47.65 Up 2.78E-04 AL553774 KIAA1462 protein -3.39007 2.175099 47.35 Up 5.44E-03 NM_0066 Homo sapiens cell 14 adhesion molecule with homology to L1 CAM
(close homologue of L1) (CHL1), mRNA.
/PROD=cell adhesion molecule with homology to L1 CAM(close homologue of L1) /FL=gb:AF002246.1 g b: N M_006614.1 -1.77041 3.785027 47.03 Up 1.43E-03 NM_0039 Homo sapiens sema 66 domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
(SEMA5A), mRNA.
/PROD=sema domain, seven thrombospondin repeats (type1 and type 1-like), transmem -2.1243 3.414352 46.48 Up 7.42E-04 AL590118 Novel human mRNA from chromosome 22. Splice variant of dJ222 E 13. C22.1.
/PROD=hypothetical protein -3.71922 1.808255 46.13 Up 6.31 E-05 NM_0123 Homo sapiens atrophin-1 01 interacting protein 1;
activin receptor interacting protein 1 (KIAA0705), mRNA. /PROD=atrophin-1 interacting protein 1;
activinreceptor interacting protein 1 /F L=g b: N M_012301.1 gb:AF038563.1 0.282425 5.79006 45.49 Up 2.52E-04 AW77219 Homo sapiens clone 2 23736 mRNA sequence 1.314051 6.761422 43.63 Up 8.20E-05 80000740 Homo sapiens,
299 cholecystokinin B
receptor, clone MGC:2199, mRNA, complete cds.
/PROD=cholecystokinin B
receptor /FL=gb:L07746.1 gb:L08112.1 gb:S70057.1 gb:B0000740.1 gb:L04473.1 g b: N M_000731.1 1.048741 6.488423 43.4 Up 1.43E-04 NM 0018 Homo sapiens cystatin S
99 (CST4), mRNA.
/PROD=cystatin S
/F L=g b: N M_001899.1 -0.26005 5.163577 42.92 Up 3.89E-04 R72286 microfibrillar-associated protein 4 -3.53207 1.859147 41.97 Up 6.92E-04 NM_0027 Homo sapiens protease, 69 serine, 1 (trypsin 1) (PRSS1), mRNA.
/PROD=protease, serine, 1 (trypsin 1) /F L=g b: M22612.1 g b: N M_002769.1 -0.2425 5.144972 41.86 Up 1.91 E-04 NM_0182 Homo sapiens 86 hypothetical protein FLJ10970(FLJ10970), mRNA.
/PROD=hypothetical protein FLJ10970 /F L=g b: N M_018286.1 -3.14727 2.237789 41.79 Up 9.13E-03 NM_0011 Homo sapiens 47 angiopoietin 2 (ANGPT2), mRNA.
/PROD=angiopoietin 2 /FL=gb:AB009865.1 gb:AF004327.1 g b: N M_001147.1 -3.69577 1.687554 41.74 Up 3.38E-03 AL133386 Human DNA sequence from clone RP1-181 C24 on chromosome 6pl 1.1-12.2. Contains the 3 end of the BMP5 gene for bone morphogenetic protein 5, ESTs, STSs and GSSs /FL=gb:M60314.1 g b: N M_021073.1 0.828899 6.191145 41.13 Up 1.33E-04 NM_0012 Homo sapiens bone 00 morphogenetic protein 2 (BMP2), mRNA.
/PROD=bone morphogenetic protein 2 precursor /F L=g b: N M_001200.1 -3.26893 2.058218 40.15 Up 5.08E-04 NM_0017 Homo sapiens cytidine 85 deaminase (CDA), mRNA.
/PROD=cytidine deaminase /FL=gb:L27943.1 g b: N M_001785.1
300 0.804491 6.097871 39.22 Up 1.58E-04 AA583044 bone morphogenetic protein 2 /F L=g b: N M_001200.1 -3.25961 2.021534 38.89 Up 1.07E-02 NM_0163 Homo sapiens pancreas-41 enriched phospholipase C
(LOC51196), mRNA.
/PROD=pancreas-enriched phospholipase C
/F L=g b:AF 117948.1 gb:NM_016341.1 g b:AF 190642.2 -1.83503 3.428167 38.4 Up 1.04E-03 AA552969 ESTs -1.9473 3.313481 38.34 Up 1.92E-03 U43328 Human link protein mRNA, complete cds. /PROD=link protein /F L=g b: N M_001884.1 gb:U43328.1 1.563993 6.815362 38.09 Up 6.31 E-05 NM_0024 Homo sapiens microsomal 13 glutathione S-transferase 2 (MGST2), mRNA.
/PROD=microsomal glutathione S-transferase 2 /FL=gb:NM_002413.1 g b: U 77604.1 0.753353 5.985265 37.58 Up 6.31 E-05 NM_0218 Homo sapiens 27 hypothetical protein FLJ23514 (FLJ23514), mRNA.
/PROD=hypothetical protein FLJ23514 /F L=g b: N M_021827.1 -3.95062 1.221052 36.04 Up 2.88E-03 AU 144247 Homo sapiens cDNA
FLJ13443 fis, clone -1.92059 3.223801 35.37 Up 7.42E-04 A1738662 homeo box HB9 /F L=g b: N M_005515.1 0.007601 5.147748 35.26 Up 1.45E-04 N63706 ESTs -3.12184 2.01388 35.16 Up 5.36E-04 A1700341 ESTs 1.470195 6.597094 34.94 Up 8.20E-05 A1676059 ESTs -2.81405 2.284598 34.26 Up 1.27E-03 A1694325 ESTs -2.83906 2.251765 34.08 Up 1.40E-04 T15545 ESTs -0.27888 4.797361 33.74 Up 1.91 E-04 AF225513 Homo sapiens cAMP-dependent protein kinase inhibitor beta mRNA, complete cds.
/PROD=cAMP-dependent protein kinase inhibitor beta /FL=gb:AF225513.1 -2.80061 2.271493 33.64 Up 1.79E-03 NM _0146 Homo sapiens S100 24 calcium-binding protein A6 (calcyclin) (S100A6), mRNA. /PROD=S100 calcium-binding protein A6 /F L=g b: N M_014624.2 gb:B0001431.1 -3.7619 1.277348 32.88 Up 1.63E-04 NM _0161 Homo sapiens transient 79 receptor potential channel 4 (TRPC4), mRNA.
/PROD=transient receptor
301 potential 4 /F L=g b: N M_016179.1 gb:AF175406.1 0.366041 5.37746 32.25 Up 1.45E-04 A1242583 Homo sapiens cDNA
FLJ1 1550 fis, clone 1.696658 6.703009 32.14 Up 1.02E-04 L01639 Human (clone HSY3RR) neuropeptide Y receptor (NPYR) mRNA, complete cds. /PROD=neuropeptide Y receptor /FL=gb:L06797.1 g b: N M_003467.1 gb:AF025375.1 gb:AF147204.1 gb:M99293.1 gb:L01639.1 -3.62742 1.377732 32.11 Up 4.73E-03 AA772920 ESTs -0.22337 4.733912 31.07 Up 6.84E-04 NM_0218 Homo sapiens phorbolin-22 like protein MDS019 (MDS019), mRNA.
/PROD= ph o rbol i n-like protein MDS019 /F L=g b:AF 182420.1 g b: N M_021822.1 -2.33835 2.59894 30.64 Up 8.18E-03 L33477 Human (clone 8B1) Br-cadherin mRNA, complete cds. /PROD=Br-cadherin /F L=g b: L34057.1 gb:L33477.1 g b: N M_004061.1 0.713597 5.633194 30.27 Up 4.33E-04 BF508344 ESTs 0.299946 5.21645 30.2 Up 3.47E-03 NM_0013 Homo sapiens cystatin SA
22 (CST2), mRNA.
/PROD=cystatin SA
/F L=g b: N M_001322.1 -1.43446 3.469297 29.93 Up 3.61 E-03 AW29148 ESTs -0.11092 4.785145 29.78 Up 2.75E-04 BF591483 ESTs 2.3t68939 7,24917 29,45 Up 1,43E-04 A\ 2,2 869 ; omo X , 4 S~'N ^~ e~A~~~~\~\1~~~`~ receptor -2.68947 2.167726 28.98 Up 1.86E-02 AW29140 ESTs -3.25309 1.589977 28.7 Up 2.04E-03 AL050154 Homo sapiens mRNA;
cDNA DKFZp586LO120 (from clone DKFZp586LO1 20).
-3.17056 1.66331 28.52 Up 2.66E-04 A1801626 ESTs, Moderately similar to ALU4_HUMAN ALU

SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -0.41404 4.412864 28.38 Up 3.12E-04 A1332407 secreted frizzled-related protein 1 /FL=gb:AF056087.1 g b: N M_003012.2 gb:AF017987.1
302 gb:AF001900.1 -0.47614 4.348662 28.34 Up 2.59E-04 BF508639 Homo sapiens mRNA;
cDNA DKFZp434E082 (from clone DKFZp434E082) -0.88175 3.931755 28.12 Up 6.39E-04 A1650874 ESTs -2.66737 2.145076 28.1 Up 6.31 E-05 BF060736 ESTs -1.42034 3.315265 26.64 Up 7.42E-04 BE737251 Homo sapiens cDNA:
FLJ22482 fis, clone HRC1 0859, highly similar to IR0180147 Homo sapiens mRNA full length insert cDNA clone -3.9115 0.79001 26.02 Up 2.08E-03 NM_0057 Homo sapiens RAS
39 guanyl releasing protein 1 (calcium and DAG-regulated) (RASGRP1), mRNA. /PROD=RAS
guanyl releasing protein 1 /FL=gb:AF081195.1 gb:NM_005739.2 gb:AF106071.1 0.041468 4.741042 25.98 Up 4.95E-04 BF130943 ESTs -2.45311 2.234445 25.77 Up 2.11 E-02 BC042378 Homo sapiens, clone IMAGE:5277693, mRNA.
-2.50168 2.154999 25.22 Up 1.22E-02 X16468 Human mRNA for alpha-1 type 11 collagen.
-2.81453 1.810003 24.67 Up 2.55E-02 BC014585 Homo sapiens, clone IMAGE:4047715, mRNA.
-1.54464 3.064723 24.41 Up 1.58E-04 A1743534 Homo sapiens mRNA;
cDNA DKFZp564B1 162 (from clone DKFZp564B1 162);
complete cds /F L=g b:AL 136646.1 -0.20114 4.391607 24.13 Up 2.40E-04 NM_0002 Homo sapiens paired box 80 gene 6 (aniridia, keratitis) (PAX6), mRNA.
/PROD=paired box gene 6, isoform a /F L=g b: N M_000280.1 gb:M93650.1 -2.26295 2.328666 24.11 Up 3.38E-03 A1735586 ESTs 2.194421 6.729686 23.19 Up 6.31 E-05 AF348491 Homo sapiens chemokine receptor CXCR4 mRNA, complete cds.
/PROD=chemokine receptor CXCR4 /F L=g b:AF348491.1 -2.05438 2.47465 23.09 Up 7.80E-03 BG29090 ESTs, Moderately similar 8 to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) -2.56112 1.953388 22.86 Up 3.79E-02 NM_0020 Homo sapiens guanylate 98 cyclase activator 1 B
303 (retina) (GUCA1 B), mRNA. /PROD=guanylate cyclase activator 1 B
(retina) /FL=gb:M95174.1 g b: N M_002098.1 gb:M97496.1 1.186033 5.699787 22.84 Up 3.11 E-04 A1627704 ESTs, Weakly similar to T17346 hypothetical protein DKFZp58601624.1 (H.sapiens) -0.37709 4.122407 22.62 Up 1.32E-04 AU 152102 Homo sapiens cDNA
FLJ 12993 fis, clone -3.10838 1.371 22.31 Up 7.67E-04 N50412 ESTs 0.581614 5.04863 22.12 Up 1.91 E-04 AF005775 Homo sapiens caspase-like apoptosis regulatory protein 2 (clarp) mRNA, alternatively spliced, complete cds.
/PROD=caspase-like apoptosis regulatory protein 2 /FL=gb:AF005775.1 -0.15629 4.305757 22.04 Up 5.69E-04 A1799018 ESTs -1.22896 3.220593 21.85 Up 3.57E-04 AA628967 ESTs, Highly similar to IHH_HUMAN INDIAN
HEDGEHOG PROTEIN
PRECURSOR (H.sapiens) -0.5982 3.842585 21.72 Up 1.62E-02 A180651 0 putative 47 kDa protein -3.64219 0.7939 21.65 Up 4.82E-02 NM_0169 Homo sapiens testican 3 50 (HSAJ1454), mRNA.
/PROD=testican 3 /F L=g b: N M_016950.1 g b: 80000460.1 gb:B0003017.1 1.168713 5.589508 21.42 Up 7.42E-04 NM_0161 Homo sapiens 16.7Kd 39 protein (LOC51142), mRNA. /PROD=16.7Kd protein /F L=g b: N M_016139.1 gb:AF078845.1 g b: 80003079.1 -0.35867 4.059826 21.38 Up 3.11 E-04 NM_0019 Homo sapiens endothelin 57 receptor type A (EDNRA), mRNA.
/PROD=endothelin receptor type A
/FL=gb:NM_001957.1 g b: L06622.1 -2.06656 2.342712 21.25 Up 3.19E-03 AF141339 Homo sapiens LYST-interacting protein LIP3 mRNA, partial cds.
/PROD=LYST-interacting protein LIP3 -0.5292 3.876079 21.19 Up 1.54E-03 A1127440 ESTs -3.10357 1.289233 21.01 Up 2.09E-04 NM_0014 Homo sapiens forkhead 53 box Cl (FOXC1), mRNA.
/PROD=forkhead box Cl
304 /F L=g b: N M_001453.1 0.143286 4.530622 20.93 Up 2.37E-03 AW15754 insulin-like growth factor 8 binding protein 5 /F L=g b: M65062.1 gb:M62782.1 g b: N M_000599.1 gb:AF055033.1 -2.7734 1.613669 20.92 Up 2.19E-03 BF515913 ESTs 0.240245 4.617197 20.78 Up 7.42E-04 BF940761 ESTs 1.203777 5.579613 20.76 Up 9.87E-05 AA633203 conserved gene amplified in osteosarcoma -0.95126 3.407252 20.51 Up 3.70E-04 NM_0211 Homo sapiens bHLH
70 factor Hes4 (LOC57801), mRNA. /PROD=bHLH
factor Hes4 /F L=g b: N M_021170.1 gb:AB048791.1 -2.50705 1.830533 20.22 Up 1.44E-02 NM 0011 Homo sapiens Rho 74 GTPase activating protein 6 (ARHGAP6), transcript variant 2, mRNA.
/PROD=Rho GTPase activating protein 6 isoform 2 /FL=gb:AF022212.2 g b: N M_001174.2 0.476688 4.813764 20.21 Up 2.22E-04 NM_0245 Homo sapiens 81 hypothetical protein FLJ 13942 (F LJ 13942), mRNA.
/PROD=hypothetical protein FLJ13942 /F L=g b: N M_024581.1 -3.12747 1.195263 20.01 Up 1.04E-03 AV726956 ESTs, Weakly similar to C35826 hypothetical 13K
protein A (H.sapiens) 1.868094 6.17918 19.85 Up 1.30E-04 H92988 tyrosine 3-monooxygenasetryptopha n 5-monooxygenase activation protein, eta polypeptide -2.08299 2.183935 19.25 Up 2.64E-02 NM_0020 Homo sapiens growth 48 arrest-specific 1 (GAS1), mRNA. /PROD=growth arrest-specific 1 /F L=g b: N M_002048.1 g b: L 13698.1 0.417034 4.677559 19.17 Up 4.65E-04 AL571375 hypothetical protein -1.42686 2.825005 19.05 Up 1.38E-03 NM_0072 Homo sapiens Kruppel-50 like factor 8 (KLF8), mRNA. /PROD=Kruppel-like factor 8 /F L=g b: U 28282.1 gb:NM_007250.1 1.829497 6.079493 19.03 Up 2.21 E-04 AA534817 ESTs, Weakly similar to ALU8_HUMAN ALU
SUBFAMILY SX
SEQUENCE
305 CONTAMINATION
WARNING ENTRY
(H.sapiens) -2.33658 1.906847 18.94 Up 4.55E-03 AW29953 ESTs -3.7558 0.485727 18.92 Up 8.76E-03 AW47365 ESTs -2.20597 2.032138 18.87 Up 3.53E-03 A1968904 ESTs -0.23726 3.987817 18.7 Up 5.55E-04 AA912476 Homo sapiens cDNA
FLJ13221 fis, clone 0.02885 4.245437 18.59 Up 1.45E-04 AL534095 hypothetical protein 1.275191 5.478497 18.42 Up 2.30E-04 A1587307 hypothetical protein /F L=g b: N M_024641.1 -2.65285 1.547186 18.38 Up 5.15E-04 BE549700 ESTs -2.40046 1.790023 18.26 Up 9.66E-03 NM_0021 Homo sapiens glycophorin 02 E (GYPE), mRNA.
/PROD=glycophorin E
/F L=g b: N M_002102.1 gb:M29610.1 0.903379 5.089167 18.2 Up 5.59E-04 AF229179 Homo sapiens kidney-specific membrane protein NX-17 mRNA, complete cds. /PROD=kidney-specific membrane protein /FL=gb:AF229179.1 -1.78964 2.376462 17.95 Up 9.77E-03 NM_0048 Homo sapiens 61 cerebroside (3-phosphoadenylylsulfate:g alactosylceramide 3) sulfotransferase (CST), mRNA.
/PROD=galactosylceramid e sulfotransferase /F L=g b: N M_004861.1 gb:D88667.1 1.641644 5.800724 17.87 Up 9.96E-04 A1922855 carboxypeptidase E
/FL=gb:NM_001873.1 -3.18081 0.961939 17.66 Up 2.69E-04 AW44981 KIAA0918 protein -2.49139 1.64952 17.64 Up 2.29E-04 AJ277914 Homo sapiens partial LHX9 gene for LIM-homeobox 9, 3UTR.
0.780949 4.89808 17.35 Up 2.32E-04 NM_0056 Homo sapiens solute 30 carrier family 21 (prostaglandin transporter), member 2 (SLC21A2), mRNA.
/PROD=solute carrier family 21 (prostag land i n tra ns porte r), member 2 /F L=g b: U 70867.1 g b: N M_005630.1 2.648874 6.762839 17.32 Up 1.18E-04AW00753 Human insulin-like growth 2 factor binding protein 5
306 (IGFBP5) mRNA
-1.99136 2.122261 17.31 Up 1.87E-03 AL 109653 Human DNA sequence from clone GS1-115M3 on chromosome Xq27.1-28 Contains a gene for a novel protein, CXorf1 (chromosome X open reading frame 1), ESTs, STSs, GSSs and a CpG
Island -3.18582 0.924726 17.27 Up 1.83E-03 A1991033 heparan sulfate proteoglycan 2 (perlecan) /F L=g b: M85289.1 g b: N M_005529.2 2.59334 6.695074 17.17 Up 9.96E-05 AA045184 ribosomal protein L14 -2.28658 1.813753 17.15 Up 4.49E-03 NM_0308 Homo sapiens 17 hypothetical protein DKFZp434FO318 (DKFZP434FO318), mRNA.
/PROD=hypothetical protein DKFZp434FO318 /F L=g b: N M_030817.1 1.603889 5.703513 17.14 Up 2.09E-04 NM_0016 Homo sapiens ADP-61 ribosylation factor 4-like (ARF4L), mRNA.
/PROD=ADP-ribosylation factor 4-like /FL=gb:U25771.1 g b: L38490.1 g b: N M_001661.1 g b: 80000043.1 -1.44072 2.657871 17.13 Up 9.96E-04 AF260333 Homo sapiens AD036 mRNA, complete cds.
/PROD=AD036 /FL=gb:AF260333.1 -0.74006 3.356451 17.11 Up 6.19E-04 NM_0143 Homo sapiens cardiac 91 ankyrin repeat protein (CARP), mRNA.
/PROD=cardiac ankyrin repeat protein /F L=g b: N M_014391.1 -1.58689 2.507158 17.08 Up 5.06E-04 A1808090 ESTs 0.800778 4.890724 17.03 Up 1.91 E-04 AF020769 Homo sapiens cardiac ventricular troponin C
mRNA, complete cds.
/PROD=cardiac ventricular troponin C
/F L=g b: N M_003280.1 gb:AF020769.1 -1.39277 2.693344 16.98 Up 3.73E-04 A1629041 ESTs -0.70855 3.373415 16.94 Up 7.93E-04 A1917371 ESTs -1.18408 2.895859 16.91 Up 1.39E-03 NM_0064 Homo sapiens 56 sialyltransferase (STHM), mRNA.
/PROD=sialyltransferase /FL=gb:U 14550.1 g b: N M_006456.1 1.076427 5.150301 16.84 Up 1.91 E-04 A1640307 protocadherin 10
307 -1.35345 2.70797 16.7 Up 1.40E-03 AW15757 ESTs, Weakly similar to 1 T00331 hypothetical protein KIAA0555 (H.sapiens) -0.60671 3.453551 16.68 Up 2.09E-03 NM_0004 Homo sapiens 58 transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor (TCF2), transcript variant a, mRNA.
/PROD=transcription factor 2, isoform a /F L=g b: N M_000458.1 -1.65513 2.402967 16.66 Up 1.07E-02 NM_0049 Homo sapiens 23 metallothionein-like 5, testis-specific (tesmin) (MTL5), mRNA.
/PRO D=meta l loth ionei n-like 5, testis-specific(tesmin) /FL=gb:U86074.1 g b: N M_004923.1 -0.45718 3.590445 16.54 Up 4.87E-04 BF939489 glycoprotein M6A
/FL=gb:D49958.1 -1.95127 2.075959 16.3 Up 3.25E-03 L12468 Homo sapiens aminopeptidase A mRNA, complete cds.
/PROD=aminopeptidase A
/F L=g b: L 12468.1 g b: N M_001977.1 gb:L14721.1 2.168853 6.193675 16.28 Up 8.20E-05 AA284532 tyrosine 3-monooxygenasetryptopha n 5-monooxygenase activation protein, eta polypeptide -4.19938 -0.18035 16.21 Up 2.14E-02 BC027866 Homo sapiens, Similar to sialyltransferase 8D
(alpha-2, 8-polysialytransfe rase), clone MGC:34450 IMAGE:5203343, mRNA, complete cds.
/PROD=Similar to sialyltransferase 8D
(alpha-2,8-polysialytransfe rase) /FL=gb:BC027866.1 -2.47297 1.540991 16.16 Up 3.51 E-02 NM_0052 Homo sapiens v-erb-a 35 avian erythroblastic leukemia viral oncogene homolog-like 4 (ERBB4), mRNA. /PROD=v-erb-a avian erythroblastic leukemia viraloncogene homolog-like 4 /FL=gb:L07868.1 g b: N M_005235.1 1.166518 5.166811 16 Up 3.17E-04 80002671 Homo sapiens, dual
308 specificity phosphatase 4, clone MGC:3713, mRNA, complete cds.
/PROD=dual specificity phosphatase 4 /F L=g b: N M_001394.2 g b: 60002671.1 gb:U48807.1 gb:U21108.1 -1.25086 2.738997 15.89 Up 4.57E-03 NM_0218 Homo sapiens angiotensin 04 I converting enzyme (peptidyl-dipeptidase A) 2 (ACE2), mRNA.
/PROD=angiotensin I
converting enzyme(peptidyl-dipeptidase A) 2 /F L=g b: N M_021804.1 gb:AF241254.1 gb:AB046569.1 gb:AF291820.1 0.502333 4.476006 15.71 Up 6.47E-04 AF211891 Homo sapiens Mix-like homeobox protein 1 (MILD1) mRNA, complete cds. /PROD=Mix-like homeobox protein 1 /FL=gb:AF211891.1 1.520924 5.473417 15.48 Up 4.31 E-04 U87460 Human putative endothelin receptor type B-like protein mRNA, complete cds.
/PROD=putative endothelin receptor type B-likeprotein /F L=g b: U 87460.1 1.740607 5.665717 15.19 Up 1.78E-04 NM_0021 Homo sapiens 60 hexabrachion (tenascin C, cytotactin) (HXB), mRNA.
/PROD=hexabrachion (tenascin C, cytotactin) /FL=gb:M55618.1 g b: N M_002160.1 0.449168 4.362026 15.06 Up 1.33E-04 A1688418 plexin A2 1.452987 5.359741 15 Up 1.54E-04 A1813654 ESTs, Weakly similar to T32252 hypothetical protein T15B7.2 -Caenorhabditis elegans (C.elegans) -1.10807 2.786741 14.87 Up 2.36E-04 BC028058 Homo sapiens, UDP-GIcNAc:betaGal beta-1,3-N-acetylglucosaminyltransfer ase 5, clone MGC:39847 IMAGE:5175670, mRNA, complete cds.
/PROD=UDP-GIcNAc: betaGalbeta-1,3-N-acetylglucosaminyltransfer ase 5 /FL=gb:BC028058.1
309 -2.2316 1.662544 14.87 Up 1.07E-02 AA757630 ESTs 1.861693 5.752015 14.83 Up 3.11 E-04 A1374739 ESTs 0.219552 4.102867 14.76 Up 1.43E-04 BE856336 Homo sapiens mRNA;
cDNA DKFZp761G151 (from clone DKFZp761 G151); partial cds 0.608519 4.456307 14.4 Up 1.72E-04 U97075 Homo sapiens FLICE-like inhibitory protein short form mRNA, complete cds. /PROD=FLICE-like inhibitory protein short form /FL=gb:U97075.1 1.438639 5.28126 14.35 Up 3.45E-04 BF223214 ESTs -2.47063 1.370067 14.33 Up 3.55E-03 H09657 ESTs 1.633768 5.465898 14.24 Up 1.32E-04 A1733465 collagen, type IX, alpha 2 /F L=g b: N M_001852.1 -0.94697 2.883335 14.22 Up 4.55E-03 BG20809 Homo sapiens cDNA
1 FLJ37414 fis, clone B RAW H 1000157.
0.177945 4.006546 14.21 Up 3.78E-04 NM_0206 Homo sapiens S100-type 72 calcium binding protein A14 (LOC57402), mRNA.
/PROD=S100-type calcium binding protein A14 /FL=gb:B0005019.1 g b: N M_020672.1 g b:AY007220.1 -0.95386 2.873194 14.19 Up 3.57E-04 AF312769 Homo sapiens cryptic mRNA, complete cds.
/PROD=cryptic /FL=gb:AF312769.1 -1.84267 1.976613 14.12 Up 4.45E-02 AF213678 Homo sapiens HAI-2 related small protein (HAl-2) mRNA, complete cds.
/PROD=HAI-2 related small protein /FL=gb:AB038317.1 gb:AF213678.1 -1.42965 2.38124 14.03 Up 5.47E-03 M60721 Human homeobox gene, complete cds.
/FL=gb:M60721.1 g b: N M_021958.1 -0.75724 3.050773 14.01 Up 3.87E-03 AL445192 Human DNA sequence from clone RP1 1-269H4 on chromosome 20 Contains the 3 end of the KIAA1415 gene similar to T-Lymphona invasion and metastasis inducing protein 1, ESTs, STSs and GSSs -0.53584 3.260892 13.9 Up 5.76E-03 NM_0021 Homo sapiens glycophorin 00 B (includes Ss blood group) (GYPB), mRNA.
/PROD=glycophorin B
precursor /FL=gb:J02982.1 g b: N M_002100.2
310 0.424882 4.20576 13.75 Up 8.98E-04 A1692659 heat shock 90kD protein 1, alpha -0.13427 3.646365 13.74 Up 4.95E-04 D49958 Homo sapiens mRNA for membrane glycoprotein M6, complete cds.
/PROD=membrane glycoprotein M6 /FL=gb:D49958.1 1.359845 5.139453 13.73 Up 2.09E-04 NM_0021 Homo sapiens insulin-like 78 growth factor binding protein 6 (IGFBP6), mRNA. /PROD=insulin-like growth factor binding protein 6 /FL=gb:B0005007.1 g b: M62402.1 g b: 60003507.1 g b: N M_002178.1 0.451744 4.228949 13.71 Up 1.03E-03 NM_0013 Homo sapiens ectodermal 99 dysplasia 1, anhidrotic (ED1), mRNA.
/PROD=ectodermal dysplasia 1, anhidrotic /F L=g b:AF060999.1 g b: N M_001399.1 gb:AF040628.1 gb:AF061189.1 -1.83238 1.938552 13.65 Up 1.15E-02 A1807197 ESTs -2.85208 0.915477 13.62 Up 4.78E-03 A1423201 ESTs -0.05814 3.703455 13.56 Up 3.59E-04 BF308645 KIAA1415 protein -1.25995 2.496941 13.52 Up 7.42E-04 AK026607 Homo sapiens cDNA:
FLJ22954 fis, clone KAT09813, highly similar to AF010315 Homo sapiens Pigl1 (PIG11) mRNA.
-1.42171 2.3129 13.31 Up 4.72E-04 NM_0050 Homo sapiens neuronal cell adhesion molecule (NRCAM), mRNA.
/PROD=neuronal cell adhesion molecule /FL=gb:AB002341.1 g b: N M_005010.1 2.593137 6.314378 13.19 Up 1.91 E-04 NM_0018 Homo sapiens 73 carboxypeptidase E
(CPE), mRNA.
/PROD=carboxypeptidase E precursor /F L=g b: N M_001873.1 -2.15454 1.548754 13.03 Up 3.70E-02 NM_0120 Homo sapiens Friend of 82 GATA2 (FOG2), mRNA.
/PROD=Friend of GATA2 /F L=g b: N M_012082.2 gb:AF1 19334.1 -2.23424 1.463376 12.97 Up 3.45E-03 U22178 Human prostatic secretory protein 57 mRNA, complete cds.
/PROD=PSP57 /FL=gb:U22178.1
311 0.882447 4.579373 12.97 Up 8.26E-04 U15979 Human (dlk) mRNA, complete cds.
/F L=g b: N M_003836.1 g b: U 15979.1 0.999053 4.691273 12.93 Up 1.43E-04 AW12959 tudor repeat associator 3 with PCTAIRE 2 -0.20099 3.487721 12.89 Up 7.70E-04 BF984830 retinoic acid induced 1 -1.08244 2.60456 12.88 Up 1.81 E-03 X75208 X75208 /FEATURE=cds /DEFINITION=HSPTKR
H.sapiens HEK2 mRNA
for protein tyrosine kinase receptor -1.2719 2.409872 12.83 Up 1.92E-03 NM_0204 Homo sapiens 06 polycythemia rubra vera 1;
cell surface receptor (PRV1), mRNA.
/PROD=polycythemia rubra vera 1; cell s u rface rece ptor /F L=g b: N M_020406.1 gb:AF146747.1 3.042634 6.716272 12.76 Up 1.52E-04 NM_0054 Homo sapiens 42 eomesodermin (Xenopus laevis) homolog (EOMES), mRNA.
/PROD=eomesodermin (Xenopus laevis) homolog /FL=gb:AB031038.1 g b: N M_005442.1 0.279226 3.951227 12.75 Up 2.73E-04 AF278532 Homo sapiens beta-netrin mRNA, complete cds.
/PROD=beta-netrin /FL=gb:AF1 19916.1 gb:AF29771 1.1 g b: N M_021229.1 gb:AF278532.1 1.071985 4.738394 12.7 Up 1.78E-04 NM_0045 Homo sapiens receptor 60 tyrosine kinase-like orphan receptor 2 (ROR2), mRNA.
/PROD=receptor tyrosine kinase-like orphan receptor 2 /FL=gb:M97639.1 g b: N M_004560.1 2.839833 6.489379 12.55 Up 1.45E-04 A1078167 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha /F L=g b: N M_020529.1 g b: 60002601.1 g b: 60004983.1 g b: M69043.1 -0.28951 3.358536 12.54 Up 3.81 E-04 NM_0183 Homo sapiens 88 hypothetical protein FLJ11316 (FLJ11316), mRNA.
/PROD=hypothetical protein FLJ11316
312 /F L=g b: N M_018388.1 -1.89628 1.750206 12.52 Up 1.09E-03 AA557324 ESTs, Weakly similar to fatty acid omega-hydroxylase (H.sapiens) -0.41578 3.210639 12.35 Up 9.09E-04 NM_0023 Homo sapiens lumican 45 (LUM), mRNA.
/PROD=lumican /F L=g b: N M_002345.1 gb:U18728.1 gb:U21128.1 -2.37004 1.251403 12.31 Up 2.48E-02 AL136607 Homo sapiens mRNA;
cDNA DKFZp56410422 (from clone DKFZp56410422);
complete cds.
/PROD=hypothetical protein /FL=gb:AL136607.1 -1.71673 1.894393 12.22 Up 1.15E-03 NM_0004 Homo sapiens Kell blood 20 group (KEL), mRNA.
/PROD=Kell blood group antigen /FL=gb:B0003135.1 g b: N M_000420.1 1.192657 4.801382 12.2 Up 2.40E-04 NM_0246 Homo sapiens 41 hypothetical protein FLJ12838(FLJ12838), mRNA.
/PROD=hypothetical protein FLJ12838 /F L=g b: N M_024641.1 -1.18483 2.411486 12.09 Up 4.96E-03 BE551416 ESTs, Weakly similar to KIAA1330 protein (H.sapiens) -2.33994 1.256182 12.09 Up 1.80E-02 AL134708 ESTs 1.040647 4.635771 12.08 Up 5.15E-04 A1348094 KIAA0882 protein -0.68921 2.90298 12.06 Up 1.76E-04 NM_0165 Homo sapiens 46 complement Cl r-like proteinase precursor, (LOC51279), mRNA.
/PROD=complement Cl r-like proteinase precursor, /FL=gb:AF178985.1 g b: N M_016546.1 0.631332 4.218347 12.02 Up 2.78E-04 A1130705 ESTs, Weakly similar to A46302 PTB-associated splicing factor, long form (H.sapiens) 0.449933 4.035966 12.01 Up 1.08E-03 Z21533 H.sapiens HEX gene encoding homeobox related protein.
/PROD=homeobox related protein -0.29145 3.291186 11.98 Up 1.87E-03 A1197932 ESTs -0.12863 3.441776 11.88 Up 9.23E-04 AV699825 Homo sapiens cDNA
FLJ13221 fis, clone -1.2534 2.309237 11.82 Up 1.91 E-03 AW16772 ESTs -3.44338 0.118393 11.81 Up 5.12E-04 A1336920 ESTs, Weakly similar to
313 138428 T-complex protein 10A (H.sapiens) -1.74597 1.814225 11.8 Up 1.77E-02 AW26981 hypothetical protein /F L=g b: N M_022068.1 -1.28224 2.27746 11.79 Up 4.88E-04 NM_0055 Homo sapiens LIM
68 homeobox protein 1 (LHX1), mRNA.
/PROD=LIM homeobox protein 1 /F L=g b: N M_005568.1 gb:U14755.1 -1.28314 2.272713 11.76 Up 1.08E-02 NM_0018 Homo sapiens cartilage 84 linking protein 1 (CRTL1), mRNA. /PROD=cartilage linking protein 1 /F L=g b: N M_001884.1 gb:U43328.1 0.085832 3.636571 11.72 Up 5.91 E-04 AA639753 ESTs -0.41626 3.117859 11.58 Up 4.87E-04 BF110534 ESTs 0.134434 3.659063 11.51 Up 4.41 E-04 AV758821 ESTs, Weakly similar to Z132_HUMAN ZINC

(H.sapiens) -0.13959 3.371263 11.4 Up 1.78E-04 BG10985 Homo sapiens clone TUA8 Cri-du-chat region mRNA
-0.21951 3.281608 11.32 Up 4.51 E-04 AL575177 noggin /F L=g b: N M_005450.1 1.470971 4.963113 11.25 Up 1.58E-04 NM_0228 Homo sapiens porcupine 25 (MG61), mRNA.
/PROD=porcupine /FL=gb:AF317059.1 gb:AF317058.1 g b: N M_022825.1 -1.77455 1.705193 11.16 Up 9.89E-03 AF140507 Homo sapiens Ca2+calmodulin-dependent protein kinase kinase beta (CAMKKB) mRNA, complete cds.
/PROD =Ca2+ca l m od u l i n-dependent protein kinase kinasebeta /FL=gb:AF140507.1 -0.63867 2.838534 11.14 Up 1.33E-04 BF508948 phorbolin-like protein 1.372194 4.848723 11.13 Up 2.69E-04 A1677701 ESTs, Weakly similar to S38383 SEB4B protein (H.sapiens) 2.377335 5.850689 11.11 Up 3.11 E-04 NM_0053 Homo sapiens hyaluronan 28 synthase 2 (HAS2), mRNA.
/PROD=hyaluronan synthase 2 /F L=g b: U 54804.1 g b: N M_005328.1 0.244521 3.706479 11.02 Up 1.54E-04 AF1 90725 Homo sapiens beta-site APP cleaving enzyme (BACE) mRNA, complete
314 cds. /PROD=beta-site APP cleaving enzyme /FL=gb:AF200343.1 gb:AF204943.1 gb:AF190725.1 gb:AF201468.1 gb:NM_012104.1 1.790331 5.251922 11.02 Up 3.68E-04 AA775681 hypothetical protein 1.592531 5.049671 10.98 Up 7.29E-04 BE502982 ESTs 4-0 ,. 7.483078 10, .. 61 \ P = E 0 . N,\ Z. 0 .., k eo:'t:\; `~~~~ 4~''m cerbcma 541 , (Xenopu ,aevis) hoznok~g (Cystein'e knot ...',.hA, IIP O i=cerberi 4.897427 -0.40571 39.48 Down 5.51 E-03 R06655 ESTs, Moderately similar to AF078844 1 hqp0376 protein (H.sapiens) 2.000419 -2.84891 28.83 Down 3.77E-03 NM 0312 Homo sapiens testis 72 expressed sequence 14 (TEX14), mRNA.
/PROD=testis expressed sequence 14 /FL=gb:NM_031272.1 2.75017 -1.94826 25.96 Down 1.63E-04 NM 0148 Homo sapiens KIAA0469 51 gene product (KIAA0469), mRNA. /PROD=KIAA0469 gene product /FL=gb:AB007938.1 g b: N M_014851.1 3.862686 -0.73843 24.27 Down 7.42E-04 NM 0071 Homo sapiens tumor 15 necrosis factor, alpha-induced protein 6 (TNFAIP6), mRNA.
/PROD=tumor necrosis factor, alpha-induced protein 6 /F L=g b: N M_007115.1 0.144221 -4.24111 20.9 Down 1.35E-02 BC028359 Homo sapiens, clone IMAGE:4828836, mRNA.
3.77776 -0.50822 19.51 Down 1.45E-04 BU729850 hypothetical protein 0.99752 -3.16289 17.88 Down 1.40E-02 AB046400 Homo sapiens mRNA for SCCA2b, complete cds.
/PROD=SCCA2b /FL=gb:AB046400.1 3.409815 -0.56562 15.73 Down 3.09E-04 NM_0165 Homo sapiens neuritin 88 (LOC51299), mRNA.
/PROD=neuritin /F L=g b: N M_016588.1 g b: 60002683.1 gb:AF136631.1 0.757197 -3.1394 14.89 Down 1.40E-03 AF213459 Homo sapiens ephrin receptor EPHA3 complete form (EPHA3) mRNA, complete cds.
/PROD=ephrin receptor EPHA3 complete form
315 /F L=g b: N M_005233.1 gb:M83941.1 gb:AF213459.1 0.381955 -3.46654 14.41 Down 2.29E-03 NM 0176 Homo sapiens 55 hypothetical protein FLJ20075 (FLJ20075), mRNA.
/PROD=hypothetical protein FLJ20075 /F L=g b: N M_017655.1 0.579765 -3.20358 13.77 Down 1.32E-04 A1393930 ESTs 3.655193 -0.10882 13.59 Down 1.31 E-02 A1659927 Homo sapiens cDNA:
FLJ22547 fis, clone 5.303843 1.677393 12.35 Down 4.87E-04 A1129626 ESTs 1.10782 -2.42265 11.56 Down 1.71 E-02 BC029425 Homo sapiens, Similar to KIAA1275 protein, clone IMAGE:4616553, mRNA.
2.28595 -1.22933 11.43 Down 1.44E-03 BE504838 ESTs 2.514693 -0.98766 11.33 Down 3.64E-04 NM_1450 Homo sapiens 32 hypothetical protein MGC21636 (MGC21636), mRNA.
/FL=gb:BC020572.1 gb:NM_145032.2 2.982965 -0.50149 11.19 Down 1.41 E-03 AK026829 Homo sapiens cDNA:
FLJ23176 fis, clone LNG 10452.
2.350127 -1.0564 10.6 Down 4.33E-04 AK026106 Homo sapiens cDNA:
FLJ22453 fis, clone HRC09679, highly similar to AF059516 Homo sapiens tolloid-like 2 protein (TLL2) mRNA.
1.892794 -1.50555 10.54 Down 5.19E-03 AL138349 KIAA0367 protein 1.357098 -1.99222 10.19 Down 1.15E-02 AW02642 Homo sapiens mRNA;
6 cDNA DKFZp761J1324 (from clone DKFZp761 J 1324) 0.860464 -2.46893 10.05 Down 1.07E-02 NM 0030 Homo sapiens 07 semenogelin I (SEMG1), mRNA.
/PROD=semenogelin I
/F L=g b:J04440.1 g b: N M_003007.1 4.308564 0.981775 10.03 Down 2.66E-04 NM 1719 Homo sapiens sal-like 3 99 (Drosophila) (SALL3), mRNA. /PROD=sal-like 3 /F L=g b: N M_171999.1 0.857744 -2.42855 9.76 Down 3.75E-02 AB085901 Homo sapiens DBL mRNA
for DBL proto-oncogene splicing variant 1, complete cds.
/PROD=DBL proto-oncogene splicing variant 1 /FL=gb:AB085901.1 3.947271 0.673296 9.67 Down 6.85E-03 A1928035 ESTs 4.847114 1.59891 9.5 Down 3.74E-03 NM_0064 Homo sapiens lung type-I
74 cell membrane-associated
316 glycoprotein (T1A-2), transcript variant 2, mRNA. /PROD=lung type-I cell membrane-associatedg lycoprotei n, isoform 2 precursor /F L=g b: N M_006474.1 gb:AF030428.1 4.796495 1.557748 9.44 Down 1.32E-04 A1653107 ESTs 4.952105 1.726419 9.35 Down 1.09E-03 BG16436 microtubule-associated protein 1 B
/F L=g b: N M_005909.1 5.398488 2.236155 8.95 Down 2.40E-04 NM_0011 Homo sapiens alpha-34 fetoprotein (AFP), mRNA.
/PROD=alpha-fetoprotein /F L=g b: N M_001134.1 gb:J00077.1 1.360363 -1.7842 8.84 Down 7.29E-03 BM47903 Homo sapiens, clone 4 IMAGE:5301169, mRNA
2.336954 -0.80072 8.8 Down 5.07E-02 A1632259 ESTs 4.788115 1.679617 8.62 Down 1.42E-04 AW01474 ESTs 3.094055 -0.00508 8.57 Down 1.58E-04 AW18819 tumor necrosis factor, 8 alpha-induced protein 6 /F L=g b: N M_007115.1 3.380359 0.288493 8.53 Down 1.58E-04 A1553933 solute carrier family 30 (zinc transporter), member 6.568635 3.486111 8.47 Down 3.77E-04 AL031602 Human DNA sequence from clone RP5-1174N9 on chromosome 1p34.1-35.3. Contains the gene for a novel protein with IBR domain, a (pseudo?) gene for a novel protein similar to MT1 E
(metallothionein 1 E
(functional)), ESTs, STSs, GSSs and two putative Cp...
2.79562 -0.27455 8.4 Down 6.95E-04 NM 0245 Homo sapiens 82 hypothetical protein FLJ23056 (FLJ23056), mRNA.
/PROD=hypothetical protein FLJ23056 /F L=g b: N M_024582.1 4.507212 1.466775 8.23 Down 1.45E-04 AW19694 ESTs 1.349693 -1.67509 8.14 Down 2.76E-04 A1963083 ESTs 3.19487 0.179371 8.09 Down 2.85E-03 NM_1735 Homo sapiens 53 hypothetical protein FLJ25801 (FLJ25801), mRNA.
/FL=gb:NM_l 73553.1 5.650767 2.645343 8.03 Down 1.24E-03 NM_0020 Homo sapiens fibroblast 06 growth factor 2 (basic) (FGF2), mRNA.
/PROD=fibroblast growth
317 factor 2 (basic) /F L=g b: N M_002006.1 gb:M27968.1 3.113698 0.120494 7.96 Down 1.54E-03 NM 0021 Homo sapiens insulinoma-96 associated 1 (INSM1), mRNA.
/PROD=insulinoma-associated 1 /F L=g b: N M_002196.1 gb:M93119.1 3.56272 0.596221 7.82 Down 1.58E-04 NM_0032 Homo sapiens 47 thrombospondin 2 (THBS2), mRNA.
/PROD=thrombospondin 2 /F L=g b: N M_003247.1 gb:L12350.1 2.273566 -0.68409 7.77 Down 1.21 E-03 AL 133653 Homo sapiens mRNA;
cDNA DKFZp434M2415 (from clone DKFZp434M2415).
4.143011 1.250592 7.43 Down 8.26E-04 AW66495 Homo sapiens mRNA;
3 cDNA DKFZp434P1 115 (from clone DKFZp434P1 115); partial cds 4.012773 1.121978 7.42 Down 1.58E-04 NM_0062 Homo sapiens splicing 75 factor, arginineserine-rich 6 (SFRS6), mRNA.
/PROD=splicing factor, arginineserine-rich 6 /FL=gb:U30883.1 g b: N M_006275.1 4.178686 1.291693 7.4 Down 1.22E-03 NM 0032 Homo sapiens tissue 56 inhibitor of metalloproteinase 4 (TIMP4), mRNA.
/PROD=tissue inhibitor of metalloproteinase 4precursor /F L=g b: N M_003256.1 gb:U76456.1 1.179422 -1.69499 7.33 Down 7.84E-03 N21096 ESTs 4.39721 1.545243 7.22 Down 1.25E-02 NM_0180 Homo sapiens 63 hypothetical protein FLJ10339 (FLJ10339), mRNA.
/PROD=hypothetical protein FLJ10339 /F L=g b: N M_018063.1 1.200505 -1.65141 7.22 Down 2.22E-04 A1939511 ESTs 2.763752 -0.07502 7.15 Down 1.05E-02 A1078169 Homo sapiens cDNA:
FLJ23176 fis, clone 2.456617 -0.3811 7.15 Down 1.10E-03 AW27401 ESTs 3.806044 0.973798 7.12 Down 3.11 E-04 AV734646 DNA segment on chromosome X (unique) 9928 expressed sequence 1.05854 -1.7603 7.06 Down 1.28E-02 A1703321 wingless-type MMTV
318 integration site family, member 5A
3.365852 0.550606 7.04 Down 4.65E-04 NM_0033 Homo sapiens wingless-92 type MMTV integration site family, member 5A
(WNT5A), mRNA.
/PROD=wingless-type MMTV integration site family, member 5A
/F L=g b: N M_003392.1 g b: L20861.1 2.768094 -0.0094 6.86 Down 1.91 E-04 A1968085 wingless-type MMTV
integration site family, member 5A
0.951905 -1.82311 6.84 Down 3.46E-02 NM 0030 Homo sapiens SWISNF
70 related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2), mRNA. /PROD=SWISNF
related, matrix associated, actindependent regulator of chromatin, subfamily a, member 2 /FL=gb:NM_003070.1 gb 4.715355 1.945181 6.82 Down 5.10E-04 AA788946 ESTs, Moderately similar to CA1C RAT COLLAGEN
ALPHA 1(XI1) CHAIN
(R. norvegicus) 2.967768 0.209555 6.77 Down 2.08E-03 AL121753 Human DNA sequence from clone RP4-61404 on chromosome 20g11.1-12 Contains the 3 part of the MMP24 (matrix metalloproteinase 24 (membrane-inserted)) gene, the ITGB4BP
(integrin beta 4 binding protein) gene, the 3 end of a novel gene, the 3 end 0...
3.932141 1.175689 6.76 Down 9.73E-04 NM_0044 Homo sapiens growth 90 factor receptor-bound protein 14 (GRB14), mRNA. /PROD=growth factor receptor-bound protein 14 /F L=g b: L76687.1 g b: N M_004490.1 1.515893 -1.22358 6.68 Down 3.73E-04 AF146343 Homo sapiens CYP7A
promoter binding factor (CPF) mRNA, complete cds. /PROD=CYP7A
promoter binding factor /F L=g b: N M_003822.1 gb:AF146343.1 gb:U80251.1 1.264681 -1.46804 6.65 Down 9.80E-03 BF724558 ESTs, Moderately similar to ALU8_HUMAN ALU
319 SUBFAMILY SX
SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 1.713798 -1.01596 6.63 Down 1.04E-03 A1692645 ESTs 3.725552 1.002058 6.6 Down 1.05E-03 AL136805 Homo sapiens mRNA;
cDNA DKFZp434J1521 (from clone DKFZp434J 1521);
complete cds.
/PROD=hypothetical protein /FL=gb:AL136805.1 3.08363 0.365051 6.58 Down 1.15E-03 U73778 Human collagen type XII
alpha-1 precursor (COL12A1) mRNA.
/PROD=collagen type XII
alpha-1 /F L=g b: N M_004370.3 5.13621 2.424893 6.55 Down 1.22E-03 BC013944 Homo sapiens, Similar to myosin, heavy polypeptide 7, cardiac muscle, beta, clone IMAGE:4064393, mRNA.
2.316204 -0.37946 6.48 Down 4.62E-03 R21486 sal (Drosophila)-like 3 4.90146 2.20907 6.46 Down 2.13E-03 AB037813 Homo sapiens mRNA for KIAA1392 protein, partial cds. /PROD=KIAA1392 protein 3.863484 1.1739 6.45 Down 2.04E-04 BE552428 hypothetical protein 2.11536 -0.56359 6.4 Down 2.50E-04 A1919519 ESTs 7.149479 4.474262 6.39 Down 4.95E-04 M10943 Human metallothionein-If gene (hMT-If) 7.360687 4.694371 6.35 Down 4.22E-04 BF217861 metallothionein 1E
(functional) 5.343502 2.678631 6.34 Down 1.35E-02 A1685060 caldesmon 1 /FL=gb:M641 10.1 g b: N M_004342.2 7.144308 4.501103 6.25 Down 7.42E-04 BF246115 RNA helicase-related protein 1.075159 -1.5631 6.23 Down 4.27E-02 J03580 Human, parathyroid-like protein (associated with humoral hypercalcemia of malignancy) mRNA, complete cds.
/FL=gb:J03580.1 1.640803 -0.9861 6.18 Down 3.01 E-03 BC042832 Homo sapiens, clone IMAGE:5314747, mRNA.
1.012356 -1.60426 6.13 Down 5.10E-04 BC036731 Homo sapiens, Similar to KIAA0441 gene product, clone MGC:45124 IMAGE:5578893, mRNA, complete cds.
/PROD=Similar to KIAA0441 gene product /FL=gb:BC036731.1 2.64743 0.040287 6.09 Down 2.48E-03 A1702438 ESTs
320 2.324824 -0.28186 6.09 Down 1.61 E-03 AL096771 Human DNA sequence from clone RP1-238D15 on chromosome 6g12-14.3 Contains part of COL12A1 (collagen, type XII, alpha 1) gene and STSs 1.840613 -0.75086 6.03 Down 1.02E-02 A1949760 ESTs, Weakly similar to unnamed protein product (H.sapiens) 4.229884 1.643039 6.01 Down 1.12E-02 BC032716 Homo sapiens, clone MGC:45425 IMAGE:5518697, mRNA, complete cds.
/PROD=Unknown (protein for MGC:45425) /FL=gb:BC032716.1 1.041771 -1.52819 5.94 Down 2.75E-02 A1798863 ESTs 5.715937 3.148402 5.93 Down 1.89E-04 U85658 Human transcription factor ERF-1 mRNA, complete cds. /PROD=ERF-1 /F L=g b: N M_003222.1 g b: U85658.1 1.546166 -1.02082 5.93 Down 1.96E-03 NM_0031 Homo sapiens tachykinin, 82 precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, neuromedin L, neurokinin alpha, neuropeptide K,neuropeptide gamma) (TAC1), transcript variant beta, mRNA.
/PROD=tachykinin 2 precursor, isoform beta /FL=gb:U3 0.170617 -2.3896 5.9 Down 2.62E-02 A1760495 ESTs 2.262799 -0.29226 5.88 Down 5.43E-03 AV725365 SWISNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 /F L=g b: N M_003070.1 gb:D26155.1 2.256527 -0.29339 5.86 Down 9.65E-05 T68445 ESTs 3.280973 0.732773 5.85 Down 8.36E-03 AL139377 Human DNA sequence from clone RP11-251J8 on chromosome 13 Contains ESTs, STSs, GSSs and a CpG island.
Contains two novel genes with two isoforms each and the KIAA0610 gene with two isoforms 2.396883 -0.14976 5.84 Down 9.07E-04 NM 0004 Homo sapiens laminin, 26 alpha 2 (merosin, congenital muscular dystrophy) (LAMA2), mRNA. /PROD=laminin alpha 2 subunit precursor
321 /F L=g b: N M_000426.1 4.738703 2.192611 5.84 Down 5.19E-04 NM_0140 Homo sapiens 33 DKFZP586AO522 protein (DKFZP586A0522), mRNA.
/PROD=DKFZP586A0522 protein /F L=g b: N M_014033.1 0.624075 -1.92148 5.84 Down 4.41 E-02 NM_1735 Homo sapiens 49 hypothetical protein FLJ39553 (FLJ39553), mRNA.
/F L=g b: N M_173549.1 4.904591 2.37385 5.78 Down 4.91 E-03 NM 0032 Homo sapiens 46 thrombospondin 1 (THBS1), mRNA.
/PROD=thrombospondin 1 /F L=g b: N M_003246.1 7.424722 4.894249 5.78 Down 3.11 E-04 AF333388 Homo sapiens metallothionein 1 H-like protein mRNA, complete cds.
/PROD=metallothionein 1 H-like protein /FL=gb:AF333388.1 3.368771 0.840887 5.77 Down 1.30E-04 BE502594 ESTs 0.899011 -1.62659 5.76 Down 2.54E-02 NM 0028 Homo sapiens parathyroid 20 hormone-like hormone (PTHLH), mRNA.
/PROD=parathyroid hormone-like hormone /FL=gb:J03802.1 g b: N M_002820.1 2.626097 0.101116 5.76 Down 2.74E-03 NM 0011 Homo sapiens ankyrin 3, 49 node of Ranvier (ankyrin G) (ANK3), transcript variant 2, mRNA.
/PROD=ankyrin 3, isoform 2 /FL=gb:NM_001149.1 gb:U43965.1 0.424388 -2.09844 5.75 Down 2.63E-02 NM 0024 Homo sapiens myelin 33 oligodendrocyte glycoprotein (MOG), mRNA. /PROD=myelin of igode nd rocyte g lycoprote i n /FL=gb:U 18798.1 gb:U64564.1 g b: N M_002433.1 2.572851 0.057742 5.72 Down 1.48E-03 AW59256 KIAA0455 gene product 7.768254 5.269899 5.65 Down 2.22E-04 NM 0059 Homo sapiens 53 metallothionein 2A
(MT2A), mRNA.
/PROD=metallothionein 2A /FL=gb:NM_005953.1 2.883717 0.391944 5.62 Down 1.29E-03 NM_0012 Homo sapiens carbonyl 36 reductase 3 (CBR3), mRNA. /PROD=carbonyl
322 reductase 3 /F L=g b: N M_001236.2 g b: 60002812.1 gb:AB004854.1 2.36447 -0.12562 5.62 Down 6.57E-03 NM 0051 Homo sapiens carbonic 81 anhydrase III, muscle specific (CA3), mRNA.
/PROD=carbonic anhydrase III
/F L=g b: 60004897.1 g b: N M_005181.2 1.578748 -0.89916 5.57 Down 2.81 E-04 AW87466 ESTs 5.295204 2.822156 5.55 Down 6.08E-04 D32039 Human pgH3 mRNA for proteoglycan PG-M(V3), complete cds.
/PROD=proteoglycan PG-M(V3) /FL=gb:D32039.1 5.817948 3.354828 5.51 Down 1.13E-04 NM0206 Homo sapiens transporter 62 similar to yeast MRS2 (MRS2L), mRNA.
/PROD=transporter similar to yeast MRS2 /F L=g b:AF288288.1 g b: N M_020662.1 0.915911 -1.54553 5.51 Down 2.09E-02 N50912 ESTs 3.557525 1.099544 5.49 Down 2.08E-03 BF514079 Kruppel-like factor 4 (gut) 2.055951 -0.39628 5.47 Down 1.36E-02 NM 0010 Homo sapiens ryanodine 35 receptor 2 (cardiac) (RYR2), mRNA.
/PROD=ryanodine receptor 2 (cardiac) /F L=g b: N M_001035.1 1.657973 -0.79412 5.47 Down 1.69E-02 NM 0017 Homo sapiens brain-09 derived neurotrophic factor (BDNF), mRNA.
/PROD=brain-derived neurotrophic factor /F L=g b: N M_001709.1 4.154511 1.702833 5.47 Down 4.62E-03 AJ010395 Homo sapiens DKC1 gene, exons 1 to 11 5.041032 2.594003 5.45 Down 1.54E-03 AK022686 Homo sapiens cDNA
FLJ 12624 fis, clone NT2RM4001754.
3.795526 1.350041 5.45 Down 6.34E-04 A1871745 ESTs 4.294951 1.865106 5.39 Down 7.73E-04 A1634411 ESTs 1.677862 -0.74993 5.38 Down 2.64E-02 AW14012 ESTs, Weakly similar to 2 ALU4_HUMAN ALU

SEQUENCE
CONTAMINATION
WARNING ENTRY
(H.sapiens) 5.43052 3.00534 5.37 Down 3.45E-04 AU154455 lung type-I cell membrane-associated glycoprotein 2.056044 -0.36367 5.35 Down 2.80E-03 NM_0043 Homo sapiens cerebellin 1 52 precursor (CBLN1), mRNA. /PROD=cerebellin 1 precursor
323 /F L=g b: N M_004352.1 gb:M58583.1 2.332365 -0.08446 5.34 Down 3.73E-04 NM_0227 Homo sapiens 83 hypothetical protein FLJ12428(FLJ12428), mRNA.
/PROD=hypothetical protein FLJ12428 /F L=g b: N M_022783.1 gb:AL136678.1 0.261162 -2.15545 5.34 Down 3.31 E-03 AW02322 ESTs 5.441963 3.026487 5.33 Down 9.59E-04 NM_0166 Homo sapiens 51 heptacellular carcinoma novel gene-3 protein (LOC51339), mRNA.
/PROD=heptacellular carcinoma novel gene-3 protein /F L=g b: N M_016651.2 gb:AF251079.2 1.389794 -1.02563 5.33 Down 1.41 E-03 BG49869 ESTs 1.611395 -0.79534 5.3 Down 1.89E-02 A1633640 ESTs 2.816671 0.411432 5.3 Down 1.27E-03 AB002438 Homo sapiens mRNA
from chromosome 5g21-22, clone:FBR89.
3.12458 0.725853 5.27 Down 1.05E-03 AW02807 ESTs, Highly similar to S21424 nestin (H.sapiens) 2.904034 0.514711 5.24 Down 1.73E-02 NM_0175 Homo sapiens surfeit 2 03 (SURF2), mRNA.
/PROD=surfeit 2 /F L=g b: N M_017503.1 1.639038 -0.74617 5.22 Down 4.51 E-04 AW02787 ESTs, Weakly similar to 9 NBHUC8 decorin precursor (H.sapiens) 1.861339 -0.51278 5.18 Down 1.56E-03 NM_0038 Homo sapiens nuclear 22 receptor subfamily 5, group A, member 2 (NR5A2), mRNA.
/PROD=nuclear receptor subfamily 5, group A, member 2 /F L=g b: N M_003822.1 gb:AF146343.1 g b: U80251.1 7.224807 4.851007 5.18 Down 4.41 E-04 NM0059 Homo sapiens 51 metallothionein 1H
(MT1 H), mRNA.
/PROD=metallothionein 1 H /F L=g b: N M_005951.1 5.094773 2.721788 5.18 Down 2.50E-03 80001811 Homo sapiens, Similar to regulator for ribosome resistance homolog (S.
cerevisiae), clone MGC:2755, mRNA, complete cds.
/PROD=Similar to regulator for ribosome
324 resistancehomolog (S.
cerevisiae) /F L=g b: 60001811.1 5.332534 2.968398 5.15 Down 1.32E-03 AW18988 protocadherin 18 1.117304 -1.24345 5.14 Down 1.21 E-03 AL046992 G protein-coupled receptor 1 /F L=g b: N M_005279.1 7.426418 5.068036 5.13 Down 8.05E-04 NM_0059 Homo sapiens 52 metallothionein 1X
(MT1X), mRNA.
/PROD=metallothionein lx /FL=gb:NM_005952.1 3.508683 1.151949 5.12 Down 1.91 E-04 AK027231 Homo sapiens cDNA:
FLJ23578 fis, clone LNG 12709.
3.243916 0.897369 5.09 Down 1.91 E-04 NM 0216 Homo sapiens potassium 14 intermediatesmall conductance calcium-activated channel, subfamily N, member 2 (KCNN2), mRNA.
/PROD=potassium intermediatesmall conductancecalcium-activated channel, subfamily N, member 2 /F L=g b: N M_021614.1 gb:AF239613.1 3.396839 1.052549 5.08 Down 3.25E-04 BC043295 Homo sapiens, zinc finger protein 398, clone MGC:44469 IMAGE:5298104, mRNA, complete cds.
/PROD=zinc finger protein 398 /FL=gb:BC043295.1 2.750597 0.411007 5.06 Down 1.55E-02 NM 0069 Homo sapiens SRY (sex 42 determining region Y)-box 20 (SOX20), mRNA.
/PROD=SRY (sex determining region Y)-box 20 /FL=gb:NM_006942.1 g b: 60000985.1 gb:AB006867.1 1.709228 -0.63019 5.06 Down 1.50E-02 A1375083 ESTs 5.819522 3.484185 5.05 Down 4.28E-04 AK023446 Homo sapiens cDNA
FLJ13384 fis, clone PLACE1001062, highly similar to Homo sapiens mRNA for lysine-ketog l utarate red uctasesaccharopi ne dehydrogenase.
4.038177 1.706644 5.03 Down 6.66E-04 BF449053 ESTs 0.310919 -2.01457 5.01 Down 4.41 E-02 BG05479 ESTs 2.360697 0.036146 5.01 Down 2.65E-02 NM_0180 Homo sapiens 42 hypothetical protein FLJ10260(FLJ10260),
325 mRNA.
/PROD=hypothetical protein FLJ10260 /F L=g b: N M_018042.1 3.553409 1.229902 5.01 Down 7.70E-04 NM_0048 Homo sapiens phosphate 45 cytidylyltransferase 1, choline, beta isoform (PCYT1 B), mRNA.
/PROD=phosphate cytidylyltransferase 1, choline, betaisoform /FL=gb:AF052510.1 g b: N M_004845.1 6.93459 4.611479 5 Down 4.34E-04 AF078844 Homo sapiens hqp0376 protein mRNA, complete cds. /PROD=hgp0376 protein /F L=g b:AF078844.1
326 Table VII- Correlation coefficient between differentiated ES cells, EXPRES 01, EXPRES 02 and various time points during differentiation to DE

ES EXPRES EXPRES

EXPRES 02 0.882 EXPRES 01 0.906 0.912 2 hr DE 0.914 0.895 0.922 6 hr DE 0.904 0.887 0.915 24hr DE 0.912 0.898 0.924 30hr DE 0.91 0.902 0.926 48hr DE 0.906 0.913 0.921 72hr DE 0.896 0.918 0.91 96hr DE 0.895 0.919 0.912 days DE 0.883 0.925 0.904
327 Table VIII OD490 readings for EXPRES 01 and 02 cells cultured for 4 hrs in low 02 or atmospheric oxygen tension.

a) ...............................................................................
...............................................................................
................................................... .
Of 1 normal oxygen 1 2 3 4 5 6 7 8 9 10 11 12 e:.:ils1w&i ..................:...............:..............;...............:.............
...:.............................:..............:...............:..............
:...............:.................................
1.2163 :1.2607:1.2923:1.4392:1.3991 1.3549 0.8957::0.9162:0.8877:0.8854:0.9165::0.9030 & 'Wk, 0.8215 0.86650.8850:0.9298 0.9727 0.9451 0.7175 0.7140:0.8123:0.8161:0.7516:0.6362 40000 ...................:..............:...............:..............:.............
..>.............................:...............:..............:...............
:..............:..................................
0.5815 :0.6768: 0.8321: 0.8127: 0.8372 0.8159 0.5256: 0.4501 0.5246: 0.4877:
0.4900: 0.4308 2WOO,, 0.4118 0.4209:0.4460:0.45010.5507 0.4664 0.3158:0.33410.31810.33210.2936:0.2979 >0000 ...................:..............:...............:..............:.............
..:.............................:...............:..............:...............
:..............:..................................
0.3093 0.3326: 0.3262: 0.4011 0.3860 0.3997 0.2531 0.2498: 0.2458: 0.2458:
0.2518:0.2189 500 0 ...................:..............:...............:..............:.............
..>.............................:...............:..............:...............
:..............:..................................
0.2289 0.2428:0.2292:0.2390: 0.2239 0.2718 0.19430.1918:0.2006:0.1917:0.1877:0.1888 2:*:O
0.1912 0.2041: 0.2061: 0.2094: 0.2078 0.2089 0.1772:0.1779:0.1731:0.1714:
0.1818:0.1758 0.1529 0.1625:0.1637:0.1630: 0.1618 0.1628 01622:0.15990.16960.16300.16160.1644 0 Plate 2 low oxygen 1 2 3 4 5 6 7 8 9 10 11 12 ce~
<;:::al .
1.2492 1.2799:1 2998: 1.3045: 1.2598 1.2682 0.8743:0 8889 0.9029: 0.9095 0.8978:0.9006 8; 0 ..................:...............:...............:..............:.............
................................:..............:...............:..............:
..............................................
0.9462 0.9493: 1.1588: 1.1644: 1.1837 1.1095 0.7572:0.7734:0.8213:0.7843:0.8631 :0.6452 ,;`,.000 ...................:..............:...............:..............:.............
..:.............................:...............:..............:...............
:..............:..................................
0.6420 0.7420:0.8089:0.7952 0.8037 0.7863 0.5278:0.5314:0.5436:0.5488:0.56880.4330 2000,0 0.4250 0.5385: 0.5513: 0.5684: 0.5520 0.5080 0.3608:0.3573: 0.3359: 0.3490:
0.3546:0.2779 .`. ,W:
..................................:...............:..............:.............
................................:..............................:...............
...............:.................................
0.3191 0.3280: 0.3714: 0.3683:: 0.3815 0.3576 0.2547: 0.2437: 0.2503: 0.2415:
0.2436::0.2172 5011-110, ...................:..............................:...............:............
................................................:..............................
:...............:.................................
0.2240 0.2465: 0.2487: 0.2642: 0.2631 0.2575 0.2016: 0.2036: 0.1984: 0.1952:
0.1979:0.1805 20.1919 0.2040: 0.1977: 0.2054: 0.2015 0.2126 0.1827: 0.1819: 0.1787: 0.1794:
0.1802:0.1651 1250:
0.1029 0.1007: 0.1056: 0.1048:: 0.1043 0.1030 0.1662 ; 0.1673: 0.1661 0.1633:
0.1655:0.1623 ix;: re 01 ix;: e&02 b) c) av OD plate 1 av OD plate 2 ...................................` .........: ..................
.................
Ex :re`O i : Ex ,re s,02 xpre.`-.s :Ex r 3 1.327 0.901:: 1.277: 0.896' ..............................................
..............................................:
0.903: 0.741: 1.085: 0.774:
0.759: 0.485: 0.763: 0.526 ......................:.......................: .......................
:....................... :
0.458: 0.315: 0.524: 0.339:
0.359: 0.244: 0.354: 0.242:
..............................................
...............................................:
0.239: 0.192: 0.251: 0.196 0.205 0 176: 0.202:: 0.178:
.......................:.......................: .......................
:....................... :
0.161: 0.163: 0.104: 0.165
328 d) e) f) %CV within plate 1 %CV within platen %CV between plates ...............................................
...............................................
................................................
: xp,es \p. =~`O2 :n;\,p:'e:2{'i \;\p.e..: Ex ies-: I :_\.. u1 a.
6.4 1.5 1.7 1.4 5.0 1.4 ....................... .......................
................................................ .. ....
6.2 9.2 10.1 9.5 12.7 9.2 13.9 7.9 8.4 9.1...... 10.9 9.2.......
10.9.......: 5.3 10.0 9.2 12.2 8.3 11.4 5.2 7.1 5.4 9.1 5.1 7.3 2.4 6.0 4.2 6.8 3.4 3.3 2.1 3.5 3.6 3.3 2.9 2.5 2.1 1.7 1.2 22.8 1.7
329 Table IX Expression of cytokines, growth factors, and receptors as measured by protein arrays a) Sample #1 Sample #2 Sample #1 Sample #2 POS 54,220 54,220 54,220 54,220 Angiogenin 1,049 957 2,098 1,494 CK beta 8-1 0 0 0 0 Eotaxin 0 43 0 30 Eotaxin-2 0 0 36 44 Eotaxin-3 0 0 0 0 Flt-3 Ligand 74 39 33 6 Fractalkine 468 376 457 341 IFN-gamma 792 830 702 841 IGFBP-2 1,262 1,408 846 867 IGF-I 1,437 1,368 1,880 1,597 IL-lalpha 1,274 1,022 1,053 1,055 IL-1 beta 219 53 0 0 IL-1ra 66 103 0 0 IL-7 1,214 1,013 1,005 1,074 Leptin 0 0 0 0 MCP-1 1,611 1,632 6,146 4,338
330 MIP-1-delta 107 236 145 281 MIP-3-alpha 386 518 472 495 PDGF-BB 2,623 1,755 467 583 TGF-beta 1 716 788 806 840 TGF-beta 3 73 111 0 16 TNF-alpha 748 825 760 908 TNF-beta 269 316 247 307 b) Sample #1 Sample #2 Sample #1 Sample #2 POS 43,203.88 39,506.01 36,640.81 42,748.84 NEG 0.00 0.00 0.00 0.00 Activin A 1,044.38 797.16 429.05 408.73 ALCAM 926.38 812.41 1,132.59 1,111.92 B7-1(CD80) 164.38 193.08 183.69 149.23 BMP-5 62.38 39.17 65.41 67.20 BMP-7 203.88 165.35 203.92 235.90 Cardiotrophin-1 420.38 390.43 330.99 529.97 CD14 551.38 581.78 449.28 504.69 CXCL- 16 144.38 126.52 114.65 144.58 DR6 (TNFRSF21) 317.88 278.12 254.92 294.20 Endoglin 769.88 610.44 824.79 738.91 ErbB3 453.88 383.50 352.10 276.14 E-Selectin 175.88 145.47 158.63 204.43 Fas Ligand 325.38 272.11 290.98 421.63 ICAM-2 165.88 105.73 97.51 244.15 IGF-11 8,897.88 9,437.80 8,026.40 5,317.62 IL-1 R II 92.38 2.66 28.91 131.69 IL-10 Rbeta 156.88 65.05 65.41 242.09 IL-13 Ralpha2 362.88 140.39 82.12 312.77 IL-18 BPalpha 334.88 267.49 415.86 535.13 IL-18 Rbeta 161.38 97.87 152.47 127.04 IL-2 Ralpha 0.88 0.00 30.23 0.00 IL-2 Rbeta 0.00 2.20 19.24 0.00 IL-2 Rgamma 0.00 0.00 0.00 0.00 IL-21 R 452.38 433.42 399.15 458.26 IL-5 Ralpha 446.88 302.62 397.83 297.81 IL-9 340.38 342.83 454.55 325.67 IP-10 364.88 310.01 295.82 382.42 LAP 1,194.38 1,087.42 3,883.43 4,764.05 Leptin R 272.38 200.47 179.29 286.46 LIF 326.38 89.09 74.64 180.18 L-Selectin 83.38 55.35 29.79 97.12 M -C S F R 60.38 0.00 21.00 0.00 MMP-1 12.88 36.86 23.63 62.55 MMP-13 158.38 25.30 54.85 144.58 MMP-9 504.38 450.98 282.19 257.05
331 MPIF-1 0.00 16.99 50.46 30.57 N G F R 30.38 43.79 29.35 6.84 PDGF AA 442.38 454.68 436.52 356.62 PDGF-AB 507.38 459.76 124.33 187.40 PDGF Ralpha 278.88 228.21 254.92 207.01 PDGF Rbeta 483.38 379.34 413.66 465.48 P E CAM-1 199.38 148.25 157.75 181.21 Prolactin 312.88 218.04 184.13 182.25 SCF R 472.88 353.92 454.11 483.02 SD F-1 beta 1,047.88 765.73 382.44 469.09 Siglec-5 0.00 0.00 0.00 0.00 TGF-alpha 113.88 123.29 50.90 55.33 TGF beta2 68.38 50.73 14.84 53.27 Tie-1 291.38 218.96 165.22 198.24 Tie-2 57.88 53.50 119.49 94.02 T I M P -4 166.88 143.16 109.38 180.70 VE-Cadherin 432.38 329.89 1,175.24 208.04 VEGF R2 510.88 367.33 437.40 801.34 VEGF R3 41.38 38.25 20.12 0.00 Internal Control 23,824.38 23,824.38 23,824.38 23,824.38 c) Sample #1 Sample #2 Sample #1 Sample #2 POS 55,531.00 63,702.50 55,954.13 76,525.06 NEG 0.00 0.00 0.00 0.00 Ac rp 30 140.00 100.45 119.63 179.61 AgRP 221.50 239.23 261.80 443.17 Angiopoietin-2 0.00 0.00 58.85 104.61 Amphiregulin 0.00 0.00 0.00 0.00 AXI 210.00 351.20 368.94 523.07 bFGF 64,959.00 75,788.69 57,182.11 65,024.38 b-N G F 0.00 0.00 0.00 0.00 BTC 0.00 0.00 0.00 0.00 CCL-28 455.50 399.01 258.71 415.13 CTACK 57.00 48.55 70.18 12.09 Dtk 0.00 0.00 0.00 0.00 EGF-R 83.50 92.28 30.52 33.82 ENA-78 726.00 842.78 781.52 939.43 Fas/TNFRSF6 374.00 460.83 352.97 450.17 FGF-4 232.50 130.77 110.36 218.17 FGF-9 271.00 520.31 295.28 460.69 GCSF 688.00 895.85 223.68 973.77 GITR-Ligand 0.00 0.00 0.00 0.00 GITR 242.00 109.19 140.75 167.00 GRO 1,380.00 1,572.29 929.87 1,270.97 GRO-alpha 962.00 1,043.39 920.08 1,080.31 HCC-4 162.50 108.03 194.83 217.46 HG F 0.00 0.00 0.00 0.00 ICAM-1 752.00 848.62 571.88 614.89 ICAM-3 0.00 0.00 0.00 0.00 IGFBP-3 169.00 439.25 190.20 372.37 IGFBP-6 314.50 285.89 245.31 368.17 IGF-I SR 236.00 314.46 133.54 237.09 IL-1 R4/ST2 226.00 354.11 283.43 373.77
332 IL-1 RI 0.00 32.80 0.00 92.70 IL-11 187.50 178.59 135.60 299.47 IL-12 p40 174.00 130.19 91.82 227.28 IL-12 p70 163.00 198.41 140.23 245.50 IL-17 120.00 114.44 72.24 164.89 IL-2 Rapha 434.50 488.24 422.50 553.21 IL-6 R 163.00 114.44 327.73 144.57 IL-8 741.00 782.72 694.47 1,053.68 1-TAC 721.50 763.48 551.28 754.38 Lymphotactin 177.00 68.37 93.88 135.46 MIF 2,703.00 2,577.05 2,491.12 3,008.58 MIP-lalpha 251.00 257.89 236.56 341.53 MIP-l beta 15.50 0.00 14.55 56.95 MIP-3beta 242.50 233.99 184.02 279.15 MSP-alpha 376.50 303.38 250.98 408.12 NT-4 37.00 101.03 108.81 253.21 Osteoprotegerin 380.50 390.27 432.29 696.90 Oncostatin M 466.50 394.35 361.21 504.15 PIGF 180.50 198.41 195.86 220.27 sgp130 18.00 36.30 203.08 209.05 sTNF RII 0.00 0.00 0.00 0.00 sTNF-RI 11.50 0.00 694.47 267.93 TECK 0.00 0.00 0.00 0.00 T I M P -1 175.00 123.19 172.17 223.77 TIMP-2 1,718.50 2,953.76 487.41 502.74 Thrombopoietin 256.50 231.65 227.80 256.02 TRAIL R3 0.00 0.00 127.36 94.10 TRAIL R4 239.00 273.64 277.25 370.27 uPAR 104.50 84.12 103.66 319.10 VEGF 311.00 289.97 305.06 523.77 VEGF-D 0.00 0.00 0.00 0.00 Internal Control 18,664.17 18,664.17 18,664.17 18,664.17
333

Claims (83)

What is claimed is:
1. A method for deriving a population of cells comprising cells expressing pluripotency markers comprising the steps of:

a. Obtaining cells, and b. Culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
2. The method of claim 1, wherein the cells are human embryonic stem cells.
3. The method of claim 2, wherein the human embryonic stem cells are treated with a Rho kinase inhibitor.
4. The method of claim 1, wherein the cells are cells expressing markers characteristic of the definitive endoderm lineage.
5. The method of claim 1, wherein the human embryonic stem cells are cultured in normoxic conditions prior to culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
6. The method of claim 1, wherein the human embryonic stem cells are cultured in hypoxic conditions prior to culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
7. The method of claim 1, wherein the cells expressing markers characteristic of the definitive endoderm lineage are cultured in normoxic conditions prior to culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
8. The method of claim 1, wherein the cells expressing markers characteristic of the definitive endoderm lineage are cultured in hypoxic conditions prior to culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
9. The method of claim 1, wherein the hypoxic conditions are an O2 level from about 1% to about 20%.
10. The method of claim 1, wherein the hypoxic conditions are an O2 level from about 2% to about 10%.
11. The method of claim 1, wherein the hypoxic conditions are an O2 level of about 3%.
12. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration from about 2% to about 5%.
13. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration of about 2%.
14. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration from about 50ng/ml to about 100ng/ml.
15. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration of about 100ng/ml.
16. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration from about 10ng/ml to about 20ng/ml.
17. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration of about 200ng/ml.
18. The method of claim 16, wherein the Wnt ligand is Wnt-3a.
19. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing IGF-1 at a concentration from about 25ng/ml to about 50ng/ml.
20. The method of claim 1, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing IGF-1 at a concentration of about 50ng/ml.
21. The method of claim 1,wherein the cells expressing pluripotency markers express at least one of the pluripotency markers selected from the group consisting of ABCG2, cripto, FoxD3, Connexin43, Connexin45, Oct4, SOX-2, Nanog, hTERT, UTF-1, ZFP42, SSEA-3, SSEA-4, Tral-60, and Tral-81.
22. The method of claim 1, wherein the cells expressing pluripotency markers express markers characteristic of pre-primitive streak cells.
23. The method of claim 1, wherein the cells expressing pluripotency markers express markers characteristic of primitive streak cells.
24. The method of claim 1, wherein the cells expressing pluripotency markers express markers characteristic of mesoendoderm cells.
25. The method of claim 1, wherein the cells expressing pluripotency markers express markers characteristic of definite endoderm cells.
26. A method for deriving a population of cells comprising cells expressing pluripotency markers, comprising the steps of:

a. Culturing human embryonic stem cells, b. Differentiating the human embryonic stem cells into cells expressing markers characteristic of definitive endoderm cells, and c. Removing the cells, and subsequently culturing them under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
27. The method of claim 26, wherein the human embryonic stem cells are treated with a Rho kinase inhibitor.
28. The method of claim 26, wherein the human embryonic stem cells are cultured on an extracellular matrix, prior to differentiating the cells.
29. The method of claim 26, wherein the human embryonic stem cells are cultured on a feeder cell layer, prior to differentiating the cells.
30. The method of claim 26, wherein the human embryonic stem cells are differentiated on an extracellular matrix, prior to removing the cells.
31. The method of claim 26, wherein the human embryonic stem cells are differentiated on a feeder cell layer, prior to removing the cells.
32. The method of claim 26, wherein the human embryonic stem cells are cultured and differentiated in normoxic conditions, prior to removing the cells.
33. The method of claim 26, wherein the human embryonic stem cells are cultured and differentiated in hypoxic conditions, prior to removing the cells.
34. The method of claim 26, wherein the hypoxic conditions are an O2 level from about 1% to about 20%.
35. The method of claim 26, wherein the hypoxic conditions are an O2 level from about 2% to about 10%.
36. The method of claim 26, wherein the hypoxic conditions are an O2 level of about 3%.
37. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration from about 2% to about 5%.
38. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration of about 2%.
39. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration from about 50ng/ml to about 100ng/ml.
40. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration of about 100ng/ml.
41. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration from about 10ng/ml to about 20ng/ml.
42. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration of about 200ng/ml.
43. The method of claim 42, wherein the Wnt ligand is Wnt-3a.
44. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing IGF-1 at a concentration from about 25ng/ml to about 50ng/ml.
45. The method of claim 26, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing IGF-1 at a concentration of about 50ng/ml.
46. The method of claim 26,wherein the cells expressing pluripotency markers express at least one of the pluripotency markers selected from the group consisting of ABCG2, cripto, FoxD3, Connexin43, Connexin45, Oct4, SOX-2, Nanog, hTERT, UTF-1, ZFP42, SSEA-3, SSEA-4, Tral-60, and Tral-81.
47. The method of claim 26, wherein the cells expressing pluripotency markers express markers characteristic of pre-primitive streak cells.
48. The method of claim 26, wherein the cells expressing pluripotency markers express markers characteristic of primitive streak cells.
49. The method of claim 26, wherein the cells expressing pluripotency markers express markers characteristic of mesoendoderm cells.
50. The method of claim 26, wherein the cells expressing pluripotency markers express markers characteristic of definite endoderm cells.
51. A method for deriving a population of cells comprising cells expressing pluripotency markers comprising the steps of:

a. Culturing human embryonic stem cells, and b. Removing the cells, and subsequently culturing them under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix prior to culturing the cells.
52. The method of claim 51, wherein the human embryonic stem cells are treated with a Rho kinase inhibitor.
53. The method of claim 51, wherein the human embryonic stem cells are cultured on an extracellular matrix, prior to removing the cells.
54. The method of claim 51, wherein the human embryonic stem cells are cultured on a feeder cell layer, prior to removing the cells.
55. The method of claim 51, wherein the human embryonic stem cells are cultured in normoxic conditions, prior to removing the cells.
56. The method of claim 51, wherein the human embryonic stem cells are cultured a in hypoxic conditions, prior to removing the cells.
57. The method of claim 51, wherein the hypoxic conditions are an O2 level from about 1% to about 20%.
58. The method of claim 51, wherein the hypoxic conditions are an O2 level from about 2% to about 10%.
59. The method of claim 51, wherein the hypoxic conditions are an O2 level of about 3%.
60. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration from about 2% to about 5%.
61. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration of about 2%.
62. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration from about 50ng/ml to about 100ng/ml.
63. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration of about 100ng/ml.
64. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration from about 10ng/ml to about 20ng/ml.
65. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration of about 200ng/ml.
66. The method of claim 65, wherein the Wnt ligand is Wnt-3a.
67. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing IGF-1 at a concentration from about 25ng/ml to about 50ng/ml.
68. The method of claim 51, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing IGF-1 at a concentration of about 50ng/ml.
69. The method of claim 51,wherein the cells expressing pluripotency markers express at least one of the pluripotency markers selected from the group consisting of ABCG2, cripto, FoxD3, Connexin43, Connexin45, Oct4, SOX-2, Nanog, hTERT, UTF-1, ZFP42, SSEA-3, SSEA-4, Tral-60, and Tral-81.
70. The method of claim 51, wherein the cells expressing pluripotency markers express markers characteristic of pre-primitive streak cells.
71. The method of claim 51, wherein the cells expressing pluripotency markers express markers characteristic of primitive streak cells.
72. The method of claim 51, wherein the cells expressing pluripotency markers express markers characteristic of mesoendoderm cells.
73. The method of claim 51, wherein the cells expressing pluripotency markers express markers characteristic of definite endoderm cells.
74. A method to expand cells expressing markers characteristic of the definitive endoderm lineage, comprising the steps of: culturing the cells under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix.
75. The method of claim 74, wherein the cells expressing markers characteristic of the definitive endoderm lineage are derived from pluripotent cells formed by the methods of the present invention.
76. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration from about 0.2% to about 5%.
77. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing serum at a concentration of about 0.5%.
78. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration from about 50ng/ml to about 100ng/ml.
79. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing activin-A at a concentration of about 100ng/ml.
80. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration from about 10ng/ml to about 20ng/ml.
81. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a Wnt ligand at a concentration of about 200ng/ml.
82. The method of claim 80, wherein the Wnt ligand is Wnt-3a.
83. The method of claim 74, wherein the cells are cultured under hypoxic conditions, on a tissue culture substrate that is not pre-treated with a protein or an extracellular matrix, in medium containing a GSK-3B inhibitor.
CA2722619A 2008-04-24 2009-04-22 Pluripotent cells Active CA2722619C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2948488A CA2948488A1 (en) 2008-04-24 2009-04-22 Expansion of definitive endoderm lineage cells

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/108,872 US7939322B2 (en) 2008-04-24 2008-04-24 Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
US12/108,872 2008-04-24
PCT/US2009/041348 WO2009132063A2 (en) 2008-04-24 2009-04-22 Pluripotent cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2948488A Division CA2948488A1 (en) 2008-04-24 2009-04-22 Expansion of definitive endoderm lineage cells

Publications (2)

Publication Number Publication Date
CA2722619A1 true CA2722619A1 (en) 2009-10-29
CA2722619C CA2722619C (en) 2016-12-20

Family

ID=41129142

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2722619A Active CA2722619C (en) 2008-04-24 2009-04-22 Pluripotent cells
CA2948488A Abandoned CA2948488A1 (en) 2008-04-24 2009-04-22 Expansion of definitive endoderm lineage cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2948488A Abandoned CA2948488A1 (en) 2008-04-24 2009-04-22 Expansion of definitive endoderm lineage cells

Country Status (14)

Country Link
US (2) US7939322B2 (en)
EP (3) EP3327114B1 (en)
JP (1) JP5763524B2 (en)
KR (3) KR101832902B1 (en)
CN (1) CN102083965B (en)
AU (1) AU2009239442B2 (en)
BR (1) BRPI0911599A2 (en)
CA (2) CA2722619C (en)
ES (2) ES2663421T3 (en)
MX (1) MX2010011739A (en)
PL (2) PL2669366T3 (en)
RU (1) RU2553538C2 (en)
WO (1) WO2009132063A2 (en)
ZA (1) ZA201008391B (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090203141A1 (en) * 2003-05-15 2009-08-13 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant RNA agents
US8017395B2 (en) 2004-12-17 2011-09-13 Lifescan, Inc. Seeding cells on porous supports
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
DK2185693T3 (en) 2007-07-31 2019-09-23 Lifescan Inc DIFFERENTIZING HUMAN EMBRYONIC STEM CELLS
CN107574142B (en) 2007-11-27 2021-07-06 生命扫描有限公司 Differentiation of human embryonic stem cells
CA2715878C (en) 2008-02-21 2017-06-13 Centocor Ortho Biotech Inc. Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
KR20180018839A (en) 2008-06-30 2018-02-21 얀센 바이오테크 인코포레이티드 Differentiation of pluripotent stem cells
US9234178B2 (en) 2008-10-31 2016-01-12 Janssen Biotech, Inc. Differentiation of human pluripotent stem cells
JP2012507289A (en) 2008-10-31 2012-03-29 ヤンセン バイオテツク，インコーポレーテツド Differentiation of human embryonic stem cells into the pancreatic endocrine system
EP2366022B1 (en) 2008-11-20 2016-04-27 Janssen Biotech, Inc. Methods and compositions for cell attachment and cultivation on planar substrates
MX356756B (en) 2008-11-20 2018-06-11 Centocor Ortho Biotech Inc Pluripotent stem cell culture on micro-carriers.
JP6219568B2 (en) 2009-07-20 2017-10-25 ヤンセン バイオテツク，インコーポレーテツド Differentiation of human embryonic stem cells
RU2664864C1 (en) * 2009-12-23 2018-08-23 Янссен Байотек, Инк. Ways to increase expression of ngn3 and nkx6.1 in pancreatic endocrine cells
MX343786B (en) 2009-12-23 2016-11-22 Janssen Biotech Inc Differentiation of human embryonic stem cells.
JP6013196B2 (en) 2010-03-01 2016-10-25 ヤンセン バイオテツク，インコーポレーテツド Method for purifying cells derived from pluripotent stem cells
RU2587634C2 (en) 2010-05-12 2016-06-20 Янссен Байотек, Инк. Differentiation of human embryo stem cells
ES2585028T3 (en) 2010-08-31 2016-10-03 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
ES2659393T3 (en) 2010-08-31 2018-03-15 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
KR101851956B1 (en) 2010-08-31 2018-04-25 얀센 바이오테크 인코포레이티드 Differentiation of human embryonic stem cells
CN108220224A (en) 2011-06-21 2018-06-29 诺沃—诺迪斯克有限公司 Definitive entoderm is effectively induced from pluripotent stem cell
RU2705001C2 (en) 2011-12-22 2019-11-01 Янссен Байотек, Инк. Differentiation of human embryonic stem cells into single-hormonal insulin-positive cells
US8998793B2 (en) * 2012-02-14 2015-04-07 Washington State University Feeder-free method for culture of bovine and porcine spermatogonial stem cells
WO2013131012A1 (en) * 2012-03-01 2013-09-06 University Of Miami Isolation and use of pluripotent stem cell population from adult neural crest-derived tissues
CA2866590A1 (en) 2012-03-07 2013-09-12 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
WO2013151186A1 (en) * 2012-04-06 2013-10-10 国立大学法人京都大学 Method for inducing erythropoietin-producing cell
AU2013259706A1 (en) * 2012-05-07 2014-10-30 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endoderm
JP6469003B2 (en) 2012-06-08 2019-02-13 ヤンセン バイオテツク，インコーポレーテツド Differentiation of human embryonic stem cells into pancreatic endocrine cells
JP2015519085A (en) * 2012-06-14 2015-07-09 ヤンセン バイオテツク，インコーポレーテツド Treatment of pluripotent cells
GB2504996A (en) * 2012-08-17 2014-02-19 Univ Keele Embryonic stem cell culture method
EP2893000B1 (en) 2012-09-03 2019-04-10 Novo Nordisk A/S Generation of pancreatic endoderm from pluripotent stem cells using small molecules
JP6557146B2 (en) 2012-12-31 2019-08-07 ヤンセン バイオテツク，インコーポレーテツド Culture of human embryonic stem cells at the air-liquid interface for differentiation from pluripotent stem cells to pancreatic endocrine cells
EP4039798A1 (en) 2012-12-31 2022-08-10 Janssen Biotech, Inc. Suspension and clustering of human pluripotent cells
EP2938723B1 (en) 2012-12-31 2023-02-01 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulators
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
JP6602288B2 (en) * 2013-04-03 2019-11-06 フジフィルム セルラー ダイナミクス，インコーポレイテッド Methods and compositions for culturing endoderm progenitor cells in suspension
GB201317869D0 (en) * 2013-10-09 2013-11-20 Cambridge Entpr Ltd In vitro production of foregut stem cells
CA2949056A1 (en) 2014-05-16 2015-11-19 Janssen Biotech, Inc. Use of small molecules to enhance mafa expression in pancreatic endocrine cells
PT3286300T (en) 2015-04-24 2020-12-28 Univ Copenhagen Isolation of bona fide pancreatic progenitor cells
MA45479A (en) 2016-04-14 2019-02-20 Janssen Biotech Inc DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN ENDODERMAL CELLS OF MIDDLE INTESTINE
NL2017670B1 (en) * 2016-10-25 2018-05-04 Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis Molecular indicators for predicting response to hormonal therapy in breast cancer
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US10391156B2 (en) 2017-07-12 2019-08-27 Viacyte, Inc. University donor cells and related methods
JP7125977B2 (en) * 2017-07-17 2022-08-25 ミルテニイ ビオテック ベー．ファー． ウント コー．カーゲー A method for single-cell protein expression profiling of floor plate midbrain dopaminergic progenitor cells
CA2983845C (en) 2017-10-26 2024-01-30 University Of Copenhagen Generation of glucose-responsive beta cells
US10724052B2 (en) 2018-09-07 2020-07-28 Crispr Therapeutics Ag Universal donor cells
US20220233299A1 (en) 2019-05-31 2022-07-28 W. L. Gore & Associates, Inc. Cell encapsulation devices with controlled oxygen diffusion distances
EP3975926A1 (en) 2019-05-31 2022-04-06 W.L. Gore & Associates, Inc. A biocompatible membrane composite
US20220234006A1 (en) 2019-05-31 2022-07-28 W. L. Gore & Associates, Inc. A biocompatible membrane composite
JP2022534545A (en) 2019-05-31 2022-08-01 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド biocompatible membrane composite
JP2022547505A (en) 2019-09-05 2022-11-14 クリスパー セラピューティクス アクチェンゲゼルシャフト universal donor cells
CA3150233A1 (en) 2019-09-05 2021-03-11 Alireza Rezania Universal donor cells
JP2024503291A (en) 2020-12-31 2024-01-25 クリスパー セラピューティクス アクチェンゲゼルシャフト universal donor cells

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583308A (en) * 1897-05-25 m miehle
US5834308A (en) 1994-04-28 1998-11-10 University Of Florida Research Foundation, Inc. In vitro growth of functional islets of Langerhans
US5843780A (en) * 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6800480B1 (en) * 1997-10-23 2004-10-05 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6610540B1 (en) 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
IL144359A0 (en) * 1999-01-21 2002-05-23 Vitro Diagnostics Inc Immortalized cell lines and methods of making the same
US20030082155A1 (en) * 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
JP2003517592A (en) * 1999-12-13 2003-05-27 ザ スクリプス リサーチ インスティチュート Markers for identification and isolation of islet α and β precursors
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US7005252B1 (en) * 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US6458589B1 (en) 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
CA2456981C (en) * 2001-08-06 2012-02-28 Bresagen, Inc. Alternative compositions and methods for the culture of stem cells
KR101008868B1 (en) * 2001-12-07 2011-01-17 제론 코포레이션 Islet cells from human embryonic stem cells
US20060003446A1 (en) 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
AU2003228255A1 (en) 2002-05-28 2003-12-19 Becton, Dickinson And Company Pancreatic acinar cells into insulin-producing cells
US6877147B2 (en) * 2002-07-22 2005-04-05 Broadcom Corporation Technique to assess timing delay by use of layout quality analyzer comparison
CA2494040A1 (en) 2002-07-29 2004-02-05 Es Cell International Pte Ltd. Multi-step method for the differentiation of insulin positive, glucose
US20060194315A1 (en) 2003-03-31 2006-08-31 Condie Brian G Compositions and methods for the control, differentiaton and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
ITRM20030395A1 (en) 2003-08-12 2005-02-13 Istituto Naz Per Le Malattie Infettive Lazz CULTURE GROUND FOR MAINTENANCE, PROLIFERATION AND DIFFERENTIATION OF MAMMALIAN CELLS.
US20050266554A1 (en) * 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
EP1709159B1 (en) * 2003-12-23 2019-05-15 Viacyte, Inc. Definitive endoderm
US20050233446A1 (en) * 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
EP1730261A4 (en) 2004-03-10 2007-11-28 Univ California Compositions and methods for growth of embryonic stem cells
KR101278421B1 (en) 2004-04-27 2013-07-15 비아싸이트, 인크. Pdx1 expressing endoderm
JP5687816B2 (en) 2004-07-09 2015-03-25 ヴィアサイト，インコーポレイテッド Methods for identifying factors for differentiating definitive endoderm
MX2007001772A (en) 2004-08-13 2007-07-11 Univ Georgia Res Found Compositions and methods for self-renewal and differentiation in human embryonic stem cells.
CN101188942B (en) 2005-03-04 2011-11-30 生命扫描有限公司 Adult pancreatic derived stromal cells
AU2006285467A1 (en) 2005-09-02 2007-03-08 Agency For Science, Technology And Research Method of deriving mesenchymal stem cells
US9422521B2 (en) 2005-09-12 2016-08-23 Es Cell International Pte Ltd. Differentiation of pluripotent stem cells with a kinase inhibitor or PGI2
WO2007082963A1 (en) 2006-01-18 2007-07-26 Fundación Instituto Valenciano De Infertilidad Human embryo stem-cell lines and methods for using same
SG10201405380QA (en) 2006-03-02 2014-10-30 Cythera Inc Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
GB2452186B (en) * 2006-05-02 2011-01-26 Wisconsin Alumni Res Found Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
US7964402B2 (en) 2006-05-25 2011-06-21 Sanford-Burnham Medical Research Institute Methods for culture and production of single cell populations of human embryonic stem cells
US20080003676A1 (en) 2006-06-26 2008-01-03 Millipore Corporation Growth of embryonic stem cells
CN101861386A (en) 2007-07-18 2010-10-13 生命扫描有限公司 The differentiation of human embryo stem cell
DK2185693T3 (en) * 2007-07-31 2019-09-23 Lifescan Inc DIFFERENTIZING HUMAN EMBRYONIC STEM CELLS
US8623648B2 (en) * 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells

Also Published As

Publication number Publication date
EP2669366A3 (en) 2014-03-05
EP2669366B1 (en) 2018-01-31
EP3327114A1 (en) 2018-05-30
US7939322B2 (en) 2011-05-10
CA2722619C (en) 2016-12-20
PL2283113T3 (en) 2017-09-29
EP2669366A2 (en) 2013-12-04
BRPI0911599A2 (en) 2020-08-18
ES2663421T3 (en) 2018-04-12
EP2283113B1 (en) 2017-05-17
RU2010147817A (en) 2012-05-27
KR20100134127A (en) 2010-12-22
KR101690773B1 (en) 2016-12-28
KR101832902B1 (en) 2018-02-27
ZA201008391B (en) 2014-04-30
CA2948488A1 (en) 2009-10-29
KR102057056B1 (en) 2019-12-18
AU2009239442A1 (en) 2009-10-29
CN102083965B (en) 2014-10-15
WO2009132063A2 (en) 2009-10-29
CN102083965A (en) 2011-06-01
MX2010011739A (en) 2010-11-22
EP3327114B1 (en) 2019-11-06
EP2283113A2 (en) 2011-02-16
KR20180021250A (en) 2018-02-28
AU2009239442B2 (en) 2015-06-11
ES2633455T3 (en) 2017-09-21
KR20160150656A (en) 2016-12-30
RU2553538C2 (en) 2015-06-20
USRE43876E1 (en) 2012-12-25
US20090269845A1 (en) 2009-10-29
WO2009132063A3 (en) 2010-03-18
JP5763524B2 (en) 2015-08-12
PL2669366T3 (en) 2018-06-29
JP2011518562A (en) 2011-06-30

Similar Documents

Publication Publication Date Title
CA2722619C (en) Pluripotent cells
US11708562B2 (en) Differentiation of human embryonic stem cells
US10456424B2 (en) Pancreatic endocrine cells and methods thereof
EP2562248B1 (en) Differentiation of human embryonic stem cells
EP2021462B1 (en) Differentiation of human embryonic stem cells
AU2014200166B2 (en) Differentiation of human embryonic stem cells

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140415